data_1nnv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nnv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.59 -178.42 5.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.27 143.94 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.08 149.77 93.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.01 -53.34 7.14 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.558 2.172 . . . . 0.0 112.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -33.44 70.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -65.47 -52.47 52.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.67 -48.02 83.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.87 -40.7 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.87 -55.37 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.73 -53.44 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.233 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.44 77.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.22 -49.2 70.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.776 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.86 -30.84 71.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.658 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 24' ' ' MET . 23.3 mt -72.63 -27.78 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 22.2 t80 -77.23 -27.91 53.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.32 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -34.1 38.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.534 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 13.1 pt-20 -92.08 -37.47 12.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.151 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.566 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.1 mtp -76.32 -50.57 13.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -45.59 96.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.484 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.05 -115.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 111.188 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.18 -25.74 67.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.483 ' CD1' ' CE3' ' A' ' 105' ' ' TRP . 4.2 tt -94.89 150.44 20.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.007 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.414 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.09 137.22 97.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.16 -64.8 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.622 2.215 . . . . 0.0 112.985 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.17 -43.37 21.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.15 -28.68 68.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mt -67.05 -47.16 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.278 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 1.3 tp -57.95 -60.75 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.411 ' CD1' ' NE2' ' A' ' 40' ' ' GLN . 12.5 tp -46.13 -44.37 15.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.516 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.456 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.7 t80 -64.22 -26.3 68.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.802 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.92 -38.02 33.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.399 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' CD2' ' HG ' ' A' ' 35' ' ' LEU . 3.3 mm? -83.68 -40.18 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.401 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.411 ' NE2' ' CD1' ' A' ' 36' ' ' LEU . 6.6 pt20 -121.75 106.24 11.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.22 0.533 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -163.9 -38.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.025 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -63.34 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.645 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -27.93 64.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.784 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.419 ' O ' HD13 ' A' ' 76' ' ' LEU . 33.6 mtt85 -120.88 59.1 0.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 110.502 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.73 134.6 12.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.564 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.03 123.82 2.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.21 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.35 68.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.414 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.42 129.56 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.532 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 13' ' ' ALA . 57.8 t80 -90.4 94.02 9.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -90.04 178.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -104.51 -178.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 35.7 m -73.22 165.72 24.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.93 13.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.032 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.96 -28.7 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.89 46.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.34 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 91' ' ' LEU . 4.1 m95 -92.14 -42.39 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.65 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.84 64.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -161.88 -48.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.451 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.87 -73.16 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 15.2 pt -61.57 -30.12 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 93.17 45.92 3.43 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.975 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 179.5 132.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.02 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.32 141.0 58.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -125.13 145.86 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.17 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 121.27 84.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.393 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 7.1 Cg_exo -69.9 162.37 42.4 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.114 1.876 . . . . 0.0 112.142 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.02 22.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -137.15 12.98 3.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.414 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -146.18 147.17 31.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 94' ' ' HIS . . . -89.7 112.6 23.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' OE1' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -95.62 120.0 35.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -119.7 134.42 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.096 0.474 . . . . 0.0 111.079 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 9.2 m0 -122.49 117.07 25.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.679 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 54.1 t -114.72 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.426 ' O ' HD12 ' A' ' 76' ' ' LEU . . . -131.55 -135.16 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.967 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -139.79 125.88 19.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.75 175.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 111.675 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -103.78 -164.18 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -3.06 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.464 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.0 -5.15 30.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.476 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.91 96.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.667 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -148.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 tpt -178.51 58.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.387 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.59 85.74 2.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.754 0.312 . . . . 0.0 110.964 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 p -89.88 135.59 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.797 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 9.1 m-85 -91.47 -49.72 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.025 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.459 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -148.32 139.1 22.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.593 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -112.44 132.45 55.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.631 0.253 . . . . 0.0 110.565 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.2 m-85 -110.19 145.78 36.67 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 92.8 mt -127.14 105.57 8.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.177 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.37 127.5 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.2 100.36 0.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.2 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 70' ' ' ALA . 41.5 m-70 -37.09 -57.16 0.87 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.286 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -44.2 162.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.151 0.5 . . . . 0.0 111.847 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.1 pt-20 -86.0 -48.67 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -65.88 133.53 51.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.86 116.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -113.74 93.42 4.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.94 103.37 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -120.33 110.92 17.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.7 p80 -128.69 117.19 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.4 . . . . 0.0 111.148 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 7.2 p -98.1 150.27 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.32 130.08 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 29' ' ' LEU . 63.8 m95 -112.11 130.01 56.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.245 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.09 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.983 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 94' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.039 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -89.57 174.61 7.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.043 0.449 . . . . 0.0 111.358 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 147.13 62.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.94 -54.28 5.55 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.595 2.197 . . . . 0.0 112.338 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -30.06 69.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.6 m -68.36 -51.76 40.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.06 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.0 48.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.803 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -47.38 -33.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.797 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.02 -37.05 72.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.79 -62.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.053 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.13 -40.81 61.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.51 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -53.5 -57.3 11.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -61.43 -28.77 69.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 24' ' ' MET . 77.8 mt -74.34 -25.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.857 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 37' ' ' PHE . 4.4 t80 -75.13 -51.89 12.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 110.47 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -65.71 -20.74 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.28 -46.89 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -80.15 -41.12 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -52.37 150.43 4.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.386 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.95 41.26 3.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.659 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -171.64 -29.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 33.1 t30 -115.94 -35.36 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.711 0.291 . . . . 0.0 111.003 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.588 HD22 ' O ' ' A' ' 30' ' ' ASP . 2.8 tt -68.06 133.97 49.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.588 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -54.06 146.28 30.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.04 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 85.7 Cg_exo -47.64 -52.73 7.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.902 2.401 . . . . 0.0 113.017 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.4 48.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 74.1 m-20 -54.47 -32.0 56.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 29' ' ' LEU . 91.2 mt -63.73 -47.79 89.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.054 0.455 . . . . 0.0 110.046 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -50.03 -57.48 7.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.617 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' GLN . 5.5 mp -63.28 -62.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -42.61 -30.03 0.33 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -82.19 -74.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.517 . . . . 0.0 111.771 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -69.32 -29.8 67.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.252 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' LEU . 1.6 tp-100 -90.98 25.3 2.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.829 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.1 t80 -102.83 -47.6 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -55.74 -42.47 75.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -39.02 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 3.1 mmt85 -130.39 80.89 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.32 107.38 0.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 146.66 17.48 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.127 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.75 110.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.669 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.38 150.51 20.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -103.17 106.34 16.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -178.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.09 172.55 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -65.38 164.71 13.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.11 162.46 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -98.45 36.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.12 33.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.422 ' CE3' HG12 ' A' ' 60' ' ' ILE . 1.9 m95 -80.36 -20.57 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.348 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.86 61.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 -47.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HG2' ' CE3' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -84.72 -64.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG12 ' CE3' ' A' ' 56' ' ' TRP . 14.0 pt -74.99 -27.59 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 70.76 79.22 0.38 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.792 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 6.9 p 164.53 139.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.671 0.272 . . . . 0.0 110.52 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -58.93 138.08 57.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.907 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 69' ' ' TYR . 26.9 mm -133.66 100.43 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.745 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.77 108.1 1.2 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.141 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.03 158.81 23.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.144 1.896 . . . . 0.0 112.366 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 76.03 -10.53 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.373 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.422 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -118.54 16.27 13.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.709 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CD2' ' CG2' ' A' ' 64' ' ' ILE . 84.8 m-85 -138.79 132.25 30.33 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.75 112.55 24.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -90.1 128.35 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.77 136.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.304 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 13.6 m0 -119.18 139.87 51.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.728 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG12 ' CZ ' ' A' ' 37' ' ' PHE . 13.4 t -129.37 110.58 20.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.37 -155.34 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.757 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.17 50.47 1.09 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.724 0.297 . . . . 0.0 111.367 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 76' ' ' LEU . 23.7 m -43.23 171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.204 0.526 . . . . 0.0 111.892 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -120.86 -165.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.96 -28.25 69.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -75.76 -31.0 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.29 27.73 1.06 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.367 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.51 22.85 6.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.402 ' HG3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 30.11 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.217 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -27.97 36.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.976 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.88 11.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.38 124.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.435 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.481 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 3.5 m-85 -89.2 -26.75 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.343 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.31 151.75 17.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -132.65 141.04 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.5 m-85 -120.93 148.4 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.76 117.89 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.119 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -125.0 140.26 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.09 0.471 . . . . 0.0 111.857 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 p -69.49 122.08 18.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.777 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 36.8 m-70 -66.0 -32.22 73.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.287 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -55.74 177.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.71 -50.53 3.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.446 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -74.3 122.46 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.502 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.16 112.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -120.71 114.88 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.702 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.58 134.95 42.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -127.08 140.26 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.612 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.09 153.29 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.118 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 11.4 p -150.17 137.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.802 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -115.56 130.25 70.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.493 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 21.2 m95 -108.75 150.64 27.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.997 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -64.05 161.06 16.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -117.57 125.37 50.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.0 157.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.37 142.94 51.04 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.01 -57.28 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.529 2.153 . . . . 0.0 112.498 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -57.98 -41.54 83.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -52.94 -64.54 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.4 31.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.786 0.327 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -43.87 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -39.26 71.03 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.046 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.98 -66.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.848 0.356 . . . . 0.0 110.724 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.31 34.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -54.99 -50.84 68.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.21 -34.84 47.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.501 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.37 -69.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 30.1 t80 -41.43 -28.07 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.787 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -45.35 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.702 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.72 -27.04 14.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 mtp -77.0 -46.44 23.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.734 0.302 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -57.4 -174.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.389 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.81 32.02 61.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -157.84 -28.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.8 m120 -117.11 -19.85 9.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.37 161.68 13.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.23 133.14 94.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.689 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -41.7 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.734 2.289 . . . . 0.0 113.075 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.16 37.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -56.41 -32.14 64.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.303 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.56 -50.21 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.237 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -48.79 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.208 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.47 -56.0 27.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.0 t80 -51.58 -26.16 8.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.989 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.57 -63.99 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.4 -25.65 66.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.279 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -101.91 -146.16 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.733 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 t80 70.61 -58.2 0.56 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.778 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.71 -37.12 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.8 -42.76 7.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 mmt-85 -119.08 52.14 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.83 133.06 11.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.42 113.16 0.72 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 7.0 p -150.71 99.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -107.79 146.57 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.279 0.562 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -85.19 97.92 10.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.658 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.96 176.89 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.374 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.747 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.95 163.22 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.994 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.32 13.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.11 -14.34 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.98 44.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.088 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.455 ' CZ2' HD13 ' A' ' 91' ' ' LEU . 9.0 m95 -98.8 -29.8 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.915 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -68.27 61.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -162.63 -46.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.525 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -75.74 -78.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 pt -71.65 -28.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 74.28 81.53 0.44 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.485 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.67 146.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.31 113.29 8.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.441 ' CG2' ' CD2' ' A' ' 69' ' ' TYR . 31.4 mm -109.31 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.192 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 8.6 m-20 -55.56 106.29 0.65 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.25 157.12 36.73 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.108 1.872 . . . . 0.0 112.304 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 75.25 -9.24 1.42 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.348 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 1.8 pt-20 -120.13 19.83 12.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.574 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.441 ' CD2' ' CG2' ' A' ' 64' ' ' ILE . 75.5 m-85 -141.55 139.82 33.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -91.35 114.49 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.451 ' HG3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -96.67 129.39 44.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 6.0 p -135.21 130.42 51.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.547 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.557 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 14.4 m0 -114.54 135.62 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 t -127.63 111.14 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.986 0.422 . . . . 0.0 111.094 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.429 ' O ' HD11 ' A' ' 76' ' ' LEU . . . -145.12 -131.91 2.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.403 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -138.04 158.36 44.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.83 -177.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 111.306 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -118.53 -168.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.787 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -28.45 62.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.036 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.24 -14.56 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.439 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.51 72.6 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.43 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.82 148.82 41.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.28 105.78 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.26 -4.53 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.01 88.88 2.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 p -89.69 138.22 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.827 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -89.39 -48.94 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.9 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HB1' ' CZ3' ' A' ' 105' ' ' TRP . . . -138.65 166.11 25.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -146.34 135.75 22.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.8 m-85 -126.98 144.02 51.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.468 ' CD1' ' CE1' ' A' ' 102' ' ' HIS . 3.1 mt -131.67 124.02 29.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.24 142.85 42.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 112.273 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.8 p -65.09 120.29 12.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.936 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.477 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 89.2 m-70 -62.74 -24.7 67.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -54.06 174.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.67 -65.49 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -71.64 131.52 43.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.2 112.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.33 115.98 21.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.354 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.12 120.93 38.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.103 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -124.5 143.85 50.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.327 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.513 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.76 168.95 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.351 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 13.4 p -151.05 143.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.402 HD13 ' CZ3' ' A' ' 56' ' ' TRP . 3.9 mp -112.6 110.55 32.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.338 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 55.7 m95 -96.26 149.33 21.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 110.967 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.01 155.53 32.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.938 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.802 0.334 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -139.79 -178.42 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.007 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.91 139.4 47.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.82 149.31 95.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.538 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.41 -59.79 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.437 2.091 . . . . 0.0 112.415 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -24.87 65.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 16' ' ' ILE . 92.7 m -76.16 -43.34 43.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . . . -65.24 -29.37 70.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -79.83 -58.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -41.4 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.641 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -70.27 -43.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.079 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.32 89.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.015 0.436 . . . . 0.0 110.356 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.416 ' OH ' ' CE1' ' A' ' 41' ' ' PHE . 5.0 t80 -51.35 -46.82 62.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.297 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -61.72 -27.91 69.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.479 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.8 mt -75.12 -30.91 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.6 t80 -68.41 -51.28 45.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.14 -16.52 63.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.662 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 2.7 tp10 -94.13 -51.14 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.656 0.265 . . . . 0.0 111.511 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.4 mtp -74.61 -44.37 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.653 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -48.68 162.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.521 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.01 54.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.553 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -151.29 -33.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.62 0.248 . . . . 0.0 111.632 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.434 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.2 t30 -126.69 -39.18 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.723 0.297 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 34' ' ' ILE . 5.5 tt -55.56 139.23 44.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' O ' HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -57.26 136.71 81.12 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.755 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.44 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 76.8 Cg_exo -48.51 -51.92 9.41 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.0 113.297 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.59 -58.74 5.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.085 0.469 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -51.69 -29.95 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.841 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.531 HG13 HD21 ' A' ' 29' ' ' LEU . 57.5 mt -69.09 -47.79 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -45.18 -59.64 2.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.666 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 8.8 mt -56.91 -47.31 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.254 0.55 . . . . 0.0 110.241 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -48.25 -51.66 24.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.434 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -80.3 -40.79 26.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.847 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.581 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -72.73 -9.41 58.61 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.581 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 8.9 mm-40 -126.91 -137.52 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.939 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.563 ' CE1' ' HA2' ' A' ' 46' ' ' GLY . 2.6 t80 72.15 -56.09 0.65 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.796 0.332 . . . . 0.0 111.617 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -51.82 -39.64 59.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.14 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 27.44 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.89 -4.06 3.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.83 163.2 9.88 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.56 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.563 ' HA2' ' CE1' ' A' ' 41' ' ' PHE . . . -125.19 -115.02 2.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.792 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 74' ' ' VAL . 59.6 t -132.43 136.98 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.969 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -122.99 131.78 53.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 13' ' ' ALA . 17.3 t80 -88.74 113.0 23.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.094 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 71' ' ' GLU . 34.5 m -107.69 -176.88 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -98.38 170.61 8.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 111.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.3 m -70.06 157.28 37.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.95 -156.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.136 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.1 -42.14 11.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.45 129.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.736 ' O ' HG12 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -162.42 150.54 14.4 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.415 0.626 . . . . 0.0 110.304 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.04 32.48 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.219 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -113.64 -25.34 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.226 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.87 -54.57 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.622 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.466 ' CD1' HD12 ' A' ' 64' ' ' ILE . 1.2 pt -75.91 -44.82 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.789 0.328 . . . . 0.0 110.952 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 104.41 54.37 0.79 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.107 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.448 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 14.8 p 175.95 140.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 120.927 0.394 . . . . 0.0 111.467 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.86 138.62 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.736 HG12 ' O ' ' A' ' 56' ' ' TRP . 37.2 mm -111.26 128.35 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -104.55 112.11 65.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 30.6 Cg_endo -63.92 156.08 60.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.345 2.03 . . . . 0.0 112.043 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 4.1 pt-20 54.87 9.92 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.938 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -132.37 -5.33 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -126.12 143.56 51.08 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.798 0.332 . . . . 0.0 110.645 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -96.01 128.73 43.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -111.98 117.36 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.751 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.39 129.35 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.417 ' HE1' ' HE3' ' A' ' 89' ' ' LYS . 10.9 m0 -105.6 143.91 33.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.765 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 42.9 t -137.23 101.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.207 0.527 . . . . 0.0 110.934 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.65 -120.03 0.82 Allowed Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.359 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 1.9 mm? -142.31 146.8 35.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.86 178.35 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.357 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.28 -165.72 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -22.42 66.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -80.88 -81.13 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.54 -34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -56.04 132.42 50.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.033 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 36.2 ttm -88.99 79.35 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.105 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -6.55 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.88 83.21 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.301 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.69 126.96 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.074 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.2 m-85 -89.37 -32.49 17.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.227 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.34 148.98 15.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -113.44 141.72 46.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.4 m-85 -117.83 141.68 48.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.091 0.472 . . . . 0.0 111.596 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 102' ' ' HIS . 25.0 mt -125.2 156.17 38.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.605 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.411 HG13 ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -163.8 117.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.998 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.69 104.63 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.435 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 23.9 m-70 -51.9 109.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 0.0 111.244 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -166.25 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 18.7 pt-20 -138.02 -54.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.373 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -85.23 -0.23 53.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.418 0.628 . . . . 0.0 111.306 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -162.0 102.84 1.14 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -126.48 120.86 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -108.5 112.1 24.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -118.98 139.3 51.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.532 ' CE1' HD13 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -148.65 171.22 16.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.046 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.1 p -152.05 143.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.47 ' CG1' ' HD3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.62 142.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.378 177.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.451 ' CE3' ' CD1' ' A' ' 29' ' ' LEU . 65.6 m95 -113.31 149.09 34.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 159.71 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.784 0.326 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -140.21 -177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.11 144.94 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.9 148.2 71.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.92 -53.26 7.29 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.531 2.154 . . . . 0.0 112.354 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.83 -29.96 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -65.93 -56.3 12.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.62 81.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.4 mt -55.87 -42.98 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.01 -52.94 63.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.57 -59.74 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.03 -34.57 13.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.276 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -62.16 -54.08 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.68 -31.56 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' CG2' ' HG2' ' A' ' 24' ' ' MET . 55.6 mt -68.57 -71.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 41.3 t80 -40.62 -30.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.792 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.67 -39.13 58.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.852 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.51 -34.62 14.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.41 ' HG2' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -84.61 -35.95 22.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -62.59 129.99 43.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.24 44.69 0.47 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.629 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -176.04 -24.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -120.8 -35.1 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 30' ' ' ASP . 2.7 tt -64.47 139.6 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -44.32 139.21 3.39 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.994 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 4.1 Cg_endo -46.51 -52.51 7.3 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.961 2.441 . . . . 0.0 112.841 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.3 -57.44 10.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.97 -28.32 36.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 74.2 mt -65.79 -46.28 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.001 0.429 . . . . 0.0 110.009 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.47 -54.54 44.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.038 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.06 -59.85 4.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -47.3 -30.63 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.995 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.07 -45.23 18.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.816 0.341 . . . . 0.0 111.42 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 -79.1 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.999 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -80.95 84.52 6.41 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -133.31 -30.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.685 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.31 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.01 -39.51 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.483 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 5.5 mpt_? -72.56 -40.43 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.132 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.15 113.46 3.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.188 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.97 151.17 21.6 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -134.69 104.88 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 117.027 0.413 . . . . 0.0 110.961 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -94.38 147.42 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -97.01 134.26 40.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.45 177.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.915 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.32 148.45 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 111.133 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 88.4 m -45.55 165.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.06 -170.08 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.21 40.56 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -178.65 45.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.461 ' CZ3' HD11 ' A' ' 91' ' ' LEU . 2.5 m95 -72.01 -19.75 61.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.444 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.32 63.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.97 -57.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.16 -61.03 1.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 pt -86.15 -23.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.406 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.03 -54.74 3.65 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.092 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.11 153.75 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.861 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -76.29 135.9 39.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.408 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 64' ' ' ILE . 20.1 mm -130.98 116.6 34.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 111.626 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.23 122.44 87.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 29.1 Cg_endo -64.11 153.44 76.22 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.283 1.989 . . . . 0.0 112.257 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.71 3.84 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.654 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -111.2 -16.12 13.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.712 0.292 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.73 154.83 40.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.27 122.83 47.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.226 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' PHE . 9.6 pt-20 -114.6 144.59 43.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.08 0.467 . . . . 0.0 111.631 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.96 142.92 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 39.9 m0 -114.91 140.95 48.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.452 HG13 ' CE2' ' A' ' 21' ' ' PHE . 72.3 t -126.29 114.86 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 85' ' ' ASP . . . -150.65 -146.93 4.43 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.226 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 1.5 mm? -119.61 153.51 35.37 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -154.98 -168.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.857 0.36 . . . . 0.0 111.053 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -107.97 -156.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.486 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.86 -10.17 55.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.459 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -71.79 -8.75 56.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.577 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.58 78.09 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -148.37 -148.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.428 ' CA ' HG13 ' A' ' 77' ' ' VAL . 45.4 tpp -142.51 -82.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.021 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 44.12 41.01 3.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.401 ' O ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 169.31 78.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 p -90.04 134.94 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.804 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -92.73 -45.81 7.86 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.84 162.79 32.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.563 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -138.14 140.14 39.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.5 m-85 -120.93 154.25 36.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.461 HD11 ' CZ3' ' A' ' 56' ' ' TRP . 72.7 mt -139.97 121.16 14.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.646 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.6 125.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.029 0.442 . . . . 0.0 111.847 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 p -53.94 125.98 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.946 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -55.56 -41.46 73.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.146 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -56.66 143.85 34.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -32.61 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 154.14 42.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.678 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.31 -67.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.19 84.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.06 123.18 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.772 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -119.16 139.1 52.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.8 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.84 129.14 25.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.518 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.417 HG12 ' CZ2' ' A' ' 105' ' ' TRP . 11.4 p -122.48 140.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.581 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.429 HG13 ' HD3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -116.44 131.88 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 28.1 m95 -108.62 149.84 28.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.47 159.49 12.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.858 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.918 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.984 0.421 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -125.45 116.82 22.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.839 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.31 10.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.79 160.06 29.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -57.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.674 2.249 . . . . 0.0 112.171 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -31.19 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -64.81 -47.3 78.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.45 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -63.81 -50.66 68.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.4 mt -49.09 -36.58 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -38.18 72.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.722 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mt -67.35 -63.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.1 -39.8 21.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.417 ' CE2' HD21 ' A' ' 22' ' ' LEU . 30.8 t80 -55.7 -51.38 67.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.191 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -30.06 70.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 24' ' ' MET . 96.3 mt -64.27 -46.51 93.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -63.45 -52.16 62.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.447 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -59.19 -22.68 61.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.404 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 1.3 pp20? -103.94 -48.43 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 4.1 mtp -67.44 -57.41 6.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' ' CH2' ' A' ' 105' ' ' TRP . . . -45.94 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.026 0.441 . . . . 0.0 111.79 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -48.11 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.98 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -146.19 23.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.778 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 7.1 m-80 -102.89 -48.09 4.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -87.84 143.14 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.845 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.99 150.96 0.55 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.45 -19.45 13.4 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.595 2.197 . . . . 0.0 112.592 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.23 72.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.459 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -74.5 -28.65 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.419 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.17 -50.14 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.926 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -74.04 -42.91 59.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 1.4 tp -57.7 -64.46 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.4 . . . . 0.0 110.491 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 5.2 m-85 -45.41 -29.87 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.163 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.548 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -64.77 -9.63 21.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 20.7 pt20 -151.35 116.1 5.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 112.322 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' CA ' ' A' ' 45' ' ' GLY . 11.1 t80 -169.75 -38.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.938 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.48 -65.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -40.08 88.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.576 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -95.89 28.37 3.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.088 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 41' ' ' PHE . . . -94.9 120.84 6.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.606 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.34 98.22 0.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.303 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.18 97.27 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.65 137.43 35.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.822 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.45 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 75.2 t80 -92.2 116.39 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -168.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -135.3 153.7 51.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 22.4 m -56.14 162.33 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.076 0.465 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.409 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -105.45 -151.24 0.45 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.042 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.96 31.24 0.98 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.766 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 79.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -97.87 46.95 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.433 . . . . 0.0 111.195 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER -69.04 61.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.47 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -130.41 -39.22 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.45 -38.3 12.65 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 64' ' ' ILE . 4.7 pt -95.27 -26.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.049 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 90.73 -46.46 2.94 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.299 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG23 ' CE1' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -62.43 159.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.941 0.401 . . . . 0.0 111.764 -178.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 64' ' ' ILE . 4.3 mm? -78.27 135.24 37.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.627 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -112.76 90.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.372 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 1.2 m-20 -75.79 113.52 27.88 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.53 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 5.7 Cg_exo -41.36 -72.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.194 2.596 . . . . 0.0 114.524 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -74.61 8.87 2.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 65' ' ' ASP . 8.3 mt-10 -121.34 -14.44 8.29 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.623 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.4 145.0 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.122 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 91' ' ' LEU . . . -112.75 140.47 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.643 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -112.57 139.36 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.404 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.51 138.35 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.953 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -120.14 131.98 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.008 0.433 . . . . 0.0 111.162 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -121.83 113.01 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.512 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.39 -124.15 2.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.216 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -146.94 71.64 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.052 0.453 . . . . 0.0 109.857 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 82' ' ' GLU . 33.7 m -55.45 173.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 0.0 112.096 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -147.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.717 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 -5.44 16.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.8 34.65 5.12 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.664 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.31 87.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.742 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.42 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 3.3 mt-10 -156.43 155.98 33.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.881 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.2 tpp -142.63 104.1 4.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.285 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.77 -18.58 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.263 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.68 109.19 11.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.949 0.404 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.56 137.11 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -89.56 -33.6 16.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.724 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 172.93 17.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.437 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 6.6 mttm -130.57 147.37 52.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.2 m-85 -125.45 134.57 52.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 112.026 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 102' ' ' HIS . 15.0 mt -122.41 136.05 54.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.775 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 116.74 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.081 0.467 . . . . 0.0 111.835 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.7 m -46.99 149.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -89.78 23.06 2.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.558 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -92.73 165.52 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.81 -59.27 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.09 121.24 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.395 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.19 110.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.05 140.1 47.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.944 0.402 . . . . 0.0 111.228 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.9 141.85 36.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.36 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -138.15 142.03 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.511 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -144.24 130.67 19.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.211 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -119.94 140.53 43.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.84 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.31 135.2 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.784 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' A' ' 25' ' ' ALA . 38.5 m95 -106.93 147.49 29.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.62 155.92 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -93.45 -170.95 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.65 144.71 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 147.83 79.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.74 -49.52 16.96 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.565 2.177 . . . . 0.0 112.347 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -30.25 65.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -66.44 -49.76 65.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.14 90.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.4 mt -59.79 -34.43 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -44.09 76.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.0 mt -64.97 -54.78 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.55 73.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.21 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.48 -52.04 66.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.56 -32.04 71.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 24' ' ' MET . 19.4 mt -73.71 -28.75 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 32.5 t80 -77.26 -25.77 51.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.368 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.11 -32.63 50.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.254 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.01 -38.18 9.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.174 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -75.95 -50.11 15.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.63 0.252 . . . . 0.0 111.577 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -49.12 111.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.406 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.41 -96.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.852 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.95 -4.48 52.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.1 m120 -90.54 -31.45 16.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 30' ' ' ASP . 2.5 tt -92.66 139.27 30.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.65 132.9 13.94 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.976 -178.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 84.4 Cg_exo -42.07 -56.6 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.261 2.641 . . . . 0.0 113.627 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 -57.22 5.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 0.0 110.76 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.95 -27.13 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.978 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 51.3 mt -68.57 -53.48 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.129 0.49 . . . . 0.0 110.234 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -49.75 -60.38 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.181 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.409 ' CD1' ' NE2' ' A' ' 40' ' ' GLN . 4.5 mm? -51.05 -40.29 57.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.074 0.464 . . . . 0.0 110.664 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.5 t80 -64.97 -32.63 74.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.423 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.57 -39.12 28.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.18 -40.75 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.751 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.409 ' NE2' ' CD1' ' A' ' 36' ' ' LEU . 8.9 pt20 -128.98 106.38 8.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 111.811 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 34.6 t80 -165.02 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.232 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -31.75 72.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.281 0.563 . . . . 0.0 110.09 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.7 -22.65 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.113 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -130.36 31.99 4.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.997 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -120.09 114.14 2.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.773 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.94 165.94 22.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.115 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.3 t -146.0 122.43 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.764 0.282 . . . . 0.0 110.57 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.38 164.07 13.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.346 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.8 108.16 19.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.8 -178.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.39 -175.62 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -91.12 162.34 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -160.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.26 -45.48 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.8 127.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 59' ' ' GLU . 15.9 m0 -87.42 -75.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.533 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 1.5 mm-40 43.57 31.24 0.42 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -155.43 -37.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.865 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 24.1 mm-40 -82.12 -74.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.438 HD13 ' CE1' ' A' ' 102' ' ' HIS . 19.1 pt -82.13 -46.86 19.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.259 . . . . 0.0 111.67 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.67 69.32 0.31 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.6 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 13.0 p 175.57 151.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 57' ' ' GLU . 4.4 tt -64.91 -5.98 7.34 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 56' ' ' TRP . 6.9 mm 59.19 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.209 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -112.92 82.35 5.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.902 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -53.05 168.02 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.961 1.774 . . . . 0.0 111.837 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 56.25 12.47 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 27.7 mt-10 -135.15 -3.41 2.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.348 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 84.4 m-85 -132.11 142.26 49.45 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.06 34.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.888 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.34 119.91 38.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.66 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.8 137.03 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.109 0.48 . . . . 0.0 111.052 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.535 ' CD1' ' HB2' ' A' ' 89' ' ' LYS . 1.4 m0 -115.17 141.01 48.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.64 103.74 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.964 0.412 . . . . 0.0 111.356 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.44 20.56 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.703 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.458 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -102.32 153.16 20.27 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.11 -167.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.699 0.285 . . . . 0.0 110.778 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -103.62 -170.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -79.54 -13.35 59.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -74.26 -5.05 39.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.534 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.36 88.82 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.412 . . . . 0.0 111.017 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.46 -168.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -160.06 91.61 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.362 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -118.74 -9.93 10.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.137 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.74 84.75 2.26 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.958 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 73' ' ' TRP . 1.5 p -89.91 140.49 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -98.52 -29.7 12.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.43 ' CB ' ' CZ3' ' A' ' 105' ' ' TRP . . . -151.9 167.95 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 73' ' ' TRP . 17.1 ttpt -142.44 139.77 31.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.5 m-85 -122.73 145.89 48.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 102' ' ' HIS . 94.3 mt -124.52 119.35 28.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.188 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -130.08 122.35 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.819 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.411 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -55.95 118.46 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.498 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -56.39 -38.67 71.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -59.66 176.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -32.33 10.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.037 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -79.67 150.39 30.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.717 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 40.53 31.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.206 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.06 103.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.072 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -117.83 137.26 52.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.067 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 12.3 p90 -134.81 137.94 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -139.17 159.49 42.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.439 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 7.3 p -151.02 142.71 16.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.457 HD12 ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.52 140.95 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.066 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 32.9 m95 -116.99 149.88 39.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 158.63 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.883 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -112.93 127.15 56.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.46 142.54 57.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.465 ' O ' HD21 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -46.28 169.6 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.706 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.79 -59.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.95 2.433 . . . . 0.0 112.287 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.19 -28.53 68.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -57.18 -57.49 12.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.1 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.44 HG13 ' CD2' ' A' ' 49' ' ' PHE . 53.0 mt -45.04 -36.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.999 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.13 -39.89 75.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.557 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mm -61.87 -64.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.808 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' A' ' 72' ' ' VAL . . . -47.96 -41.42 24.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -51.52 -54.82 23.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.206 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -25.76 67.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.357 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' MET . 70.1 mt -75.95 -23.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.427 ' CD2' HG11 ' A' ' 74' ' ' VAL . 33.0 t80 -80.02 -32.49 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.426 . . . . 0.0 110.615 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.33 -19.57 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.72 -41.12 6.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -78.5 -45.05 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -61.14 159.72 11.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.341 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.05 40.04 4.69 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.566 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.3 -21.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.459 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.9 m-80 -110.35 -43.79 3.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.776 0.322 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 87' ' ' PHE . 3.0 tt -75.94 151.74 37.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.03 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -48.37 155.13 0.98 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.93 -30.64 86.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.793 2.329 . . . . 0.0 112.711 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.04 -58.61 5.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 111.373 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 46.2 t0 -64.5 -27.87 69.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.382 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.04 -43.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.435 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.434 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -80.16 -44.11 20.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -62.8 -70.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.485 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 1.3 t80 -48.48 -26.11 1.99 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.561 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.09 -52.15 11.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' CD2' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -69.98 -72.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.372 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.47 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 20.2 pt20 -77.19 -135.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 14.8 t80 87.51 -27.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.896 0.379 . . . . 0.0 110.622 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.35 -65.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.16 -30.56 11.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -24.23 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.58 128.24 8.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.686 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.08 153.18 24.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.114 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -139.09 125.68 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.643 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.8 157.51 18.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.44 ' CD2' HG13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -112.82 114.59 27.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 71' ' ' GLU . 12.8 m -113.7 -177.3 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -111.42 168.06 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.58 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 66' ' ' PRO . 8.3 m -54.06 154.75 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 56' ' ' TRP . . . -86.42 -163.53 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -95.43 37.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.887 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 3.0 t0 80.12 109.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -134.97 30.07 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.481 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 77.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' TRP . 4.0 mt-10 -154.87 -34.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.349 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.21 -49.66 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.97 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 60' ' ' ILE . 4.1 pt -70.69 -36.67 66.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 0.0 110.978 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 94.26 60.24 1.12 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.092 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.42 141.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.03 135.87 52.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.9 mm -105.54 128.01 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 111.538 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.68 109.94 39.3 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.385 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 52' ' ' THR . 26.9 Cg_endo -61.95 156.08 51.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.244 1.962 . . . . 0.0 112.111 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 62.04 8.28 2.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.87 -4.35 8.6 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.58 0.229 . . . . 0.0 111.427 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -148.01 135.35 20.54 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.945 0.402 . . . . 0.0 111.443 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -91.04 123.45 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.994 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' CG ' HG21 ' A' ' 50' ' ' VAL . 23.1 tt0 -101.7 119.66 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.946 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 7.0 p -127.91 124.34 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.72 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.494 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 24.9 m0 -89.84 141.74 28.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 21' ' ' PHE . 88.7 t -129.32 96.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.5 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.88 -141.31 3.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.363 -0.923 . . . . 0.0 113.853 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.34 172.09 13.16 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -153.67 163.93 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.45 -152.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -91.64 26.1 2.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 82' ' ' GLU . 5.8 pt20 -108.94 -0.4 19.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.443 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.18 38.15 28.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.749 0.309 . . . . 0.0 111.574 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.401 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 5.3 mm-40 -98.26 -158.37 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.387 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -163.44 32.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.71 0.69 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.31 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.65 73.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.979 0.419 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.88 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 8.4 m-85 -89.72 -41.66 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.99 162.46 39.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.573 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HB2' HD11 ' A' ' 104' ' ' ILE . 22.9 mttt -118.26 143.71 46.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 3.2 m-85 -124.04 136.77 54.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.076 0.465 . . . . 0.0 112.199 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.477 HD12 ' CE1' ' A' ' 102' ' ' HIS . 24.4 mt -121.27 124.32 44.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.858 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -119.27 122.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.29 127.74 33.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.022 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.46 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 98.7 m-70 -75.78 -4.47 40.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.729 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.34 116.89 24.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -40.36 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.268 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 149.24 46.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.66 -65.57 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.4 OUTLIER 61.91 92.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' N ' ' NH1' ' A' ' 99' ' ' ARG . 7.7 mm-40 -113.91 145.83 40.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.495 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 39.7 p90 -137.82 143.82 41.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.901 0.381 . . . . 0.0 111.817 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.67 150.47 46.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 104' ' ' ILE . 10.9 p -150.17 142.31 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.69 138.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 178.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 46.4 m95 -113.86 147.03 39.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.15 152.01 41.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.728 0.299 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -177.38 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.49 159.33 26.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.29 146.82 38.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.795 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.94 -54.51 5.33 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.13 -33.63 75.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.032 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 16' ' ' ILE . 86.8 m -68.15 -46.55 70.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.77 76.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.797 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.2 mt -61.76 -58.07 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.074 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.03 -31.17 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.117 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 12' ' ' THR . 3.4 mm -70.25 -59.07 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.2 86.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.2 -45.0 65.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -62.6 -40.19 96.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.825 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 mt -77.44 -15.92 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -73.07 -61.98 1.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.24 -4.89 38.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.03 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.1 tt0 -96.75 -52.33 3.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.812 0.339 . . . . 0.0 110.991 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.437 ' O ' ' C ' ' A' ' 25' ' ' ALA . 2.1 ttp -75.07 -37.12 61.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 24' ' ' MET . . . -27.62 141.53 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.145 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.72 -86.01 0.4 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 7.9 mt-10 -71.75 69.08 0.65 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.559 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 169.17 -43.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.773 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.48 HD11 ' CZ3' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -86.61 161.47 18.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.094 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -86.89 149.99 49.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.973 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.1 Cg_endo -50.95 -55.01 4.49 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.033 2.489 . . . . 0.0 113.336 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.29 -59.4 4.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.79 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.36 -24.22 42.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 40.5 mt -71.97 -39.46 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.056 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tt -59.83 -52.68 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.814 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -57.18 -46.6 82.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.243 0.544 . . . . 0.0 110.473 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 1.9 t80 -55.03 -23.06 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.773 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' HD21 ' A' ' 39' ' ' LEU . 22.1 m120 -80.59 -41.01 24.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 38' ' ' ASN . 0.8 OUTLIER -104.11 14.13 31.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -147.68 23.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.085 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.5 t80 -112.1 -12.81 13.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.177 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.92 -35.26 17.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.19 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.82 -24.78 9.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.876 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 27.66 8.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.671 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.71 110.12 3.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.025 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.47 140.67 11.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.682 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.428 HG13 ' CG2' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.76 140.38 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.925 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -125.53 131.01 52.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.981 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -73.32 114.88 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -173.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -114.08 -175.75 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.667 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 32.9 m -93.47 161.78 14.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -153.35 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.96 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.43 -45.1 10.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 3.4 p-10 172.11 93.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -107.84 47.65 0.88 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 64.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.368 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -151.44 -41.44 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.07 -55.2 5.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 60' ' ' ILE . 9.3 pt -84.34 -13.72 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.323 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 63.49 77.5 0.22 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 169.76 149.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.32 . . . . 0.0 110.76 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 125.4 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 7.4 mm -100.72 145.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -143.2 95.78 5.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.245 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 7.3 Cg_endo -49.54 160.41 1.06 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.465 2.11 . . . . 0.0 112.197 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.57 -59.25 0.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.548 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.59 -28.99 15.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.074 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.36 146.84 47.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 91' ' ' LEU . . . -99.52 140.17 34.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.258 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.74 129.75 53.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.01 0.433 . . . . 0.0 111.461 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.6 123.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.16 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.537 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 17.0 m0 -106.43 145.74 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.587 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 ' CG2' HG13 ' A' ' 47' ' ' VAL . 4.8 t -127.28 101.96 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.13 -143.49 9.05 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.591 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' A' ' 44' ' ' ARG . 2.1 tp -138.96 61.48 1.57 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.401 0.62 . . . . 0.0 110.18 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 6.9 m -47.33 174.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.612 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -130.95 -131.51 0.2 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.983 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -77.81 -22.12 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -90.23 0.21 Allowed 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.131 -0.356 . . . . 0.0 111.653 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 2.6 p30 -173.51 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.93 104.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 110.328 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.631 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 6.5 ptp -50.14 -26.03 4.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.478 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.73 -20.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -157.32 131.09 8.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.48 135.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -89.44 -35.84 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.431 ' HB3' ' CE3' ' A' ' 105' ' ' TRP . . . -157.79 163.38 38.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.301 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.537 ' HD3' ' CE2' ' A' ' 73' ' ' TRP . 1.4 mttt -132.38 147.1 52.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.4 ' CZ ' HG21 ' A' ' 103' ' ' VAL . 27.9 m-85 -134.61 135.46 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.465 HD11 ' ND1' ' A' ' 102' ' ' HIS . 3.0 mt -120.54 131.13 54.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.082 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -132.97 136.59 55.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -63.92 128.85 37.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.669 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -72.85 -25.14 61.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.321 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.69 156.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.67 -61.33 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ASP . 11.4 pt-20 -85.44 151.41 24.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER 49.8 103.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.814 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.16 126.88 43.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.33 141.27 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.056 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -135.33 142.04 45.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.207 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.571 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.91 128.08 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.383 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 89' ' ' LYS . 5.1 p -115.18 136.45 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.287 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.423 ' N ' HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -105.37 119.42 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.934 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.559 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 83.9 m95 -101.91 149.37 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.66 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -64.26 150.76 45.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.99 160.84 43.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.13 153.19 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.485 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.04 149.89 94.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.92 -55.42 3.24 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.571 2.181 . . . . 0.0 112.49 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.23 -31.15 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.207 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -64.5 -61.32 2.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.64 -44.64 81.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.41 -38.78 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -49.22 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -57.06 -49.66 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.956 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.48 67.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.55 -57.38 12.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.801 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.44 -41.91 61.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.5 mt -60.56 -70.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 20.3 t80 -39.55 -33.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.751 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.69 -41.99 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.005 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.24 -36.31 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.94 -57.11 7.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.169 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HA ' HD22 ' A' ' 28' ' ' ASN . . . -48.65 112.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.46 -90.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.07 4.53 52.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.569 0.223 . . . . 0.0 111.387 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.589 HD22 ' HA ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -101.8 -21.95 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.478 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . 3.2 tt -103.84 143.68 32.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.89 130.72 21.83 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.89 -44.36 22.64 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.92 2.414 . . . . 0.0 113.136 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.0 36.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.451 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.407 ' HB2' HD21 ' A' ' 29' ' ' LEU . 29.7 m-20 -55.72 -25.87 42.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.062 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 30' ' ' ASP . 52.0 mt -65.38 -54.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.983 0.421 . . . . 0.0 110.204 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.38 -48.93 55.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.644 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.01 -68.23 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.401 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -45.04 -32.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.006 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.84 -37.95 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.326 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -19.27 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -144.53 115.82 8.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.064 0.459 . . . . 0.0 111.19 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -171.56 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.52 -33.1 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.306 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.87 -24.1 16.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.352 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.05 43.4 3.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.724 0.297 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.18 125.6 8.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.57 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.18 113.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 t -108.48 117.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.715 0.293 . . . . 0.0 110.576 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -111.69 163.43 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -104.33 118.97 37.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.91 177.8 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.095 0.474 . . . . 0.0 111.668 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.91 152.63 21.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 m -67.84 154.77 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.588 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 56' ' ' TRP . . . -79.51 -152.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.41 -46.49 9.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' TRP . 8.0 p-10 -161.13 -41.35 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.573 ' O ' ' O ' ' A' ' 55' ' ' ASP . 3.0 p-90 22.92 114.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -139.72 19.03 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.975 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -96.49 -26.81 15.15 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.96 -68.31 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.49 HG13 ' N ' ' A' ' 61' ' ' GLY . 23.1 pt -63.48 -42.58 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.085 0.469 . . . . 0.0 110.431 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.49 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 130.89 -63.75 0.62 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.676 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -81.7 -179.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -77.23 168.77 19.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.56 HG13 ' CE2' ' A' ' 56' ' ' TRP . 21.5 mm -135.07 145.23 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.081 0.467 . . . . 0.0 111.63 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.52 107.36 36.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.201 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 32.8 Cg_endo -64.03 152.41 81.07 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.101 1.867 . . . . 0.0 112.101 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 72.33 -3.95 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.399 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -107.69 -16.62 14.29 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.952 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -137.91 146.93 43.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.06 137.78 32.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.578 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 51' ' ' GLU . 8.2 mm-40 -107.58 130.39 54.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 14.1 p -135.06 106.75 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.71 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 86' ' ' VAL . 8.2 m0 -89.17 138.92 30.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.345 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.81 112.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.475 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 -125.71 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.922 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tp -146.15 61.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.078 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 t -57.13 159.26 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.617 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.02 -170.49 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -31.42 72.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.808 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -69.29 -11.99 61.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.366 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.41 33.05 0.7 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.801 0.334 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.36 130.55 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.5 ttm -102.93 122.68 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.64 -19.79 11.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 132.13 43.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.429 HG12 ' CZ3' ' A' ' 73' ' ' TRP . 0.7 OUTLIER -103.51 144.42 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -107.02 -23.84 12.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB1' ' CE3' ' A' ' 105' ' ' TRP . . . -175.77 175.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.435 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 1.4 mttp -141.46 139.12 33.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.524 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 1.1 m-85 -126.66 131.39 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.203 0.525 . . . . 0.0 112.24 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.443 HD11 ' ND1' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -115.21 130.06 56.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.988 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -131.09 132.54 63.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -64.14 130.06 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -77.31 -18.61 57.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.468 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -67.56 168.12 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.084 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.71 -69.26 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 98' ' ' ASP . 7.9 mt-10 -61.12 144.34 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.125 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER 57.7 115.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.233 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.81 90.49 3.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.787 0.327 . . . . 0.0 110.274 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -89.65 126.62 35.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 28.4 p90 -146.28 138.39 25.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.715 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -133.94 134.47 42.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.429 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.3 p -114.39 146.8 18.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 4.8 mp -111.63 138.58 39.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.233 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.479 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 57.2 m95 -122.61 147.4 46.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.111 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.79 144.74 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.883 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.744 0.307 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -135.58 171.24 14.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.42 159.34 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.12 157.71 34.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.12 -50.32 7.65 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.551 2.167 . . . . 0.0 112.202 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.9 -30.07 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -48.44 63.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.59 87.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.57 -41.27 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -52.22 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -70.76 -39.02 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.64 -41.34 97.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -60.81 -46.27 91.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.229 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.17 -34.44 75.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.233 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 24' ' ' MET . 58.2 mt -67.13 -46.71 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.637 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 21.8 t80 -51.83 -56.75 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.74 -12.33 60.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.752 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.0 tp10 -93.62 -60.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -76.14 -38.28 56.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -47.34 110.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 111.407 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.64 -92.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.872 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.33 -2.97 47.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.6 m-80 -95.77 -28.79 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 30' ' ' ASP . 5.8 tt -92.92 157.41 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.425 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.545 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -80.44 149.91 69.47 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 111.69 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.62 -47.85 21.3 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.827 2.352 . . . . 0.0 113.38 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.95 0.97 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 111.899 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.29 -23.15 63.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.504 HG13 HD22 ' A' ' 29' ' ' LEU . 13.9 mt -70.99 -35.02 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.907 0.384 . . . . 0.0 110.213 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -69.06 -48.35 63.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.806 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 2.0 mt -60.19 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.7 t80 -39.68 -31.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.308 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -74.08 -49.2 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.615 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 2.4 mm? -82.86 -20.12 36.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -136.39 111.23 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -174.66 -49.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.321 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -51.4 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 52.71 0.88 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 0.0 111.198 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 122.71 7.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.64 119.92 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.289 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.76 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.35 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.86 136.73 36.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -87.06 133.28 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.96 -169.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.689 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -127.92 171.19 12.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.682 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -63.57 154.56 32.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 56' ' ' TRP . . . -88.42 -160.91 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.951 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -94.15 33.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.208 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 2.1 m-20 83.73 112.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.728 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.4 OUTLIER -138.74 33.33 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -59.62 79.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -155.95 -37.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.85 -47.51 7.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.663 0.268 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 60' ' ' ILE . 1.7 pt -74.52 -28.98 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.015 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 79.21 69.05 1.43 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.459 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.435 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 172.99 140.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 110.682 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -53.56 136.36 38.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.802 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 14.1 mm -110.09 131.69 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.446 . . . . 0.0 111.649 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -134.82 104.67 10.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.051 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 34.3 Cg_endo -64.67 160.59 39.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.164 1.91 . . . . 0.0 112.441 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER 74.39 -8.3 1.5 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.207 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.2 pt-20 -118.59 -5.42 10.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.177 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.473 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 60.2 m-85 -131.99 147.99 52.49 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.955 0.407 . . . . 0.0 110.825 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.35 128.66 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.051 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -96.65 132.89 41.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.0 111.492 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.39 135.23 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.728 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 89' ' ' LYS . 6.0 m0 -118.57 135.72 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.048 0.451 . . . . 0.0 111.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.73 109.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.77 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.76 -136.76 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.074 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.06 59.26 1.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 109.863 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -46.84 141.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.93 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -89.46 -129.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.229 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.537 ' C ' ' HG3' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -101.58 -176.75 3.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.299 0.571 . . . . 0.0 109.999 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HG3' ' C ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER 40.62 19.08 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.422 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' GLU . 1.7 t70 73.45 76.65 0.13 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.828 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -152.13 123.99 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.261 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.62 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 21.2 ttm -101.29 -71.98 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.047 0.451 . . . . 0.0 110.688 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -19.24 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 83' ' ' MET . 2.0 m-20 -139.2 115.26 10.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.46 149.27 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.514 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -97.1 -36.14 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . -160.59 167.97 25.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.923 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.526 ' HD2' ' CE2' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -129.87 147.12 51.6 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.2 m-85 -130.83 135.95 48.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.516 HD11 ' ND1' ' A' ' 102' ' ' HIS . 2.6 mt -128.5 131.91 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.446 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.19 129.98 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.164 0.507 . . . . 0.0 112.147 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.68 135.61 46.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.936 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -75.19 -21.02 59.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 174.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.266 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 -57.35 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 123.5 30.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.78 110.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.67 139.5 45.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.24 142.26 42.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.445 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -136.09 142.46 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.007 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.565 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.92 132.73 34.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.176 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.426 HG13 ' CZ2' ' A' ' 105' ' ' TRP . 14.2 p -122.1 144.4 31.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.516 ' HB ' ' CG ' ' A' ' 89' ' ' LYS . 1.9 mp -101.25 135.33 38.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.393 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 84.7 m95 -117.65 -90.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.73 131.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.8 mttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.866 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.608 0.242 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -141.94 172.9 12.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.362 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.6 169.61 9.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.639 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.45 144.59 29.01 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.571 0.224 . . . . 0.0 110.49 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.35 -53.64 6.77 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.494 2.129 . . . . 0.0 112.593 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -53.76 -37.42 63.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.367 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.5 ' O ' HG12 ' A' ' 16' ' ' ILE . 65.2 m -82.28 -35.27 28.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.416 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -64.96 -32.95 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.93 -59.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.002 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.6 -29.47 1.84 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.204 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 12' ' ' THR . 1.1 pp -78.62 -45.08 25.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.615 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.82 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.039 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.26 -45.01 96.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.106 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -24.91 63.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 34.8 mt -75.37 -28.47 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.492 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.421 ' CE2' ' CZ ' ' A' ' 37' ' ' PHE . 23.6 t80 -80.36 -41.85 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.85 -3.76 49.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 7.6 pt-20 -116.97 -45.07 2.78 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 ttp -85.9 -45.55 11.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -51.99 122.93 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.745 0.307 . . . . 0.0 111.49 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.56 -67.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -7.83 59.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -100.0 -72.56 0.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 30' ' ' ASP . 5.3 tt -63.96 127.62 32.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.263 0.554 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.58 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -40.24 153.42 0.21 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.642 -178.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.73 -33.09 55.61 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.717 2.278 . . . . 0.0 112.667 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.38 -55.76 27.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 111.296 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.54 -22.82 66.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.436 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' ASP . 97.0 mt -72.75 -47.46 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.51 -45.47 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.335 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.25 -57.44 10.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -55.77 -34.81 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.776 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.66 -44.28 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.498 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -77.22 -14.49 59.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.139 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.498 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 1.6 mm100 -120.36 -144.97 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.224 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 1.2 t80 83.1 -19.38 0.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.488 0.315 . . . . 0.0 111.632 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.77 -39.82 17.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.74 -29.92 8.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -115.76 27.54 9.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.002 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.71 114.54 4.46 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.402 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.33 146.49 16.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.763 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.0 t -146.77 118.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.94 155.37 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.444 . . . . 0.0 111.522 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 70.4 t80 -101.55 133.94 45.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.68 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.54 -173.17 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.446 . . . . 0.0 110.737 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 16.0 m -83.81 169.82 14.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.467 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -97.14 -160.31 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 3.7 p30 -93.77 30.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.518 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 t0 85.57 108.86 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.21 69.59 1.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.798 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 17.7 mt-10 -80.76 53.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.316 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 -49.65 2.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -83.21 -53.28 5.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' CD1' ' CD1' ' A' ' 64' ' ' ILE . 6.3 pt -81.59 -34.99 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.935 0.398 . . . . 0.0 109.954 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 57' ' ' GLU . . . 88.37 -39.72 3.11 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.55 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.473 HG12 ' CE1' ' A' ' 102' ' ' HIS . 4.1 p -58.16 154.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 111.647 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.53 120.34 16.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.475 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 2.3 mm -98.64 160.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.376 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.17 117.92 4.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 27.2 Cg_endo -62.2 152.46 75.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.308 2.005 . . . . 0.0 112.3 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -65.22 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -24.86 7.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.443 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 2.7 m-85 -110.93 149.28 30.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' LEU . . . -118.38 123.89 46.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.353 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -102.25 144.25 31.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.27 0.557 . . . . 0.0 111.367 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 90' ' ' PHE . 1.8 t -132.74 140.41 47.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.584 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 17.6 m0 -114.9 132.48 56.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.0 111.177 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 90' ' ' PHE . 62.1 t -124.98 97.59 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.628 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -126.17 -133.4 3.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.588 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -140.69 83.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.135 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 35.0 m -64.34 178.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.0 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -115.64 -171.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.96 -16.85 64.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.262 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -97.27 26.55 4.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.293 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 39.82 55.4 2.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.904 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.42 104.63 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 35.8 ttm -69.79 117.56 11.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 19.82 17.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.655 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 104.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.814 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 p -89.57 142.43 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.11 0.481 . . . . 0.0 111.524 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 13.9 m-85 -89.81 -33.74 16.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.691 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HB1' ' CE3' ' A' ' 105' ' ' TRP . . . -166.53 165.76 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.736 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' ILE . 8.9 mttt -132.16 146.23 51.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.3 m-85 -126.3 130.21 50.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.458 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.538 HD12 ' ND1' ' A' ' 102' ' ' HIS . 5.2 mt -110.78 135.6 51.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.83 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.03 123.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.577 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 156.75 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.758 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.401 ' NE2' ' CB ' ' A' ' 70' ' ' ALA . 20.4 m-70 -101.92 23.02 12.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.086 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -87.4 148.15 25.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.0 111.106 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -61.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.73 158.48 15.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 44.72 94.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.2 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.98 151.66 27.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.144 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -130.53 140.76 50.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 24.3 p90 -138.19 142.75 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -137.68 161.98 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.875 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 104' ' ' ILE . 11.9 p -150.6 143.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.12 137.26 43.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.538 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.563 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 27.2 m95 -117.02 149.83 39.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.26 28.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.877 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.925 0.393 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -98.32 -172.82 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.11 143.06 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.777 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 150.83 14.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.785 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.92 -50.18 10.94 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.164 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -21.98 60.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.205 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -82.43 -49.15 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.42 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -63.22 -36.19 82.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.258 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -72.24 -57.55 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -44.74 -48.42 10.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.736 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.72 -45.33 88.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.088 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.67 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.045 0.45 . . . . 0.0 110.265 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.5 -36.43 71.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.922 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.32 -27.24 62.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.822 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' MET . 49.3 mt -74.1 -33.16 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 47.8 t80 -78.25 -23.63 47.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.07 0.462 . . . . 0.0 110.411 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.28 -33.29 37.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.238 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.18 -34.26 11.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.285 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 27.9 mtp -83.08 -50.9 8.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.523 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HA ' ' CH2' ' A' ' 105' ' ' TRP . . . -55.14 138.76 43.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 111.321 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.79 21.07 5.51 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -160.11 -42.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.437 ' HB3' ' CG ' ' A' ' 105' ' ' TRP . 2.5 m120 -76.59 -57.47 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' CD2' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -65.25 175.05 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.793 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.76 153.66 85.19 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.74 0.305 . . . . 0.0 111.017 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -55.85 -58.02 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.907 2.404 . . . . 0.0 113.141 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.04 -46.33 11.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 111.64 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.448 ' CB ' ' CD2' ' A' ' 29' ' ' LEU . 12.7 m-20 -62.41 -27.69 69.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 84.5 mt -68.94 -48.45 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.877 0.37 . . . . 0.0 110.548 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.57 -62.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -44.68 -45.23 9.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.195 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -35.79 75.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -68.43 -53.34 24.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -83.28 -136.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 72.98 -58.66 0.59 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.687 0.279 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.47 -42.71 98.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.36 -48.98 7.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.407 ' O ' HD11 ' A' ' 76' ' ' LEU . 7.3 mpt_? -116.85 66.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.734 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.53 134.02 12.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.298 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.02 115.32 1.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.388 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.62 68.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -84.98 136.51 33.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 82.1 t80 -91.02 89.68 7.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.71 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.97 3.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 51.5 m -90.27 165.17 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.143 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.406 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -122.34 164.16 18.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.9 -31.87 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.82 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 58' ' ' GLU . 1.5 m95 -66.83 -27.94 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.72 67.35 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.506 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' TRP . 5.7 mt-10 -156.23 -54.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.19 -67.88 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.6 pt -71.46 -34.18 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.075 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.13 48.95 2.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.676 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p 179.6 132.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.71 135.3 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HD13 ' A' ' 64' ' ' ILE . 17.9 mm -121.07 146.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.62 109.39 5.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 24.4 Cg_endo -62.89 153.26 74.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.186 1.924 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 62.73 7.07 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.563 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -128.25 17.27 6.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 31.1 m-85 -150.65 142.07 23.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.9 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -89.45 116.5 27.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -110.39 104.99 13.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.58 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.89 135.78 31.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.282 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 10.0 m0 -115.77 89.76 3.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.188 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 21' ' ' PHE . 72.6 t -89.7 99.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.041 0.448 . . . . 0.0 110.972 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 76' ' ' LEU . . . -130.01 -132.55 3.46 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.462 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.2 tp -140.24 108.97 5.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.2 t -96.28 148.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.391 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -92.24 -164.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.54 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.299 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.28 -6.87 48.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.07 30.14 7.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.721 0.296 . . . . 0.0 111.332 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.54 147.47 28.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.56 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.83 86.08 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 111.103 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.31 12.76 23.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.59 91.91 1.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.879 0.371 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.72 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -97.4 -49.65 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.436 ' HB1' ' CE3' ' A' ' 105' ' ' TRP . . . -152.36 121.1 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.395 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -103.37 131.5 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.152 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.6 m-85 -111.7 153.26 26.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 0.0 111.775 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.481 HD12 ' CE1' ' A' ' 102' ' ' HIS . 15.3 mt -137.07 109.07 7.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.553 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.84 136.87 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.749 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -71.98 93.08 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.904 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.477 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 96.6 m-70 -31.92 -49.16 0.17 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.223 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -41.32 143.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.964 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -48.56 46.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 98' ' ' ASP . 8.3 mt-10 -72.11 145.33 48.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.099 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER 57.57 115.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.287 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -109.66 113.79 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.838 0.351 . . . . 0.0 110.504 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' CG ' ' HB2' ' A' ' 93' ' ' SER . 7.8 pt-20 -128.62 103.76 7.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -112.07 146.26 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.536 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.531 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -144.93 161.38 39.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.443 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.8 p -152.74 141.66 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.82 132.69 58.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.437 ' CG ' ' HB3' ' A' ' 28' ' ' ASN . 88.0 m95 -111.59 -81.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.412 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.64 139.97 11.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.871 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.96 134.07 52.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -59.1 148.3 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.988 -179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' N ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -47.28 140.22 7.2 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.687 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -58.42 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.448 2.098 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -31.3 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -59.6 -55.23 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.79 64.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.024 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 14' ' ' ILE . 82.8 mt -46.42 -38.85 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.182 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.04 -46.95 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.86 -63.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.05 -38.27 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.129 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -55.14 -52.67 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.103 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.98 -21.7 66.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.667 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 24' ' ' MET . 77.9 mt -77.2 -30.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.042 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.471 ' CE2' ' CZ ' ' A' ' 37' ' ' PHE . 15.0 t80 -76.68 -28.18 55.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.481 . . . . 0.0 110.136 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.2 -32.78 50.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.391 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.36 -38.38 10.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.128 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.544 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 19.0 mtp -74.09 -51.21 16.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.0 145.66 5.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.401 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.13 29.92 9.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.279 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -152.36 -35.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.623 0.249 . . . . 0.0 111.357 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -121.04 -30.47 4.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.326 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . 5.2 tt -68.94 141.17 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.5 140.27 84.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.53 -54.83 4.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.085 2.523 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.82 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' CB ' HD21 ' A' ' 29' ' ' LEU . 2.7 m-20 -67.21 -28.89 68.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.301 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.452 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 54.3 mt -66.1 -52.29 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -55.69 30.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -49.78 -39.57 38.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 111.417 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -80.88 -36.82 30.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.4 -23.8 46.57 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -86.18 -27.77 24.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -150.08 95.6 2.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.814 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.8 t80 -130.74 -40.24 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.201 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -68.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.919 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.42 -39.9 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.59 62.03 0.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.04 133.65 11.77 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.178 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.13 142.58 9.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.928 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -146.04 80.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -76.87 140.46 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.812 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.02 88.43 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 m -89.52 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.153 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.73 175.5 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.761 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -60.4 154.18 21.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -75.03 -149.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -38.19 14.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 110.195 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' TRP . 4.0 p30 -151.3 -35.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.234 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 59' ' ' GLU . 6.3 m95 70.84 2.28 4.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.634 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.8 59.59 0.89 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.876 0.369 . . . . 0.0 111.107 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.5 -49.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.799 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 5.1 mm-40 -75.99 -73.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 HG22 ' A' ' 62' ' ' VAL . 48.0 pt -75.13 -34.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.297 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 82.21 79.88 0.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.722 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.448 HG22 HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER 168.7 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -70.34 121.24 17.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.69 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -124.17 112.43 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.264 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.64 115.2 20.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 68' ' ' GLU . 23.9 Cg_endo -61.76 151.21 82.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.24 1.96 . . . . 0.0 111.921 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 77.71 -29.84 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 66' ' ' PRO . 25.1 mt-10 -87.05 6.36 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.391 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -141.85 151.39 42.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 111.434 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.28 131.62 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.72 110.23 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.582 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.73 135.24 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.176 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 18.7 m0 -117.9 136.35 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.321 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 HG12 ' CE2' ' A' ' 21' ' ' PHE . 58.0 t -135.59 108.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 0.0 111.39 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.57 -115.23 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -150.04 155.25 39.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 82' ' ' GLU . 34.8 m -140.58 -178.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.472 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.54 -173.86 2.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -26.12 65.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.965 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -79.16 -9.63 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.414 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.58 88.78 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 3.9 mt-10 -144.11 147.05 33.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 tpt -120.82 80.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 -5.51 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 84.95 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.84 131.73 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -89.47 -37.06 15.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.589 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.457 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -144.74 162.1 37.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.15 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 3.8 mttm -146.26 130.64 17.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -120.33 148.69 43.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 102' ' ' HIS . 58.9 mt -129.29 118.16 21.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.385 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 147.93 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.317 0.58 . . . . 0.0 112.553 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.86 122.16 26.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.534 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.439 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 92.1 m-70 -58.82 -15.37 12.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.827 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.72 -55.81 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.62 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.84 0.06 28.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 112.063 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.89 105.01 2.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.92 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.46 118.64 22.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.056 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -104.51 127.45 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 21.6 p90 -118.26 138.9 52.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.848 0.356 . . . . 0.0 111.232 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.483 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -147.62 101.6 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.4 p -99.86 144.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.026 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -119.9 131.1 73.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.974 179.24 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 26.8 m95 -105.46 153.55 21.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.42 160.45 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.896 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -177.89 5.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD1' ' CE1' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -130.16 148.54 52.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 1.2 m-20 -80.59 134.82 53.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.056 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.43 -42.17 22.87 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 112.32 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -27.32 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.649 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -77.33 -37.07 53.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.96 84.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.62 -42.63 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.959 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.34 -55.41 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.75 -42.09 94.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.031 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.42 86.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.953 0.406 . . . . 0.0 110.309 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CE1' HD13 ' A' ' 22' ' ' LEU . 25.6 t80 -57.65 -47.83 81.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.096 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.92 65.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.667 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.5 mt -62.61 -73.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.457 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 70.0 t80 -42.49 -29.45 0.28 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.381 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 18' ' ' TYR . 1.9 tp -64.69 -45.17 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.48 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.1 pt-20 -103.4 -28.57 11.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.401 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -72.14 -53.42 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 111.204 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 137.69 41.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.428 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.79 -85.7 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.894 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.6 3.59 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' CD2' ' A' ' 105' ' ' TRP . 0.9 OUTLIER -92.26 -42.64 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.263 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 30' ' ' ASP . 3.4 tt -97.27 154.56 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.95 149.91 4.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.64 -25.86 35.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.523 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.03 -60.42 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.64 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.21 -29.01 65.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.51 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.2 -47.97 91.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 110.172 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -68.76 -47.21 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.438 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.37 -59.09 5.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.426 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 4.1 t80 -42.12 -30.61 0.3 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.296 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -76.96 -50.71 12.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 1.9 mm? -83.35 -63.17 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.618 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.48 92.83 9.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 111.659 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.2 t80 -163.95 -37.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.64 -62.54 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -102.62 -15.45 16.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.529 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -102.75 -5.38 23.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.651 0.262 . . . . 0.0 111.396 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -91.15 132.71 11.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.17 145.46 13.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.368 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 t -130.99 96.65 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.906 0.384 . . . . 0.0 111.006 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.31 164.48 18.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.962 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -114.28 135.85 53.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.433 HG23 ' CG ' ' A' ' 71' ' ' GLU . 6.4 m -132.21 -174.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.17 166.09 13.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 8.0 m -54.69 155.96 3.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.88 -177.29 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.03 26.25 10.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.77 39.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.462 ' CH2' HD11 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -65.22 -29.8 70.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.276 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 14.2 mt-10 -59.44 -16.63 24.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -92.68 -34.03 14.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 36.5 mt-10 -78.93 -57.66 3.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 61' ' ' GLY . 42.0 pt -93.93 -36.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.415 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 123.61 -72.53 0.41 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m -56.88 173.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.814 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.82 136.4 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.413 ' CD1' HD12 ' A' ' 60' ' ' ILE . 25.9 mm -124.9 116.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.755 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 112.07 7.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 19.5 Cg_endo -61.42 163.75 16.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.792 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.7 pt-20 48.81 20.31 0.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.974 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -129.05 -14.44 4.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.584 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -123.92 162.7 22.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.836 0.35 . . . . 0.0 110.842 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.1 122.15 46.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' CG ' HG23 ' A' ' 50' ' ' VAL . 35.0 tt0 -106.03 123.52 48.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.99 147.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.64 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -124.44 135.92 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.42 111.01 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.091 0.472 . . . . 0.0 111.14 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.66 -127.22 3.07 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.166 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 tp -149.18 57.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 78' ' ' ASN . 6.3 p -63.71 158.55 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.702 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.417 ' N ' ' CG2' ' A' ' 77' ' ' VAL . 4.5 m-80 -95.13 -144.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.929 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -93.23 22.88 4.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.662 0.267 . . . . 0.0 111.223 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -114.23 -11.76 12.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.543 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 71.37 28.81 2.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.385 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -114.46 119.35 36.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.71 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 tpp -84.89 98.55 10.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.458 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.83 -23.88 26.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.24 125.61 16.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.41 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.08 135.59 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.11 -38.32 13.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.159 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -152.74 175.96 12.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.788 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.17 140.61 22.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -123.32 147.56 46.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.462 HD11 ' CH2' ' A' ' 56' ' ' TRP . 34.2 mt -131.47 124.8 30.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.141 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.45 149.39 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -69.34 123.29 20.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.953 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.463 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 8.3 m-70 -49.91 -48.62 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.634 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -42.87 160.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.098 0.475 . . . . 0.0 111.828 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -99.17 -34.63 10.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.112 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 3.3 pt-20 -91.3 126.69 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.93 106.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.8 148.54 45.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.507 . . . . 0.0 111.616 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.58 133.32 56.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.489 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 39.7 p90 -120.67 139.13 53.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.79 103.03 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.0 111.058 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.5 p -98.79 141.76 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.918 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.437 ' N ' HG23 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -108.2 135.55 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.151 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.485 ' CD2' ' ND2' ' A' ' 28' ' ' ASN . 46.9 m95 -115.52 140.72 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.23 159.19 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mttm . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.822 0.344 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 177.76 6.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.38 135.29 33.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.37 164.93 53.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.578 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.65 -59.21 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.219 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.87 -30.27 71.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -73.27 -42.82 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . . . -60.81 -35.33 76.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 mt -71.35 -57.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.12 -39.84 2.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.263 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.86 -57.34 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.07 61.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.809 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.12 -55.45 25.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.8 -31.21 62.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.752 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.02 -74.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.144 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 44.8 t80 -39.51 -32.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.415 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.77 -43.02 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -29.26 10.41 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -57.86 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.682 0.277 . . . . 0.0 111.434 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB1' ' CD1' ' A' ' 21' ' ' PHE . . . -50.25 116.52 1.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.395 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.21 -89.94 0.08 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.92 2.78 32.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.4 m-80 -103.04 -59.12 1.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 30' ' ' ASP . 5.1 tt -64.1 135.26 56.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.635 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.78 137.49 3.34 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.964 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.21 -43.06 32.44 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.852 2.368 . . . . 0.0 112.754 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.0 -58.86 5.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.599 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 106' ' ' LYS . 41.2 m-20 -58.06 -24.68 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 ' CG1' HD23 ' A' ' 29' ' ' LEU . 92.5 mt -67.99 -50.93 54.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 109.991 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.7 -51.13 64.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.756 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -55.16 37.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.141 0.496 . . . . 0.0 110.417 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 2.1 t80 -46.19 -30.08 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.901 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -59.07 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.466 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.18 -21.26 66.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.837 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -148.8 118.61 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.652 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' GLY . 63.4 t80 179.98 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.756 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -48.39 -63.5 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.25 -33.17 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.41 33.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -104.58 62.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.552 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.21 116.72 5.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.497 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' CG1' ' CG1' ' A' ' 72' ' ' VAL . 38.7 t -102.34 107.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.77 0.319 . . . . 0.0 110.865 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.37 150.62 24.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 35.0 t80 -103.72 141.73 35.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.091 0.472 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.12 152.41 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.921 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -92.9 158.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.702 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 98.2 m -46.88 167.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.064 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -103.07 -169.04 1.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.72 32.59 4.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.23 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.523 ' CE3' ' HB2' ' A' ' 59' ' ' GLU . 4.5 m95 68.14 6.57 5.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.991 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.45 -1.8 19.88 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.71 -44.02 5.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 60.1 mm-40 -73.3 -56.28 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.439 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.455 HG21 ' CZ3' ' A' ' 56' ' ' TRP . 18.0 pt -103.15 -35.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.675 0.274 . . . . 0.0 111.02 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 -53.02 0.6 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.301 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.78 152.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.238 0.542 . . . . 0.0 111.878 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.92 156.49 24.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.721 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -150.35 128.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.85 108.08 4.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.616 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 9.6 Cg_endo -52.9 157.69 7.56 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.288 1.992 . . . . 0.0 112.287 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 20.1 mt-10 69.64 -59.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.16 -29.03 1.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.814 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE1' ' OG ' ' A' ' 93' ' ' SER . 98.5 m-85 -116.65 152.16 34.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 111.355 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.37 133.11 54.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.816 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' PHE . 8.0 pt-20 -112.53 133.48 54.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.401 ' CG1' ' CG1' ' A' ' 47' ' ' VAL . 2.2 t -121.22 147.45 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.84 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 12.2 m0 -120.49 133.57 55.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 111.226 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 110.59 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.907 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.45 -132.27 3.75 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.264 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -142.16 64.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 0.0 110.093 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 78' ' ' ASN . 22.3 t -49.4 159.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.831 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.5 m-80 -89.65 -160.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.61 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -70.91 -9.7 58.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.95 -87.76 0.21 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.52 0.2 . . . . 0.0 111.17 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' HA ' HG13 ' A' ' 77' ' ' VAL . 1.4 p30 179.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -57.38 129.65 42.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.3 ttm -107.52 122.71 47.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.037 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.52 -3.18 13.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -137.56 108.23 6.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.863 0.363 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.38 138.74 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.858 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.0 -46.35 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.681 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -143.99 173.19 11.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -150.4 136.0 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -121.17 142.2 50.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' CD1' ' CE1' ' A' ' 102' ' ' HIS . 13.8 mt -119.96 133.43 55.56 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.02 143.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.417 ' OG ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -68.92 132.32 46.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.65 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.0 -32.95 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 178.24 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.031 0.443 . . . . 0.0 111.277 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.64 -12.84 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.356 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -133.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 51.52 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 110.665 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -62.09 141.65 58.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.116 0.484 . . . . 0.0 111.905 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -117.46 149.63 40.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.595 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 35.5 p90 -139.16 143.36 38.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.708 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.493 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.3 OUTLIER -150.04 118.79 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.143 0.497 . . . . 0.0 111.525 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 104' ' ' ILE . 14.7 p -107.24 144.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.906 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.483 ' N ' HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -111.81 135.9 49.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.533 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 37.3 m95 -117.07 149.36 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 5.1 ttmt -67.63 153.46 43.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.851 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tptt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.721 0.296 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -89.92 178.91 6.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 143.89 33.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.064 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.83 157.82 57.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.83 -64.49 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.638 2.225 . . . . 0.0 112.248 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.68 -32.83 67.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 16' ' ' ILE . 69.4 m -72.58 -36.46 68.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.437 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -65.06 -26.77 68.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 14' ' ' ILE . 45.9 mt -80.26 -62.12 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.97 -32.49 3.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.793 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CD1' HG13 ' A' ' 92' ' ' ILE . 1.3 pp -76.86 -48.04 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.74 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.84 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 110.198 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.59 -43.88 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.939 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -66.1 -27.86 68.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.136 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.25 -28.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.243 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.1 t80 -69.01 -45.97 69.19 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.0 mm? -80.02 -2.98 46.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 1.1 mm-40 -95.78 -56.83 2.54 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.3 mtp -92.18 -30.62 15.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -54.63 122.94 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.01 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.84 35.97 1.09 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.124 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -163.04 -32.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.438 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 5.2 t30 -116.27 -34.91 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 30' ' ' ASP . 3.0 tt -80.07 124.31 28.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 111.062 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.689 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -34.2 150.12 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.561 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.77 -34.49 72.83 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.536 2.157 . . . . 0.0 112.667 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.91 -58.15 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.868 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' HB2' HD23 ' A' ' 29' ' ' LEU . 61.8 m-20 -61.24 -19.43 61.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 29' ' ' LEU . 83.5 mt -75.23 -51.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.932 0.396 . . . . 0.0 110.388 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.27 -51.8 63.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.738 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -52.02 66.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.247 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 4.0 t80 -46.46 -28.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.914 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -77.01 -49.99 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 44.02 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.01 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -150.57 -44.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.02 -12.01 10.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.717 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.59 -46.55 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -119.45 -13.31 9.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.607 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -118.18 41.66 2.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.142 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.92 108.82 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.52 154.06 24.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.297 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 75.9 t -144.07 119.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -101.92 142.99 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 59.2 t80 -91.67 138.26 31.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.295 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.04 142.13 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.599 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.32 -174.78 1.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.514 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 61.7 m -72.33 165.0 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 56' ' ' TRP . . . -91.15 -160.78 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.6 OUTLIER -95.02 32.19 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.347 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 84.34 121.74 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -146.71 55.36 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.47 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -72.0 79.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.692 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.7 -43.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.772 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.59 -48.07 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.435 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 104' ' ' ILE . 5.1 pt -80.13 -14.46 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 54.86 77.4 0.15 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.25 140.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.86 122.92 12.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.68 144.85 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -146.78 105.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.284 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 31.4 Cg_endo -64.0 155.69 62.98 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 80.29 -14.62 0.82 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.904 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.507 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.9 pt-20 -115.09 2.17 14.09 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 54.5 m-85 -138.96 144.73 39.12 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.099 0.476 . . . . 0.0 111.231 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.98 120.21 41.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.918 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 50' ' ' VAL . 14.3 tt0 -92.84 130.79 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.759 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.16 141.25 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.516 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -117.62 136.26 53.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 102.03 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.472 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 76' ' ' LEU . . . -114.18 -144.39 8.66 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.079 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 75' ' ' GLY . 2.1 tp -138.64 81.79 1.87 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.276 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 2.2 m -67.17 170.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.191 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -115.34 -165.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.428 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.87 -16.29 58.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.531 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.45 -85.83 0.17 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.154 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.7 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.332 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -147.99 120.3 8.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.882 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.641 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -71.69 -25.68 62.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.38 6.51 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 83' ' ' MET . 1.5 m-20 178.42 121.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.66 141.61 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.884 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.51 -34.89 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.2 161.99 19.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.62 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 3.6 mttt -129.36 148.24 51.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.9 m-85 -128.82 138.61 52.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 111.877 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.504 HD11 ' ND1' ' A' ' 102' ' ' HIS . 3.7 mt -119.66 134.03 55.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.151 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.123 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -74.3 147.87 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -91.72 22.26 4.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -96.99 152.97 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.35 -40.57 14.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.47 114.28 28.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.47 100.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.723 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.86 127.25 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.46 156.5 18.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -149.53 144.62 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.03 159.95 40.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.015 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.457 HG21 ' N ' ' A' ' 104' ' ' ILE . 11.9 p -150.34 141.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.457 ' N ' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -106.63 133.36 51.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.752 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.475 ' CD2' ' HB2' ' A' ' 29' ' ' LEU . 33.9 m95 -115.88 150.17 37.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.93 153.57 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.6 pttm . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.888 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.784 0.326 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -127.41 139.81 52.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.114 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mt -63.98 150.47 45.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.2 141.89 93.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.12 -48.2 15.26 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.55 2.166 . . . . 0.0 112.725 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.9 -21.86 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.471 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -81.01 -61.17 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.558 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.46 -30.27 64.9 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.28 -59.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.807 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -42.1 -48.77 4.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.568 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -40.22 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.67 94.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.442 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -52.16 -44.85 64.82 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.243 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 -30.56 71.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.485 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 24' ' ' MET . 34.4 mt -73.0 -29.75 29.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t80 -67.91 -47.8 67.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -71.81 -23.41 61.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.17 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.718 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 5.8 mtp -75.1 -46.01 37.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -42.75 110.83 0.2 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.804 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.52 -114.28 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.392 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.98 -37.66 78.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.309 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.01 -37.13 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.472 HD12 ' CZ3' ' A' ' 105' ' ' TRP . 4.6 tt -88.07 151.08 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -71.13 134.55 85.21 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.097 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.11 -59.36 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.722 2.281 . . . . 0.0 112.951 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.14 -50.35 20.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.556 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.22 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -66.66 -52.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.111 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -57.34 -51.76 68.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 110.356 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.416 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 1.8 tp -52.39 -51.06 61.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 110.556 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -49.04 -42.58 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.9 -57.06 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.99 49.11 1.66 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -155.62 -48.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -42.91 -37.47 1.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.545 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.06 -45.03 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.22 -61.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.061 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.19 63.06 3.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.36 133.88 11.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.72 128.34 4.59 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.413 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.17 59.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.49 . . . . 0.0 110.245 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.22 125.61 31.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.381 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -83.63 97.65 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.45 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -90.34 166.18 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.356 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -98.17 162.08 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.853 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 48.4 m -52.09 163.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.18 162.34 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.08 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.91 -29.25 18.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.794 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.21 -2.7 22.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.674 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.437 ' CZ2' HD22 ' A' ' 91' ' ' LEU . 1.5 m95 -46.39 -29.59 1.76 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.553 0.216 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.81 63.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -166.93 -44.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.369 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.97 -70.54 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.104 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.71 -32.12 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.273 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 77.72 47.75 8.46 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.413 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.93 113.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.498 0.19 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.93 127.16 15.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.57 137.73 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -66.1 109.69 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.795 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.3 Cg_endo -59.33 157.89 28.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.326 2.017 . . . . 0.0 112.411 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.4 pt-20 48.62 20.53 0.33 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.777 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 19.2 mt-10 -137.74 18.82 2.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.713 0.292 . . . . 0.0 110.973 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 68' ' ' GLU . 20.8 m-85 -148.09 145.51 28.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.72 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -90.11 114.19 26.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' HG2' HG21 ' A' ' 50' ' ' VAL . 27.8 tt0 -110.62 103.4 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.485 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.5 136.39 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.464 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 3.8 m0 -121.25 94.16 4.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.97 106.33 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.135 0.493 . . . . 0.0 111.056 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -132.2 -137.53 3.99 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.955 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 44' ' ' ARG . 1.1 mp -139.18 112.67 8.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.298 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.13 179.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.255 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -93.7 -166.2 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.552 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.02 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.404 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -75.13 -72.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.483 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER 166.19 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.621 0.248 . . . . 0.0 111.413 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.69 135.88 3.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.9 tpp -119.56 123.91 45.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.652 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.58 21.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -160.4 89.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' A' ' 89' ' ' LYS . 7.3 p -89.67 149.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.418 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -98.69 -43.73 6.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.728 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . . . -151.53 122.27 7.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -113.59 132.89 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.6 m-85 -113.99 155.58 25.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.437 HD22 ' CZ2' ' A' ' 56' ' ' TRP . 39.8 mt -134.66 110.32 9.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.64 134.37 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.589 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.13 97.11 2.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.49 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.488 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 98.1 m-70 -37.28 -46.6 0.76 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.948 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.31 138.0 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 111.412 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.93 80.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' ARG . 10.9 pt-20 -67.38 -173.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.25 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 69.62 62.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.458 . . . . 0.0 110.509 -179.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.31 150.71 23.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 8.8 p90 -146.83 140.74 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.602 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.28 157.42 46.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -151.41 138.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -114.91 110.22 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.096 178.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.472 ' CZ3' HD12 ' A' ' 29' ' ' LEU . 91.2 m95 -92.42 149.25 21.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -176.95 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.753 0.311 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -176.59 3.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.052 0.453 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 155.43 35.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.37 147.77 53.98 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.49 -54.89 4.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.543 2.162 . . . . 0.0 112.392 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.52 -28.93 68.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 m -72.85 -44.95 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.39 89.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.62 -57.88 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.2 -45.98 5.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.232 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mt -72.89 -39.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.592 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.79 75.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.711 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.88 -43.62 77.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -35.37 77.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' CG ' ' A' ' 24' ' ' MET . 49.7 mt -66.24 -45.68 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.691 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 7.2 t80 -54.33 -59.67 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.554 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 2.8 mm? -64.01 -14.5 54.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.159 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.7 -57.75 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.4 -38.49 21.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -54.6 151.11 8.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 0.0 111.516 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 34' ' ' ILE . . . 148.52 -111.9 0.55 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.417 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -74.02 -3.64 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 1.3 m120 -98.46 -5.85 31.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.499 0.19 . . . . 0.0 111.213 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.58 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -103.59 -25.44 13.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.732 0.301 . . . . 0.0 111.481 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 29' ' ' LEU . 12.6 t70 106.01 137.23 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.754 0.822 . . . . 0.0 111.441 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.41 -58.89 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.22 2.613 . . . . 0.0 113.044 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.34 -58.62 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.034 0.445 . . . . 0.0 111.137 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' CB ' ' CD2' ' A' ' 29' ' ' LEU . 3.6 m-20 -57.32 -28.95 63.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 30' ' ' ASP . 52.9 mt -71.61 -49.82 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-O 121.301 0.572 . . . . 0.0 109.697 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 5.5 tp -45.85 -66.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.299 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 28.6 tp -53.9 -35.02 61.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.337 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 2.7 t80 -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.16 -62.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' HG ' ' A' ' 35' ' ' LEU . 2.1 mm? -52.88 -23.54 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -144.3 115.64 8.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.273 0.558 . . . . 0.0 111.817 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' O ' ' HA3' ' A' ' 45' ' ' GLY . 15.5 t80 -169.79 -53.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.919 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -34.91 72.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.14 -46.85 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.262 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -119.55 53.85 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 111.116 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -119.22 120.4 4.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.727 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.77 137.37 6.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.716 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.31 126.04 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.889 0.376 . . . . 0.0 110.964 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.48 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.997 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 70' ' ' ALA . 51.2 t80 -87.35 139.53 30.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -133.01 175.91 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.29 148.3 33.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 49.7 m -41.74 160.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.14 0.495 . . . . 0.0 111.574 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.67 -161.4 0.87 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.235 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.65 39.84 1.04 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.177 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 2.7 m-20 76.6 117.76 0.06 Allowed 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.574 ' O ' ' N ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -125.88 44.98 2.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.718 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -58.72 70.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -155.41 -45.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.731 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.72 -68.01 0.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.419 0.628 . . . . 0.0 110.268 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -69.74 -50.88 45.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.389 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 96.14 72.85 1.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.303 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 10.6 p 172.49 142.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.667 0.27 . . . . 0.0 110.577 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.99 123.22 7.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 111.347 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 27.6 mm -103.51 132.07 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.68 111.78 41.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.51 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 28.0 Cg_endo -63.1 152.97 76.82 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.406 2.071 . . . . 0.0 112.902 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 60.77 8.98 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.033 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -119.97 -13.71 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.561 0.22 . . . . 0.0 111.517 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.7 136.38 49.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 111.02 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -89.32 117.96 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.782 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' PHE . 11.0 pt-20 -107.17 138.15 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.089 0.471 . . . . 0.0 111.336 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 72' ' ' VAL . 10.8 p -134.65 142.46 40.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -106.17 144.84 32.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 90' ' ' PHE . 48.9 t -128.7 101.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.5 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.37 -138.66 5.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.392 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 75' ' ' GLY . 1.6 tp -143.59 51.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.329 0.585 . . . . 0.0 109.66 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 m -46.9 174.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.267 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -92.2 -161.31 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.667 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.22 -14.53 63.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.747 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.01 -85.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.497 0.189 . . . . 0.0 111.176 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 179.4 -35.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.592 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -45.71 137.11 5.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.754 0.311 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.7 ttm -119.8 121.15 38.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.17 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.26 -3.75 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.093 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -142.12 93.97 2.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -89.91 144.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.169 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.66 -34.86 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.357 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HB3' ' CE3' ' A' ' 105' ' ' TRP . . . -161.66 164.6 29.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.108 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.9 mttt -126.4 144.82 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -125.05 165.94 17.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 13.2 mt -147.82 123.77 10.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.378 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.68 137.72 56.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 111.749 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 117.47 7.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -59.44 -37.78 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.226 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.44 -179.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -111.37 -43.11 3.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.203 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 122.48 26.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.318 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 65.89 112.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -114.47 132.13 56.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.905 0.383 . . . . 0.0 111.246 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.16 134.83 50.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 26.6 p90 -140.96 144.24 34.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.563 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.19 156.21 47.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.858 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.493 HG21 ' N ' ' A' ' 104' ' ' ILE . 12.5 p -151.52 145.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.493 ' N ' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -110.28 136.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.214 177.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.49 ' CZ2' HG11 ' A' ' 103' ' ' VAL . 45.6 m95 -108.87 -104.13 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.739 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 153.33 6.69 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.235 0.471 . . . . 0.0 110.932 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.154 0.502 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 132.93 40.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.601 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.46 159.2 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.1 152.73 74.26 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.658 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.69 -60.21 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -65.96 -28.25 68.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -67.15 -54.21 23.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.69 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.88 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 14' ' ' ILE . 79.6 mt -47.22 -36.5 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -67.03 -39.92 87.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.32 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.11 -62.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.779 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.26 16.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.171 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.86 -54.74 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.409 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -31.77 56.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.08 -73.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.462 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CE2' ' CZ ' ' A' ' 41' ' ' PHE . 85.6 t80 -41.13 -30.35 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.817 0.342 . . . . 0.0 111.448 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -64.98 -45.1 87.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.52 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.68 -29.02 11.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -51.48 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.92 105.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.275 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.46 -82.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.703 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.47 1.1 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 6.9 m120 -93.11 -28.53 16.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.422 HD13 ' CZ3' ' A' ' 105' ' ' TRP . 3.7 tt -96.26 138.93 33.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -50.41 150.21 4.85 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.796 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 13.5 Cg_exo -70.21 25.02 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.342 2.694 . . . . 0.0 113.735 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 30' ' ' ASP . . . -120.04 -67.04 1.01 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.239 0.542 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.69 -21.69 41.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.763 178.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 30' ' ' ASP . 39.9 mt -63.33 -41.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -47.25 86.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.578 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.21 -40.61 70.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.254 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.8 t80 -58.32 -32.92 68.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.216 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -50.54 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.204 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.78 -39.13 87.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.27 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.17 -157.75 0.65 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 6.5 t80 83.85 -26.57 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -88.14 -33.2 18.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.482 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -105.86 -28.1 10.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.654 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 39.55 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.753 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 129.0 9.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.39 127.9 2.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.265 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.02 112.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.4 173.82 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 17.2 t80 -126.79 122.27 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.3 m -120.8 -165.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -124.03 171.49 9.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.1 m -60.11 161.63 6.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.56 -170.6 1.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 25.82 11.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.055 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -165.68 65.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.661 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.428 ' CZ3' ' HG3' ' A' ' 59' ' ' GLU . 4.6 m95 -95.97 -29.0 14.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.289 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.27 64.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.182 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.74 -51.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' HG3' ' CZ3' ' A' ' 56' ' ' TRP . 1.4 pm0 -78.27 -66.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.519 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 60' ' ' ILE . 29.2 pt -75.49 -38.97 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 0.0 111.429 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 83.28 81.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.601 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.47 148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 122.481 0.312 . . . . 0.0 110.344 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.86 126.54 28.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.68 94.9 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -70.47 117.5 55.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.6 152.35 74.18 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.113 1.875 . . . . 0.0 111.962 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 69.32 -1.02 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.34 -9.28 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.693 0.283 . . . . 0.0 111.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -132.75 130.9 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . . . -89.59 125.88 35.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -103.78 113.95 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.27 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.42 144.11 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.131 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.455 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 11.7 m0 -118.43 137.59 53.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.37 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 90' ' ' PHE . 51.4 t -122.95 106.29 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.426 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.32 -142.7 7.08 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.62 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.427 HD21 ' CE1' ' A' ' 87' ' ' PHE . 2.6 tp -145.06 49.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.286 0.565 . . . . 0.0 110.057 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.416 HG21 ' N ' ' A' ' 82' ' ' GLU . 13.2 p -71.15 161.85 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.288 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 80' ' ' GLN . 4.3 p30 -89.75 -140.43 0.14 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -75.01 -49.56 19.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -52.17 -18.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 50.33 49.29 20.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.088 0.47 . . . . 0.0 111.216 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' N ' HG21 ' A' ' 77' ' ' VAL . 2.0 mt-10 -95.09 23.81 5.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.469 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' GLU . 1.7 tpt 29.68 95.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' CB ' ' A' ' 85' ' ' ASP . 4.4 t70 -144.15 49.9 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 164.03 82.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.441 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -88.94 135.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 76' ' ' LEU . 5.7 m-85 -89.09 -47.88 7.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.601 0.715 . . . . 0.0 109.239 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -146.51 169.91 17.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -134.5 147.45 50.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.0 m-85 -126.28 144.24 50.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 102' ' ' HIS . 21.1 mt -133.0 127.39 34.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.718 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 148.21 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 112.535 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -67.89 129.7 40.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.725 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -75.15 -36.18 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -54.45 -178.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.6 pt-20 -104.17 -49.74 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.245 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -73.53 133.07 43.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER 58.45 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -123.13 111.37 16.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.85 132.24 53.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.407 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 9.8 p90 -123.33 140.15 53.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.0 p -150.3 141.26 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -111.11 135.71 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 84.2 m95 -109.56 148.61 30.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 153.93 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.898 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -7.08 10.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.835 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -132.27 -155.78 0.71 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.851 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.15 -48.81 2.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 110.642 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt -107.61 125.18 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.647 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.19 139.55 50.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.59 -178.42 5.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.27 143.94 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.08 149.77 93.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.01 -53.34 7.14 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.558 2.172 . . . . 0.0 112.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -33.44 70.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -65.47 -52.47 52.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 49' ' ' PHE . . . -59.67 -48.02 83.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.87 -40.7 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.87 -55.37 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.73 -53.44 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.233 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.44 77.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.22 -49.2 70.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.776 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.86 -30.84 71.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.658 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 24' ' ' MET . 23.3 mt -72.63 -27.78 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 22.2 t80 -77.23 -27.91 53.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.32 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -34.1 38.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.534 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 13.1 pt-20 -92.08 -37.47 12.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.151 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.566 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.1 mtp -76.32 -50.57 13.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -45.59 96.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.484 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.05 -115.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 111.188 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.18 -25.74 67.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.483 ' CD1' ' CE3' ' A' ' 105' ' ' TRP . 4.2 tt -94.89 150.44 20.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.007 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.09 137.22 97.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.16 -64.8 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.622 2.215 . . . . 0.0 112.985 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.17 -43.37 21.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.15 -28.68 68.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.988 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mt -67.05 -47.16 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.278 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 1.3 tp -57.95 -60.75 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.411 ' CD1' ' NE2' ' A' ' 40' ' ' GLN . 12.5 tp -46.13 -44.37 15.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.516 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.456 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.7 t80 -64.22 -26.3 68.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.802 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.92 -38.02 33.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.399 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' CD2' ' HG ' ' A' ' 35' ' ' LEU . 3.3 mm? -83.68 -40.18 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.401 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.411 ' NE2' ' CD1' ' A' ' 36' ' ' LEU . 6.6 pt20 -121.75 106.24 11.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.22 0.533 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -163.9 -38.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.025 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -63.34 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.645 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -27.93 64.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.784 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' O ' HD13 ' A' ' 76' ' ' LEU . 33.6 mtt85 -120.88 59.1 0.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 110.502 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.73 134.6 12.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.564 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.03 123.82 2.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.21 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.35 68.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.414 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.42 129.56 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.532 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 13' ' ' ALA . 57.8 t80 -90.4 94.02 9.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -90.04 178.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -104.51 -178.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 35.7 m -73.22 165.72 24.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.93 13.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.032 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.96 -28.7 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.89 46.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.34 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 91' ' ' LEU . 4.1 m95 -92.14 -42.39 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.65 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.84 64.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -161.88 -48.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.451 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.87 -73.16 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 15.2 pt -61.57 -30.12 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 93.17 45.92 3.43 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.975 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 179.5 132.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.02 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.32 141.0 58.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mm -125.13 145.86 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.17 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.35 121.27 84.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.393 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 7.1 Cg_exo -69.9 162.37 42.4 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.114 1.876 . . . . 0.0 112.142 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.02 22.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -137.15 12.98 3.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.414 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -146.18 147.17 31.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 94' ' ' HIS . . . -89.7 112.6 23.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' OE1' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -95.62 120.0 35.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -119.7 134.42 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.096 0.474 . . . . 0.0 111.079 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 9.2 m0 -122.49 117.07 25.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.679 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 54.1 t -114.72 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.426 ' O ' HD12 ' A' ' 76' ' ' LEU . . . -131.55 -135.16 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.967 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -139.79 125.88 19.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.75 175.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 111.675 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -103.78 -164.18 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -3.06 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.464 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.0 -5.15 30.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.476 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.91 96.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.667 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -148.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 tpt -178.51 58.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.387 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.59 85.74 2.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.754 0.312 . . . . 0.0 110.964 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 p -89.88 135.59 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.797 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 9.1 m-85 -91.47 -49.72 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.025 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.459 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -148.32 139.1 22.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.593 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -112.44 132.45 55.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.631 0.253 . . . . 0.0 110.565 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.2 m-85 -110.19 145.78 36.67 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 92.8 mt -127.14 105.57 8.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.177 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.37 127.5 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.2 100.36 0.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.2 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 70' ' ' ALA . 41.5 m-70 -37.09 -57.16 0.87 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.286 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -44.2 162.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.151 0.5 . . . . 0.0 111.847 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.1 pt-20 -86.0 -48.67 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -65.88 133.53 51.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.86 116.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -113.74 93.42 4.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.94 103.37 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -120.33 110.92 17.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.7 p80 -128.69 117.19 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.4 . . . . 0.0 111.148 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 7.2 p -98.1 150.27 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.479 ' CD1' ' HD2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.32 130.08 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 29' ' ' LEU . 63.8 m95 -112.11 130.01 56.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.245 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.09 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.983 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttm . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.825 0.345 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.614 ' O ' ' CG2' ' A' ' 2' ' ' THR . 1.3 m -139.16 50.93 1.8 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.564 0.697 . . . . 0.0 110.088 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -90.18 63.74 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.96 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -81.14 121.04 25.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.87 129.79 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.379 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -126.84 139.91 52.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.381 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -89.57 174.61 7.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.043 0.449 . . . . 0.0 111.358 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 147.13 62.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.94 -54.28 5.55 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.595 2.197 . . . . 0.0 112.338 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -30.06 69.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.6 m -68.36 -51.76 40.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.06 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.0 48.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.803 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -47.38 -33.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.797 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.02 -37.05 72.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.79 -62.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.053 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.13 -40.81 61.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.51 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -53.5 -57.3 11.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -61.43 -28.77 69.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 24' ' ' MET . 77.8 mt -74.34 -25.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.857 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 37' ' ' PHE . 4.4 t80 -75.13 -51.89 12.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 110.47 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -65.71 -20.74 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.28 -46.89 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -80.15 -41.12 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -52.37 150.43 4.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.386 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.95 41.26 3.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.659 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -171.64 -29.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 33.1 t30 -115.94 -35.36 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.711 0.291 . . . . 0.0 111.003 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.588 HD22 ' O ' ' A' ' 30' ' ' ASP . 2.8 tt -68.06 133.97 49.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.588 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -54.06 146.28 30.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.04 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 85.7 Cg_exo -47.64 -52.73 7.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.902 2.401 . . . . 0.0 113.017 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.4 48.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 74.1 m-20 -54.47 -32.0 56.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 29' ' ' LEU . 91.2 mt -63.73 -47.79 89.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.054 0.455 . . . . 0.0 110.046 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -50.03 -57.48 7.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.617 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' GLN . 5.5 mp -63.28 -62.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -42.61 -30.03 0.33 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -82.19 -74.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.517 . . . . 0.0 111.771 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -69.32 -29.8 67.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.252 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' LEU . 1.6 tp-100 -90.98 25.3 2.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.829 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.1 t80 -102.83 -47.6 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -55.74 -42.47 75.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -39.02 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 3.1 mmt85 -130.39 80.89 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.32 107.38 0.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 146.66 17.48 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.127 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.75 110.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.669 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.38 150.51 20.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -103.17 106.34 16.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.79 -178.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.09 172.55 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -65.38 164.71 13.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.11 162.46 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -98.45 36.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.12 33.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.422 ' CE3' HG12 ' A' ' 60' ' ' ILE . 1.9 m95 -80.36 -20.57 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.348 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.86 61.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 -47.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HG2' ' CE3' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -84.72 -64.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG12 ' CE3' ' A' ' 56' ' ' TRP . 14.0 pt -74.99 -27.59 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 70.76 79.22 0.38 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.792 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 6.9 p 164.53 139.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.671 0.272 . . . . 0.0 110.52 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -58.93 138.08 57.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.907 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 69' ' ' TYR . 26.9 mm -133.66 100.43 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.745 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.77 108.1 1.2 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.141 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.03 158.81 23.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.144 1.896 . . . . 0.0 112.366 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 76.03 -10.53 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.373 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.422 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -118.54 16.27 13.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.709 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CD2' ' CG2' ' A' ' 64' ' ' ILE . 84.8 m-85 -138.79 132.25 30.33 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.75 112.55 24.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -90.1 128.35 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.7 t -127.77 136.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.304 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 13.6 m0 -119.18 139.87 51.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.728 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG12 ' CZ ' ' A' ' 37' ' ' PHE . 13.4 t -129.37 110.58 20.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.37 -155.34 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.757 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.17 50.47 1.09 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.724 0.297 . . . . 0.0 111.367 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 76' ' ' LEU . 23.7 m -43.23 171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.204 0.526 . . . . 0.0 111.892 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -120.86 -165.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.96 -28.25 69.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -75.76 -31.0 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.29 27.73 1.06 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.367 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.51 22.85 6.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.402 ' HG3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 30.11 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.217 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -27.97 36.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.976 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.88 11.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.38 124.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.435 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.481 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 3.5 m-85 -89.2 -26.75 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.343 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.31 151.75 17.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -132.65 141.04 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.5 m-85 -120.93 148.4 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.76 117.89 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.119 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -125.0 140.26 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.09 0.471 . . . . 0.0 111.857 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.1 p -69.49 122.08 18.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.777 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 36.8 m-70 -66.0 -32.22 73.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.287 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -55.74 177.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.71 -50.53 3.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.446 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -74.3 122.46 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.502 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.16 112.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -120.71 114.88 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.702 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.58 134.95 42.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -127.08 140.26 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.612 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.09 153.29 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.118 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 11.4 p -150.17 137.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.802 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -115.56 130.25 70.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.493 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 21.2 m95 -108.75 150.64 27.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.997 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -64.05 161.06 16.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -65.99 111.93 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.506 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t -73.82 132.04 42.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -107.79 140.01 41.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 mt -91.56 124.71 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.73 -172.19 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.756 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -117.57 125.37 50.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.0 157.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.37 142.94 51.04 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -48.01 -57.28 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.529 2.153 . . . . 0.0 112.498 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -57.98 -41.54 83.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -52.94 -64.54 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.4 31.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.786 0.327 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -43.87 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -39.26 71.03 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.046 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.98 -66.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.848 0.356 . . . . 0.0 110.724 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.31 34.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -54.99 -50.84 68.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.21 -34.84 47.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.501 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.37 -69.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 30.1 t80 -41.43 -28.07 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.787 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.8 -45.35 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.702 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.72 -27.04 14.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 mtp -77.0 -46.44 23.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.734 0.302 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -57.4 -174.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.389 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.81 32.02 61.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -157.84 -28.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.8 m120 -117.11 -19.85 9.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.37 161.68 13.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.23 133.14 94.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.689 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -41.7 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.734 2.289 . . . . 0.0 113.075 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.16 37.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -56.41 -32.14 64.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.303 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.56 -50.21 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.237 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -48.79 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.208 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.47 -56.0 27.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.0 t80 -51.58 -26.16 8.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.989 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.57 -63.99 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.4 -25.65 66.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.279 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -101.91 -146.16 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.733 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 t80 70.61 -58.2 0.56 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.778 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.71 -37.12 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.8 -42.76 7.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 mmt-85 -119.08 52.14 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.83 133.06 11.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.42 113.16 0.72 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 7.0 p -150.71 99.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -107.79 146.57 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.279 0.562 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -85.19 97.92 10.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.658 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.96 176.89 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.374 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.747 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.95 163.22 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.994 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.32 13.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.11 -14.34 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.98 44.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.088 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.455 ' CZ2' HD13 ' A' ' 91' ' ' LEU . 9.0 m95 -98.8 -29.8 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.915 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -68.27 61.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -162.63 -46.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.525 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -75.74 -78.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 pt -71.65 -28.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 74.28 81.53 0.44 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.485 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.67 146.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.31 113.29 8.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.441 ' CG2' ' CD2' ' A' ' 69' ' ' TYR . 31.4 mm -109.31 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.192 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 8.6 m-20 -55.56 106.29 0.65 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.25 157.12 36.73 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.108 1.872 . . . . 0.0 112.304 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 75.25 -9.24 1.42 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.348 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 1.8 pt-20 -120.13 19.83 12.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.574 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.441 ' CD2' ' CG2' ' A' ' 64' ' ' ILE . 75.5 m-85 -141.55 139.82 33.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -91.35 114.49 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' HG3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -96.67 129.39 44.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 6.0 p -135.21 130.42 51.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.547 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.557 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 14.4 m0 -114.54 135.62 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 t -127.63 111.14 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.986 0.422 . . . . 0.0 111.094 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' O ' HD11 ' A' ' 76' ' ' LEU . . . -145.12 -131.91 2.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.403 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -138.04 158.36 44.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.83 -177.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 111.306 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -118.53 -168.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.787 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -28.45 62.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.036 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.24 -14.56 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.439 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.51 72.6 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.43 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.82 148.82 41.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.28 105.78 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.26 -4.53 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.01 88.88 2.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 p -89.69 138.22 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.827 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -89.39 -48.94 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.9 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HB1' ' CZ3' ' A' ' 105' ' ' TRP . . . -138.65 166.11 25.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -146.34 135.75 22.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.8 m-85 -126.98 144.02 51.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.468 ' CD1' ' CE1' ' A' ' 102' ' ' HIS . 3.1 mt -131.67 124.02 29.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.24 142.85 42.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 112.273 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.8 p -65.09 120.29 12.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.936 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 89.2 m-70 -62.74 -24.7 67.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -54.06 174.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.67 -65.49 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -71.64 131.52 43.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.2 112.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.33 115.98 21.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.354 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.12 120.93 38.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.103 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -124.5 143.85 50.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.327 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.513 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.76 168.95 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.351 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 13.4 p -151.05 143.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.402 HD13 ' CZ3' ' A' ' 56' ' ' TRP . 3.9 mp -112.6 110.55 32.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.338 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 55.7 m95 -96.26 149.33 21.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 110.967 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.01 155.53 32.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.938 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.01 9.04 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -177.13 136.42 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -85.97 -54.86 4.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt -112.36 127.22 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -173.58 3.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.844 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -139.79 -178.42 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.007 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.91 139.4 47.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.82 149.31 95.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.538 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.41 -59.79 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.437 2.091 . . . . 0.0 112.415 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -24.87 65.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 16' ' ' ILE . 92.7 m -76.16 -43.34 43.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . . . -65.24 -29.37 70.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -79.83 -58.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -41.4 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.641 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -70.27 -43.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.079 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.32 89.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.015 0.436 . . . . 0.0 110.356 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.416 ' OH ' ' CE1' ' A' ' 41' ' ' PHE . 5.0 t80 -51.35 -46.82 62.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.297 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -61.72 -27.91 69.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.479 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.8 mt -75.12 -30.91 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.6 t80 -68.41 -51.28 45.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.14 -16.52 63.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.662 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 2.7 tp10 -94.13 -51.14 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.656 0.265 . . . . 0.0 111.511 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.4 mtp -74.61 -44.37 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.653 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -48.68 162.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.521 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.01 54.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.553 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -151.29 -33.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.62 0.248 . . . . 0.0 111.632 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.434 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.2 t30 -126.69 -39.18 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.723 0.297 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 34' ' ' ILE . 5.5 tt -55.56 139.23 44.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' O ' HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -57.26 136.71 81.12 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.755 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.44 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 76.8 Cg_exo -48.51 -51.92 9.41 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.0 113.297 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.59 -58.74 5.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.085 0.469 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -51.69 -29.95 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.841 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.531 HG13 HD21 ' A' ' 29' ' ' LEU . 57.5 mt -69.09 -47.79 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tp -45.18 -59.64 2.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.666 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 8.8 mt -56.91 -47.31 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.254 0.55 . . . . 0.0 110.241 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -48.25 -51.66 24.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.434 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -80.3 -40.79 26.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.847 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.581 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -72.73 -9.41 58.61 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.581 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 8.9 mm-40 -126.91 -137.52 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.939 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.563 ' CE1' ' HA2' ' A' ' 46' ' ' GLY . 2.6 t80 72.15 -56.09 0.65 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.796 0.332 . . . . 0.0 111.617 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -51.82 -39.64 59.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.14 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 27.44 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.89 -4.06 3.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.83 163.2 9.88 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.56 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' HA2' ' CE1' ' A' ' 41' ' ' PHE . . . -125.19 -115.02 2.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.792 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 74' ' ' VAL . 59.6 t -132.43 136.98 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.969 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -122.99 131.78 53.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 13' ' ' ALA . 17.3 t80 -88.74 113.0 23.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.094 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 71' ' ' GLU . 34.5 m -107.69 -176.88 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -98.38 170.61 8.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 111.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.3 m -70.06 157.28 37.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.95 -156.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.136 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.1 -42.14 11.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.45 129.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.736 ' O ' HG12 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -162.42 150.54 14.4 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.415 0.626 . . . . 0.0 110.304 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.04 32.48 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.219 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -113.64 -25.34 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.226 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.87 -54.57 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.622 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.466 ' CD1' HD12 ' A' ' 64' ' ' ILE . 1.2 pt -75.91 -44.82 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.789 0.328 . . . . 0.0 110.952 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 104.41 54.37 0.79 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.107 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.448 ' CG1' ' CE1' ' A' ' 102' ' ' HIS . 14.8 p 175.95 140.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 120.927 0.394 . . . . 0.0 111.467 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.86 138.62 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.736 HG12 ' O ' ' A' ' 56' ' ' TRP . 37.2 mm -111.26 128.35 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -104.55 112.11 65.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 30.6 Cg_endo -63.92 156.08 60.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.345 2.03 . . . . 0.0 112.043 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 4.1 pt-20 54.87 9.92 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.938 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -132.37 -5.33 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -126.12 143.56 51.08 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.798 0.332 . . . . 0.0 110.645 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -96.01 128.73 43.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -111.98 117.36 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.751 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.39 129.35 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.417 ' HE1' ' HE3' ' A' ' 89' ' ' LYS . 10.9 m0 -105.6 143.91 33.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.765 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 42.9 t -137.23 101.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.207 0.527 . . . . 0.0 110.934 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.65 -120.03 0.82 Allowed Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.359 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 1.9 mm? -142.31 146.8 35.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.86 178.35 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.357 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.28 -165.72 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -22.42 66.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -80.88 -81.13 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.54 -34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -56.04 132.42 50.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.033 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 36.2 ttm -88.99 79.35 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.105 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -6.55 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.88 83.21 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.301 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.69 126.96 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.074 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.2 m-85 -89.37 -32.49 17.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.227 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.34 148.98 15.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -113.44 141.72 46.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.4 m-85 -117.83 141.68 48.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.091 0.472 . . . . 0.0 111.596 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 102' ' ' HIS . 25.0 mt -125.2 156.17 38.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.605 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.411 HG13 ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -163.8 117.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.998 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.69 104.63 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.435 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 23.9 m-70 -51.9 109.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 0.0 111.244 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -166.25 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 18.7 pt-20 -138.02 -54.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.373 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -85.23 -0.23 53.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.418 0.628 . . . . 0.0 111.306 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -162.0 102.84 1.14 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -126.48 120.86 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -108.5 112.1 24.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -118.98 139.3 51.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.532 ' CE1' HD13 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -148.65 171.22 16.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.046 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.1 p -152.05 143.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.47 ' CG1' ' HD3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.62 142.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.378 177.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.451 ' CE3' ' CD1' ' A' ' 29' ' ' LEU . 65.6 m95 -113.31 149.09 34.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 159.71 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.828 0.347 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 3' ' ' THR . 1.1 m -64.19 -32.43 74.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.578 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 2' ' ' THR . 3.1 t 46.1 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -94.87 -27.67 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.33 141.45 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -89.91 -178.66 5.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -140.21 -177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.11 144.94 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.9 148.2 71.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.92 -53.26 7.29 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.531 2.154 . . . . 0.0 112.354 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.83 -29.96 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -65.93 -56.3 12.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.62 81.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.4 mt -55.87 -42.98 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.01 -52.94 63.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.57 -59.74 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.03 -34.57 13.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.276 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -62.16 -54.08 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.68 -31.56 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' CG2' ' HG2' ' A' ' 24' ' ' MET . 55.6 mt -68.57 -71.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 41.3 t80 -40.62 -30.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.792 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.67 -39.13 58.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.852 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.51 -34.62 14.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.41 ' HG2' ' CG2' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -84.61 -35.95 22.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -62.59 129.99 43.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.24 44.69 0.47 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.629 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -176.04 -24.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -120.8 -35.1 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 30' ' ' ASP . 2.7 tt -64.47 139.6 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -44.32 139.21 3.39 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.994 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 4.1 Cg_endo -46.51 -52.51 7.3 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.961 2.441 . . . . 0.0 112.841 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.3 -57.44 10.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.97 -28.32 36.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 74.2 mt -65.79 -46.28 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.001 0.429 . . . . 0.0 110.009 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.47 -54.54 44.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.038 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.06 -59.85 4.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -47.3 -30.63 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.995 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.07 -45.23 18.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.816 0.341 . . . . 0.0 111.42 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 -79.1 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.999 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -80.95 84.52 6.41 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -133.31 -30.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.685 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.31 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.01 -39.51 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.483 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 5.5 mpt_? -72.56 -40.43 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.132 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.15 113.46 3.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.188 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.97 151.17 21.6 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -134.69 104.88 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 117.027 0.413 . . . . 0.0 110.961 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -94.38 147.42 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -97.01 134.26 40.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.45 177.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.915 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.32 148.45 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 111.133 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 88.4 m -45.55 165.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.06 -170.08 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.21 40.56 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -178.65 45.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.461 ' CZ3' HD11 ' A' ' 91' ' ' LEU . 2.5 m95 -72.01 -19.75 61.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.444 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.32 63.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.97 -57.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.16 -61.03 1.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.8 pt -86.15 -23.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.406 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.03 -54.74 3.65 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.092 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.11 153.75 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.861 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -76.29 135.9 39.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.408 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 64' ' ' ILE . 20.1 mm -130.98 116.6 34.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 111.626 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.23 122.44 87.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 29.1 Cg_endo -64.11 153.44 76.22 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.283 1.989 . . . . 0.0 112.257 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.71 3.84 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.654 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -111.2 -16.12 13.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.712 0.292 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.73 154.83 40.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.27 122.83 47.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.226 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' PHE . 9.6 pt-20 -114.6 144.59 43.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.08 0.467 . . . . 0.0 111.631 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.96 142.92 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 39.9 m0 -114.91 140.95 48.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.452 HG13 ' CE2' ' A' ' 21' ' ' PHE . 72.3 t -126.29 114.86 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 85' ' ' ASP . . . -150.65 -146.93 4.43 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.226 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 1.5 mm? -119.61 153.51 35.37 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -154.98 -168.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.857 0.36 . . . . 0.0 111.053 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -107.97 -156.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.486 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.86 -10.17 55.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.459 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -71.79 -8.75 56.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.577 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.58 78.09 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -148.37 -148.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.428 ' CA ' HG13 ' A' ' 77' ' ' VAL . 45.4 tpp -142.51 -82.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.021 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 44.12 41.01 3.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.401 ' O ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 169.31 78.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 p -90.04 134.94 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.804 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -92.73 -45.81 7.86 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.84 162.79 32.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.563 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.1 OUTLIER -138.14 140.14 39.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.5 m-85 -120.93 154.25 36.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.461 HD11 ' CZ3' ' A' ' 56' ' ' TRP . 72.7 mt -139.97 121.16 14.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.646 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.6 125.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.029 0.442 . . . . 0.0 111.847 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 p -53.94 125.98 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.946 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -55.56 -41.46 73.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.146 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -56.66 143.85 34.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -32.61 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 154.14 42.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.678 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.31 -67.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.19 84.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.06 123.18 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.772 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -119.16 139.1 52.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.8 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.84 129.14 25.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.518 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.417 HG12 ' CZ2' ' A' ' 105' ' ' TRP . 11.4 p -122.48 140.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.581 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.429 HG13 ' HD3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -116.44 131.88 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 28.1 m95 -108.62 149.84 28.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.47 159.49 12.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.858 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.918 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.05 24.44 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -77.35 119.08 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.721 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -111.23 104.76 13.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 mm -71.04 128.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.325 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.03 166.73 11.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.648 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -125.45 116.82 22.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.839 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.31 10.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.79 160.06 29.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -57.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.674 2.249 . . . . 0.0 112.171 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -31.19 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -64.81 -47.3 78.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.45 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -63.81 -50.66 68.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.4 mt -49.09 -36.58 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -38.18 72.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.722 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.9 mt -67.35 -63.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.1 -39.8 21.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.417 ' CE2' HD21 ' A' ' 22' ' ' LEU . 30.8 t80 -55.7 -51.38 67.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.191 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -30.06 70.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 24' ' ' MET . 96.3 mt -64.27 -46.51 93.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -63.45 -52.16 62.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.447 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -59.19 -22.68 61.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.404 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 1.3 pp20? -103.94 -48.43 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 4.1 mtp -67.44 -57.41 6.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' ' CH2' ' A' ' 105' ' ' TRP . . . -45.94 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.026 0.441 . . . . 0.0 111.79 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -48.11 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.98 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -146.19 23.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.778 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 7.1 m-80 -102.89 -48.09 4.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -87.84 143.14 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.845 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.99 150.96 0.55 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.45 -19.45 13.4 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.595 2.197 . . . . 0.0 112.592 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.23 72.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.459 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -74.5 -28.65 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.419 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.17 -50.14 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.926 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -74.04 -42.91 59.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 1.4 tp -57.7 -64.46 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.4 . . . . 0.0 110.491 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 5.2 m-85 -45.41 -29.87 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.163 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.548 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -64.77 -9.63 21.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 20.7 pt20 -151.35 116.1 5.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 112.322 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' CA ' ' A' ' 45' ' ' GLY . 11.1 t80 -169.75 -38.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.938 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.48 -65.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -40.08 88.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.576 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -95.89 28.37 3.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.088 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 41' ' ' PHE . . . -94.9 120.84 6.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.606 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.34 98.22 0.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.303 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.18 97.27 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.65 137.43 35.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.822 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 75.2 t80 -92.2 116.39 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -168.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -135.3 153.7 51.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 22.4 m -56.14 162.33 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.076 0.465 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.409 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -105.45 -151.24 0.45 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.042 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.96 31.24 0.98 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.766 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 79.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -97.87 46.95 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.433 . . . . 0.0 111.195 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER -69.04 61.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.47 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -130.41 -39.22 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.45 -38.3 12.65 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 64' ' ' ILE . 4.7 pt -95.27 -26.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.049 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 90.73 -46.46 2.94 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.299 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG23 ' CE1' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -62.43 159.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.941 0.401 . . . . 0.0 111.764 -178.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 64' ' ' ILE . 4.3 mm? -78.27 135.24 37.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.627 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -112.76 90.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.372 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 1.2 m-20 -75.79 113.52 27.88 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.53 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 5.7 Cg_exo -41.36 -72.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.194 2.596 . . . . 0.0 114.524 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -74.61 8.87 2.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 65' ' ' ASP . 8.3 mt-10 -121.34 -14.44 8.29 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.623 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.4 145.0 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.122 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 91' ' ' LEU . . . -112.75 140.47 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.643 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -112.57 139.36 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.404 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.51 138.35 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.953 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -120.14 131.98 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.008 0.433 . . . . 0.0 111.162 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.6 t -121.83 113.01 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.512 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.39 -124.15 2.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.216 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -146.94 71.64 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.052 0.453 . . . . 0.0 109.857 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 82' ' ' GLU . 33.7 m -55.45 173.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 0.0 112.096 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -147.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.717 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 -5.44 16.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.8 34.65 5.12 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.664 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.31 87.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.742 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.42 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 3.3 mt-10 -156.43 155.98 33.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.881 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.2 tpp -142.63 104.1 4.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.285 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.77 -18.58 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.263 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.68 109.19 11.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.949 0.404 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.56 137.11 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -89.56 -33.6 16.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.724 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 172.93 17.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.437 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 6.6 mttm -130.57 147.37 52.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.2 m-85 -125.45 134.57 52.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 112.026 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 102' ' ' HIS . 15.0 mt -122.41 136.05 54.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.775 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 116.74 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.081 0.467 . . . . 0.0 111.835 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.7 m -46.99 149.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -89.78 23.06 2.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.558 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -92.73 165.52 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.81 -59.27 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.09 121.24 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.395 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.19 110.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.05 140.1 47.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.944 0.402 . . . . 0.0 111.228 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.9 141.85 36.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.36 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -138.15 142.03 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.511 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -144.24 130.67 19.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.211 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -119.94 140.53 43.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.84 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.31 135.2 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.784 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' A' ' 25' ' ' ALA . 38.5 m95 -106.93 147.49 29.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.62 155.92 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -165.61 -53.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.537 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.9 t -167.53 109.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.33 -59.7 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 mm -97.57 133.6 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 129.78 44.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -93.45 -170.95 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.65 144.71 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 147.83 79.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.74 -49.52 16.96 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.565 2.177 . . . . 0.0 112.347 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -30.25 65.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -66.44 -49.76 65.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.14 90.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.4 mt -59.79 -34.43 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -44.09 76.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.0 mt -64.97 -54.78 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.55 73.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.21 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.48 -52.04 66.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.56 -32.04 71.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 24' ' ' MET . 19.4 mt -73.71 -28.75 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 32.5 t80 -77.26 -25.77 51.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.368 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.11 -32.63 50.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.254 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.01 -38.18 9.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.174 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -75.95 -50.11 15.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.63 0.252 . . . . 0.0 111.577 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -49.12 111.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.406 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.41 -96.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.852 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.95 -4.48 52.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.1 m120 -90.54 -31.45 16.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 30' ' ' ASP . 2.5 tt -92.66 139.27 30.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.65 132.9 13.94 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.976 -178.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 84.4 Cg_exo -42.07 -56.6 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.261 2.641 . . . . 0.0 113.627 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 -57.22 5.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 0.0 110.76 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.95 -27.13 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.978 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 51.3 mt -68.57 -53.48 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.129 0.49 . . . . 0.0 110.234 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -49.75 -60.38 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.181 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.409 ' CD1' ' NE2' ' A' ' 40' ' ' GLN . 4.5 mm? -51.05 -40.29 57.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.074 0.464 . . . . 0.0 110.664 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.5 t80 -64.97 -32.63 74.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.423 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.57 -39.12 28.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.18 -40.75 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.751 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.409 ' NE2' ' CD1' ' A' ' 36' ' ' LEU . 8.9 pt20 -128.98 106.38 8.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 111.811 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 34.6 t80 -165.02 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.232 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -31.75 72.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.281 0.563 . . . . 0.0 110.09 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.7 -22.65 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.113 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -130.36 31.99 4.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.997 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -120.09 114.14 2.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.773 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.94 165.94 22.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.115 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.3 t -146.0 122.43 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.764 0.282 . . . . 0.0 110.57 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.38 164.07 13.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.346 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.8 108.16 19.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.8 -178.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.39 -175.62 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.9 m -91.12 162.34 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.07 -160.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.26 -45.48 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.8 127.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 59' ' ' GLU . 15.9 m0 -87.42 -75.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.533 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 1.5 mm-40 43.57 31.24 0.42 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -155.43 -37.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.865 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 24.1 mm-40 -82.12 -74.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.438 HD13 ' CE1' ' A' ' 102' ' ' HIS . 19.1 pt -82.13 -46.86 19.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.259 . . . . 0.0 111.67 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 119.67 69.32 0.31 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.6 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 13.0 p 175.57 151.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 57' ' ' GLU . 4.4 tt -64.91 -5.98 7.34 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 56' ' ' TRP . 6.9 mm 59.19 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.209 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -112.92 82.35 5.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.902 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -53.05 168.02 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.961 1.774 . . . . 0.0 111.837 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 56.25 12.47 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 27.7 mt-10 -135.15 -3.41 2.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.348 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 84.4 m-85 -132.11 142.26 49.45 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.06 34.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.888 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.34 119.91 38.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.66 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.8 137.03 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.109 0.48 . . . . 0.0 111.052 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.535 ' CD1' ' HB2' ' A' ' 89' ' ' LYS . 1.4 m0 -115.17 141.01 48.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.64 103.74 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.964 0.412 . . . . 0.0 111.356 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.44 20.56 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.703 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.458 ' CD2' ' CE2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -102.32 153.16 20.27 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.11 -167.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.699 0.285 . . . . 0.0 110.778 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -103.62 -170.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -79.54 -13.35 59.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -74.26 -5.05 39.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.534 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.36 88.82 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.412 . . . . 0.0 111.017 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.46 -168.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -160.06 91.61 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.362 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -118.74 -9.93 10.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.137 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.74 84.75 2.26 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.958 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 73' ' ' TRP . 1.5 p -89.91 140.49 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -98.52 -29.7 12.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.43 ' CB ' ' CZ3' ' A' ' 105' ' ' TRP . . . -151.9 167.95 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 73' ' ' TRP . 17.1 ttpt -142.44 139.77 31.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.5 m-85 -122.73 145.89 48.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 102' ' ' HIS . 94.3 mt -124.52 119.35 28.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.188 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -130.08 122.35 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.819 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.411 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -55.95 118.46 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.498 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -56.39 -38.67 71.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -59.66 176.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -32.33 10.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.037 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -79.67 150.39 30.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.717 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 40.53 31.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.206 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.06 103.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.072 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -117.83 137.26 52.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.067 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 12.3 p90 -134.81 137.94 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -139.17 159.49 42.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.439 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 7.3 p -151.02 142.71 16.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.457 HD12 ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.52 140.95 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.066 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 32.9 m95 -116.99 149.88 39.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 158.63 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.883 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpp? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.775 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.564 ' O ' ' CG2' ' A' ' 2' ' ' THR . 1.1 m 64.88 13.83 8.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 t -144.25 -166.2 2.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.796 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -144.97 69.83 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt -88.39 142.25 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 173.46 7.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.003 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -112.93 127.15 56.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.46 142.54 57.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' O ' HD21 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -46.28 169.6 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.706 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.79 -59.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.95 2.433 . . . . 0.0 112.287 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.19 -28.53 68.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -57.18 -57.49 12.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.1 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.44 HG13 ' CD2' ' A' ' 49' ' ' PHE . 53.0 mt -45.04 -36.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.999 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.13 -39.89 75.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.557 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mm -61.87 -64.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.808 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' A' ' 72' ' ' VAL . . . -47.96 -41.42 24.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -51.52 -54.82 23.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.206 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -25.76 67.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.357 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' MET . 70.1 mt -75.95 -23.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.427 ' CD2' HG11 ' A' ' 74' ' ' VAL . 33.0 t80 -80.02 -32.49 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.426 . . . . 0.0 110.615 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.33 -19.57 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.72 -41.12 6.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -78.5 -45.05 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -61.14 159.72 11.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.341 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.05 40.04 4.69 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.566 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.3 -21.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.459 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.9 m-80 -110.35 -43.79 3.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.776 0.322 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 87' ' ' PHE . 3.0 tt -75.94 151.74 37.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.03 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -48.37 155.13 0.98 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.93 -30.64 86.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.793 2.329 . . . . 0.0 112.711 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.04 -58.61 5.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 111.373 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 46.2 t0 -64.5 -27.87 69.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.382 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.04 -43.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.435 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.434 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -80.16 -44.11 20.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -62.8 -70.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.485 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 1.3 t80 -48.48 -26.11 1.99 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.561 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.09 -52.15 11.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' CD2' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -69.98 -72.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.372 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.47 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 20.2 pt20 -77.19 -135.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 14.8 t80 87.51 -27.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.896 0.379 . . . . 0.0 110.622 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.35 -65.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.16 -30.56 11.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -24.23 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.58 128.24 8.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.686 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.08 153.18 24.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.114 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -139.09 125.68 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.643 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -108.8 157.51 18.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.44 ' CD2' HG13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -112.82 114.59 27.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 71' ' ' GLU . 12.8 m -113.7 -177.3 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -111.42 168.06 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.58 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 66' ' ' PRO . 8.3 m -54.06 154.75 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 56' ' ' TRP . . . -86.42 -163.53 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -95.43 37.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.887 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 3.0 t0 80.12 109.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -134.97 30.07 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.481 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 77.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' TRP . 4.0 mt-10 -154.87 -34.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.349 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.21 -49.66 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.97 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 60' ' ' ILE . 4.1 pt -70.69 -36.67 66.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 0.0 110.978 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 94.26 60.24 1.12 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.092 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.42 141.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.03 135.87 52.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.9 mm -105.54 128.01 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 111.538 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.68 109.94 39.3 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.385 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 52' ' ' THR . 26.9 Cg_endo -61.95 156.08 51.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.244 1.962 . . . . 0.0 112.111 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 62.04 8.28 2.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.87 -4.35 8.6 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.58 0.229 . . . . 0.0 111.427 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -148.01 135.35 20.54 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.945 0.402 . . . . 0.0 111.443 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -91.04 123.45 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.994 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' CG ' HG21 ' A' ' 50' ' ' VAL . 23.1 tt0 -101.7 119.66 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.946 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 7.0 p -127.91 124.34 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.72 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.494 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 24.9 m0 -89.84 141.74 28.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 21' ' ' PHE . 88.7 t -129.32 96.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.5 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.88 -141.31 3.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.363 -0.923 . . . . 0.0 113.853 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.34 172.09 13.16 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -153.67 163.93 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.45 -152.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -91.64 26.1 2.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 82' ' ' GLU . 5.8 pt20 -108.94 -0.4 19.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.443 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.18 38.15 28.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.749 0.309 . . . . 0.0 111.574 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 5.3 mm-40 -98.26 -158.37 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.387 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -163.44 32.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.71 0.69 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.31 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.65 73.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.979 0.419 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.88 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 8.4 m-85 -89.72 -41.66 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.99 162.46 39.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.573 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HB2' HD11 ' A' ' 104' ' ' ILE . 22.9 mttt -118.26 143.71 46.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 3.2 m-85 -124.04 136.77 54.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.076 0.465 . . . . 0.0 112.199 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.477 HD12 ' CE1' ' A' ' 102' ' ' HIS . 24.4 mt -121.27 124.32 44.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.858 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -119.27 122.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.29 127.74 33.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.022 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.46 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 98.7 m-70 -75.78 -4.47 40.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.729 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.34 116.89 24.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -40.36 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.268 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 149.24 46.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.66 -65.57 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.4 OUTLIER 61.91 92.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' N ' ' NH1' ' A' ' 99' ' ' ARG . 7.7 mm-40 -113.91 145.83 40.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.495 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 39.7 p90 -137.82 143.82 41.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.901 0.381 . . . . 0.0 111.817 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.67 150.47 46.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.43 HG22 ' N ' ' A' ' 104' ' ' ILE . 10.9 p -150.17 142.31 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.69 138.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 178.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 46.4 m95 -113.86 147.03 39.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.15 152.01 41.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mmm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.828 0.346 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -65.43 -46.23 80.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.557 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.3 t -151.05 -43.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.967 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -110.35 166.98 10.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mt -125.84 152.61 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -89.97 127.72 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.634 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -177.38 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.49 159.33 26.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.29 146.82 38.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.795 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.94 -54.51 5.33 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.13 -33.63 75.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.032 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 16' ' ' ILE . 86.8 m -68.15 -46.55 70.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.77 76.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.797 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.2 mt -61.76 -58.07 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.074 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.03 -31.17 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.117 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 12' ' ' THR . 3.4 mm -70.25 -59.07 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.2 86.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.2 -45.0 65.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -62.6 -40.19 96.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.825 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.4 mt -77.44 -15.92 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -73.07 -61.98 1.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.43 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.24 -4.89 38.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.03 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.1 tt0 -96.75 -52.33 3.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.812 0.339 . . . . 0.0 110.991 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.437 ' O ' ' C ' ' A' ' 25' ' ' ALA . 2.1 ttp -75.07 -37.12 61.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 24' ' ' MET . . . -27.62 141.53 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.145 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.72 -86.01 0.4 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 7.9 mt-10 -71.75 69.08 0.65 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.559 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 169.17 -43.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.773 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD11 ' CZ3' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -86.61 161.47 18.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.094 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -86.89 149.99 49.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.973 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.1 Cg_endo -50.95 -55.01 4.49 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.033 2.489 . . . . 0.0 113.336 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.29 -59.4 4.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.79 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.36 -24.22 42.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 40.5 mt -71.97 -39.46 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.056 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tt -59.83 -52.68 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.814 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -57.18 -46.6 82.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.243 0.544 . . . . 0.0 110.473 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 1.9 t80 -55.03 -23.06 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.773 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' HD21 ' A' ' 39' ' ' LEU . 22.1 m120 -80.59 -41.01 24.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 38' ' ' ASN . 0.8 OUTLIER -104.11 14.13 31.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -147.68 23.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.085 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.5 t80 -112.1 -12.81 13.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.177 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.92 -35.26 17.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.19 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.82 -24.78 9.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.876 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 27.66 8.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.671 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.71 110.12 3.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.025 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.47 140.67 11.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.682 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG13 ' CG2' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.76 140.38 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.925 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -125.53 131.01 52.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.981 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -73.32 114.88 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.602 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -173.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -114.08 -175.75 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.667 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 32.9 m -93.47 161.78 14.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -153.35 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.96 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.43 -45.1 10.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 3.4 p-10 172.11 93.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -107.84 47.65 0.88 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 64.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.368 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -151.44 -41.44 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.07 -55.2 5.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 60' ' ' ILE . 9.3 pt -84.34 -13.72 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.323 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 63.49 77.5 0.22 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 169.76 149.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.32 . . . . 0.0 110.76 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 125.4 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 7.4 mm -100.72 145.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -143.2 95.78 5.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.245 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 7.3 Cg_endo -49.54 160.41 1.06 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.465 2.11 . . . . 0.0 112.197 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.57 -59.25 0.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.548 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.59 -28.99 15.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.074 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.36 146.84 47.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 91' ' ' LEU . . . -99.52 140.17 34.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.258 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.74 129.75 53.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.01 0.433 . . . . 0.0 111.461 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.6 123.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.16 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.537 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 17.0 m0 -106.43 145.74 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.587 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.428 ' CG2' HG13 ' A' ' 47' ' ' VAL . 4.8 t -127.28 101.96 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.13 -143.49 9.05 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.591 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' A' ' 44' ' ' ARG . 2.1 tp -138.96 61.48 1.57 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.401 0.62 . . . . 0.0 110.18 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 6.9 m -47.33 174.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.612 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -130.95 -131.51 0.2 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.983 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -77.81 -22.12 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -90.23 0.21 Allowed 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.131 -0.356 . . . . 0.0 111.653 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 2.6 p30 -173.51 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.93 104.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 110.328 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.631 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 6.5 ptp -50.14 -26.03 4.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.478 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.73 -20.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -157.32 131.09 8.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.48 135.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -89.44 -35.84 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.431 ' HB3' ' CE3' ' A' ' 105' ' ' TRP . . . -157.79 163.38 38.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.301 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.537 ' HD3' ' CE2' ' A' ' 73' ' ' TRP . 1.4 mttt -132.38 147.1 52.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.4 ' CZ ' HG21 ' A' ' 103' ' ' VAL . 27.9 m-85 -134.61 135.46 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.465 HD11 ' ND1' ' A' ' 102' ' ' HIS . 3.0 mt -120.54 131.13 54.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.082 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -132.97 136.59 55.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -63.92 128.85 37.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.669 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -72.85 -25.14 61.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.321 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.69 156.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.67 -61.33 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ASP . 11.4 pt-20 -85.44 151.41 24.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER 49.8 103.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.814 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.16 126.88 43.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.33 141.27 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.056 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -135.33 142.04 45.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.207 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.571 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.91 128.08 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.383 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 89' ' ' LYS . 5.1 p -115.18 136.45 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.287 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.423 ' N ' HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -105.37 119.42 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.934 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.559 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 83.9 m95 -101.91 149.37 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.66 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -64.26 150.76 45.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.85 0.357 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -102.78 -50.15 3.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.556 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 t -167.52 99.67 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.853 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -118.3 75.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.6 mm -117.92 129.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.464 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -150.16 16.68 0.84 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.239 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.99 160.84 43.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.13 153.19 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.485 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.04 149.89 94.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.92 -55.42 3.24 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.571 2.181 . . . . 0.0 112.49 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.23 -31.15 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.207 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -64.5 -61.32 2.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.64 -44.64 81.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.41 -38.78 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -49.22 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -57.06 -49.66 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.956 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.48 67.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.132 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.55 -57.38 12.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.801 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.44 -41.91 61.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.5 mt -60.56 -70.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.737 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 20.3 t80 -39.55 -33.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.751 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.69 -41.99 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.005 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.24 -36.31 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.94 -57.11 7.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.169 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HA ' HD22 ' A' ' 28' ' ' ASN . . . -48.65 112.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.46 -90.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.07 4.53 52.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.569 0.223 . . . . 0.0 111.387 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.589 HD22 ' HA ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -101.8 -21.95 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.478 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . 3.2 tt -103.84 143.68 32.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.89 130.72 21.83 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.89 -44.36 22.64 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.92 2.414 . . . . 0.0 113.136 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.0 36.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.451 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.407 ' HB2' HD21 ' A' ' 29' ' ' LEU . 29.7 m-20 -55.72 -25.87 42.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.062 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 30' ' ' ASP . 52.0 mt -65.38 -54.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.983 0.421 . . . . 0.0 110.204 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.38 -48.93 55.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.644 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.1 mt -60.01 -68.23 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.401 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -45.04 -32.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.006 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.84 -37.95 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.326 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -19.27 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -144.53 115.82 8.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.064 0.459 . . . . 0.0 111.19 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -171.56 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.52 -33.1 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.306 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.87 -24.1 16.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.352 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.05 43.4 3.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.724 0.297 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.18 125.6 8.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.57 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.18 113.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 t -108.48 117.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.715 0.293 . . . . 0.0 110.576 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -111.69 163.43 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -104.33 118.97 37.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.91 177.8 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.095 0.474 . . . . 0.0 111.668 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.91 152.63 21.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 m -67.84 154.77 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.588 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 56' ' ' TRP . . . -79.51 -152.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.41 -46.49 9.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' TRP . 8.0 p-10 -161.13 -41.35 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.573 ' O ' ' O ' ' A' ' 55' ' ' ASP . 3.0 p-90 22.92 114.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -139.72 19.03 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.975 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -96.49 -26.81 15.15 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.96 -68.31 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.49 HG13 ' N ' ' A' ' 61' ' ' GLY . 23.1 pt -63.48 -42.58 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.085 0.469 . . . . 0.0 110.431 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.49 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 130.89 -63.75 0.62 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.676 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -81.7 -179.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -77.23 168.77 19.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.56 HG13 ' CE2' ' A' ' 56' ' ' TRP . 21.5 mm -135.07 145.23 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.081 0.467 . . . . 0.0 111.63 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.52 107.36 36.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.201 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 32.8 Cg_endo -64.03 152.41 81.07 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.101 1.867 . . . . 0.0 112.101 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 72.33 -3.95 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.399 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -107.69 -16.62 14.29 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.952 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -137.91 146.93 43.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.06 137.78 32.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.578 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 51' ' ' GLU . 8.2 mm-40 -107.58 130.39 54.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 90' ' ' PHE . 14.1 p -135.06 106.75 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.71 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 86' ' ' VAL . 8.2 m0 -89.17 138.92 30.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.345 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.81 112.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.475 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 -125.71 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.922 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tp -146.15 61.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.078 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 t -57.13 159.26 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.617 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.02 -170.49 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -31.42 72.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.808 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -69.29 -11.99 61.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.366 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.41 33.05 0.7 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.801 0.334 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.36 130.55 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.5 ttm -102.93 122.68 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.64 -19.79 11.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 132.13 43.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.429 HG12 ' CZ3' ' A' ' 73' ' ' TRP . 0.7 OUTLIER -103.51 144.42 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -107.02 -23.84 12.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB1' ' CE3' ' A' ' 105' ' ' TRP . . . -175.77 175.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.435 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 1.4 mttp -141.46 139.12 33.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.524 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 1.1 m-85 -126.66 131.39 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.203 0.525 . . . . 0.0 112.24 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.443 HD11 ' ND1' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -115.21 130.06 56.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.988 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -131.09 132.54 63.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -64.14 130.06 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -77.31 -18.61 57.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.468 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -67.56 168.12 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.084 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.71 -69.26 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 98' ' ' ASP . 7.9 mt-10 -61.12 144.34 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.125 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER 57.7 115.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.233 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.81 90.49 3.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.787 0.327 . . . . 0.0 110.274 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -89.65 126.62 35.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 28.4 p90 -146.28 138.39 25.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.715 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -133.94 134.47 42.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.429 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.3 p -114.39 146.8 18.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 4.8 mp -111.63 138.58 39.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.233 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.479 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 57.2 m95 -122.61 147.4 46.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.111 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.79 144.74 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.883 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 2' ' ' THR . 3.1 t -82.34 59.06 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.184 0.516 . . . . 0.0 110.661 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p 60.73 -171.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.772 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 97.64 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -127.36 165.04 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.743 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.61 -179.46 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.791 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -135.58 171.24 14.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.42 159.34 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.12 157.71 34.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.12 -50.32 7.65 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.551 2.167 . . . . 0.0 112.202 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.9 -30.07 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -48.44 63.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.59 87.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.57 -41.27 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -52.22 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -70.76 -39.02 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.64 -41.34 97.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -60.81 -46.27 91.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.229 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.17 -34.44 75.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.233 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 24' ' ' MET . 58.2 mt -67.13 -46.71 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.637 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 21.8 t80 -51.83 -56.75 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.74 -12.33 60.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.752 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.0 tp10 -93.62 -60.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -76.14 -38.28 56.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -47.34 110.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 111.407 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.64 -92.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.872 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.33 -2.97 47.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.6 m-80 -95.77 -28.79 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 30' ' ' ASP . 5.8 tt -92.92 157.41 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.425 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.545 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -80.44 149.91 69.47 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 111.69 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.62 -47.85 21.3 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.827 2.352 . . . . 0.0 113.38 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.95 0.97 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 111.899 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.29 -23.15 63.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.504 HG13 HD22 ' A' ' 29' ' ' LEU . 13.9 mt -70.99 -35.02 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.907 0.384 . . . . 0.0 110.213 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -69.06 -48.35 63.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.806 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 2.0 mt -60.19 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.7 t80 -39.68 -31.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.308 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -74.08 -49.2 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.615 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 2.4 mm? -82.86 -20.12 36.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -136.39 111.23 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -174.66 -49.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.321 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -51.4 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 52.71 0.88 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 0.0 111.198 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 122.71 7.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.64 119.92 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.289 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.76 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.35 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.86 136.73 36.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -87.06 133.28 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.96 -169.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.689 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -127.92 171.19 12.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.682 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -63.57 154.56 32.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 56' ' ' TRP . . . -88.42 -160.91 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.951 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -94.15 33.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.208 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 2.1 m-20 83.73 112.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.728 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.4 OUTLIER -138.74 33.33 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -59.62 79.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -155.95 -37.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.85 -47.51 7.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.663 0.268 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 60' ' ' ILE . 1.7 pt -74.52 -28.98 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.015 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 79.21 69.05 1.43 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.459 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.435 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 172.99 140.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 110.682 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -53.56 136.36 38.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.802 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 14.1 mm -110.09 131.69 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.446 . . . . 0.0 111.649 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -134.82 104.67 10.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.051 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 34.3 Cg_endo -64.67 160.59 39.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.164 1.91 . . . . 0.0 112.441 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER 74.39 -8.3 1.5 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.207 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.2 pt-20 -118.59 -5.42 10.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.177 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.473 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 60.2 m-85 -131.99 147.99 52.49 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.955 0.407 . . . . 0.0 110.825 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.35 128.66 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.051 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -96.65 132.89 41.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.0 111.492 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.39 135.23 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.728 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 89' ' ' LYS . 6.0 m0 -118.57 135.72 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.048 0.451 . . . . 0.0 111.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.73 109.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.77 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.76 -136.76 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.074 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.06 59.26 1.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 109.863 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -46.84 141.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.93 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -89.46 -129.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.229 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.537 ' C ' ' HG3' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -101.58 -176.75 3.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.299 0.571 . . . . 0.0 109.999 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HG3' ' C ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER 40.62 19.08 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.422 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' GLU . 1.7 t70 73.45 76.65 0.13 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.828 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -152.13 123.99 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.261 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.62 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 21.2 ttm -101.29 -71.98 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.047 0.451 . . . . 0.0 110.688 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -19.24 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 83' ' ' MET . 2.0 m-20 -139.2 115.26 10.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.46 149.27 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.514 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -97.1 -36.14 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . -160.59 167.97 25.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.923 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.526 ' HD2' ' CE2' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -129.87 147.12 51.6 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.2 m-85 -130.83 135.95 48.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 HD11 ' ND1' ' A' ' 102' ' ' HIS . 2.6 mt -128.5 131.91 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.446 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.19 129.98 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.164 0.507 . . . . 0.0 112.147 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.68 135.61 46.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.936 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -75.19 -21.02 59.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 174.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.266 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 -57.35 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 123.5 30.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.78 110.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.67 139.5 45.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.24 142.26 42.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.445 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -136.09 142.46 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.007 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.565 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.92 132.73 34.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.176 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.426 HG13 ' CZ2' ' A' ' 105' ' ' TRP . 14.2 p -122.1 144.4 31.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.516 ' HB ' ' CG ' ' A' ' 89' ' ' LYS . 1.9 mp -101.25 135.33 38.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.393 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 84.7 m95 -117.65 -90.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.73 131.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.8 mttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.866 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.794 0.33 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.04 158.8 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.296 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -104.91 -15.33 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.243 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.17 138.4 52.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.44 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 144.03 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -89.81 -172.93 3.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.629 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -141.94 172.9 12.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.362 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.6 169.61 9.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.639 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.45 144.59 29.01 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.571 0.224 . . . . 0.0 110.49 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.35 -53.64 6.77 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.494 2.129 . . . . 0.0 112.593 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -53.76 -37.42 63.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.367 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.5 ' O ' HG12 ' A' ' 16' ' ' ILE . 65.2 m -82.28 -35.27 28.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.416 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -64.96 -32.95 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.93 -59.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.002 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.6 -29.47 1.84 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.204 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 12' ' ' THR . 1.1 pp -78.62 -45.08 25.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.615 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.82 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.039 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.26 -45.01 96.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.106 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -24.91 63.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 34.8 mt -75.37 -28.47 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.492 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.421 ' CE2' ' CZ ' ' A' ' 37' ' ' PHE . 23.6 t80 -80.36 -41.85 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.85 -3.76 49.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 7.6 pt-20 -116.97 -45.07 2.78 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 ttp -85.9 -45.55 11.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -51.99 122.93 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.745 0.307 . . . . 0.0 111.49 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.56 -67.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -7.83 59.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -100.0 -72.56 0.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 30' ' ' ASP . 5.3 tt -63.96 127.62 32.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.263 0.554 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.58 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -40.24 153.42 0.21 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.642 -178.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.73 -33.09 55.61 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.717 2.278 . . . . 0.0 112.667 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.38 -55.76 27.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 111.296 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.54 -22.82 66.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.436 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 30' ' ' ASP . 97.0 mt -72.75 -47.46 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.51 -45.47 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.335 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.25 -57.44 10.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -55.77 -34.81 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.776 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.66 -44.28 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.498 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -77.22 -14.49 59.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.139 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.498 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 1.6 mm100 -120.36 -144.97 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.224 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 1.2 t80 83.1 -19.38 0.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.488 0.315 . . . . 0.0 111.632 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.77 -39.82 17.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.74 -29.92 8.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -115.76 27.54 9.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.002 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.71 114.54 4.46 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.402 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.33 146.49 16.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.763 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.0 t -146.77 118.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.94 155.37 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.444 . . . . 0.0 111.522 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 70.4 t80 -101.55 133.94 45.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.68 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.54 -173.17 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.446 . . . . 0.0 110.737 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 16.0 m -83.81 169.82 14.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.467 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -97.14 -160.31 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 3.7 p30 -93.77 30.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.518 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 t0 85.57 108.86 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.21 69.59 1.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.798 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 17.7 mt-10 -80.76 53.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.316 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 -49.65 2.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -83.21 -53.28 5.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' CD1' ' CD1' ' A' ' 64' ' ' ILE . 6.3 pt -81.59 -34.99 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.935 0.398 . . . . 0.0 109.954 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 57' ' ' GLU . . . 88.37 -39.72 3.11 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.55 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.473 HG12 ' CE1' ' A' ' 102' ' ' HIS . 4.1 p -58.16 154.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 111.647 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.53 120.34 16.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.475 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 2.3 mm -98.64 160.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.376 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.17 117.92 4.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 27.2 Cg_endo -62.2 152.46 75.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.308 2.005 . . . . 0.0 112.3 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -65.22 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -24.86 7.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.443 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 2.7 m-85 -110.93 149.28 30.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' LEU . . . -118.38 123.89 46.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.353 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -102.25 144.25 31.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.27 0.557 . . . . 0.0 111.367 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 90' ' ' PHE . 1.8 t -132.74 140.41 47.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.584 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 17.6 m0 -114.9 132.48 56.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.0 111.177 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 90' ' ' PHE . 62.1 t -124.98 97.59 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.628 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -126.17 -133.4 3.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.588 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -140.69 83.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.135 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 35.0 m -64.34 178.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.0 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -115.64 -171.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.96 -16.85 64.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.262 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -97.27 26.55 4.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.293 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 39.82 55.4 2.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.904 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.42 104.63 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 35.8 ttm -69.79 117.56 11.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 19.82 17.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.655 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 104.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.814 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 p -89.57 142.43 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.11 0.481 . . . . 0.0 111.524 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 13.9 m-85 -89.81 -33.74 16.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.691 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HB1' ' CE3' ' A' ' 105' ' ' TRP . . . -166.53 165.76 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.736 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' ILE . 8.9 mttt -132.16 146.23 51.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.3 m-85 -126.3 130.21 50.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.458 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.538 HD12 ' ND1' ' A' ' 102' ' ' HIS . 5.2 mt -110.78 135.6 51.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.83 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.03 123.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.577 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 156.75 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.758 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' NE2' ' CB ' ' A' ' 70' ' ' ALA . 20.4 m-70 -101.92 23.02 12.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.086 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -87.4 148.15 25.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.0 111.106 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -61.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.73 158.48 15.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 44.72 94.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.2 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.98 151.66 27.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.144 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -130.53 140.76 50.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 24.3 p90 -138.19 142.75 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -137.68 161.98 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.875 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 104' ' ' ILE . 11.9 p -150.6 143.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.12 137.26 43.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.538 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.563 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 27.2 m95 -117.02 149.83 39.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.26 28.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.877 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 129.75 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 p -93.51 -14.68 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 78.18 21.5 0.86 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.787 0.327 . . . . 0.0 110.996 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mm -129.77 128.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -130.07 161.5 30.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -98.32 -172.82 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.11 143.06 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.777 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 150.83 14.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.785 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.92 -50.18 10.94 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.164 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -21.98 60.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.205 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -82.43 -49.15 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -63.22 -36.19 82.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.258 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -72.24 -57.55 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -44.74 -48.42 10.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.736 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.72 -45.33 88.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.088 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.67 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.045 0.45 . . . . 0.0 110.265 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.5 -36.43 71.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.922 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.32 -27.24 62.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.822 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' MET . 49.3 mt -74.1 -33.16 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 47.8 t80 -78.25 -23.63 47.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.07 0.462 . . . . 0.0 110.411 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.28 -33.29 37.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.238 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.18 -34.26 11.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.285 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 27.9 mtp -83.08 -50.9 8.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.523 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HA ' ' CH2' ' A' ' 105' ' ' TRP . . . -55.14 138.76 43.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 111.321 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.79 21.07 5.51 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -160.11 -42.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.437 ' HB3' ' CG ' ' A' ' 105' ' ' TRP . 2.5 m120 -76.59 -57.47 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' CD2' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -65.25 175.05 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.793 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.76 153.66 85.19 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.74 0.305 . . . . 0.0 111.017 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 52.2 Cg_exo -55.85 -58.02 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.907 2.404 . . . . 0.0 113.141 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.04 -46.33 11.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 111.64 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.448 ' CB ' ' CD2' ' A' ' 29' ' ' LEU . 12.7 m-20 -62.41 -27.69 69.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 31' ' ' PRO . 84.5 mt -68.94 -48.45 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.877 0.37 . . . . 0.0 110.548 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.57 -62.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -44.68 -45.23 9.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.195 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -35.79 75.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -68.43 -53.34 24.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -83.28 -136.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 72.98 -58.66 0.59 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.687 0.279 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.47 -42.71 98.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.36 -48.98 7.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' O ' HD11 ' A' ' 76' ' ' LEU . 7.3 mpt_? -116.85 66.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.734 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.53 134.02 12.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.298 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.02 115.32 1.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.388 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.62 68.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -84.98 136.51 33.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 82.1 t80 -91.02 89.68 7.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.71 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.97 3.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 51.5 m -90.27 165.17 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.143 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.406 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -122.34 164.16 18.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.9 -31.87 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.82 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.498 ' O ' ' N ' ' A' ' 58' ' ' GLU . 1.5 m95 -66.83 -27.94 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.72 67.35 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.506 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' TRP . 5.7 mt-10 -156.23 -54.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.19 -67.88 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.6 pt -71.46 -34.18 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.075 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.13 48.95 2.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.676 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p 179.6 132.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.71 135.3 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HD13 ' A' ' 64' ' ' ILE . 17.9 mm -121.07 146.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.62 109.39 5.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 24.4 Cg_endo -62.89 153.26 74.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.186 1.924 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 62.73 7.07 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.563 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -128.25 17.27 6.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 31.1 m-85 -150.65 142.07 23.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.9 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -89.45 116.5 27.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -110.39 104.99 13.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.58 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.89 135.78 31.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.282 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 10.0 m0 -115.77 89.76 3.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.188 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 21' ' ' PHE . 72.6 t -89.7 99.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.041 0.448 . . . . 0.0 110.972 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 76' ' ' LEU . . . -130.01 -132.55 3.46 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.462 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.2 tp -140.24 108.97 5.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.2 t -96.28 148.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.391 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -92.24 -164.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.54 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.299 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.28 -6.87 48.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.07 30.14 7.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.721 0.296 . . . . 0.0 111.332 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.54 147.47 28.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.56 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.83 86.08 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 111.103 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.31 12.76 23.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.59 91.91 1.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.879 0.371 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.72 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -97.4 -49.65 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.436 ' HB1' ' CE3' ' A' ' 105' ' ' TRP . . . -152.36 121.1 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.395 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -103.37 131.5 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.152 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.6 m-85 -111.7 153.26 26.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 0.0 111.775 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.481 HD12 ' CE1' ' A' ' 102' ' ' HIS . 15.3 mt -137.07 109.07 7.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.553 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.84 136.87 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.749 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -71.98 93.08 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.904 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 96.6 m-70 -31.92 -49.16 0.17 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.223 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -41.32 143.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.964 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -48.56 46.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 98' ' ' ASP . 8.3 mt-10 -72.11 145.33 48.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.099 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER 57.57 115.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.287 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -109.66 113.79 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.838 0.351 . . . . 0.0 110.504 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' CG ' ' HB2' ' A' ' 93' ' ' SER . 7.8 pt-20 -128.62 103.76 7.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -112.07 146.26 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.536 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.531 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -144.93 161.38 39.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.443 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.8 p -152.74 141.66 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.82 132.69 58.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.437 ' CG ' ' HB3' ' A' ' 28' ' ' ASN . 88.0 m95 -111.59 -81.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.412 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.64 139.97 11.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.871 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.14 121.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.79 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -98.86 131.03 45.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.69 -60.96 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.67 142.65 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 175.56 5.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.96 134.07 52.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -59.1 148.3 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.988 -179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' N ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -47.28 140.22 7.2 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.687 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -58.42 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.448 2.098 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -31.3 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -59.6 -55.23 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.79 64.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.024 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 14' ' ' ILE . 82.8 mt -46.42 -38.85 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.182 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.04 -46.95 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.86 -63.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.05 -38.27 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.129 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -55.14 -52.67 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.103 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.98 -21.7 66.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.667 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 24' ' ' MET . 77.9 mt -77.2 -30.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.042 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' CE2' ' CZ ' ' A' ' 37' ' ' PHE . 15.0 t80 -76.68 -28.18 55.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.481 . . . . 0.0 110.136 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.2 -32.78 50.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.391 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.36 -38.38 10.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.128 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.544 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 19.0 mtp -74.09 -51.21 16.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.0 145.66 5.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.401 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.13 29.92 9.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.279 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -152.36 -35.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.623 0.249 . . . . 0.0 111.357 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -121.04 -30.47 4.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.326 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . 5.2 tt -68.94 141.17 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.5 140.27 84.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.53 -54.83 4.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.085 2.523 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.82 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' CB ' HD21 ' A' ' 29' ' ' LEU . 2.7 m-20 -67.21 -28.89 68.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.301 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.452 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 54.3 mt -66.1 -52.29 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -55.69 30.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -49.78 -39.57 38.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 111.417 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -80.88 -36.82 30.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.4 -23.8 46.57 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -86.18 -27.77 24.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -150.08 95.6 2.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.814 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.8 t80 -130.74 -40.24 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.201 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -68.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.919 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.42 -39.9 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.59 62.03 0.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.04 133.65 11.77 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.178 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.13 142.58 9.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.928 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -146.04 80.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -76.87 140.46 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.812 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.02 88.43 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 m -89.52 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.153 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.73 175.5 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.761 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -60.4 154.18 21.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -75.03 -149.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -38.19 14.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 110.195 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' TRP . 4.0 p30 -151.3 -35.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.234 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 59' ' ' GLU . 6.3 m95 70.84 2.28 4.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.634 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.8 59.59 0.89 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.876 0.369 . . . . 0.0 111.107 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.5 -49.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.799 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 5.1 mm-40 -75.99 -73.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 HG22 ' A' ' 62' ' ' VAL . 48.0 pt -75.13 -34.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.297 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 82.21 79.88 0.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.722 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.448 HG22 HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER 168.7 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -70.34 121.24 17.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.69 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.0 mm -124.17 112.43 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.264 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.64 115.2 20.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 68' ' ' GLU . 23.9 Cg_endo -61.76 151.21 82.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.24 1.96 . . . . 0.0 111.921 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 77.71 -29.84 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 66' ' ' PRO . 25.1 mt-10 -87.05 6.36 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.391 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -141.85 151.39 42.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 111.434 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.28 131.62 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.72 110.23 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.582 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -113.73 135.24 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.176 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 18.7 m0 -117.9 136.35 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.321 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 HG12 ' CE2' ' A' ' 21' ' ' PHE . 58.0 t -135.59 108.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 0.0 111.39 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.57 -115.23 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -150.04 155.25 39.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 82' ' ' GLU . 34.8 m -140.58 -178.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.472 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.54 -173.86 2.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -26.12 65.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.965 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -79.16 -9.63 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.414 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.58 88.78 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 3.9 mt-10 -144.11 147.05 33.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 tpt -120.82 80.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 -5.51 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 84.95 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.84 131.73 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.665 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -89.47 -37.06 15.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.589 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.457 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -144.74 162.1 37.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.15 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 3.8 mttm -146.26 130.64 17.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -120.33 148.69 43.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 102' ' ' HIS . 58.9 mt -129.29 118.16 21.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.385 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 147.93 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.317 0.58 . . . . 0.0 112.553 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.86 122.16 26.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.534 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.439 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 92.1 m-70 -58.82 -15.37 12.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.827 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.72 -55.81 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.62 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.84 0.06 28.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 112.063 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.89 105.01 2.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.92 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.46 118.64 22.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.056 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -104.51 127.45 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 21.6 p90 -118.26 138.9 52.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.848 0.356 . . . . 0.0 111.232 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.483 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -147.62 101.6 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.4 p -99.86 144.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.026 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -119.9 131.1 73.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.974 179.24 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 26.8 m95 -105.46 153.55 21.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.42 160.45 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.896 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.592 0.234 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.68 26.05 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.487 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 m -92.15 143.63 26.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.644 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -138.6 156.06 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mt -94.51 157.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 115.63 28.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -177.89 5.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD1' ' CE1' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -130.16 148.54 52.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 1.2 m-20 -80.59 134.82 53.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.056 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.43 -42.17 22.87 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 112.32 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -27.32 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.649 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -77.33 -37.07 53.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.96 84.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.62 -42.63 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.959 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.34 -55.41 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.75 -42.09 94.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.031 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.12 -39.42 86.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.953 0.406 . . . . 0.0 110.309 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CE1' HD13 ' A' ' 22' ' ' LEU . 25.6 t80 -57.65 -47.83 81.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.096 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.92 65.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.667 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.5 mt -62.61 -73.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.457 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 70.0 t80 -42.49 -29.45 0.28 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.381 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 18' ' ' TYR . 1.9 tp -64.69 -45.17 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.48 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.1 pt-20 -103.4 -28.57 11.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.401 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -72.14 -53.42 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 111.204 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 137.69 41.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.428 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.79 -85.7 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.894 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.6 3.59 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' CD2' ' A' ' 105' ' ' TRP . 0.9 OUTLIER -92.26 -42.64 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.263 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 30' ' ' ASP . 3.4 tt -97.27 154.56 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.95 149.91 4.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.64 -25.86 35.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.523 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.03 -60.42 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.64 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.21 -29.01 65.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.51 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.2 -47.97 91.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 110.172 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -68.76 -47.21 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.438 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.37 -59.09 5.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.426 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 4.1 t80 -42.12 -30.61 0.3 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.296 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -76.96 -50.71 12.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 1.9 mm? -83.35 -63.17 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.618 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.48 92.83 9.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 111.659 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.2 t80 -163.95 -37.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.64 -62.54 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -102.62 -15.45 16.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.529 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -102.75 -5.38 23.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.651 0.262 . . . . 0.0 111.396 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -91.15 132.71 11.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.17 145.46 13.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.368 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 t -130.99 96.65 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.906 0.384 . . . . 0.0 111.006 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.31 164.48 18.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.962 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -114.28 135.85 53.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.433 HG23 ' CG ' ' A' ' 71' ' ' GLU . 6.4 m -132.21 -174.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.17 166.09 13.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 8.0 m -54.69 155.96 3.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.88 -177.29 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.03 26.25 10.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.77 39.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.462 ' CH2' HD11 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -65.22 -29.8 70.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.276 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 14.2 mt-10 -59.44 -16.63 24.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -92.68 -34.03 14.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 36.5 mt-10 -78.93 -57.66 3.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 61' ' ' GLY . 42.0 pt -93.93 -36.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.415 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 123.61 -72.53 0.41 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m -56.88 173.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.814 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.82 136.4 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.413 ' CD1' HD12 ' A' ' 60' ' ' ILE . 25.9 mm -124.9 116.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.755 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.36 112.07 7.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 19.5 Cg_endo -61.42 163.75 16.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.792 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.7 pt-20 48.81 20.31 0.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.974 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -129.05 -14.44 4.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.584 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -123.92 162.7 22.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.836 0.35 . . . . 0.0 110.842 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.1 122.15 46.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' CG ' HG23 ' A' ' 50' ' ' VAL . 35.0 tt0 -106.03 123.52 48.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.99 147.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.64 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -124.44 135.92 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.42 111.01 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.091 0.472 . . . . 0.0 111.14 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.66 -127.22 3.07 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.166 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 tp -149.18 57.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 78' ' ' ASN . 6.3 p -63.71 158.55 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.702 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.417 ' N ' ' CG2' ' A' ' 77' ' ' VAL . 4.5 m-80 -95.13 -144.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.929 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -93.23 22.88 4.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.662 0.267 . . . . 0.0 111.223 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -114.23 -11.76 12.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.543 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 71.37 28.81 2.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.385 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -114.46 119.35 36.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.71 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 tpp -84.89 98.55 10.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.458 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.83 -23.88 26.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.24 125.61 16.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.41 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.08 135.59 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.11 -38.32 13.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.159 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -152.74 175.96 12.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.788 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.17 140.61 22.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -123.32 147.56 46.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.462 HD11 ' CH2' ' A' ' 56' ' ' TRP . 34.2 mt -131.47 124.8 30.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.141 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.45 149.39 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -69.34 123.29 20.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.953 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.463 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 8.3 m-70 -49.91 -48.62 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.634 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -42.87 160.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.098 0.475 . . . . 0.0 111.828 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -99.17 -34.63 10.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.112 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 3.3 pt-20 -91.3 126.69 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.93 106.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.8 148.54 45.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.507 . . . . 0.0 111.616 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.58 133.32 56.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.489 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 39.7 p90 -120.67 139.13 53.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.79 103.03 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.0 111.058 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.5 p -98.79 141.76 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.918 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.437 ' N ' HG23 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -108.2 135.55 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.151 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.485 ' CD2' ' ND2' ' A' ' 28' ' ' ASN . 46.9 m95 -115.52 140.72 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.23 159.19 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -110.33 -33.49 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.533 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -131.16 110.33 11.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 179.56 77.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 mt -128.72 127.78 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -106.71 123.73 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.785 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 177.76 6.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.38 135.29 33.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.37 164.93 53.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.578 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.65 -59.21 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.219 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.87 -30.27 71.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -73.27 -42.82 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . . . -60.81 -35.33 76.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.8 mt -71.35 -57.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.12 -39.84 2.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.263 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.86 -57.34 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.07 61.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.809 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.12 -55.45 25.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.8 -31.21 62.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.752 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.02 -74.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.144 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 44.8 t80 -39.51 -32.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.415 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.77 -43.02 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -29.26 10.41 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -57.86 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.682 0.277 . . . . 0.0 111.434 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB1' ' CD1' ' A' ' 21' ' ' PHE . . . -50.25 116.52 1.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.395 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.21 -89.94 0.08 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.92 2.78 32.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.4 m-80 -103.04 -59.12 1.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 30' ' ' ASP . 5.1 tt -64.1 135.26 56.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.635 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.78 137.49 3.34 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.964 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.21 -43.06 32.44 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.852 2.368 . . . . 0.0 112.754 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.0 -58.86 5.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.599 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 106' ' ' LYS . 41.2 m-20 -58.06 -24.68 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 ' CG1' HD23 ' A' ' 29' ' ' LEU . 92.5 mt -67.99 -50.93 54.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 109.991 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.7 -51.13 64.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.756 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -55.16 37.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.141 0.496 . . . . 0.0 110.417 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 2.1 t80 -46.19 -30.08 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.901 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -59.07 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.466 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.18 -21.26 66.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.837 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -148.8 118.61 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.652 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' GLY . 63.4 t80 179.98 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.756 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -48.39 -63.5 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.25 -33.17 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.41 33.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -104.58 62.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.552 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.21 116.72 5.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.497 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' CG1' ' CG1' ' A' ' 72' ' ' VAL . 38.7 t -102.34 107.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.77 0.319 . . . . 0.0 110.865 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.37 150.62 24.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 35.0 t80 -103.72 141.73 35.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.091 0.472 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.12 152.41 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.921 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -92.9 158.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.702 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 98.2 m -46.88 167.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.064 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' N ' ' CG2' ' A' ' 52' ' ' THR . . . -103.07 -169.04 1.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.72 32.59 4.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.23 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.523 ' CE3' ' HB2' ' A' ' 59' ' ' GLU . 4.5 m95 68.14 6.57 5.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.991 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.45 -1.8 19.88 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.71 -44.02 5.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 60.1 mm-40 -73.3 -56.28 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.439 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.455 HG21 ' CZ3' ' A' ' 56' ' ' TRP . 18.0 pt -103.15 -35.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.675 0.274 . . . . 0.0 111.02 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 -53.02 0.6 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.301 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.78 152.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.238 0.542 . . . . 0.0 111.878 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.92 156.49 24.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.721 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.5 mm -150.35 128.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.85 108.08 4.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.616 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 9.6 Cg_endo -52.9 157.69 7.56 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.288 1.992 . . . . 0.0 112.287 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 20.1 mt-10 69.64 -59.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.16 -29.03 1.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.814 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE1' ' OG ' ' A' ' 93' ' ' SER . 98.5 m-85 -116.65 152.16 34.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 111.355 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -112.37 133.11 54.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.816 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' PHE . 8.0 pt-20 -112.53 133.48 54.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.401 ' CG1' ' CG1' ' A' ' 47' ' ' VAL . 2.2 t -121.22 147.45 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.84 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 12.2 m0 -120.49 133.57 55.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 111.226 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 110.59 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.907 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.45 -132.27 3.75 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.264 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -142.16 64.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 0.0 110.093 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 78' ' ' ASN . 22.3 t -49.4 159.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.831 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.5 m-80 -89.65 -160.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.61 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -70.91 -9.7 58.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.95 -87.76 0.21 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.52 0.2 . . . . 0.0 111.17 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' HA ' HG13 ' A' ' 77' ' ' VAL . 1.4 p30 179.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -57.38 129.65 42.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.3 ttm -107.52 122.71 47.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.037 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.52 -3.18 13.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -137.56 108.23 6.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.863 0.363 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.38 138.74 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.858 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.0 -46.35 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.681 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' CB ' ' CE3' ' A' ' 105' ' ' TRP . . . -143.99 173.19 11.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -150.4 136.0 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -121.17 142.2 50.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' CD1' ' CE1' ' A' ' 102' ' ' HIS . 13.8 mt -119.96 133.43 55.56 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.02 143.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.417 ' OG ' ' CE1' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -68.92 132.32 46.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.65 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.0 -32.95 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 178.24 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.031 0.443 . . . . 0.0 111.277 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.64 -12.84 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.356 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -133.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 51.52 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 110.665 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -62.09 141.65 58.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.116 0.484 . . . . 0.0 111.905 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -117.46 149.63 40.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.595 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 35.5 p90 -139.16 143.36 38.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.708 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.493 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.3 OUTLIER -150.04 118.79 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.143 0.497 . . . . 0.0 111.525 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 104' ' ' ILE . 14.7 p -107.24 144.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.906 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.483 ' N ' HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -111.81 135.9 49.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.533 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 37.3 m95 -117.07 149.36 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 5.1 ttmt -67.63 153.46 43.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.851 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.825 0.345 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.95 25.36 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m 60.83 95.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.42 -34.98 5.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.924 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -82.35 134.62 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.245 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -115.04 162.06 17.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.708 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -89.92 178.91 6.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.71 143.89 33.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.064 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.83 157.82 57.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.83 -64.49 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.638 2.225 . . . . 0.0 112.248 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.68 -32.83 67.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 16' ' ' ILE . 69.4 m -72.58 -36.46 68.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -65.06 -26.77 68.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 14' ' ' ILE . 45.9 mt -80.26 -62.12 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.97 -32.49 3.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.793 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CD1' HG13 ' A' ' 92' ' ' ILE . 1.3 pp -76.86 -48.04 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.74 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.84 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 110.198 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.59 -43.88 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.939 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -66.1 -27.86 68.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.136 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.25 -28.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.243 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.1 t80 -69.01 -45.97 69.19 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.0 mm? -80.02 -2.98 46.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 1.1 mm-40 -95.78 -56.83 2.54 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.3 mtp -92.18 -30.62 15.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -54.63 122.94 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.01 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.84 35.97 1.09 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.124 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -163.04 -32.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.438 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 5.2 t30 -116.27 -34.91 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 30' ' ' ASP . 3.0 tt -80.07 124.31 28.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 111.062 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.689 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -34.2 150.12 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.561 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.77 -34.49 72.83 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.536 2.157 . . . . 0.0 112.667 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.91 -58.15 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.868 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' HB2' HD23 ' A' ' 29' ' ' LEU . 61.8 m-20 -61.24 -19.43 61.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 29' ' ' LEU . 83.5 mt -75.23 -51.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.932 0.396 . . . . 0.0 110.388 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.27 -51.8 63.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.738 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -52.02 66.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.247 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 4.0 t80 -46.46 -28.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.914 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -77.01 -49.99 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 44.02 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.01 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -150.57 -44.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.02 -12.01 10.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.717 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.59 -46.55 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -119.45 -13.31 9.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.607 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -118.18 41.66 2.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.142 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.92 108.82 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.52 154.06 24.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.297 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 75.9 t -144.07 119.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -101.92 142.99 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 59.2 t80 -91.67 138.26 31.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.295 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.04 142.13 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.599 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.32 -174.78 1.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.514 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 61.7 m -72.33 165.0 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 56' ' ' TRP . . . -91.15 -160.78 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.6 OUTLIER -95.02 32.19 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.347 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 84.34 121.74 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -146.71 55.36 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.47 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -72.0 79.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.692 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.7 -43.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.772 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.59 -48.07 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.435 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 104' ' ' ILE . 5.1 pt -80.13 -14.46 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 54.86 77.4 0.15 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.25 140.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.86 122.92 12.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.68 144.85 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -146.78 105.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.284 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 31.4 Cg_endo -64.0 155.69 62.98 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 80.29 -14.62 0.82 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.904 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.507 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.9 pt-20 -115.09 2.17 14.09 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 54.5 m-85 -138.96 144.73 39.12 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.099 0.476 . . . . 0.0 111.231 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.98 120.21 41.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.918 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 50' ' ' VAL . 14.3 tt0 -92.84 130.79 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.759 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.16 141.25 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.516 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -117.62 136.26 53.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 102.03 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.472 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 76' ' ' LEU . . . -114.18 -144.39 8.66 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.079 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 75' ' ' GLY . 2.1 tp -138.64 81.79 1.87 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.276 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 2.2 m -67.17 170.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.191 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -115.34 -165.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.428 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.87 -16.29 58.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.531 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.45 -85.83 0.17 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.154 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.7 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.332 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -147.99 120.3 8.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.882 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.641 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -71.69 -25.68 62.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.38 6.51 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 83' ' ' MET . 1.5 m-20 178.42 121.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.66 141.61 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.884 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.51 -34.89 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.2 161.99 19.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.62 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 3.6 mttt -129.36 148.24 51.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.9 m-85 -128.82 138.61 52.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 111.877 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.504 HD11 ' ND1' ' A' ' 102' ' ' HIS . 3.7 mt -119.66 134.03 55.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.151 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.123 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -74.3 147.87 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -91.72 22.26 4.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -96.99 152.97 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.35 -40.57 14.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.47 114.28 28.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.47 100.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.723 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.86 127.25 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.46 156.5 18.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -149.53 144.62 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.03 159.95 40.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.015 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.457 HG21 ' N ' ' A' ' 104' ' ' ILE . 11.9 p -150.34 141.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.457 ' N ' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -106.63 133.36 51.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.752 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.475 ' CD2' ' HB2' ' A' ' 29' ' ' LEU . 33.9 m95 -115.88 150.17 37.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.93 153.57 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.6 pttm . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.888 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.658 0.266 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.432 ' CG2' ' N ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 58.54 -176.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.432 ' N ' ' CG2' ' A' ' 2' ' ' THR . 4.8 t -135.13 97.81 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.36 -174.3 2.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.49 169.65 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -170.2 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -127.41 139.81 52.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.114 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mt -63.98 150.47 45.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.2 141.89 93.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.12 -48.2 15.26 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.55 2.166 . . . . 0.0 112.725 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.9 -21.86 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.471 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -81.01 -61.17 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.558 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.46 -30.27 64.9 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.28 -59.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.807 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -42.1 -48.77 4.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.568 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -40.22 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.67 94.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.442 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -52.16 -44.85 64.82 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.243 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 -30.56 71.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.485 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 24' ' ' MET . 34.4 mt -73.0 -29.75 29.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t80 -67.91 -47.8 67.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -71.81 -23.41 61.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.17 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.718 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 5.8 mtp -75.1 -46.01 37.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -42.75 110.83 0.2 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.804 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.52 -114.28 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.392 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.98 -37.66 78.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.309 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.01 -37.13 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.472 HD12 ' CZ3' ' A' ' 105' ' ' TRP . 4.6 tt -88.07 151.08 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -71.13 134.55 85.21 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.097 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.11 -59.36 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.722 2.281 . . . . 0.0 112.951 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.14 -50.35 20.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.556 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.22 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -66.66 -52.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.111 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -57.34 -51.76 68.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 110.356 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 1.8 tp -52.39 -51.06 61.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 110.556 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -49.04 -42.58 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.9 -57.06 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.99 49.11 1.66 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -155.62 -48.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -42.91 -37.47 1.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.545 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.06 -45.03 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.22 -61.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.061 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.19 63.06 3.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.36 133.88 11.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.72 128.34 4.59 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.413 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.17 59.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.49 . . . . 0.0 110.245 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.22 125.61 31.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.381 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -83.63 97.65 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.45 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -90.34 166.18 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.356 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -98.17 162.08 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.853 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 48.4 m -52.09 163.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.18 162.34 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.08 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.91 -29.25 18.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.794 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.21 -2.7 22.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.674 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.437 ' CZ2' HD22 ' A' ' 91' ' ' LEU . 1.5 m95 -46.39 -29.59 1.76 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.553 0.216 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.81 63.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -166.93 -44.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.369 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.97 -70.54 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.104 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.71 -32.12 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.273 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 77.72 47.75 8.46 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.413 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.93 113.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.498 0.19 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.93 127.16 15.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.57 137.73 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -66.1 109.69 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.795 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.3 Cg_endo -59.33 157.89 28.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.326 2.017 . . . . 0.0 112.411 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.4 pt-20 48.62 20.53 0.33 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.777 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 19.2 mt-10 -137.74 18.82 2.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.713 0.292 . . . . 0.0 110.973 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 68' ' ' GLU . 20.8 m-85 -148.09 145.51 28.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.72 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' CB ' ' CE1' ' A' ' 94' ' ' HIS . . . -90.11 114.19 26.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' HG2' HG21 ' A' ' 50' ' ' VAL . 27.8 tt0 -110.62 103.4 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.485 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.3 p -94.5 136.39 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.464 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 3.8 m0 -121.25 94.16 4.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.97 106.33 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.135 0.493 . . . . 0.0 111.056 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -132.2 -137.53 3.99 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.955 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 44' ' ' ARG . 1.1 mp -139.18 112.67 8.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.298 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.13 179.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.255 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -93.7 -166.2 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.552 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.02 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.404 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -75.13 -72.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.483 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER 166.19 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.621 0.248 . . . . 0.0 111.413 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.69 135.88 3.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.9 tpp -119.56 123.91 45.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.652 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.58 21.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -160.4 89.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' A' ' 89' ' ' LYS . 7.3 p -89.67 149.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.418 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -98.69 -43.73 6.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.728 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . . . -151.53 122.27 7.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -113.59 132.89 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.6 m-85 -113.99 155.58 25.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.437 HD22 ' CZ2' ' A' ' 56' ' ' TRP . 39.8 mt -134.66 110.32 9.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.64 134.37 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.589 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.13 97.11 2.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.49 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.488 ' CE1' ' CB ' ' A' ' 70' ' ' ALA . 98.1 m-70 -37.28 -46.6 0.76 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.948 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.31 138.0 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 111.412 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.93 80.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' ARG . 10.9 pt-20 -67.38 -173.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.25 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 69.62 62.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.458 . . . . 0.0 110.509 -179.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.31 150.71 23.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 8.8 p90 -146.83 140.74 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.602 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.28 157.42 46.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -151.41 138.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -114.91 110.22 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.096 178.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.472 ' CZ3' HD12 ' A' ' 29' ' ' LEU . 91.2 m95 -92.42 149.25 21.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -176.95 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 ttp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -105.08 -10.8 16.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.683 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -87.4 -36.75 17.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.35 -53.23 60.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 mt -103.41 144.74 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.003 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 147.15 23.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.592 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -176.59 3.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.052 0.453 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 155.43 35.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.37 147.77 53.98 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.49 -54.89 4.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.543 2.162 . . . . 0.0 112.392 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.52 -28.93 68.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 m -72.85 -44.95 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.39 89.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.62 -57.88 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.2 -45.98 5.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.232 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mt -72.89 -39.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.592 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.79 75.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.711 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.88 -43.62 77.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -35.37 77.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' CG ' ' A' ' 24' ' ' MET . 49.7 mt -66.24 -45.68 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.691 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 7.2 t80 -54.33 -59.67 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.554 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 2.8 mm? -64.01 -14.5 54.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.159 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.7 -57.75 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.4 -38.49 21.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -54.6 151.11 8.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 0.0 111.516 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 34' ' ' ILE . . . 148.52 -111.9 0.55 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.417 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -74.02 -3.64 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 1.3 m120 -98.46 -5.85 31.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.499 0.19 . . . . 0.0 111.213 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.58 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -103.59 -25.44 13.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.732 0.301 . . . . 0.0 111.481 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 29' ' ' LEU . 12.6 t70 106.01 137.23 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.754 0.822 . . . . 0.0 111.441 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.41 -58.89 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.22 2.613 . . . . 0.0 113.044 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.34 -58.62 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.034 0.445 . . . . 0.0 111.137 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' CB ' ' CD2' ' A' ' 29' ' ' LEU . 3.6 m-20 -57.32 -28.95 63.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 30' ' ' ASP . 52.9 mt -71.61 -49.82 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-O 121.301 0.572 . . . . 0.0 109.697 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 39' ' ' LEU . 5.5 tp -45.85 -66.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.299 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 28.6 tp -53.9 -35.02 61.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.337 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 2.7 t80 -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.16 -62.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' HG ' ' A' ' 35' ' ' LEU . 2.1 mm? -52.88 -23.54 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -144.3 115.64 8.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.273 0.558 . . . . 0.0 111.817 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' O ' ' HA3' ' A' ' 45' ' ' GLY . 15.5 t80 -169.79 -53.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.919 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -34.91 72.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.14 -46.85 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.262 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -119.55 53.85 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 111.116 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -119.22 120.4 4.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.727 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.77 137.37 6.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.716 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.31 126.04 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.889 0.376 . . . . 0.0 110.964 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.48 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.997 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 70' ' ' ALA . 51.2 t80 -87.35 139.53 30.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -133.01 175.91 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.29 148.3 33.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 49.7 m -41.74 160.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.14 0.495 . . . . 0.0 111.574 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.67 -161.4 0.87 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.235 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.65 39.84 1.04 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.177 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 2.7 m-20 76.6 117.76 0.06 Allowed 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.574 ' O ' ' N ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -125.88 44.98 2.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.718 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -58.72 70.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -155.41 -45.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.731 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.72 -68.01 0.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.419 0.628 . . . . 0.0 110.268 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -69.74 -50.88 45.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.389 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 96.14 72.85 1.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.303 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 10.6 p 172.49 142.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.667 0.27 . . . . 0.0 110.577 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.99 123.22 7.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 111.347 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 27.6 mm -103.51 132.07 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.68 111.78 41.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.51 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 28.0 Cg_endo -63.1 152.97 76.82 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.406 2.071 . . . . 0.0 112.902 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 60.77 8.98 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.033 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -119.97 -13.71 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.561 0.22 . . . . 0.0 111.517 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.7 136.38 49.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 111.02 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -89.32 117.96 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.782 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' PHE . 11.0 pt-20 -107.17 138.15 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.089 0.471 . . . . 0.0 111.336 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 72' ' ' VAL . 10.8 p -134.65 142.46 40.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -106.17 144.84 32.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 90' ' ' PHE . 48.9 t -128.7 101.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.5 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.37 -138.66 5.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.392 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 75' ' ' GLY . 1.6 tp -143.59 51.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.329 0.585 . . . . 0.0 109.66 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 m -46.9 174.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.267 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -92.2 -161.31 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.667 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.22 -14.53 63.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.747 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.01 -85.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.497 0.189 . . . . 0.0 111.176 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 179.4 -35.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.592 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -45.71 137.11 5.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.754 0.311 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.7 ttm -119.8 121.15 38.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.17 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.26 -3.75 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.093 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -142.12 93.97 2.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -89.91 144.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.169 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.66 -34.86 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.357 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HB3' ' CE3' ' A' ' 105' ' ' TRP . . . -161.66 164.6 29.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.108 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.9 mttt -126.4 144.82 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -125.05 165.94 17.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 13.2 mt -147.82 123.77 10.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.378 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.68 137.72 56.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 111.749 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 117.47 7.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -59.44 -37.78 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.226 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.44 -179.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -111.37 -43.11 3.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.203 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 122.48 26.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.318 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 65.89 112.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 tpp85 -114.47 132.13 56.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.905 0.383 . . . . 0.0 111.246 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.16 134.83 50.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 26.6 p90 -140.96 144.24 34.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.563 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.19 156.21 47.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.858 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.493 HG21 ' N ' ' A' ' 104' ' ' ILE . 12.5 p -151.52 145.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.493 ' N ' HG21 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -110.28 136.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.214 177.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.49 ' CZ2' HG11 ' A' ' 103' ' ' VAL . 45.6 m95 -108.87 -104.13 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.739 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 153.33 6.69 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.235 0.471 . . . . 0.0 110.932 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptp . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.862 0.363 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -172.9 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 4' ' ' GLU . 1.3 p 76.76 -147.28 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.367 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' N ' ' OG1' ' A' ' 3' ' ' THR . 15.1 mm-40 44.37 -168.86 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.934 0.397 . . . . 0.0 111.698 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mt -130.39 156.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.515 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.21 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 110.46 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 132.93 40.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.601 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.46 159.2 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.1 152.73 74.26 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.658 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.69 -60.21 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -65.96 -28.25 68.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -67.15 -54.21 23.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.69 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.88 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 14' ' ' ILE . 79.6 mt -47.22 -36.5 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -67.03 -39.92 87.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.32 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.11 -62.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.779 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.26 16.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.171 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.86 -54.74 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.409 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -31.77 56.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.08 -73.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.462 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CE2' ' CZ ' ' A' ' 41' ' ' PHE . 85.6 t80 -41.13 -30.35 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.817 0.342 . . . . 0.0 111.448 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -64.98 -45.1 87.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.52 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.68 -29.02 11.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -51.48 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.92 105.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.275 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.46 -82.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.703 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.47 1.1 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 6.9 m120 -93.11 -28.53 16.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.422 HD13 ' CZ3' ' A' ' 105' ' ' TRP . 3.7 tt -96.26 138.93 33.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -50.41 150.21 4.85 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.796 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 13.5 Cg_exo -70.21 25.02 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.342 2.694 . . . . 0.0 113.735 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 30' ' ' ASP . . . -120.04 -67.04 1.01 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.239 0.542 . . . . 0.0 109.876 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.69 -21.69 41.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.763 178.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 30' ' ' ASP . 39.9 mt -63.33 -41.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -47.25 86.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.578 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.21 -40.61 70.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.254 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.8 t80 -58.32 -32.92 68.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.216 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -50.54 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.204 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.78 -39.13 87.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.27 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.17 -157.75 0.65 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 6.5 t80 83.85 -26.57 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -88.14 -33.2 18.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.482 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -105.86 -28.1 10.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.654 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 39.55 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.753 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 129.0 9.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.39 127.9 2.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.265 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.02 112.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.4 173.82 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 17.2 t80 -126.79 122.27 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.3 m -120.8 -165.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -124.03 171.49 9.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.1 m -60.11 161.63 6.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.56 -170.6 1.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 25.82 11.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.055 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -165.68 65.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.661 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.428 ' CZ3' ' HG3' ' A' ' 59' ' ' GLU . 4.6 m95 -95.97 -29.0 14.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.289 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.27 64.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.182 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.74 -51.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' HG3' ' CZ3' ' A' ' 56' ' ' TRP . 1.4 pm0 -78.27 -66.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.519 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 60' ' ' ILE . 29.2 pt -75.49 -38.97 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 0.0 111.429 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . 83.28 81.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.601 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.47 148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 122.481 0.312 . . . . 0.0 110.344 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.86 126.54 28.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.68 94.9 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -70.47 117.5 55.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.6 152.35 74.18 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.113 1.875 . . . . 0.0 111.962 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 69.32 -1.02 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.34 -9.28 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.693 0.283 . . . . 0.0 111.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -132.75 130.9 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . . . -89.59 125.88 35.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -103.78 113.95 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.27 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.42 144.11 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.131 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.455 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 11.7 m0 -118.43 137.59 53.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.37 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 90' ' ' PHE . 51.4 t -122.95 106.29 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.426 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.32 -142.7 7.08 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.62 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.427 HD21 ' CE1' ' A' ' 87' ' ' PHE . 2.6 tp -145.06 49.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.286 0.565 . . . . 0.0 110.057 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.416 HG21 ' N ' ' A' ' 82' ' ' GLU . 13.2 p -71.15 161.85 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.288 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 80' ' ' GLN . 4.3 p30 -89.75 -140.43 0.14 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -75.01 -49.56 19.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -52.17 -18.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 50.33 49.29 20.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.088 0.47 . . . . 0.0 111.216 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' N ' HG21 ' A' ' 77' ' ' VAL . 2.0 mt-10 -95.09 23.81 5.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.469 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' GLU . 1.7 tpt 29.68 95.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' CB ' ' A' ' 85' ' ' ASP . 4.4 t70 -144.15 49.9 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 164.03 82.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.441 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -88.94 135.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 76' ' ' LEU . 5.7 m-85 -89.09 -47.88 7.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.601 0.715 . . . . 0.0 109.239 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -146.51 169.91 17.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -134.5 147.45 50.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.0 m-85 -126.28 144.24 50.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 102' ' ' HIS . 21.1 mt -133.0 127.39 34.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.718 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 148.21 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 112.535 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -67.89 129.7 40.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.725 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -75.15 -36.18 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -54.45 -178.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.6 pt-20 -104.17 -49.74 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.245 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -73.53 133.07 43.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER 58.45 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -123.13 111.37 16.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.85 132.24 53.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.407 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 9.8 p90 -123.33 140.15 53.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.0 p -150.3 141.26 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -111.11 135.71 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 84.2 m95 -109.56 148.61 30.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 153.93 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.898 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.59 -178.42 5.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.27 143.94 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.08 149.77 93.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.01 -53.34 7.14 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.558 2.172 . . . . 0.0 112.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -33.44 70.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.526 ' O ' HD12 ' A' ' 16' ' ' ILE . 4.4 m -65.47 -52.47 52.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -59.67 -48.02 83.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.87 -40.7 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.87 -55.37 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 12' ' ' THR . 3.3 mt -58.73 -53.44 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.233 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.885 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -57.32 -40.44 77.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.22 -49.2 70.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.776 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.86 -30.84 71.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.658 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.885 HD12 ' HA ' ' A' ' 17' ' ' ALA . 23.3 mt -72.63 -27.78 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.714 ' CD2' HG11 ' A' ' 74' ' ' VAL . 22.2 t80 -77.23 -27.91 53.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.32 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -34.1 38.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.534 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 13.1 pt-20 -92.08 -37.47 12.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.151 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.1 mtp -76.32 -50.57 13.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -45.59 96.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.484 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.05 -115.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 111.188 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.18 -25.74 67.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.91 HD12 ' CZ3' ' A' ' 105' ' ' TRP . 4.2 tt -94.89 150.44 20.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.007 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.87 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.09 137.22 97.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 34' ' ' ILE . 71.5 Cg_exo -49.16 -64.8 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.622 2.215 . . . . 0.0 112.985 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.17 -43.37 21.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.66 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.3 m-20 -66.15 -28.68 68.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.988 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 31' ' ' PRO . 18.4 mt -67.05 -47.16 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.278 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.3 tp -57.95 -60.75 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.616 HD11 ' NE2' ' A' ' 40' ' ' GLN . 12.5 tp -46.13 -44.37 15.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.516 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.456 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.7 t80 -64.22 -26.3 68.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.802 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.92 -38.02 33.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.399 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.512 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.3 mm? -83.68 -40.18 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.401 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.837 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.6 pt20 -121.75 106.24 11.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.22 0.533 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 76' ' ' LEU . 55.3 t80 -163.9 -38.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.025 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -63.34 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.645 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -27.93 64.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.784 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -120.88 59.1 0.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 110.502 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.62 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -91.73 134.6 12.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.564 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.03 123.82 2.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.21 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.893 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -150.35 68.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.414 . . . . 0.0 110.46 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.42 129.56 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.532 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' ' HB1' ' A' ' 13' ' ' ALA . 57.8 t80 -90.4 94.02 9.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 71' ' ' GLU . 10.8 m -90.04 178.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.916 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -104.51 -178.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 35.7 m -73.22 165.72 24.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 52' ' ' THR . . . -139.2 171.93 13.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.032 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.96 -28.7 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.89 46.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.34 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.879 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.1 m95 -92.14 -42.39 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.65 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.84 64.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -161.88 -48.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.451 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.87 -73.16 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.554 HG23 ' HZ3' ' A' ' 56' ' ' TRP . 15.2 pt -61.57 -30.12 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.612 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 93.17 45.92 3.43 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.975 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.612 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 179.5 132.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.02 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.3 pp -66.32 141.0 58.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 63' ' ' LEU . 37.2 mm -125.13 145.86 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -73.35 121.27 84.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.393 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 7.1 Cg_exo -69.9 162.37 42.4 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.114 1.876 . . . . 0.0 112.142 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.02 22.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -137.15 12.98 3.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.414 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -146.18 147.17 31.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.846 ' HB3' HG12 ' A' ' 92' ' ' ILE . . . -89.7 112.6 23.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.62 120.0 35.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.498 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.0 t -119.7 134.42 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.096 0.474 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 9.2 m0 -122.49 117.07 25.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.679 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.893 HG22 ' CG1' ' A' ' 47' ' ' VAL . 54.1 t -114.72 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -131.55 -135.16 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.967 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -139.79 125.88 19.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 45' ' ' GLY . 32.8 m -114.75 175.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 111.675 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -103.78 -164.18 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -3.06 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.464 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.0 -5.15 30.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.476 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.91 96.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.667 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -148.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 tpt -178.51 58.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.387 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.59 85.74 2.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.754 0.312 . . . . 0.0 110.964 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 p -89.88 135.59 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.797 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 9.1 m-85 -91.47 -49.72 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.025 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -148.32 139.1 22.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -112.44 132.45 55.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.631 0.253 . . . . 0.0 110.565 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.495 ' CD2' ' HB ' ' A' ' 103' ' ' VAL . 1.2 m-85 -110.19 145.78 36.67 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.879 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 92.8 mt -127.14 105.57 8.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.177 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -109.37 127.5 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.875 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.2 100.36 0.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.2 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -37.09 -57.16 0.87 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.286 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -44.2 162.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.151 0.5 . . . . 0.0 111.847 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.1 pt-20 -86.0 -48.67 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -65.88 133.53 51.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.86 116.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -113.74 93.42 4.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.94 103.37 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -120.33 110.92 17.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -128.69 117.19 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.4 . . . . 0.0 111.148 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.495 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 7.2 p -98.1 150.27 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.32 130.08 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.91 ' CZ3' HD12 ' A' ' 29' ' ' LEU . 63.8 m95 -112.11 130.01 56.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.245 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.09 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.983 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 94' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.039 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -89.57 174.61 7.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.043 0.449 . . . . 0.0 111.358 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 147.13 62.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.94 -54.28 5.55 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.595 2.197 . . . . 0.0 112.338 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -30.06 69.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.6 m -68.36 -51.76 40.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.06 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.0 48.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.803 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -47.38 -33.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.797 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.02 -37.05 72.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 20' ' ' ILE . 13.8 mm -61.79 -62.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' CB ' HG11 ' A' ' 72' ' ' VAL . . . -52.13 -40.81 61.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.51 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -53.5 -57.3 11.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -61.43 -28.77 69.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 16' ' ' ILE . 77.8 mt -74.34 -25.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.857 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 37' ' ' PHE . 4.4 t80 -75.13 -51.89 12.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 110.47 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -65.71 -20.74 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.28 -46.89 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -80.15 -41.12 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.37 150.43 4.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.386 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.95 41.26 3.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.659 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -171.64 -29.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 33.1 t30 -115.94 -35.36 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.711 0.291 . . . . 0.0 111.003 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.767 HD23 HG13 ' A' ' 34' ' ' ILE . 2.8 tt -68.06 133.97 49.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -54.06 146.28 30.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.04 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.7 Cg_exo -47.64 -52.73 7.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.902 2.401 . . . . 0.0 113.017 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.4 48.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.58 ' CB ' HD21 ' A' ' 29' ' ' LEU . 74.1 m-20 -54.47 -32.0 56.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.767 HG13 HD23 ' A' ' 29' ' ' LEU . 91.2 mt -63.73 -47.79 89.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.054 0.455 . . . . 0.0 110.046 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -50.03 -57.48 7.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.617 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' GLN . 5.5 mp -63.28 -62.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -42.61 -30.03 0.33 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -82.19 -74.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.517 . . . . 0.0 111.771 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -69.32 -29.8 67.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.252 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' LEU . 1.6 tp-100 -90.98 25.3 2.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.829 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.1 t80 -102.83 -47.6 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -55.74 -42.47 75.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -39.02 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.936 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.1 mmt85 -130.39 80.89 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.32 107.38 0.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 146.66 17.48 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.127 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 74' ' ' VAL . 44.1 t -132.75 110.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.669 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.38 150.51 20.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 64.5 t80 -103.17 106.34 16.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.652 HG23 ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -105.79 -178.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.09 172.55 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 53' ' ' ALA . 7.6 m -65.38 164.71 13.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 52' ' ' THR . . . -128.11 162.46 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -98.45 36.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.12 33.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.687 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.9 m95 -80.36 -20.57 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.348 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.86 61.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 -47.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HG2' ' CE3' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -84.72 -64.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.687 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 14.0 pt -74.99 -27.59 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 70.76 79.22 0.38 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.792 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.64 ' CG1' HD12 ' A' ' 60' ' ' ILE . 6.9 p 164.53 139.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.671 0.272 . . . . 0.0 110.52 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -58.93 138.08 57.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.907 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 63' ' ' LEU . 26.9 mm -133.66 100.43 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.745 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.77 108.1 1.2 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.141 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.03 158.81 23.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.144 1.896 . . . . 0.0 112.366 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 76.03 -10.53 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.373 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -118.54 16.27 13.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.709 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 84.8 m-85 -138.79 132.25 30.33 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -90.75 112.55 24.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.797 ' OE1' HD21 ' A' ' 91' ' ' LEU . 7.8 tp10 -90.1 128.35 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.7 t -127.77 136.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.304 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 13.6 m0 -119.18 139.87 51.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.728 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 47' ' ' VAL . 13.4 t -129.37 110.58 20.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.643 ' C ' HD13 ' A' ' 76' ' ' LEU . . . -146.37 -155.34 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.757 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.992 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.17 50.47 1.09 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.724 0.297 . . . . 0.0 111.367 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 83' ' ' MET . 23.7 m -43.23 171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.204 0.526 . . . . 0.0 111.892 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.86 -165.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.96 -28.25 69.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -75.76 -31.0 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.29 27.73 1.06 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.367 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.51 22.85 6.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.8 ' HA ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 30.11 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.217 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -27.97 36.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.976 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.88 11.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -108.38 124.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.435 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.992 ' CE2' HD21 ' A' ' 76' ' ' LEU . 3.5 m-85 -89.2 -26.75 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.343 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.31 151.75 17.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -132.65 141.04 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.5 m-85 -120.93 148.4 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 71' ' ' GLU . 44.7 mt -132.76 117.89 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -125.0 140.26 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.09 0.471 . . . . 0.0 111.857 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 99' ' ' ARG . 3.1 p -69.49 122.08 18.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.777 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 36.8 m-70 -66.0 -32.22 73.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.287 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -55.74 177.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.71 -50.53 3.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.446 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -74.3 122.46 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.502 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.16 112.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.413 HH21 HG21 ' A' ' 16' ' ' ILE . 4.9 ttt-85 -120.71 114.88 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.702 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.58 134.95 42.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 23.5 p90 -127.08 140.26 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.09 153.29 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.118 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 11.4 p -150.17 137.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.802 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -115.56 130.25 70.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.601 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.2 m95 -108.75 150.64 27.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.997 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -64.05 161.06 16.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -117.57 125.37 50.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 12' ' ' THR . 1.9 mt -52.0 157.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.37 142.94 51.04 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.612 ' O ' HD12 ' A' ' 14' ' ' ILE . 77.7 Cg_exo -48.01 -57.28 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.529 2.153 . . . . 0.0 112.498 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -57.98 -41.54 83.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.67 HG22 HD11 ' A' ' 16' ' ' ILE . 11.9 m -52.94 -64.54 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -47.92 -46.4 31.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.786 0.327 . . . . 0.0 111.353 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -51.78 -43.87 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -39.26 71.03 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.046 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' THR . 5.1 mt -66.98 -66.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.848 0.356 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -48.7 -42.31 34.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -54.99 -50.84 68.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.21 -34.84 47.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.501 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.37 -69.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 30.1 t80 -41.43 -28.07 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.787 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -71.8 -45.35 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.702 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.72 -27.04 14.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 mtp -77.0 -46.44 23.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.734 0.302 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -57.4 -174.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.389 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 34' ' ' ILE . . . 56.81 32.02 61.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -157.84 -28.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.8 m120 -117.11 -19.85 9.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -98.37 161.68 13.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.745 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.4 p30 -62.23 133.14 94.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.689 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.84 ' HA ' HD12 ' A' ' 34' ' ' ILE . 79.2 Cg_exo -41.7 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.734 2.289 . . . . 0.0 113.075 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.16 37.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.723 ' CB ' HD22 ' A' ' 29' ' ' LEU . 42.7 t0 -56.41 -32.14 64.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.303 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.8 mt -61.56 -50.21 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.237 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.588 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -66.2 -48.79 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.208 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.627 HD13 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -57.47 -56.0 27.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.0 t80 -51.58 -26.16 8.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.989 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.57 -63.99 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 39' ' ' LEU . 1.4 mm? -67.4 -25.65 66.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.279 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HG3' HD13 ' A' ' 36' ' ' LEU . 31.1 mm-40 -101.91 -146.16 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 t80 70.61 -58.2 0.56 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.778 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.71 -37.12 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.8 -42.76 7.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 mmt-85 -119.08 52.14 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.83 133.06 11.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.42 113.16 0.72 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 74' ' ' VAL . 7.0 p -150.71 99.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -107.79 146.57 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.279 0.562 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 66.2 t80 -85.19 97.92 10.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.658 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 71' ' ' GLU . 3.0 m -89.96 176.89 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.374 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.747 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.95 163.22 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.32 13.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.11 -14.34 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.98 44.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.088 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.67 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 9.0 m95 -98.8 -29.8 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.915 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -68.27 61.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -162.63 -46.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.525 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -75.74 -78.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 64' ' ' ILE . 27.0 pt -71.65 -28.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.449 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.646 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 74.28 81.53 0.44 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.485 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.646 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.67 146.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 63' ' ' LEU . 3.0 pp -71.31 113.29 8.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.467 HG22 ' CD2' ' A' ' 69' ' ' TYR . 31.4 mm -109.31 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.192 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 8.6 m-20 -55.56 106.29 0.65 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 52' ' ' THR . 18.3 Cg_endo -60.25 157.12 36.73 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.108 1.872 . . . . 0.0 112.304 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 75.25 -9.24 1.42 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.348 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 1.8 pt-20 -120.13 19.83 12.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.574 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.467 ' CD2' HG22 ' A' ' 64' ' ' ILE . 75.5 m-85 -141.55 139.82 33.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.965 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.35 114.49 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.869 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -96.67 129.39 44.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.715 HG11 ' HB1' ' A' ' 17' ' ' ALA . 6.0 p -135.21 130.42 51.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.547 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 14.4 m0 -114.54 135.62 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 47' ' ' VAL . 16.6 t -127.63 111.14 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.986 0.422 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.12 -131.91 2.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.403 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.512 HD13 ' HE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -138.04 158.36 44.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -147.83 -177.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 111.306 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -118.53 -168.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.787 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -28.45 62.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.036 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.24 -14.56 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.439 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.51 72.6 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.43 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG12 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -140.82 148.82 41.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.28 105.78 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.26 -4.53 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.01 88.88 2.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.729 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.5 p -89.69 138.22 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.827 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.512 ' HE2' HD13 ' A' ' 76' ' ' LEU . 16.9 m-85 -89.39 -48.94 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.9 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.692 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -138.65 166.11 25.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.729 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -146.34 135.75 22.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.8 m-85 -126.98 144.02 51.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.905 HD12 ' CE1' ' A' ' 102' ' ' HIS . 3.1 mt -131.67 124.02 29.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -130.24 142.85 42.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 112.273 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.8 p -65.09 120.29 12.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.936 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.965 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 89.2 m-70 -62.74 -24.7 67.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -54.06 174.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.67 -65.49 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -71.64 131.52 43.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.2 112.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.33 115.98 21.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.354 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.12 120.93 38.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.103 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.42 ' HB3' HG22 ' A' ' 92' ' ' ILE . 19.5 p90 -124.5 143.85 50.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.327 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.905 ' CE1' HD12 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -143.76 168.95 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.351 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 13.4 p -151.05 143.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.471 HG21 ' HE3' ' A' ' 89' ' ' LYS . 3.9 mp -112.6 110.55 32.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.338 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.692 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 55.7 m95 -96.26 149.33 21.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 110.967 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.01 155.53 32.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.938 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.802 0.334 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -139.79 -178.42 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.007 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 12' ' ' THR . 1.9 mt -111.91 139.4 47.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.82 149.31 95.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.538 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.41 -59.79 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.437 2.091 . . . . 0.0 112.415 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -24.87 65.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 16' ' ' ILE . 92.7 m -76.16 -43.34 43.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.24 -29.37 70.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -79.83 -58.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -41.4 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.641 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -70.27 -43.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.079 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -64.11 -45.32 89.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.015 0.436 . . . . 0.0 110.356 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -51.35 -46.82 62.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -61.72 -27.91 69.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.479 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 17' ' ' ALA . 51.8 mt -75.12 -30.91 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.6 t80 -68.41 -51.28 45.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.14 -16.52 63.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.662 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 2.7 tp10 -94.13 -51.14 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.656 0.265 . . . . 0.0 111.511 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.411 ' CE ' HG12 ' A' ' 103' ' ' VAL . 15.4 mtp -74.61 -44.37 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -48.68 162.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.521 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.01 54.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.553 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -151.29 -33.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.62 0.248 . . . . 0.0 111.632 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.2 t30 -126.69 -39.18 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.723 0.297 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.891 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.5 tt -55.56 139.23 44.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.891 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -57.26 136.71 81.12 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.755 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 76.8 Cg_exo -48.51 -51.92 9.41 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.0 113.297 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.59 -58.74 5.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.085 0.469 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.625 ' CB ' HD21 ' A' ' 29' ' ' LEU . 68.3 m-20 -51.69 -29.95 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.841 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 38' ' ' ASN . 57.5 mt -69.09 -47.79 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 39' ' ' LEU . 1.2 tp -45.18 -59.64 2.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.666 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 8.8 mt -56.91 -47.31 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.254 0.55 . . . . 0.0 110.241 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HZ ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -48.25 -51.66 24.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.434 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.724 HD21 HG22 ' A' ' 34' ' ' ILE . 1.8 p30 -80.3 -40.79 26.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.847 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.6 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -72.73 -9.41 58.61 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 8.9 mm-40 -126.91 -137.52 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.939 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' HA2' ' A' ' 46' ' ' GLY . 2.6 t80 72.15 -56.09 0.65 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.796 0.332 . . . . 0.0 111.617 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -51.82 -39.64 59.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.14 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 27.44 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.673 ' HB3' HD12 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -131.89 -4.06 3.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA3' HG22 ' A' ' 77' ' ' VAL . . . 135.83 163.2 9.88 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.56 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA2' ' CE1' ' A' ' 41' ' ' PHE . . . -125.19 -115.02 2.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.792 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 73' ' ' TRP . 59.6 t -132.43 136.98 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.969 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -122.99 131.78 53.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 17.3 t80 -88.74 113.0 23.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.094 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 71' ' ' GLU . 34.5 m -107.69 -176.88 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -98.38 170.61 8.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 111.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.3 m -70.06 157.28 37.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.95 -156.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.136 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.1 -42.14 11.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.45 129.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.767 ' O ' HG12 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -162.42 150.54 14.4 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.415 0.626 . . . . 0.0 110.304 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.04 32.48 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.219 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -113.64 -25.34 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.226 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.87 -54.57 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.622 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.2 pt -75.91 -44.82 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.789 0.328 . . . . 0.0 110.952 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 104.41 54.37 0.79 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.107 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.455 HG12 HD12 ' A' ' 60' ' ' ILE . 14.8 p 175.95 140.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 120.927 0.394 . . . . 0.0 111.467 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.86 138.62 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 56' ' ' TRP . 37.2 mm -111.26 128.35 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -104.55 112.11 65.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 30.6 Cg_endo -63.92 156.08 60.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.345 2.03 . . . . 0.0 112.043 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 4.1 pt-20 54.87 9.92 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.938 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -132.37 -5.33 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -126.12 143.56 51.08 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.798 0.332 . . . . 0.0 110.645 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -96.01 128.73 43.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.686 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -111.98 117.36 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.751 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 t -119.39 129.35 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.9 m0 -105.6 143.91 33.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.765 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 47' ' ' VAL . 42.9 t -137.23 101.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.207 0.527 . . . . 0.0 110.934 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . . . -152.65 -120.03 0.82 Allowed Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.359 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 44' ' ' ARG . 1.9 mm? -142.31 146.8 35.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 83' ' ' MET . 3.6 m -115.86 178.35 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -107.28 -165.72 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -22.42 66.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -80.88 -81.13 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 77' ' ' VAL . 1.0 OUTLIER 173.54 -34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -56.04 132.42 50.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.033 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.533 ' HA ' HG12 ' A' ' 77' ' ' VAL . 36.2 ttm -88.99 79.35 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -6.55 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.88 83.21 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.301 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 86' ' ' VAL . 2.0 p -89.69 126.96 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.074 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.2 m-85 -89.37 -32.49 17.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.227 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.34 148.98 15.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -113.44 141.72 46.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.4 m-85 -117.83 141.68 48.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.091 0.472 . . . . 0.0 111.596 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 64' ' ' ILE . 25.0 mt -125.2 156.17 38.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.605 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.932 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -163.8 117.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.998 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.69 104.63 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.622 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 11.9 m80 -51.9 109.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 0.0 111.244 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -166.25 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 18.7 pt-20 -138.02 -54.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.373 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -85.23 -0.23 53.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.418 0.628 . . . . 0.0 111.306 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -162.0 102.84 1.14 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -126.48 120.86 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -108.5 112.1 24.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.467 ' HB2' HG23 ' A' ' 92' ' ' ILE . 1.9 p90 -118.98 139.3 51.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.65 171.22 16.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.046 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' LYS . 8.1 p -152.05 143.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.62 142.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.378 177.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.878 ' CE3' HD12 ' A' ' 29' ' ' LEU . 65.6 m95 -113.31 149.09 34.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 159.71 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.784 0.326 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -140.21 -177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.11 144.94 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.9 148.2 71.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.92 -53.26 7.29 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.531 2.154 . . . . 0.0 112.354 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.83 -29.96 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -65.93 -56.3 12.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -56.69 -46.62 81.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.4 mt -55.87 -42.98 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.01 -52.94 63.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 13' ' ' ALA . 3.4 mt -60.57 -59.74 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -49.03 -34.57 13.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.276 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -62.16 -54.08 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.68 -31.56 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' A' ' 24' ' ' MET . 55.6 mt -68.57 -71.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.786 ' CD2' HG11 ' A' ' 74' ' ' VAL . 41.3 t80 -40.62 -30.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.792 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.67 -39.13 58.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.852 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.51 -34.62 14.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.746 ' HG2' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -84.61 -35.95 22.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -62.59 129.99 43.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.24 44.69 0.47 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.629 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -176.04 -24.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -120.8 -35.1 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.781 HD23 HG13 ' A' ' 34' ' ' ILE . 2.7 tt -64.47 139.6 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -44.32 139.21 3.39 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.994 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 4.1 Cg_endo -46.51 -52.51 7.3 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.961 2.441 . . . . 0.0 112.841 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.3 -57.44 10.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.693 ' CB ' HD21 ' A' ' 29' ' ' LEU . 4.2 m-20 -53.97 -28.32 36.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.781 HG13 HD23 ' A' ' 29' ' ' LEU . 74.2 mt -65.79 -46.28 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.001 0.429 . . . . 0.0 110.009 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.604 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.47 -54.54 44.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.038 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.06 -59.85 4.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -47.3 -30.63 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.995 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.07 -45.23 18.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.816 0.341 . . . . 0.0 111.42 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.604 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -76.05 -79.1 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.999 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -80.95 84.52 6.41 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -133.31 -30.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.685 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.31 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.01 -39.51 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.483 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.5 mpt_? -72.56 -40.43 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.132 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.15 113.46 3.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.188 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.97 151.17 21.6 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 74' ' ' VAL . 47.8 t -134.69 104.88 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 117.027 0.413 . . . . 0.0 110.961 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -94.38 147.42 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 72' ' ' VAL . 56.4 t80 -97.01 134.26 40.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -131.45 177.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.915 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.32 148.45 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 111.133 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 53' ' ' ALA . 88.4 m -45.55 165.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 52' ' ' THR . . . -117.06 -170.08 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.21 40.56 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -178.65 45.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.913 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 2.5 m95 -72.01 -19.75 61.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.444 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.32 63.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -148.97 -57.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.16 -61.03 1.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.473 HD11 HG13 ' A' ' 64' ' ' ILE . 33.8 pt -86.15 -23.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.406 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.03 -54.74 3.65 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.092 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.564 HG13 HD11 ' A' ' 64' ' ' ILE . 8.1 p -51.11 153.75 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.861 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -76.29 135.9 39.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.408 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 62' ' ' VAL . 20.1 mm -130.98 116.6 34.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 111.626 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.23 122.44 87.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 29.1 Cg_endo -64.11 153.44 76.22 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.283 1.989 . . . . 0.0 112.257 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.71 3.84 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.654 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -111.2 -16.12 13.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.712 0.292 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.73 154.83 40.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -106.27 122.83 47.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.226 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HG3' HG23 ' A' ' 50' ' ' VAL . 9.6 pt-20 -114.6 144.59 43.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.08 0.467 . . . . 0.0 111.631 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 49' ' ' PHE . 1.6 t -142.96 142.92 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 39.9 m0 -114.91 140.95 48.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.786 HG11 ' CD2' ' A' ' 21' ' ' PHE . 72.3 t -126.29 114.86 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 85' ' ' ASP . . . -150.65 -146.93 4.43 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.226 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.891 HD21 ' CE2' ' A' ' 87' ' ' PHE . 1.5 mm? -119.61 153.51 35.37 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -154.98 -168.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.857 0.36 . . . . 0.0 111.053 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -107.97 -156.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.486 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.86 -10.17 55.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.459 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -71.79 -8.75 56.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.577 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.58 78.09 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.813 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -148.37 -148.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.4 tpp -142.51 -82.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.021 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 44.12 41.01 3.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 169.31 78.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 p -90.04 134.94 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.804 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.891 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -92.73 -45.81 7.86 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -136.84 162.79 32.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.563 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' HG13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -138.14 140.14 39.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.5 m-85 -120.93 154.25 36.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.913 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 72.7 mt -139.97 121.16 14.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.646 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -135.6 125.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.029 0.442 . . . . 0.0 111.847 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 p -53.94 125.98 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.946 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -55.56 -41.46 73.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.146 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -56.66 143.85 34.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -32.61 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 154.14 42.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.678 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.31 -67.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.19 84.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.06 123.18 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.772 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -119.16 139.1 52.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.8 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.84 129.14 25.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.518 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 24' ' ' MET . 11.4 p -122.48 140.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.581 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.44 131.88 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.664 ' HE3' HD12 ' A' ' 29' ' ' LEU . 28.1 m95 -108.62 149.84 28.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 0.2 OUTLIER -61.47 159.49 12.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.858 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.918 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.984 0.421 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -125.45 116.82 22.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.839 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.31 10.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.79 160.06 29.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -57.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.674 2.249 . . . . 0.0 112.171 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -31.19 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -64.81 -47.3 78.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.915 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -63.81 -50.66 68.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.4 mt -49.09 -36.58 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -38.18 72.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.722 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.9 mt -67.35 -63.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.1 -39.8 21.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.079 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.507 ' HD1' HG21 ' A' ' 47' ' ' VAL . 30.8 t80 -55.7 -51.38 67.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.191 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -30.06 70.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 17' ' ' ALA . 96.3 mt -64.27 -46.51 93.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -63.45 -52.16 62.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.447 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -59.19 -22.68 61.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.404 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 1.3 pp20? -103.94 -48.43 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 4.1 mtp -67.44 -57.41 6.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . . . -45.94 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.026 0.441 . . . . 0.0 111.79 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -48.11 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.98 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -146.19 23.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.778 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 7.1 m-80 -102.89 -48.09 4.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.0 tt -87.84 143.14 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.845 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.798 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.99 150.96 0.55 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.3 Cg_endo -53.45 -19.45 13.4 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.595 2.197 . . . . 0.0 112.592 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.23 72.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.459 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -74.5 -28.65 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.419 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.0 mt -59.17 -50.14 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.926 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -74.04 -42.91 59.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 87' ' ' PHE . 1.4 tp -57.7 -64.46 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.4 . . . . 0.0 110.491 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 5.2 m-85 -45.41 -29.87 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.163 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.548 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.77 -9.63 21.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 10.3 pt20 -151.35 116.1 5.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 112.322 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' CA ' ' A' ' 45' ' ' GLY . 11.1 t80 -169.75 -38.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.938 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.48 -65.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -40.08 88.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.576 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -95.89 28.37 3.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.088 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 41' ' ' PHE . . . -94.9 120.84 6.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.606 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.34 98.22 0.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.303 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 74' ' ' VAL . 21.4 t -94.18 97.27 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.65 137.43 35.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.822 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 75.2 t80 -92.2 116.39 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -168.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -135.3 153.7 51.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 22.4 m -56.14 162.33 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.076 0.465 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB3' ' HD1' ' A' ' 56' ' ' TRP . . . -105.45 -151.24 0.45 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.042 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.96 31.24 0.98 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.766 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 79.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.697 ' HD1' ' HB3' ' A' ' 53' ' ' ALA . 7.7 p-90 -97.87 46.95 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.433 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER -69.04 61.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.47 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -130.41 -39.22 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.45 -38.3 12.65 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.685 HD11 ' CD1' ' A' ' 64' ' ' ILE . 4.7 pt -95.27 -26.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.049 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 90.73 -46.46 2.94 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.299 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -62.43 159.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.941 0.401 . . . . 0.0 111.764 -178.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -78.27 135.24 37.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.627 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.685 ' CD1' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.76 90.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.372 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 1.2 m-20 -75.79 113.52 27.88 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 5.7 Cg_exo -41.36 -72.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.194 2.596 . . . . 0.0 114.524 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -74.61 8.87 2.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 65' ' ' ASP . 8.3 mt-10 -121.34 -14.44 8.29 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.623 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.4 145.0 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.122 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -112.75 140.47 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.643 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -112.57 139.36 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.404 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.0 t -139.51 138.35 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.953 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -120.14 131.98 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.008 0.433 . . . . 0.0 111.162 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 47' ' ' VAL . 53.6 t -121.83 113.01 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.39 -124.15 2.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.216 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 76' ' ' LEU . 2.4 tp -146.94 71.64 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.052 0.453 . . . . 0.0 109.857 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 82' ' ' GLU . 33.7 m -55.45 173.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 0.0 112.096 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 80' ' ' GLN . 52.8 p-10 -89.69 -147.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.717 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 -5.44 16.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HG2' ' ND2' ' A' ' 78' ' ' ASN . 4.2 pt20 -118.8 34.65 5.12 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.664 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.31 87.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.742 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.3 mt-10 -156.43 155.98 33.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.881 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.2 tpp -142.63 104.1 4.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.285 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.77 -18.58 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.263 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.68 109.19 11.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.949 0.404 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.56 137.11 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 22.7 m-85 -89.56 -33.6 16.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.724 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 172.93 17.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.437 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.879 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.6 mttm -130.57 147.37 52.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.2 m-85 -125.45 134.57 52.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 112.026 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.495 HD13 HG23 ' A' ' 64' ' ' ILE . 15.0 mt -122.41 136.05 54.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.775 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -149.94 116.74 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.081 0.467 . . . . 0.0 111.835 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.7 m -46.99 149.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 19.5 m-70 -89.78 23.06 2.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -92.73 165.52 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.81 -59.27 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.09 121.24 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.395 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.19 110.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.05 140.1 47.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.944 0.402 . . . . 0.0 111.228 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.9 141.85 36.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.36 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 92' ' ' ILE . 30.6 p90 -138.15 142.03 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CD2' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -144.24 130.67 19.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.211 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -119.94 140.53 43.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.84 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.31 135.2 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.784 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 38.5 m95 -106.93 147.49 29.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.62 155.92 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -93.45 -170.95 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.65 144.71 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 147.83 79.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.74 -49.52 16.96 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.565 2.177 . . . . 0.0 112.347 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -30.25 65.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -66.44 -49.76 65.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -65.01 -44.14 90.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.021 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.4 mt -59.79 -34.43 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -44.09 76.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 13' ' ' ALA . 5.0 mt -64.97 -54.78 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.88 -40.55 73.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.21 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.48 -52.04 66.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.56 -32.04 71.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 17' ' ' ALA . 19.4 mt -73.71 -28.75 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 32.5 t80 -77.26 -25.77 51.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.368 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.1 tp -78.11 -32.63 50.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.254 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.01 -38.18 9.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.174 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -75.95 -50.11 15.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.63 0.252 . . . . 0.0 111.577 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -49.12 111.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.406 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.41 -96.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.852 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.95 -4.48 52.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.1 m120 -90.54 -31.45 16.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.661 HD12 ' HE3' ' A' ' 105' ' ' TRP . 2.5 tt -92.66 139.27 30.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.65 132.9 13.94 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.976 -178.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.63 ' HA ' HD12 ' A' ' 34' ' ' ILE . 84.4 Cg_exo -42.07 -56.6 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.261 2.641 . . . . 0.0 113.627 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 -57.22 5.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 0.0 110.76 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.5 m-20 -49.95 -27.13 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.978 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 31' ' ' PRO . 51.3 mt -68.57 -53.48 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.129 0.49 . . . . 0.0 110.234 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -49.75 -60.38 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.181 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.53 HD12 ' NE2' ' A' ' 40' ' ' GLN . 4.5 mm? -51.05 -40.29 57.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.074 0.464 . . . . 0.0 110.664 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.5 t80 -64.97 -32.63 74.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.423 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.57 -39.12 28.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -79.18 -40.75 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.751 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.53 ' NE2' HD12 ' A' ' 36' ' ' LEU . 8.9 pt20 -128.98 106.38 8.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 111.811 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 34.6 t80 -165.02 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.232 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -31.75 72.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.281 0.563 . . . . 0.0 110.09 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.7 -22.65 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.113 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.761 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -130.36 31.99 4.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.997 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.09 114.14 2.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.773 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.94 165.94 22.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.115 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 73' ' ' TRP . 48.3 t -146.0 122.43 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.764 0.282 . . . . 0.0 110.57 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.38 164.07 13.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.346 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.814 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 16.0 t80 -106.8 108.16 19.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG23 ' CG ' ' A' ' 71' ' ' GLU . 3.2 m -103.8 -178.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.39 -175.62 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 53' ' ' ALA . 89.9 m -91.12 162.34 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' THR . . . -82.07 -160.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.26 -45.48 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.8 127.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.839 ' CH2' HD11 ' A' ' 91' ' ' LEU . 15.9 m0 -87.42 -75.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.533 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 1.5 mm-40 43.57 31.24 0.42 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -155.43 -37.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.865 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.551 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 24.1 mm-40 -82.12 -74.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 64' ' ' ILE . 19.1 pt -82.13 -46.86 19.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.259 . . . . 0.0 111.67 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 119.67 69.32 0.31 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.6 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 64' ' ' ILE . 13.0 p 175.57 151.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -64.91 -5.98 7.34 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.775 HD13 HG13 ' A' ' 62' ' ' VAL . 6.9 mm 59.19 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.209 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -112.92 82.35 5.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.902 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 35.8 Cg_exo -53.05 168.02 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.961 1.774 . . . . 0.0 111.837 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 56.25 12.47 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 27.7 mt-10 -135.15 -3.41 2.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.348 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 84.4 m-85 -132.11 142.26 49.45 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.814 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -91.02 124.06 34.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.888 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.713 ' CG ' HG23 ' A' ' 50' ' ' VAL . 6.1 tp10 -99.34 119.91 38.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.66 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.65 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -122.8 137.03 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.109 0.48 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.785 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m0 -115.17 141.01 48.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 47' ' ' VAL . 28.1 t -129.64 103.74 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.964 0.412 . . . . 0.0 111.356 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.44 20.56 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.703 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -102.32 153.16 20.27 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.824 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -150.11 -167.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.699 0.285 . . . . 0.0 110.778 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.426 ' H ' HG12 ' A' ' 77' ' ' VAL . 29.7 m-80 -103.62 -170.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -79.54 -13.35 59.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -74.26 -5.05 39.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.534 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.36 88.82 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.412 . . . . 0.0 111.017 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.824 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -151.46 -168.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.38 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.402 ' HE1' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -160.06 91.61 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.362 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -118.74 -9.93 10.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.137 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.74 84.75 2.26 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.958 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 73' ' ' TRP . 1.5 p -89.91 140.49 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -98.52 -29.7 12.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.9 167.95 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 103' ' ' VAL . 17.1 ttpt -142.44 139.77 31.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.5 m-85 -122.73 145.89 48.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.839 HD11 ' CH2' ' A' ' 56' ' ' TRP . 94.3 mt -124.52 119.35 28.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.188 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -130.08 122.35 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.819 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -55.95 118.46 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.498 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -56.39 -38.67 71.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -59.66 176.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -32.33 10.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.037 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -79.67 150.39 30.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.717 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 40.53 31.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.206 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.06 103.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.072 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -117.83 137.26 52.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.067 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 12.3 p90 -134.81 137.94 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.547 ' ND1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -139.17 159.49 42.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.439 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' LYS . 7.3 p -151.02 142.71 16.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.594 HD11 ' HE3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.52 140.95 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.066 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.703 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 32.9 m95 -116.99 149.88 39.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 158.63 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.883 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -112.93 127.15 56.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.013 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.46 142.54 57.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.586 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -46.28 169.6 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.706 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.79 -59.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.95 2.433 . . . . 0.0 112.287 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.19 -28.53 68.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -57.18 -57.49 12.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.834 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.87 -52.1 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 49' ' ' PHE . 53.0 mt -45.04 -36.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.999 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.13 -39.89 75.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.557 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 20' ' ' ILE . 29.8 mm -61.87 -64.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.808 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.813 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -47.96 -41.42 24.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -51.52 -54.82 23.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.206 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -25.76 67.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.357 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 17' ' ' ALA . 70.1 mt -75.95 -23.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.697 ' CG ' HG11 ' A' ' 74' ' ' VAL . 33.0 t80 -80.02 -32.49 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.426 . . . . 0.0 110.615 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD13 ' HZ ' ' A' ' 37' ' ' PHE . 3.0 mm? -80.33 -19.57 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.72 -41.12 6.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 20' ' ' ILE . 22.7 mtp -78.5 -45.05 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -61.14 159.72 11.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.341 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.05 40.04 4.69 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.566 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.3 -21.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.9 m-80 -110.35 -43.79 3.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.776 0.322 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.0 tt -75.94 151.74 37.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.03 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.863 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -48.37 155.13 0.98 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 44.6 Cg_exo -56.93 -30.64 86.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.793 2.329 . . . . 0.0 112.711 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.04 -58.61 5.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 111.373 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.672 ' OD2' HD13 ' A' ' 29' ' ' LEU . 46.2 t0 -64.5 -27.87 69.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.382 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 87.2 mt -60.04 -43.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.435 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.579 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -80.16 -44.11 20.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -62.8 -70.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.485 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.571 ' HZ ' HD13 ' A' ' 22' ' ' LEU . 1.3 t80 -48.48 -26.11 1.99 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.561 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.09 -52.15 11.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -69.98 -72.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.372 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.47 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 10.0 pt20 -77.19 -135.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 14.8 t80 87.51 -27.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.896 0.379 . . . . 0.0 110.622 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.35 -65.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.16 -30.56 11.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -24.23 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.58 128.24 8.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.686 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.08 153.18 24.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.114 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 73' ' ' TRP . 62.5 t -139.09 125.68 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.643 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 pt-20 -108.8 157.51 18.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.82 114.59 27.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 71' ' ' GLU . 12.8 m -113.7 -177.3 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -111.42 168.06 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.58 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.3 m -54.06 154.75 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.825 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -86.42 -163.53 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -95.43 37.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.887 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 3.0 t0 80.12 109.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.825 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -134.97 30.07 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.481 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 77.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' TRP . 4.0 mt-10 -154.87 -34.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.349 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.21 -49.66 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.97 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 64' ' ' ILE . 4.1 pt -70.69 -36.67 66.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 0.0 110.978 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.64 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 94.26 60.24 1.12 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.092 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.64 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.42 141.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.03 135.87 52.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 60' ' ' ILE . 6.9 mm -105.54 128.01 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 111.538 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.68 109.94 39.3 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.385 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.95 156.08 51.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.244 1.962 . . . . 0.0 112.111 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 62.04 8.28 2.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.87 -4.35 8.6 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.58 0.229 . . . . 0.0 111.427 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -148.01 135.35 20.54 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.945 0.402 . . . . 0.0 111.443 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.04 123.45 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.994 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.462 ' CG ' HG23 ' A' ' 50' ' ' VAL . 23.1 tt0 -101.7 119.66 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.946 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 48' ' ' GLU . 7.0 p -127.91 124.34 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.72 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.83 ' O ' HG13 ' A' ' 47' ' ' VAL . 24.9 m0 -89.84 141.74 28.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.697 HG11 ' CG ' ' A' ' 21' ' ' PHE . 88.7 t -129.32 96.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.5 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.88 -141.31 3.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.363 -0.923 . . . . 0.0 113.853 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.34 172.09 13.16 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 78' ' ' ASN . 6.2 t -153.67 163.93 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.503 ' N ' HG12 ' A' ' 77' ' ' VAL . 5.6 m120 -89.45 -152.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -91.64 26.1 2.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -108.94 -0.4 19.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.443 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.18 38.15 28.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.749 0.309 . . . . 0.0 111.574 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' N ' HG11 ' A' ' 77' ' ' VAL . 5.3 mm-40 -98.26 -158.37 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.387 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -163.44 32.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.71 0.69 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.31 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.65 73.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.979 0.419 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.88 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 8.4 m-85 -89.72 -41.66 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.99 162.46 39.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.573 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.791 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.9 mttt -118.26 143.71 46.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 3.2 m-85 -124.04 136.77 54.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.076 0.465 . . . . 0.0 112.199 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.566 HD12 ' CD2' ' A' ' 102' ' ' HIS . 24.4 mt -121.27 124.32 44.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.858 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.698 HG22 ' NH2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -119.27 122.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.29 127.74 33.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.022 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.989 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.7 m-70 -75.78 -4.47 40.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.729 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.34 116.89 24.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -40.36 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.268 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 149.24 46.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.66 -65.57 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.698 ' NH2' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 61.91 92.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' N ' ' NH1' ' A' ' 99' ' ' ARG . 7.7 mm-40 -113.91 145.83 40.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.517 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 39.7 p90 -137.82 143.82 41.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.901 0.381 . . . . 0.0 111.817 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.566 ' CD2' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -138.67 150.47 46.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 89' ' ' LYS . 10.9 p -150.17 142.31 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.849 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.69 138.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 178.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 46.4 m95 -113.86 147.03 39.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.15 152.01 41.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.728 0.299 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -177.38 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.49 159.33 26.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.29 146.82 38.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.795 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.94 -54.51 5.33 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.696 ' HA ' HD12 ' A' ' 14' ' ' ILE . 6.3 p-10 -67.13 -33.63 75.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.032 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 16' ' ' ILE . 86.8 m -68.15 -46.55 70.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.77 76.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.797 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 11' ' ' ASP . 48.2 mt -61.76 -58.07 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.03 -31.17 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.117 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 12' ' ' THR . 3.4 mm -70.25 -59.07 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB3' HG11 ' A' ' 72' ' ' VAL . . . -61.67 -47.2 86.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.2 -45.0 65.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -62.6 -40.19 96.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.825 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.4 mt -77.44 -15.92 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 72.2 t80 -73.07 -61.98 1.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.24 -4.89 38.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.03 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.1 tt0 -96.75 -52.33 3.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.812 0.339 . . . . 0.0 110.991 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.437 ' O ' ' C ' ' A' ' 25' ' ' ALA . 2.1 ttp -75.07 -37.12 61.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 21' ' ' PHE . . . -27.62 141.53 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.145 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.72 -86.01 0.4 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -71.75 69.08 0.65 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 169.17 -43.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.773 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.906 HD12 ' CE3' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -86.61 161.47 18.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.094 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.832 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -86.89 149.99 49.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.973 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.1 Cg_endo -50.95 -55.01 4.49 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.033 2.489 . . . . 0.0 113.336 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.29 -59.4 4.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.79 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.788 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -56.36 -24.22 42.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 40.5 mt -71.97 -39.46 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.056 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.4 tt -59.83 -52.68 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -57.18 -46.6 82.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.243 0.544 . . . . 0.0 110.473 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 1.9 t80 -55.03 -23.06 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.773 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB2' HD22 ' A' ' 39' ' ' LEU . 22.1 m120 -80.59 -41.01 24.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -104.11 14.13 31.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB2' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -147.68 23.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.085 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.5 t80 -112.1 -12.81 13.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.177 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.92 -35.26 17.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.19 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.82 -24.78 9.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.876 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.443 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 27.66 8.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.671 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.71 110.12 3.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.025 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.47 140.67 11.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.682 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.76 140.38 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.925 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -125.53 131.01 52.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.981 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 70.7 t80 -73.32 114.88 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.46 -173.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -114.08 -175.75 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.667 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 53' ' ' ALA . 32.9 m -93.47 161.78 14.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -85.23 -153.35 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.96 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.43 -45.1 10.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 3.4 p-10 172.11 93.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.77 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -107.84 47.65 0.88 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 64.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.368 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -151.44 -41.44 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.07 -55.2 5.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.75 HD11 ' CD1' ' A' ' 64' ' ' ILE . 9.3 pt -84.34 -13.72 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.323 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 63.49 77.5 0.22 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 169.76 149.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.32 . . . . 0.0 110.76 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 125.4 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.75 ' CD1' HD11 ' A' ' 60' ' ' ILE . 7.4 mm -100.72 145.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -143.2 95.78 5.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.245 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 7.3 Cg_endo -49.54 160.41 1.06 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.465 2.11 . . . . 0.0 112.197 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.57 -59.25 0.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.548 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.59 -28.99 15.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.074 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.36 146.84 47.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -99.52 140.17 34.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.258 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 50' ' ' VAL . 5.8 tp10 -105.74 129.75 53.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.01 0.433 . . . . 0.0 111.461 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.761 HG11 ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -131.6 123.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.16 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.561 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 17.0 m0 -106.43 145.74 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.587 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 4.8 t -127.28 101.96 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.13 -143.49 9.05 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.591 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 40' ' ' GLN . 2.1 tp -138.96 61.48 1.57 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.401 0.62 . . . . 0.0 110.18 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 6.9 m -47.33 174.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.612 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -130.95 -131.51 0.2 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.983 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -77.81 -22.12 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -94.15 -90.23 0.21 Allowed 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.131 -0.356 . . . . 0.0 111.653 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 77' ' ' VAL . 2.6 p30 -173.51 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.93 104.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 110.328 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.657 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 6.5 ptp -50.14 -26.03 4.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.478 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.73 -20.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -157.32 131.09 8.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.48 135.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.624 ' CE2' HD22 ' A' ' 76' ' ' LEU . 9.1 m-85 -89.44 -35.84 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -157.79 163.38 38.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.301 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.903 ' O ' HG23 ' A' ' 103' ' ' VAL . 1.4 mttt -132.38 147.1 52.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -134.61 135.46 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.799 ' C ' HD13 ' A' ' 92' ' ' ILE . 3.0 mt -120.54 131.13 54.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.082 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.799 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -132.97 136.59 55.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -63.92 128.85 37.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.669 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.458 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 22.3 m-70 -72.85 -25.14 61.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.321 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.69 156.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.67 -61.33 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ASP . 11.4 pt-20 -85.44 151.41 24.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER 49.8 103.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.814 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.16 126.88 43.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.33 141.27 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.056 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -135.33 142.04 45.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.207 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.571 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.91 128.08 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.383 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 89' ' ' LYS . 5.1 p -115.18 136.45 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.287 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -105.37 119.42 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.934 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.906 ' CE3' HD12 ' A' ' 29' ' ' LEU . 83.9 m95 -101.91 149.37 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.66 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -64.26 150.76 45.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' ' HB3' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -150.99 160.84 43.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.13 153.19 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.485 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.04 149.89 94.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.92 -55.42 3.24 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.571 2.181 . . . . 0.0 112.49 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.23 -31.15 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.207 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -64.5 -61.32 2.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.64 -44.64 81.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.41 -38.78 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -49.22 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 HG21 ' NH2' ' A' ' 99' ' ' ARG . 5.2 mm -57.06 -49.66 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.956 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.43 -37.48 67.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.132 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.55 -57.38 12.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.801 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.44 -41.91 61.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 17' ' ' ALA . 13.5 mt -60.56 -70.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 20.3 t80 -39.55 -33.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.751 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tp -69.69 -41.99 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.005 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.24 -36.31 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -66.94 -57.11 7.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.169 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . . . -48.65 112.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.46 -90.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.07 4.53 52.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.569 0.223 . . . . 0.0 111.387 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 105' ' ' TRP . 1.1 p30 -101.8 -21.95 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' A' ' 105' ' ' TRP . 3.2 tt -103.84 143.68 32.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.573 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -49.89 130.72 21.83 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.2 Cg_exo -46.89 -44.36 22.64 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.92 2.414 . . . . 0.0 113.136 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.0 36.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.451 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -55.72 -25.87 42.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 31' ' ' PRO . 52.0 mt -65.38 -54.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.983 0.421 . . . . 0.0 110.204 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.38 -48.93 55.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.644 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.721 HD22 ' OE1' ' A' ' 40' ' ' GLN . 16.1 mt -60.01 -68.23 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.401 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -45.04 -32.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.006 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.84 -37.95 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.326 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.18 -19.27 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.721 ' OE1' HD22 ' A' ' 36' ' ' LEU . 3.7 pt20 -144.53 115.82 8.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.064 0.459 . . . . 0.0 111.19 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -171.56 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.52 -33.1 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.306 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.87 -24.1 16.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.352 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.05 43.4 3.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.724 0.297 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.18 125.6 8.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.57 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.18 113.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 74' ' ' VAL . 35.7 t -108.48 117.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.715 0.293 . . . . 0.0 110.576 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -111.69 163.43 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.765 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 41.4 t80 -104.33 118.97 37.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.69 HG23 ' CB ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -109.91 177.8 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.095 0.474 . . . . 0.0 111.668 -179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' C ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.91 152.63 21.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 21.9 m -67.84 154.77 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.588 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.977 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -79.51 -152.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.41 -46.49 9.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' TRP . 8.0 p-10 -161.13 -41.35 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.977 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 3.0 p-90 22.92 114.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -139.72 19.03 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.975 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -96.49 -26.81 15.15 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.96 -68.31 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.962 ' CD1' HD11 ' A' ' 64' ' ' ILE . 23.1 pt -63.48 -42.58 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.085 0.469 . . . . 0.0 110.431 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 130.89 -63.75 0.62 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.676 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -81.7 -179.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -77.23 168.77 19.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.962 HD11 ' CD1' ' A' ' 60' ' ' ILE . 21.5 mm -135.07 145.23 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.081 0.467 . . . . 0.0 111.63 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-20 -121.52 107.36 36.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 32.8 Cg_endo -64.03 152.41 81.07 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.101 1.867 . . . . 0.0 112.101 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 72.33 -3.95 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.399 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -107.69 -16.62 14.29 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.952 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -137.91 146.93 43.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -93.06 137.78 32.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.578 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.69 ' CB ' HG23 ' A' ' 50' ' ' VAL . 8.2 mm-40 -107.58 130.39 54.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.826 HG11 ' CB ' ' A' ' 17' ' ' ALA . 14.1 p -135.06 106.75 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.71 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' HG11 ' A' ' 86' ' ' VAL . 8.2 m0 -89.17 138.92 30.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.345 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 47' ' ' VAL . 42.0 t -120.81 112.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.475 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 -125.71 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.922 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.6 tp -146.15 61.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.078 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 78' ' ' ASN . 26.7 t -57.13 159.26 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.617 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -108.02 -170.49 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -31.42 72.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.808 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -69.29 -11.99 61.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.366 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.41 33.05 0.7 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.801 0.334 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.36 130.55 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.423 ' HB2' HG22 ' A' ' 77' ' ' VAL . 24.5 ttm -102.93 122.68 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.991 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.64 -19.79 11.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 132.13 43.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG11 ' CZ3' ' A' ' 73' ' ' TRP . 0.7 OUTLIER -103.51 144.42 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 76' ' ' LEU . 1.7 m-85 -107.02 -23.84 12.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -175.77 175.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.435 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.4 mttp -141.46 139.12 33.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.539 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 1.1 m-85 -126.66 131.39 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.203 0.525 . . . . 0.0 112.24 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -115.21 130.06 56.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.988 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -131.09 132.54 63.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -64.14 130.06 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.845 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 93.8 m-70 -77.31 -18.61 57.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.468 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -67.56 168.12 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.084 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.71 -69.26 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 98' ' ' ASP . 7.9 mt-10 -61.12 144.34 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.125 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER 57.7 115.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.233 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH2' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.81 90.49 3.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.787 0.327 . . . . 0.0 110.274 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -89.65 126.62 35.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 28.4 p90 -146.28 138.39 25.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.715 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -133.94 134.47 42.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.429 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.3 p -114.39 146.8 18.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 89' ' ' LYS . 4.8 mp -111.63 138.58 39.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.233 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.667 ' HE3' HD12 ' A' ' 29' ' ' LEU . 57.2 m95 -122.61 147.4 46.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.111 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.79 144.74 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.883 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.744 0.307 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -135.58 171.24 14.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.42 159.34 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.12 157.71 34.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.12 -50.32 7.65 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.551 2.167 . . . . 0.0 112.202 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.9 -30.07 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -48.44 63.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.59 87.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.57 -41.27 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -52.22 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.53 ' CD1' HD12 ' A' ' 92' ' ' ILE . 1.4 pp -70.76 -39.02 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -61.64 -41.34 97.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.582 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -60.81 -46.27 91.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.229 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.17 -34.44 75.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.233 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 17' ' ' ALA . 58.2 mt -67.13 -46.71 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.637 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 21.8 t80 -51.83 -56.75 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.74 -12.33 60.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.752 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.0 tp10 -93.62 -60.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -76.14 -38.28 56.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -47.34 110.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 111.407 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.64 -92.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.872 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.33 -2.97 47.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 8.6 m120 -95.77 -28.79 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.8 tt -92.92 157.41 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.425 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.935 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -80.44 149.91 69.47 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 111.69 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.62 -47.85 21.3 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.827 2.352 . . . . 0.0 113.38 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.95 0.97 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 111.899 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.733 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -60.29 -23.15 63.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 29' ' ' LEU . 13.9 mt -70.99 -35.02 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.907 0.384 . . . . 0.0 110.213 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -69.06 -48.35 63.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.806 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.607 HD23 ' NE2' ' A' ' 40' ' ' GLN . 2.0 mt -60.19 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.7 t80 -39.68 -31.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.308 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -74.08 -49.2 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.615 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 2.4 mm? -82.86 -20.12 36.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.607 ' NE2' HD23 ' A' ' 36' ' ' LEU . 3.9 pt20 -136.39 111.23 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -174.66 -49.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.321 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -51.4 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 52.71 0.88 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 0.0 111.198 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 122.71 7.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.64 119.92 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.289 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 74' ' ' VAL . 39.1 t -104.76 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.35 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.86 136.73 36.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -87.06 133.28 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -129.96 -169.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.689 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -127.92 171.19 12.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.682 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -63.57 154.56 32.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -88.42 -160.91 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.951 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -94.15 33.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.208 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 2.1 m-20 83.73 112.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.728 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.8 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -138.74 33.33 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -59.62 79.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -155.95 -37.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.85 -47.51 7.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.663 0.268 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 64' ' ' ILE . 1.7 pt -74.52 -28.98 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.015 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.648 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 79.21 69.05 1.43 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.459 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 172.99 140.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 110.682 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -53.56 136.36 38.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.802 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 60' ' ' ILE . 14.1 mm -110.09 131.69 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.446 . . . . 0.0 111.649 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 73.8 m-20 -134.82 104.67 10.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.051 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 34.3 Cg_endo -64.67 160.59 39.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.164 1.91 . . . . 0.0 112.441 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER 74.39 -8.3 1.5 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.207 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.486 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.2 pt-20 -118.59 -5.42 10.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.177 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.486 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 60.2 m-85 -131.99 147.99 52.49 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.955 0.407 . . . . 0.0 110.825 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.35 128.66 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.051 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' HG23 ' A' ' 50' ' ' VAL . 4.8 tp10 -96.65 132.89 41.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.0 111.492 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 17' ' ' ALA . 1.5 t -131.39 135.23 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.728 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.545 ' CE2' ' HD2' ' A' ' 89' ' ' LYS . 6.0 m0 -118.57 135.72 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.048 0.451 . . . . 0.0 111.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 47' ' ' VAL . 36.0 t -126.73 109.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.77 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.76 -136.76 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.074 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.661 HD22 ' HE1' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -142.06 59.26 1.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 109.863 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.725 HG12 ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -46.84 141.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.93 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -89.46 -129.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.229 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.543 ' C ' ' HG3' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -101.58 -176.75 3.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.299 0.571 . . . . 0.0 109.999 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HG3' ' C ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER 40.62 19.08 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.422 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' GLU . 1.7 t70 73.45 76.65 0.13 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.828 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.725 ' C ' HG12 ' A' ' 77' ' ' VAL . 1.4 mt-10 -152.13 123.99 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.261 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.652 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 21.2 ttm -101.29 -71.98 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.047 0.451 . . . . 0.0 110.688 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -19.24 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 83' ' ' MET . 2.0 m-20 -139.2 115.26 10.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.46 149.27 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.514 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.661 ' HE1' HD22 ' A' ' 76' ' ' LEU . 3.6 m-85 -97.1 -36.14 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . -160.59 167.97 25.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.923 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HB2' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -129.87 147.12 51.6 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.2 m-85 -130.83 135.95 48.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' ND1' ' A' ' 102' ' ' HIS . 2.6 mt -128.5 131.91 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.446 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -142.19 129.98 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.164 0.507 . . . . 0.0 112.147 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.68 135.61 46.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.936 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -75.19 -21.02 59.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 174.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.266 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 -57.35 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 123.5 30.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.78 110.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.67 139.5 45.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.24 142.26 42.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.445 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB3' HG23 ' A' ' 92' ' ' ILE . 27.4 p90 -136.09 142.46 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.007 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.565 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.92 132.73 34.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.176 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.2 p -122.1 144.4 31.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 89' ' ' LYS . 1.9 mp -101.25 135.33 38.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.393 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.791 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.7 m95 -117.65 -90.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.73 131.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.8 mttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.866 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.608 0.242 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -141.94 172.9 12.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.362 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -99.6 169.61 9.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.515 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.2 m-20 -104.45 144.59 29.01 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.571 0.224 . . . . 0.0 110.49 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.35 -53.64 6.77 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.494 2.129 . . . . 0.0 112.593 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -53.76 -37.42 63.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.367 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 16' ' ' ILE . 65.2 m -82.28 -35.27 28.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.416 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.613 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -64.96 -32.95 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.93 -59.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.002 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.6 -29.47 1.84 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.204 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 12' ' ' THR . 1.1 pp -78.62 -45.08 25.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.615 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -70.24 -31.82 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.039 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.26 -45.01 96.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.106 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -24.91 63.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.8 mt -75.37 -28.47 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.492 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.729 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.6 t80 -80.36 -41.85 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.85 -3.76 49.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 7.6 pt-20 -116.97 -45.07 2.78 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 ttp -85.9 -45.55 11.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -51.99 122.93 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.745 0.307 . . . . 0.0 111.49 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.56 -67.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -7.83 59.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.0 -72.56 0.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 30' ' ' ASP . 5.3 tt -63.96 127.62 32.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.263 0.554 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.832 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -40.24 153.42 0.21 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.642 -178.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HA ' HD12 ' A' ' 34' ' ' ILE . 22.9 Cg_exo -64.73 -33.09 55.61 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.717 2.278 . . . . 0.0 112.667 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.38 -55.76 27.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 111.296 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.661 ' CB ' HD21 ' A' ' 29' ' ' LEU . 6.5 m-20 -62.54 -22.82 66.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.436 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 31' ' ' PRO . 97.0 mt -72.75 -47.46 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.51 -45.47 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.335 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.25 -57.44 10.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -55.77 -34.81 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.776 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.66 -44.28 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -77.22 -14.49 59.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.139 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 1.6 mm100 -120.36 -144.97 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.224 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 1.2 t80 83.1 -19.38 0.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.488 0.315 . . . . 0.0 111.632 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.77 -39.82 17.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.74 -29.92 8.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' CB ' ' HG ' ' A' ' 76' ' ' LEU . 1.5 mmp_? -115.76 27.54 9.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.002 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.71 114.54 4.46 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.402 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.33 146.49 16.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.763 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 73' ' ' TRP . 88.0 t -146.77 118.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.183 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.94 155.37 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.444 . . . . 0.0 111.522 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CE1' ' HB1' ' A' ' 13' ' ' ALA . 70.4 t80 -101.55 133.94 45.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -142.6 140.68 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.54 -173.17 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.446 . . . . 0.0 110.737 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 16.0 m -83.81 169.82 14.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.467 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.81 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -97.14 -160.31 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 3.7 p30 -93.77 30.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.518 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 t0 85.57 108.86 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -129.21 69.59 1.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.798 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 17.7 mt-10 -80.76 53.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.316 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 -49.65 2.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -83.21 -53.28 5.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 ' CD1' ' A' ' 64' ' ' ILE . 6.3 pt -81.59 -34.99 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.935 0.398 . . . . 0.0 109.954 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 57' ' ' GLU . . . 88.37 -39.72 3.11 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.55 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.504 HG11 ' CE1' ' A' ' 102' ' ' HIS . 4.1 p -58.16 154.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 111.647 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.53 120.34 16.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.475 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 2.3 mm -98.64 160.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.376 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.17 117.92 4.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 27.2 Cg_endo -62.2 152.46 75.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.308 2.005 . . . . 0.0 112.3 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -65.22 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -24.86 7.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.471 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 2.7 m-85 -110.93 149.28 30.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -118.38 123.89 46.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.353 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' HG2' HG23 ' A' ' 50' ' ' VAL . 17.4 tt0 -102.25 144.25 31.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.27 0.557 . . . . 0.0 111.367 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 17' ' ' ALA . 1.8 t -132.74 140.41 47.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.584 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.809 ' O ' HG13 ' A' ' 47' ' ' VAL . 17.6 m0 -114.9 132.48 56.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.0 111.177 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 47' ' ' VAL . 62.1 t -124.98 97.59 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.628 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -126.17 -133.4 3.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.588 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.633 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.4 tp -140.69 83.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 83' ' ' MET . 35.0 m -64.34 178.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.0 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -115.64 -171.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.96 -16.85 64.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.262 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -97.27 26.55 4.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.293 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 39.82 55.4 2.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.904 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.42 104.63 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.597 ' HB2' HG12 ' A' ' 77' ' ' VAL . 35.8 ttm -69.79 117.56 11.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 19.82 17.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.655 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 104.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.814 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 p -89.57 142.43 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.11 0.481 . . . . 0.0 111.524 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HE2' HD13 ' A' ' 76' ' ' LEU . 13.9 m-85 -89.81 -33.74 16.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.691 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -166.53 165.76 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.736 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.795 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.9 mttt -132.16 146.23 51.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.3 m-85 -126.3 130.21 50.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.458 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.522 HD12 ' ND1' ' A' ' 102' ' ' HIS . 5.2 mt -110.78 135.6 51.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.83 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.404 HG13 HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -139.03 123.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.577 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 156.75 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.758 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.825 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 20.4 m-70 -101.92 23.02 12.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.086 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -87.4 148.15 25.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.0 111.106 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -61.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.73 158.48 15.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 44.72 94.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.2 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.98 151.66 27.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.144 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -130.53 140.76 50.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 24.3 p90 -138.19 142.75 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -137.68 161.98 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.875 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.6 143.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.512 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.12 137.26 43.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.538 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 27.2 m95 -117.02 149.83 39.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.26 28.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.877 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.925 0.393 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -98.32 -172.82 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -105.11 143.06 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.777 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 150.83 14.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.785 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.92 -50.18 10.94 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.164 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -21.98 60.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.205 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.415 HG22 HD22 ' A' ' 8' ' ' LEU . 27.9 m -82.43 -49.15 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.409 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -63.22 -36.19 82.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.258 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -72.24 -57.55 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -44.74 -48.42 10.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.736 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -66.72 -45.33 88.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.088 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.67 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.045 0.45 . . . . 0.0 110.265 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.5 -36.43 71.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.922 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.32 -27.24 62.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.822 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.546 HG22 ' HE2' ' A' ' 90' ' ' PHE . 49.3 mt -74.1 -33.16 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.691 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 47.8 t80 -78.25 -23.63 47.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.07 0.462 . . . . 0.0 110.411 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.28 -33.29 37.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.238 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.18 -34.26 11.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.285 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 27.9 mtp -83.08 -50.9 8.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.523 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -55.14 138.76 43.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 111.321 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.79 21.07 5.51 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -160.11 -42.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HB3' ' CG ' ' A' ' 105' ' ' TRP . 2.5 m120 -76.59 -57.47 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -65.25 175.05 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.793 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.846 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -75.76 153.66 85.19 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.74 0.305 . . . . 0.0 111.017 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.73 ' HA ' HD12 ' A' ' 34' ' ' ILE . 52.2 Cg_exo -55.85 -58.02 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.907 2.404 . . . . 0.0 113.141 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.04 -46.33 11.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 111.64 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.64 ' CB ' HD22 ' A' ' 29' ' ' LEU . 12.7 m-20 -62.41 -27.69 69.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.5 mt -68.94 -48.45 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.877 0.37 . . . . 0.0 110.548 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.9 tp -57.57 -62.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -44.68 -45.23 9.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.195 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -35.79 75.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -68.43 -53.34 24.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.4 mm? -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -83.28 -136.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 72.98 -58.66 0.59 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.687 0.279 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.47 -42.71 98.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.36 -48.98 7.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -116.85 66.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.734 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.53 134.02 12.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.298 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.02 115.32 1.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.388 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -151.62 68.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -84.98 136.51 33.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 82.1 t80 -91.02 89.68 7.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.71 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.97 3.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 51.5 m -90.27 165.17 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.143 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 52' ' ' THR . . . -122.34 164.16 18.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.9 -31.87 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.82 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.826 ' CH2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -66.83 -27.94 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -60.72 67.35 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.506 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' TRP . 5.7 mt-10 -156.23 -54.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.19 -67.88 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' CG1' ' A' ' 62' ' ' VAL . 45.6 pt -71.46 -34.18 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 94.13 48.95 2.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.676 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.591 HG13 HD11 ' A' ' 64' ' ' ILE . 9.6 p 179.6 132.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' HG3' ' A' ' 57' ' ' GLU . 1.3 mt -65.71 135.3 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.591 HD11 HG13 ' A' ' 62' ' ' VAL . 17.9 mm -121.07 146.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.62 109.39 5.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 24.4 Cg_endo -62.89 153.26 74.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.186 1.924 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 62.73 7.07 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.563 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -128.25 17.27 6.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.405 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 31.1 m-85 -150.65 142.07 23.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.9 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.991 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -89.45 116.5 27.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -110.39 104.99 13.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.58 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.89 135.78 31.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.282 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 10.0 m0 -115.77 89.76 3.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.188 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 47' ' ' VAL . 72.6 t -89.7 99.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.041 0.448 . . . . 0.0 110.972 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.01 -132.55 3.46 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.462 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.2 tp -140.24 108.97 5.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 82' ' ' GLU . 57.2 t -96.28 148.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -92.24 -164.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.54 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.299 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.28 -6.87 48.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HA ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 67.07 30.14 7.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.721 0.296 . . . . 0.0 111.332 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.4 mm-40 -105.54 147.47 28.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.56 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.83 86.08 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 111.103 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.31 12.76 23.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.59 91.91 1.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.879 0.371 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.721 HG21 ' HG2' ' A' ' 89' ' ' LYS . 2.5 p -89.72 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' A' ' 76' ' ' LEU . 3.2 m-85 -97.4 -49.65 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.36 121.1 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.395 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.721 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -103.37 131.5 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.152 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.546 ' HE2' HG22 ' A' ' 20' ' ' ILE . 2.6 m-85 -111.7 153.26 26.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 0.0 111.775 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.826 HD11 ' CH2' ' A' ' 56' ' ' TRP . 15.3 mt -137.07 109.07 7.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.553 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.504 HG21 ' NH2' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -115.84 136.87 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.749 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -71.98 93.08 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.904 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.991 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 96.6 m-70 -31.92 -49.16 0.17 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.223 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -41.32 143.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.964 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -48.56 46.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 98' ' ' ASP . 8.3 mt-10 -72.11 145.33 48.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.099 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER 57.57 115.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.287 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 92' ' ' ILE . 13.4 tpt180 -109.66 113.79 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.838 0.351 . . . . 0.0 110.504 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CG ' ' HB2' ' A' ' 93' ' ' SER . 7.8 pt-20 -128.62 103.76 7.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 92' ' ' ILE . 26.2 p90 -112.07 146.26 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.93 161.38 39.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.443 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.8 p -152.74 141.66 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.82 132.69 58.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 29' ' ' LEU . 88.0 m95 -111.59 -81.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.412 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.64 139.97 11.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.871 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.96 134.07 52.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.952 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.1 148.3 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.988 -179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.597 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -47.28 140.22 7.2 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.687 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -58.42 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.448 2.098 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -31.3 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -59.6 -55.23 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.906 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -58.36 -52.79 64.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.024 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -46.42 -38.85 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.182 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.04 -46.95 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 13' ' ' ALA . 4.7 mt -60.86 -63.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.902 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -47.05 -38.27 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -55.14 -52.67 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.103 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.98 -21.7 66.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.667 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 17' ' ' ALA . 77.9 mt -77.2 -30.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.042 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' CD2' HG11 ' A' ' 74' ' ' VAL . 15.0 t80 -76.68 -28.18 55.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.481 . . . . 0.0 110.136 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.1 tp -78.2 -32.78 50.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.391 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.36 -38.38 10.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.128 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 19.0 mtp -74.09 -51.21 16.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -50.0 145.66 5.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.401 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.13 29.92 9.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.279 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -152.36 -35.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.623 0.249 . . . . 0.0 111.357 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.469 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -121.04 -30.47 4.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.326 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD12 ' HE3' ' A' ' 105' ' ' TRP . 5.2 tt -68.94 141.17 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -58.5 140.27 84.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.53 -54.83 4.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.085 2.523 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.82 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.21 -28.89 68.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.301 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.591 HG12 HD22 ' A' ' 29' ' ' LEU . 54.3 mt -66.1 -52.29 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -55.69 30.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -49.78 -39.57 38.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 111.417 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -80.88 -36.82 30.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.4 -23.8 46.57 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -86.18 -27.77 24.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.622 ' HG3' HD21 ' A' ' 76' ' ' LEU . 12.4 pt20 -150.08 95.6 2.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.814 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.8 t80 -130.74 -40.24 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.201 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -68.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.919 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.42 -39.9 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.7 mpt_? -112.59 62.03 0.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.04 133.65 11.77 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.178 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.13 142.58 9.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.928 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 74' ' ' VAL . 39.5 t -146.04 80.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -76.87 140.46 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.812 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.02 88.43 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' CG ' ' A' ' 71' ' ' GLU . 1.8 m -89.52 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.153 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.73 175.5 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.761 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -60.4 154.18 21.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -75.03 -149.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -38.19 14.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 110.195 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 56' ' ' TRP . 4.0 p30 -151.3 -35.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.234 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.622 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 6.3 m95 70.84 2.28 4.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.634 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.8 59.59 0.89 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.876 0.369 . . . . 0.0 111.107 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.5 -49.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.799 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 5.1 mm-40 -75.99 -73.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.622 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 48.0 pt -75.13 -34.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.297 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 82.21 79.88 0.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.722 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 168.7 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -70.34 121.24 17.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.69 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 60' ' ' ILE . 27.0 mm -124.17 112.43 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.264 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.64 115.2 20.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.76 151.21 82.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.24 1.96 . . . . 0.0 111.921 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 77.71 -29.84 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.05 6.36 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.391 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -141.85 151.39 42.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 111.434 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -99.28 131.62 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.651 ' CG ' HG23 ' A' ' 50' ' ' VAL . 2.2 tp10 -115.72 110.23 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.582 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.902 HG11 ' HB1' ' A' ' 17' ' ' ALA . 8.8 p -113.73 135.24 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.176 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 18.7 m0 -117.9 136.35 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.321 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 47' ' ' VAL . 58.0 t -135.59 108.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 0.0 111.39 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.57 -115.23 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.622 HD21 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -150.04 155.25 39.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -140.58 -178.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.472 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.54 -173.86 2.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -26.12 65.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.965 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -79.16 -9.63 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.414 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.58 88.78 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.828 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.9 mt-10 -144.11 147.05 33.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 tpt -120.82 80.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 -5.51 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 84.95 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.7 p -89.84 131.73 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.665 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 76' ' ' LEU . 14.7 m-85 -89.47 -37.06 15.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.589 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.883 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -144.74 162.1 37.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.15 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.653 ' HE2' HD12 ' A' ' 104' ' ' ILE . 3.8 mttm -146.26 130.64 17.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.614 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -120.33 148.69 43.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 56' ' ' TRP . 58.9 mt -129.29 118.16 21.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.385 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -129.29 147.93 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.317 0.58 . . . . 0.0 112.553 -178.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.86 122.16 26.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.534 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.943 ' CE1' HD12 ' A' ' 8' ' ' LEU . 92.1 m-70 -58.82 -15.37 12.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.827 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.72 -55.81 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.62 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.84 0.06 28.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 112.063 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.89 105.01 2.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.92 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.46 118.64 22.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.056 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -104.51 127.45 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 21.6 p90 -118.26 138.9 52.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.848 0.356 . . . . 0.0 111.232 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -147.62 101.6 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.4 p -99.86 144.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.026 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.653 HD12 ' HE2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.9 131.1 73.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.974 179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.883 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 26.8 m95 -105.46 153.55 21.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.42 160.45 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.896 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -177.89 5.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.087 HD21 ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -130.16 148.54 52.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HD22 ' A' ' 8' ' ' LEU . 1.2 m-20 -80.59 134.82 53.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.056 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.43 -42.17 22.87 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 112.32 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -27.32 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.649 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -77.33 -37.07 53.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.087 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -65.71 -44.96 84.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.62 -42.63 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.959 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.34 -55.41 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.75 -42.09 94.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.031 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -60.12 -39.42 86.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.953 0.406 . . . . 0.0 110.309 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.65 -47.83 81.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.096 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.92 65.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.667 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.5 mt -62.61 -73.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 70.0 t80 -42.49 -29.45 0.28 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.381 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.51 HD12 ' HZ ' ' A' ' 37' ' ' PHE . 1.9 tp -64.69 -45.17 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.48 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.1 pt-20 -103.4 -28.57 11.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.405 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -72.14 -53.42 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 111.204 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 137.69 41.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.428 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.771 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 162.79 -85.7 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.894 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.6 3.59 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' CD2' ' A' ' 105' ' ' TRP . 0.9 OUTLIER -92.26 -42.64 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.263 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.851 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.4 tt -97.27 154.56 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.851 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.95 149.91 4.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.8 Cg_endo -53.64 -25.86 35.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.523 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.03 -60.42 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.64 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.659 ' HB3' HD22 ' A' ' 29' ' ' LEU . 45.1 t0 -58.21 -29.01 65.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.51 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 96.5 mt -61.2 -47.97 91.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 110.172 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -68.76 -47.21 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.438 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.454 HD23 ' OE1' ' A' ' 40' ' ' GLN . 5.6 mp -60.37 -59.09 5.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.426 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HZ ' HD12 ' A' ' 22' ' ' LEU . 4.1 t80 -42.12 -30.61 0.3 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.296 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -76.96 -50.71 12.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 35' ' ' LEU . 1.9 mm? -83.35 -63.17 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.618 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.859 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.48 92.83 9.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 111.659 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.2 t80 -163.95 -37.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.64 -62.54 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -102.62 -15.45 16.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.529 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' O ' HD12 ' A' ' 76' ' ' LEU . 20.6 mmt180 -102.75 -5.38 23.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.651 0.262 . . . . 0.0 111.396 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -91.15 132.71 11.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.17 145.46 13.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.368 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 74' ' ' VAL . 28.9 t -130.99 96.65 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.906 0.384 . . . . 0.0 111.006 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' A' ' 83' ' ' MET . 2.2 pt-20 -84.31 164.48 18.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.962 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.615 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 36.8 t80 -114.28 135.85 53.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.496 HG23 ' CG ' ' A' ' 71' ' ' GLU . 6.4 m -132.21 -174.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.17 166.09 13.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 66' ' ' PRO . 8.0 m -54.69 155.96 3.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.88 -177.29 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.03 26.25 10.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.77 39.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.853 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -65.22 -29.8 70.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.276 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 14.2 mt-10 -59.44 -16.63 24.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -92.68 -34.03 14.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 36.5 mt-10 -78.93 -57.66 3.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.853 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 42.0 pt -93.93 -36.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.415 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 123.61 -72.53 0.41 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m -56.88 173.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.814 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' O ' HD13 ' A' ' 64' ' ' ILE . 4.7 mp -89.82 136.4 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.485 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CG1' HD11 ' A' ' 60' ' ' ILE . 25.9 mm -124.9 116.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.755 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -65.36 112.07 7.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG21 ' A' ' 52' ' ' THR . 19.5 Cg_endo -61.42 163.75 16.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.792 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.7 pt-20 48.81 20.31 0.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.974 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -129.05 -14.44 4.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.584 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HE2' ' HG ' ' A' ' 93' ' ' SER . 64.2 m-85 -123.92 162.7 22.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.836 0.35 . . . . 0.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -109.1 122.15 46.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.496 ' CG ' HG23 ' A' ' 50' ' ' VAL . 35.0 tt0 -106.03 123.52 48.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.499 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.5 t -115.99 147.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.64 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -124.44 135.92 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 47' ' ' VAL . 49.1 t -128.42 111.01 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.091 0.472 . . . . 0.0 111.14 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.66 -127.22 3.07 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.166 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.859 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.8 tp -149.18 57.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' ASN . 6.3 p -63.71 158.55 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.702 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.5 m-80 -95.13 -144.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.929 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -93.23 22.88 4.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.662 0.267 . . . . 0.0 111.223 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -114.23 -11.76 12.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.543 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 71.37 28.81 2.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.385 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 77' ' ' VAL . 65.3 mt-10 -114.46 119.35 36.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.71 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.401 ' HE2' ' HG2' ' A' ' 48' ' ' GLU . 10.0 tpp -84.89 98.55 10.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.458 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.83 -23.88 26.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.24 125.61 16.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.41 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -107.08 135.59 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.709 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.3 m-85 -90.11 -38.32 13.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.74 175.96 12.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.788 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.637 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.17 140.61 22.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -123.32 147.56 46.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.778 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 34.2 mt -131.47 124.8 30.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.141 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.45 149.39 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.467 ' HG ' ' HE2' ' A' ' 69' ' ' TYR . 17.8 m -69.34 123.29 20.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.953 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.754 ' NE2' HD12 ' A' ' 8' ' ' LEU . 11.5 m80 -49.91 -48.62 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.634 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -42.87 160.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.098 0.475 . . . . 0.0 111.828 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -99.17 -34.63 10.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.112 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 3.3 pt-20 -91.3 126.69 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.93 106.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.8 148.54 45.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.507 . . . . 0.0 111.616 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.58 133.32 56.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.489 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 39.7 p90 -120.67 139.13 53.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.79 103.03 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.0 111.058 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.5 p -98.79 141.76 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.918 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.514 HD12 ' CE ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -108.2 135.55 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.151 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.801 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 46.9 m95 -115.52 140.72 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.23 159.19 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mttm . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.822 0.344 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 177.76 6.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 16' ' ' ILE . 3.2 mt -139.38 135.29 33.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.37 164.93 53.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.578 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.65 -59.21 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.219 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 14' ' ' ILE . 9.7 t70 -63.87 -30.27 71.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 8' ' ' LEU . 13.7 m -73.27 -42.82 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -60.81 -35.33 76.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 11' ' ' ASP . 23.8 mt -71.35 -57.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.12 -39.84 2.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.263 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.1 mt -65.86 -57.34 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -56.59 -29.07 61.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.12 -55.45 25.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.8 -31.21 62.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.752 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 17' ' ' ALA . 78.7 mt -64.02 -74.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.144 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 44.8 t80 -39.51 -32.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.415 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 22' ' ' LEU . 2.0 tp -63.77 -43.02 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -29.26 10.41 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -57.86 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.682 0.277 . . . . 0.0 111.434 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -50.25 116.52 1.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.395 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.21 -89.94 0.08 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.92 2.78 32.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.4 m-80 -103.04 -59.12 1.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 33' ' ' ASP . 5.1 tt -64.1 135.26 56.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.78 137.49 3.34 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.964 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 34' ' ' ILE . 6.1 Cg_endo -48.21 -43.06 32.44 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.852 2.368 . . . . 0.0 112.754 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.0 -58.86 5.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.599 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.719 ' CB ' HD21 ' A' ' 29' ' ' LEU . 41.2 m-20 -58.06 -24.68 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 31' ' ' PRO . 92.5 mt -67.99 -50.93 54.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 109.991 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -53.7 -51.13 64.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.756 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -55.16 37.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.141 0.496 . . . . 0.0 110.417 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 2.1 t80 -46.19 -30.08 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.901 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -59.07 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.466 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.2 mm? -64.18 -21.26 66.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.837 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.619 ' HG3' HD21 ' A' ' 76' ' ' LEU . 3.9 pt20 -148.8 118.61 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.652 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' GLY . 63.4 t80 179.98 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.756 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -48.39 -63.5 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.25 -33.17 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.41 33.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -104.58 62.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.552 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.21 116.72 5.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.497 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 72' ' ' VAL . 38.7 t -102.34 107.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.77 0.319 . . . . 0.0 110.865 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.37 150.62 24.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.415 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 35.0 t80 -103.72 141.73 35.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.091 0.472 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.709 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.12 152.41 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.921 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -92.9 158.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.702 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 98.2 m -46.88 167.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.064 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 52' ' ' THR . . . -103.07 -169.04 1.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.72 32.59 4.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.23 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.959 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.5 m95 68.14 6.57 5.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.991 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.45 -1.8 19.88 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.71 -44.02 5.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 60.1 mm-40 -73.3 -56.28 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.439 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.815 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 18.0 pt -103.15 -35.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.675 0.274 . . . . 0.0 111.02 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 -53.02 0.6 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.301 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.78 152.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.238 0.542 . . . . 0.0 111.878 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -62.92 156.49 24.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.721 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 63' ' ' LEU . 34.5 mm -150.35 128.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.85 108.08 4.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.616 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 9.6 Cg_endo -52.9 157.69 7.56 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.288 1.992 . . . . 0.0 112.287 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 20.1 mt-10 69.64 -59.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.16 -29.03 1.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.814 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -116.65 152.16 34.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 111.355 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -112.37 133.11 54.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.816 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG3' HG23 ' A' ' 50' ' ' VAL . 8.0 pt-20 -112.53 133.48 54.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG13 ' CG1' ' A' ' 47' ' ' VAL . 2.2 t -121.22 147.45 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.84 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.452 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 12.2 m0 -120.49 133.57 55.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 111.226 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 21' ' ' PHE . 45.1 t -126.93 110.59 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.907 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.45 -132.27 3.75 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.264 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.619 HD21 ' HG3' ' A' ' 40' ' ' GLN . 2.3 tp -142.16 64.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 0.0 110.093 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 83' ' ' MET . 22.3 t -49.4 159.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.831 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.5 m-80 -89.65 -160.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.61 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -70.91 -9.7 58.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -91.95 -87.76 0.21 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.52 0.2 . . . . 0.0 111.17 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HA ' HG11 ' A' ' 77' ' ' VAL . 1.4 p30 179.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -57.38 129.65 42.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 77' ' ' VAL . 25.3 ttm -107.52 122.71 47.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.037 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.52 -3.18 13.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -137.56 108.23 6.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.863 0.363 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -97.38 138.74 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.858 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.568 ' HE2' HD22 ' A' ' 76' ' ' LEU . 2.5 m-85 -90.0 -46.35 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.681 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.723 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -143.99 173.19 11.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -150.4 136.0 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' HG21 ' A' ' 103' ' ' VAL . 1.4 m-85 -121.17 142.2 50.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.959 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 13.8 mt -119.96 133.43 55.56 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.02 143.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.92 132.32 46.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.65 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.0 -32.95 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 178.24 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.031 0.443 . . . . 0.0 111.277 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.64 -12.84 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.356 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -133.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 51.52 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 110.665 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -62.09 141.65 58.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.116 0.484 . . . . 0.0 111.905 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -117.46 149.63 40.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.595 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 35.5 p90 -139.16 143.36 38.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.708 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.705 ' CD2' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -150.04 118.79 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.143 0.497 . . . . 0.0 111.525 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -107.24 144.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.906 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -111.81 135.9 49.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 37.3 m95 -117.07 149.36 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 5.1 ttmt -67.63 153.46 43.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.851 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tptt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.721 0.296 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -89.92 178.91 6.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' HG22 ' A' ' 12' ' ' THR . 0.9 OUTLIER -105.71 143.89 33.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.064 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.83 157.82 57.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.83 -64.49 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.638 2.225 . . . . 0.0 112.248 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.68 -32.83 67.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' CD2' ' A' ' 8' ' ' LEU . 69.4 m -72.58 -36.46 68.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.437 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -65.06 -26.77 68.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.26 -62.12 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.97 -32.49 3.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.793 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 12' ' ' THR . 1.3 pp -76.86 -48.04 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.74 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.59 -35.84 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 110.198 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.59 -43.88 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.939 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -66.1 -27.86 68.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.136 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 17' ' ' ALA . 50.3 mt -74.25 -28.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.1 t80 -69.01 -45.97 69.19 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -80.02 -2.98 46.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 1.1 mm-40 -95.78 -56.83 2.54 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.3 mtp -92.18 -30.62 15.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.63 122.94 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.01 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.84 35.97 1.09 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.124 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -163.04 -32.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.44 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 5.2 t30 -116.27 -34.91 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 33' ' ' ASP . 3.0 tt -80.07 124.31 28.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 111.062 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.771 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -34.2 150.12 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.561 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 34' ' ' ILE . 26.9 Cg_endo -62.77 -34.49 72.83 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.536 2.157 . . . . 0.0 112.667 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.91 -58.15 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.868 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.792 ' HB2' HD21 ' A' ' 29' ' ' LEU . 61.8 m-20 -61.24 -19.43 61.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 31' ' ' PRO . 83.5 mt -75.23 -51.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.932 0.396 . . . . 0.0 110.388 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.3 tt -54.27 -51.8 63.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.738 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -52.02 66.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.247 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 4.0 t80 -46.46 -28.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.914 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -77.01 -49.99 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.6 44.02 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.01 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -150.57 -44.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.2 t80 -61.02 -12.01 10.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.717 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.59 -46.55 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -119.45 -13.31 9.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.607 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.461 ' O ' HD12 ' A' ' 76' ' ' LEU . 6.0 mtt-85 -118.18 41.66 2.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.142 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.92 108.82 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.52 154.06 24.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.297 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 73' ' ' TRP . 75.9 t -144.07 119.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -101.92 142.99 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.71 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 59.2 t80 -91.67 138.26 31.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.295 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.04 142.13 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.599 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.32 -174.78 1.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 53' ' ' ALA . 61.7 m -72.33 165.0 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -91.15 -160.78 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.6 OUTLIER -95.02 32.19 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.347 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 84.34 121.74 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -146.71 55.36 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.47 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -72.0 79.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.692 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.7 -43.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.772 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.59 -48.07 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.435 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 64' ' ' ILE . 5.1 pt -80.13 -14.46 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 54.86 77.4 0.15 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.25 140.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.86 122.92 12.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 60' ' ' ILE . 9.2 mm -97.68 144.85 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 43.5 m-20 -146.78 105.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.284 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 31.4 Cg_endo -64.0 155.69 62.98 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 80.29 -14.62 0.82 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.904 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.9 pt-20 -115.09 2.17 14.09 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.523 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 54.5 m-85 -138.96 144.73 39.12 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.099 0.476 . . . . 0.0 111.231 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.71 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -110.98 120.21 41.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.918 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 50' ' ' VAL . 14.3 tt0 -92.84 130.79 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.759 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -117.16 141.25 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.516 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.5 m0 -117.62 136.26 53.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 21' ' ' PHE . 59.8 t -125.07 102.03 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.472 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.18 -144.39 8.66 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.079 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 87' ' ' PHE . 2.1 tp -138.64 81.79 1.87 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.276 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 2.2 m -67.17 170.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.191 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -115.34 -165.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.428 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.87 -16.29 58.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.531 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.45 -85.83 0.17 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.154 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.7 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.332 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.618 ' C ' HG12 ' A' ' 77' ' ' VAL . 32.3 mt-10 -147.99 120.3 8.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -71.69 -25.68 62.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.38 6.51 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' MET . 1.5 m-20 178.42 121.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.66 141.61 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.884 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD22 ' A' ' 76' ' ' LEU . 2.3 m-85 -89.51 -34.89 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.413 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.2 161.99 19.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.62 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.826 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.6 mttt -129.36 148.24 51.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' A' ' 103' ' ' VAL . 2.9 m-85 -128.82 138.61 52.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 111.877 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.444 HD12 ' ND1' ' A' ' 102' ' ' HIS . 3.7 mt -119.66 134.03 55.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.151 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.123 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -74.3 147.87 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -91.72 22.26 4.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -96.99 152.97 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.35 -40.57 14.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.47 114.28 28.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.47 100.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.723 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.86 127.25 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.46 156.5 18.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -149.53 144.62 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.03 159.95 40.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.015 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.34 141.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.63 133.36 51.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.752 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.634 ' HE3' HD12 ' A' ' 29' ' ' LEU . 33.9 m95 -115.88 150.17 37.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.93 153.57 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.6 pttm . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.888 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.784 0.326 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -127.41 139.81 52.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.114 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD22 ' CG2' ' A' ' 12' ' ' THR . 3.7 mt -63.98 150.47 45.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.2 141.89 93.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' HD12 ' A' ' 14' ' ' ILE . 88.8 Cg_exo -47.12 -48.2 15.26 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.55 2.166 . . . . 0.0 112.725 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.9 -21.86 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.471 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.659 ' CG2' HD22 ' A' ' 8' ' ' LEU . 26.6 m -81.01 -61.17 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.558 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.46 -30.27 64.9 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 10' ' ' PRO . 96.1 mt -76.28 -59.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -42.1 -48.77 4.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.568 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CD1' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -63.62 -40.22 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.04 -42.67 94.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.442 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -52.16 -44.85 64.82 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.243 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 -30.56 71.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.485 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.4 mt -73.0 -29.75 29.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t80 -67.91 -47.8 67.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -71.81 -23.41 61.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.17 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.718 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.49 ' CE ' HG11 ' A' ' 103' ' ' VAL . 5.8 mtp -75.1 -46.01 37.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -42.75 110.83 0.2 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.804 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.52 -114.28 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.392 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.98 -37.66 78.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.309 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.01 -37.13 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.6 tt -88.07 151.08 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.913 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -71.13 134.55 85.21 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.097 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.947 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.3 Cg_exo -46.11 -59.36 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.722 2.281 . . . . 0.0 112.951 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.14 -50.35 20.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.556 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 29' ' ' LEU . 47.0 m-20 -60.22 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.7 mt -66.66 -52.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.111 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.731 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -57.34 -51.76 68.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 110.356 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 1.8 tp -52.39 -51.06 61.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 110.556 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -49.04 -42.58 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.9 -57.06 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.731 HD22 ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -89.99 49.11 1.66 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.498 ' HB3' HD21 ' A' ' 76' ' ' LEU . 19.3 mm-40 -155.62 -48.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -42.91 -37.47 1.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.545 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.06 -45.03 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.22 -61.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.061 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.19 63.06 3.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.36 133.88 11.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.72 128.34 4.59 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.413 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -150.17 59.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.49 . . . . 0.0 110.245 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.22 125.61 31.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.381 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 79.3 t80 -83.63 97.65 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.45 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.476 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -90.34 166.18 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.356 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -98.17 162.08 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.853 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 48.4 m -52.09 163.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' THR . . . -137.18 162.34 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.08 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.91 -29.25 18.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.794 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.21 -2.7 22.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.674 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.764 ' CZ2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -46.39 -29.59 1.76 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.553 0.216 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.81 63.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -166.93 -44.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.369 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.97 -70.54 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.104 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.71 -32.12 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.273 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 62' ' ' VAL . . . 77.72 47.75 8.46 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.93 113.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.498 0.19 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.93 127.16 15.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.57 137.73 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -66.1 109.69 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.795 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.3 Cg_endo -59.33 157.89 28.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.326 2.017 . . . . 0.0 112.411 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.4 pt-20 48.62 20.53 0.33 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.777 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 19.2 mt-10 -137.74 18.82 2.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.713 0.292 . . . . 0.0 110.973 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 68' ' ' GLU . 20.8 m-85 -148.09 145.51 28.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.72 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.001 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -90.11 114.19 26.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' HG2' HG23 ' A' ' 50' ' ' VAL . 27.8 tt0 -110.62 103.4 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.485 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 17' ' ' ALA . 13.3 p -94.5 136.39 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.464 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.601 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 3.8 m0 -121.25 94.16 4.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 47' ' ' VAL . 96.1 t -97.97 106.33 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.135 0.493 . . . . 0.0 111.056 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -132.2 -137.53 3.99 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.955 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.506 HD22 ' HE2' ' A' ' 87' ' ' PHE . 1.1 mp -139.18 112.67 8.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.298 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 81' ' ' ASP . 16.0 m -100.13 179.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.255 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -93.7 -166.2 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.552 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.02 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.404 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -75.13 -72.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.483 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 166.19 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.621 0.248 . . . . 0.0 111.413 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.69 135.88 3.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.9 tpp -119.56 123.91 45.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.652 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.58 21.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -160.4 89.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.854 HG21 ' HG3' ' A' ' 89' ' ' LYS . 7.3 p -89.67 149.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.418 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HE2' HD22 ' A' ' 76' ' ' LEU . 24.6 m-85 -98.69 -43.73 6.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.728 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.765 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.53 122.27 7.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.854 ' HG3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.59 132.89 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 2.6 m-85 -113.99 155.58 25.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.764 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 39.8 mt -134.66 110.32 9.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.558 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.64 134.37 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.589 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.13 97.11 2.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.49 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 1.001 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m-70 -37.28 -46.6 0.76 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.948 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.31 138.0 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 111.412 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.93 80.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' ARG . 10.9 pt-20 -67.38 -173.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.25 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 69.62 62.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.458 . . . . 0.0 110.509 -179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.31 150.71 23.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 8.8 p90 -146.83 140.74 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -138.28 157.42 46.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -151.41 138.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -114.91 110.22 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.096 178.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.908 ' CE3' HD12 ' A' ' 29' ' ' LEU . 91.2 m95 -92.42 149.25 21.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -176.95 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.753 0.311 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -176.59 3.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.052 0.453 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 155.43 35.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.37 147.77 53.98 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.49 -54.89 4.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.543 2.162 . . . . 0.0 112.392 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.52 -28.93 68.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 16' ' ' ILE . 58.3 m -72.85 -44.95 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.39 89.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.62 -57.88 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.2 -45.98 5.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.232 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 12' ' ' THR . 5.6 mt -72.89 -39.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -61.15 -49.79 75.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.711 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.88 -43.62 77.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -35.37 77.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 17' ' ' ALA . 49.7 mt -66.24 -45.68 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.691 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 74' ' ' VAL . 7.2 t80 -54.33 -59.67 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.554 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.8 mm? -64.01 -14.5 54.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.159 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.7 -57.75 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.539 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -83.4 -38.49 21.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.6 151.11 8.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 0.0 111.516 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.762 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 148.52 -111.9 0.55 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.417 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -74.02 -3.64 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 1.3 m120 -98.46 -5.85 31.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.499 0.19 . . . . 0.0 111.213 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.735 HD23 HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -103.59 -25.44 13.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.732 0.301 . . . . 0.0 111.481 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 29' ' ' LEU . 12.6 t70 106.01 137.23 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.754 0.822 . . . . 0.0 111.441 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -43.41 -58.89 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.22 2.613 . . . . 0.0 113.044 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.34 -58.62 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.034 0.445 . . . . 0.0 111.137 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.71 ' C ' HD21 ' A' ' 29' ' ' LEU . 3.6 m-20 -57.32 -28.95 63.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' O ' ' A' ' 26' ' ' GLY . 52.9 mt -71.61 -49.82 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-O 121.301 0.572 . . . . 0.0 109.697 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.629 ' HG ' HD23 ' A' ' 39' ' ' LEU . 5.5 tp -45.85 -66.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.299 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.544 HD23 ' CZ ' ' A' ' 87' ' ' PHE . 28.6 tp -53.9 -35.02 61.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.337 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 2.7 t80 -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.16 -62.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.1 mm? -52.88 -23.54 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.622 ' O ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.3 115.64 8.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.273 0.558 . . . . 0.0 111.817 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' O ' ' HA3' ' A' ' 45' ' ' GLY . 15.5 t80 -169.79 -53.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.919 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -34.91 72.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.14 -46.85 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.262 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -119.55 53.85 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 111.116 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -119.22 120.4 4.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.727 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.77 137.37 6.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.716 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.31 126.04 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.889 0.376 . . . . 0.0 110.964 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.48 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.997 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 51.2 t80 -87.35 139.53 30.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -133.01 175.91 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.29 148.3 33.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 49.7 m -41.74 160.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.14 0.495 . . . . 0.0 111.574 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -99.67 -161.4 0.87 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.235 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.65 39.84 1.04 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.177 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 2.7 m-20 76.6 117.76 0.06 Allowed 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.703 ' HZ2' HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -125.88 44.98 2.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.718 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -58.72 70.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -155.41 -45.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.731 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.72 -68.01 0.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.419 0.628 . . . . 0.0 110.268 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -69.74 -50.88 45.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.389 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 96.14 72.85 1.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.303 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 60' ' ' ILE . 10.6 p 172.49 142.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.667 0.27 . . . . 0.0 110.577 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.99 123.22 7.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 111.347 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.901 HD11 ' CD1' ' A' ' 60' ' ' ILE . 27.6 mm -103.51 132.07 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.68 111.78 41.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.51 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 28.0 Cg_endo -63.1 152.97 76.82 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.406 2.071 . . . . 0.0 112.902 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 60.77 8.98 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.033 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -119.97 -13.71 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.561 0.22 . . . . 0.0 111.517 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.7 136.38 49.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 111.02 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -89.32 117.96 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.782 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.779 ' HG3' HG23 ' A' ' 50' ' ' VAL . 11.0 pt-20 -107.17 138.15 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.089 0.471 . . . . 0.0 111.336 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 17' ' ' ALA . 10.8 p -134.65 142.46 40.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -106.17 144.84 32.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 21' ' ' PHE . 48.9 t -128.7 101.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.5 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.37 -138.66 5.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.392 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.643 HD22 ' CE2' ' A' ' 87' ' ' PHE . 1.6 tp -143.59 51.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.329 0.585 . . . . 0.0 109.66 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 83' ' ' MET . 24.8 m -46.9 174.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.267 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -92.2 -161.31 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.667 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.22 -14.53 63.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.747 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.01 -85.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.497 0.189 . . . . 0.0 111.176 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' HG11 ' A' ' 77' ' ' VAL . 3.5 p-10 179.4 -35.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.592 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -45.71 137.11 5.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.754 0.311 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.592 ' HA ' HG12 ' A' ' 77' ' ' VAL . 49.7 ttm -119.8 121.15 38.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.17 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.26 -3.75 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.093 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -142.12 93.97 2.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -89.91 144.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.169 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.643 ' CE2' HD22 ' A' ' 76' ' ' LEU . 29.0 m-85 -89.66 -34.86 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.357 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -161.66 164.6 29.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.108 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 103' ' ' VAL . 4.9 mttt -126.4 144.82 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -125.05 165.94 17.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.703 HD21 ' HZ2' ' A' ' 56' ' ' TRP . 13.2 mt -147.82 123.77 10.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.378 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.58 HG22 ' HD2' ' A' ' 99' ' ' ARG . 2.2 mp -125.68 137.72 56.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 111.749 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 117.47 7.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -59.44 -37.78 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.226 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.44 -179.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -111.37 -43.11 3.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.203 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 122.48 26.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.318 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 65.89 112.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 92' ' ' ILE . 2.9 tpp85 -114.47 132.13 56.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.905 0.383 . . . . 0.0 111.246 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.16 134.83 50.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 26.6 p90 -140.96 144.24 34.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.547 ' CD2' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -138.19 156.21 47.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.858 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.5 p -151.52 145.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.28 136.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.214 177.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.671 ' HE3' HD12 ' A' ' 29' ' ' LEU . 45.6 m95 -108.87 -104.13 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.739 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 153.33 6.69 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.235 0.471 . . . . 0.0 110.932 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.154 0.502 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 132.93 40.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.601 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.46 159.2 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.1 152.73 74.26 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.658 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.69 -60.21 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -65.96 -28.25 68.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -67.15 -54.21 23.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.69 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.88 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.6 mt -47.22 -36.5 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -67.03 -39.92 87.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.32 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.11 -62.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.779 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.46 -37.26 16.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.86 -54.74 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.409 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -31.77 56.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 17' ' ' ALA . 53.4 mt -62.08 -73.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CE2' ' CZ ' ' A' ' 41' ' ' PHE . 85.6 t80 -41.13 -30.35 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.817 0.342 . . . . 0.0 111.448 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.9 tp -64.98 -45.1 87.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.52 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.68 -29.02 11.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -51.48 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.92 105.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.275 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.46 -82.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.703 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.47 1.1 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 6.9 m120 -93.11 -28.53 16.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.845 HD12 ' CE3' ' A' ' 105' ' ' TRP . 3.7 tt -96.26 138.93 33.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.542 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -50.41 150.21 4.85 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.796 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 13.5 Cg_exo -70.21 25.02 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.342 2.694 . . . . 0.0 113.735 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.04 -67.04 1.01 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.239 0.542 . . . . 0.0 109.876 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.825 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.69 -21.69 41.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.763 178.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.564 HG13 HD22 ' A' ' 29' ' ' LEU . 39.9 mt -63.33 -41.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -61.77 -47.25 86.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.578 178.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -55.21 -40.61 70.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.254 179.144 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.8 t80 -58.32 -32.92 68.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.216 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -50.54 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.204 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.1 mm? -66.78 -39.13 87.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.27 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.17 -157.75 0.65 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 6.5 t80 83.85 -26.57 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -88.14 -33.2 18.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.482 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -105.86 -28.1 10.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.654 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 39.55 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.753 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 129.0 9.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.39 127.9 2.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.265 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 73' ' ' TRP . 40.0 t -127.02 112.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.4 173.82 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.697 ' CZ ' ' HB1' ' A' ' 70' ' ' ALA . 17.2 t80 -126.79 122.27 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 71' ' ' GLU . 30.3 m -120.8 -165.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -124.03 171.49 9.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 53' ' ' ALA . 57.1 m -60.11 161.63 6.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 52' ' ' THR . . . -113.56 -170.6 1.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 25.82 11.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.055 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -165.68 65.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.661 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.747 ' CH2' HD11 ' A' ' 91' ' ' LEU . 4.6 m95 -95.97 -29.0 14.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.289 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' CD ' HD22 ' A' ' 63' ' ' LEU . 43.0 mt-10 -69.27 64.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.182 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.74 -51.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HG3' ' CZ3' ' A' ' 56' ' ' TRP . 1.4 pm0 -78.27 -66.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.519 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 104' ' ' ILE . 29.2 pt -75.49 -38.97 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 0.0 111.429 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 83.28 81.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.601 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.47 148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 122.481 0.312 . . . . 0.0 110.344 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -58.86 126.54 28.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 63' ' ' LEU . 23.7 mm -125.68 94.9 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -70.47 117.5 55.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.6 152.35 74.18 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.113 1.875 . . . . 0.0 111.962 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 69.32 -1.02 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.34 -9.28 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.693 0.283 . . . . 0.0 111.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -132.75 130.9 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 49' ' ' PHE . . . -89.59 125.88 35.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.542 ' HA ' HD23 ' A' ' 91' ' ' LEU . 30.9 tt0 -103.78 113.95 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.27 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.42 144.11 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.131 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.594 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m0 -118.43 137.59 53.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.37 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 47' ' ' VAL . 51.4 t -122.95 106.29 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.426 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.32 -142.7 7.08 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.62 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.702 HD22 ' CZ ' ' A' ' 87' ' ' PHE . 2.6 tp -145.06 49.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.286 0.565 . . . . 0.0 110.057 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 78' ' ' ASN . 13.2 p -71.15 161.85 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.288 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.3 p30 -89.75 -140.43 0.14 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -75.01 -49.56 19.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.446 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 2.4 pt20 -52.17 -18.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' HG21 ' A' ' 77' ' ' VAL . 4.2 p-10 50.33 49.29 20.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.088 0.47 . . . . 0.0 111.216 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 77' ' ' VAL . 2.0 mt-10 -95.09 23.81 5.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.469 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' GLU . 1.7 tpt 29.68 95.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' CB ' ' A' ' 85' ' ' ASP . 4.4 t70 -144.15 49.9 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 164.03 82.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.441 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 5.3 p -88.94 135.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.702 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 5.7 m-85 -89.09 -47.88 7.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.601 0.715 . . . . 0.0 109.239 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -146.51 169.91 17.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -134.5 147.45 50.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.0 m-85 -126.28 144.24 50.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.747 HD11 ' CH2' ' A' ' 56' ' ' TRP . 21.1 mt -133.0 127.39 34.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.718 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 148.21 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 112.535 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -67.89 129.7 40.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.725 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.511 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 37.9 m-70 -75.15 -36.18 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -54.45 -178.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.6 pt-20 -104.17 -49.74 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.245 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -73.53 133.07 43.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER 58.45 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -123.13 111.37 16.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.85 132.24 53.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 9.8 p90 -123.33 140.15 53.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.0 p -150.3 141.26 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -111.11 135.71 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.845 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.2 m95 -109.56 148.61 30.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 153.93 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.898 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -7.08 10.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.835 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -132.27 -155.78 0.71 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.851 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.15 -48.81 2.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 110.642 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt -107.61 125.18 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.647 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.19 139.55 50.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.59 -178.42 5.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.27 143.94 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.08 149.77 93.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.01 -53.34 7.14 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.558 2.172 . . . . 0.0 112.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -33.44 70.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.526 ' O ' HD12 ' A' ' 16' ' ' ILE . 4.4 m -65.47 -52.47 52.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -59.67 -48.02 83.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.87 -40.7 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.87 -55.37 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 12' ' ' THR . 3.3 mt -58.73 -53.44 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.233 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.885 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -57.32 -40.44 77.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.22 -49.2 70.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.776 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.86 -30.84 71.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.658 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.885 HD12 ' HA ' ' A' ' 17' ' ' ALA . 23.3 mt -72.63 -27.78 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.714 ' CD2' HG11 ' A' ' 74' ' ' VAL . 22.2 t80 -77.23 -27.91 53.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.32 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -34.1 38.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.534 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 13.1 pt-20 -92.08 -37.47 12.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.151 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.1 mtp -76.32 -50.57 13.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -45.59 96.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.484 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.05 -115.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 111.188 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.18 -25.74 67.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.91 HD12 ' CZ3' ' A' ' 105' ' ' TRP . 4.2 tt -94.89 150.44 20.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.007 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.87 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.09 137.22 97.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 34' ' ' ILE . 71.5 Cg_exo -49.16 -64.8 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.622 2.215 . . . . 0.0 112.985 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.17 -43.37 21.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.66 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.3 m-20 -66.15 -28.68 68.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.988 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 31' ' ' PRO . 18.4 mt -67.05 -47.16 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.278 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.3 tp -57.95 -60.75 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.616 HD11 ' NE2' ' A' ' 40' ' ' GLN . 12.5 tp -46.13 -44.37 15.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.516 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.456 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.7 t80 -64.22 -26.3 68.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.802 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.92 -38.02 33.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.399 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.512 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.3 mm? -83.68 -40.18 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.401 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.837 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.6 pt20 -121.75 106.24 11.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.22 0.533 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 76' ' ' LEU . 55.3 t80 -163.9 -38.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.025 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -63.34 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.645 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -27.93 64.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.784 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -120.88 59.1 0.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 110.502 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.62 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -91.73 134.6 12.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.564 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.03 123.82 2.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.21 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.893 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -150.35 68.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.414 . . . . 0.0 110.46 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.42 129.56 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.532 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' ' HB1' ' A' ' 13' ' ' ALA . 57.8 t80 -90.4 94.02 9.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 71' ' ' GLU . 10.8 m -90.04 178.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.916 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -104.51 -178.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 35.7 m -73.22 165.72 24.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 52' ' ' THR . . . -139.2 171.93 13.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.032 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.96 -28.7 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.89 46.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.34 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.879 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.1 m95 -92.14 -42.39 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.65 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.84 64.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -161.88 -48.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.451 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.87 -73.16 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.554 HG23 ' HZ3' ' A' ' 56' ' ' TRP . 15.2 pt -61.57 -30.12 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.612 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 93.17 45.92 3.43 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.975 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.612 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 179.5 132.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.02 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.3 pp -66.32 141.0 58.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 63' ' ' LEU . 37.2 mm -125.13 145.86 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -73.35 121.27 84.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.393 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 7.1 Cg_exo -69.9 162.37 42.4 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.114 1.876 . . . . 0.0 112.142 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.02 22.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -137.15 12.98 3.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.414 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -146.18 147.17 31.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.846 ' HB3' HG12 ' A' ' 92' ' ' ILE . . . -89.7 112.6 23.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.62 120.0 35.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.498 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.0 t -119.7 134.42 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.096 0.474 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 9.2 m0 -122.49 117.07 25.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.679 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.893 HG22 ' CG1' ' A' ' 47' ' ' VAL . 54.1 t -114.72 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -131.55 -135.16 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.967 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -139.79 125.88 19.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 45' ' ' GLY . 32.8 m -114.75 175.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 111.675 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -103.78 -164.18 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -3.06 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.464 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.0 -5.15 30.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.476 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.91 96.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.667 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -148.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 tpt -178.51 58.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.387 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.59 85.74 2.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.754 0.312 . . . . 0.0 110.964 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 p -89.88 135.59 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.797 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 9.1 m-85 -91.47 -49.72 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.025 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -148.32 139.1 22.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -112.44 132.45 55.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.631 0.253 . . . . 0.0 110.565 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.495 ' CD2' ' HB ' ' A' ' 103' ' ' VAL . 1.2 m-85 -110.19 145.78 36.67 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.879 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 92.8 mt -127.14 105.57 8.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.177 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -109.37 127.5 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.875 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.2 100.36 0.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.2 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -37.09 -57.16 0.87 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.286 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -44.2 162.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.151 0.5 . . . . 0.0 111.847 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.1 pt-20 -86.0 -48.67 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -65.88 133.53 51.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.86 116.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -113.74 93.42 4.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.94 103.37 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -120.33 110.92 17.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -128.69 117.19 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.4 . . . . 0.0 111.148 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.495 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 7.2 p -98.1 150.27 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.32 130.08 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.91 ' CZ3' HD12 ' A' ' 29' ' ' LEU . 63.8 m95 -112.11 130.01 56.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.245 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.09 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.983 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttm . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.825 0.345 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.784 HG22 ' O ' ' A' ' 2' ' ' THR . 1.3 m -139.16 50.93 1.8 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.564 0.697 . . . . 0.0 110.088 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -90.18 63.74 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.96 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -81.14 121.04 25.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.87 129.79 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.379 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -126.84 139.91 52.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.381 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -89.57 174.61 7.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.043 0.449 . . . . 0.0 111.358 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 147.13 62.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.94 -54.28 5.55 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.595 2.197 . . . . 0.0 112.338 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -30.06 69.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.6 m -68.36 -51.76 40.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.06 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.0 48.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.803 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -47.38 -33.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.797 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.02 -37.05 72.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 20' ' ' ILE . 13.8 mm -61.79 -62.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' CB ' HG11 ' A' ' 72' ' ' VAL . . . -52.13 -40.81 61.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.51 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -53.5 -57.3 11.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -61.43 -28.77 69.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 16' ' ' ILE . 77.8 mt -74.34 -25.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.857 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 37' ' ' PHE . 4.4 t80 -75.13 -51.89 12.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 110.47 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -65.71 -20.74 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.28 -46.89 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -80.15 -41.12 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.37 150.43 4.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.386 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.95 41.26 3.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.659 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -171.64 -29.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 33.1 t30 -115.94 -35.36 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.711 0.291 . . . . 0.0 111.003 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.767 HD23 HG13 ' A' ' 34' ' ' ILE . 2.8 tt -68.06 133.97 49.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -54.06 146.28 30.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.04 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.7 Cg_exo -47.64 -52.73 7.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.902 2.401 . . . . 0.0 113.017 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.4 48.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.58 ' CB ' HD21 ' A' ' 29' ' ' LEU . 74.1 m-20 -54.47 -32.0 56.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.767 HG13 HD23 ' A' ' 29' ' ' LEU . 91.2 mt -63.73 -47.79 89.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.054 0.455 . . . . 0.0 110.046 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -50.03 -57.48 7.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.617 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' GLN . 5.5 mp -63.28 -62.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -42.61 -30.03 0.33 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -82.19 -74.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.517 . . . . 0.0 111.771 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -69.32 -29.8 67.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.252 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' LEU . 1.6 tp-100 -90.98 25.3 2.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.829 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.1 t80 -102.83 -47.6 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -55.74 -42.47 75.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -39.02 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.936 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.1 mmt85 -130.39 80.89 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.32 107.38 0.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 146.66 17.48 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.127 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 74' ' ' VAL . 44.1 t -132.75 110.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.669 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.38 150.51 20.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 64.5 t80 -103.17 106.34 16.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.652 HG23 ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -105.79 -178.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.09 172.55 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 53' ' ' ALA . 7.6 m -65.38 164.71 13.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 52' ' ' THR . . . -128.11 162.46 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -98.45 36.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.12 33.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.687 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.9 m95 -80.36 -20.57 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.348 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.86 61.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 -47.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HG2' ' CE3' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -84.72 -64.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.687 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 14.0 pt -74.99 -27.59 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 70.76 79.22 0.38 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.792 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.64 ' CG1' HD12 ' A' ' 60' ' ' ILE . 6.9 p 164.53 139.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.671 0.272 . . . . 0.0 110.52 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -58.93 138.08 57.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.907 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 63' ' ' LEU . 26.9 mm -133.66 100.43 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.745 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.77 108.1 1.2 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.141 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.03 158.81 23.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.144 1.896 . . . . 0.0 112.366 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 76.03 -10.53 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.373 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -118.54 16.27 13.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.709 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 84.8 m-85 -138.79 132.25 30.33 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -90.75 112.55 24.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.797 ' OE1' HD21 ' A' ' 91' ' ' LEU . 7.8 tp10 -90.1 128.35 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.7 t -127.77 136.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.304 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 13.6 m0 -119.18 139.87 51.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.728 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 47' ' ' VAL . 13.4 t -129.37 110.58 20.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.643 ' C ' HD13 ' A' ' 76' ' ' LEU . . . -146.37 -155.34 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.757 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.992 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.17 50.47 1.09 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.724 0.297 . . . . 0.0 111.367 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 83' ' ' MET . 23.7 m -43.23 171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.204 0.526 . . . . 0.0 111.892 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.86 -165.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.96 -28.25 69.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -75.76 -31.0 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.29 27.73 1.06 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.367 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.51 22.85 6.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.8 ' HA ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 30.11 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.217 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -27.97 36.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.976 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.88 11.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -108.38 124.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.435 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.992 ' CE2' HD21 ' A' ' 76' ' ' LEU . 3.5 m-85 -89.2 -26.75 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.343 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.31 151.75 17.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -132.65 141.04 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.5 m-85 -120.93 148.4 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 71' ' ' GLU . 44.7 mt -132.76 117.89 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -125.0 140.26 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.09 0.471 . . . . 0.0 111.857 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 99' ' ' ARG . 3.1 p -69.49 122.08 18.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.777 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 36.8 m-70 -66.0 -32.22 73.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.287 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -55.74 177.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.71 -50.53 3.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.446 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -74.3 122.46 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.502 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.16 112.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.413 HH21 HG21 ' A' ' 16' ' ' ILE . 4.9 ttt-85 -120.71 114.88 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.702 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.58 134.95 42.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 23.5 p90 -127.08 140.26 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.09 153.29 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.118 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 11.4 p -150.17 137.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.802 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -115.56 130.25 70.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.601 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.2 m95 -108.75 150.64 27.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.997 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -64.05 161.06 16.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -65.99 111.93 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.506 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t -73.82 132.04 42.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -107.79 140.01 41.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG21 ' HG2' ' A' ' 95' ' ' ARG . 2.7 mt -91.56 124.71 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.73 -172.19 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.756 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -117.57 125.37 50.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 12' ' ' THR . 1.9 mt -52.0 157.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.37 142.94 51.04 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' O ' HD12 ' A' ' 14' ' ' ILE . 77.7 Cg_exo -48.01 -57.28 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.529 2.153 . . . . 0.0 112.498 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -57.98 -41.54 83.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.67 HG22 HD11 ' A' ' 16' ' ' ILE . 11.9 m -52.94 -64.54 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -47.92 -46.4 31.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.786 0.327 . . . . 0.0 111.353 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -51.78 -43.87 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -39.26 71.03 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.046 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' THR . 5.1 mt -66.98 -66.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.848 0.356 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -48.7 -42.31 34.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -54.99 -50.84 68.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.21 -34.84 47.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.501 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.37 -69.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 30.1 t80 -41.43 -28.07 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.787 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -71.8 -45.35 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.702 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.72 -27.04 14.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 mtp -77.0 -46.44 23.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.734 0.302 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -57.4 -174.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.389 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 34' ' ' ILE . . . 56.81 32.02 61.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -157.84 -28.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.8 m120 -117.11 -19.85 9.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -98.37 161.68 13.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.745 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.4 p30 -62.23 133.14 94.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.689 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.84 ' HA ' HD12 ' A' ' 34' ' ' ILE . 79.2 Cg_exo -41.7 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.734 2.289 . . . . 0.0 113.075 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.16 37.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.723 ' CB ' HD22 ' A' ' 29' ' ' LEU . 42.7 t0 -56.41 -32.14 64.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.303 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.8 mt -61.56 -50.21 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.237 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.588 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -66.2 -48.79 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.208 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.627 HD13 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -57.47 -56.0 27.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.0 t80 -51.58 -26.16 8.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.989 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.57 -63.99 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 39' ' ' LEU . 1.4 mm? -67.4 -25.65 66.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.279 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HG3' HD13 ' A' ' 36' ' ' LEU . 31.1 mm-40 -101.91 -146.16 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 t80 70.61 -58.2 0.56 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.778 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.71 -37.12 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.8 -42.76 7.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 mmt-85 -119.08 52.14 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.83 133.06 11.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.42 113.16 0.72 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 74' ' ' VAL . 7.0 p -150.71 99.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -107.79 146.57 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.279 0.562 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 66.2 t80 -85.19 97.92 10.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.658 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 71' ' ' GLU . 3.0 m -89.96 176.89 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.374 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.747 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.95 163.22 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.32 13.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.11 -14.34 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.98 44.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.088 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.67 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 9.0 m95 -98.8 -29.8 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.915 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -68.27 61.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -162.63 -46.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.525 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -75.74 -78.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 64' ' ' ILE . 27.0 pt -71.65 -28.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.449 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.646 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 74.28 81.53 0.44 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.485 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.646 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.67 146.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 63' ' ' LEU . 3.0 pp -71.31 113.29 8.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.467 HG22 ' CD2' ' A' ' 69' ' ' TYR . 31.4 mm -109.31 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.192 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 8.6 m-20 -55.56 106.29 0.65 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 52' ' ' THR . 18.3 Cg_endo -60.25 157.12 36.73 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.108 1.872 . . . . 0.0 112.304 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 75.25 -9.24 1.42 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.348 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 1.8 pt-20 -120.13 19.83 12.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.574 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' CD2' HG22 ' A' ' 64' ' ' ILE . 75.5 m-85 -141.55 139.82 33.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.965 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.35 114.49 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.869 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -96.67 129.39 44.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.715 HG11 ' HB1' ' A' ' 17' ' ' ALA . 6.0 p -135.21 130.42 51.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.547 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 14.4 m0 -114.54 135.62 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 47' ' ' VAL . 16.6 t -127.63 111.14 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.986 0.422 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.12 -131.91 2.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.403 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.512 HD13 ' HE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -138.04 158.36 44.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -147.83 -177.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 111.306 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -118.53 -168.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.787 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -28.45 62.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.036 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.24 -14.56 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.439 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.51 72.6 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.43 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG12 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -140.82 148.82 41.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.28 105.78 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.26 -4.53 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.01 88.88 2.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.729 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.5 p -89.69 138.22 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.827 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.512 ' HE2' HD13 ' A' ' 76' ' ' LEU . 16.9 m-85 -89.39 -48.94 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.9 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.692 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -138.65 166.11 25.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.729 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -146.34 135.75 22.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.8 m-85 -126.98 144.02 51.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.905 HD12 ' CE1' ' A' ' 102' ' ' HIS . 3.1 mt -131.67 124.02 29.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -130.24 142.85 42.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 112.273 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.8 p -65.09 120.29 12.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.936 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.965 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 89.2 m-70 -62.74 -24.7 67.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.445 ' HG2' HG21 ' A' ' 5' ' ' ILE . 57.6 mtp180 -54.06 174.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.67 -65.49 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -71.64 131.52 43.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.2 112.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.33 115.98 21.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.354 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.12 120.93 38.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.103 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.42 ' HB3' HG22 ' A' ' 92' ' ' ILE . 19.5 p90 -124.5 143.85 50.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.327 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.905 ' CE1' HD12 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -143.76 168.95 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.351 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 13.4 p -151.05 143.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.471 HG21 ' HE3' ' A' ' 89' ' ' LYS . 3.9 mp -112.6 110.55 32.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.338 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.692 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 55.7 m95 -96.26 149.33 21.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 110.967 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.01 155.53 32.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.938 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 2' ' ' THR . 0.5 OUTLIER -129.01 9.04 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -177.13 136.42 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -85.97 -54.86 4.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt -112.36 127.22 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -173.58 3.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.844 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -139.79 -178.42 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.007 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 12' ' ' THR . 1.9 mt -111.91 139.4 47.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.82 149.31 95.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.538 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.41 -59.79 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.437 2.091 . . . . 0.0 112.415 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -24.87 65.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 16' ' ' ILE . 92.7 m -76.16 -43.34 43.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.24 -29.37 70.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -79.83 -58.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -41.4 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.641 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -70.27 -43.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.079 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -64.11 -45.32 89.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.015 0.436 . . . . 0.0 110.356 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -51.35 -46.82 62.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -61.72 -27.91 69.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.479 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 17' ' ' ALA . 51.8 mt -75.12 -30.91 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.6 t80 -68.41 -51.28 45.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.14 -16.52 63.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.662 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 2.7 tp10 -94.13 -51.14 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.656 0.265 . . . . 0.0 111.511 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.411 ' CE ' HG12 ' A' ' 103' ' ' VAL . 15.4 mtp -74.61 -44.37 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -48.68 162.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.521 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.01 54.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.553 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -151.29 -33.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.62 0.248 . . . . 0.0 111.632 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.2 t30 -126.69 -39.18 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.723 0.297 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.891 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.5 tt -55.56 139.23 44.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.891 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -57.26 136.71 81.12 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.755 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 76.8 Cg_exo -48.51 -51.92 9.41 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.0 113.297 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.59 -58.74 5.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.085 0.469 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.625 ' CB ' HD21 ' A' ' 29' ' ' LEU . 68.3 m-20 -51.69 -29.95 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.841 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 38' ' ' ASN . 57.5 mt -69.09 -47.79 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 39' ' ' LEU . 1.2 tp -45.18 -59.64 2.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.666 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 8.8 mt -56.91 -47.31 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.254 0.55 . . . . 0.0 110.241 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HZ ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -48.25 -51.66 24.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.434 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.724 HD21 HG22 ' A' ' 34' ' ' ILE . 1.8 p30 -80.3 -40.79 26.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.847 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.6 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -72.73 -9.41 58.61 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 8.9 mm-40 -126.91 -137.52 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.939 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' HA2' ' A' ' 46' ' ' GLY . 2.6 t80 72.15 -56.09 0.65 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.796 0.332 . . . . 0.0 111.617 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -51.82 -39.64 59.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.14 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 27.44 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.673 ' HB3' HD12 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -131.89 -4.06 3.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA3' HG22 ' A' ' 77' ' ' VAL . . . 135.83 163.2 9.88 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.56 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA2' ' CE1' ' A' ' 41' ' ' PHE . . . -125.19 -115.02 2.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.792 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 73' ' ' TRP . 59.6 t -132.43 136.98 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.969 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -122.99 131.78 53.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 17.3 t80 -88.74 113.0 23.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.094 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 71' ' ' GLU . 34.5 m -107.69 -176.88 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -98.38 170.61 8.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 111.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.3 m -70.06 157.28 37.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.95 -156.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.136 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.1 -42.14 11.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.45 129.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.767 ' O ' HG12 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -162.42 150.54 14.4 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.415 0.626 . . . . 0.0 110.304 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.04 32.48 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.219 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -113.64 -25.34 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.226 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.87 -54.57 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.622 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.2 pt -75.91 -44.82 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.789 0.328 . . . . 0.0 110.952 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 104.41 54.37 0.79 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.107 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.455 HG12 HD12 ' A' ' 60' ' ' ILE . 14.8 p 175.95 140.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 120.927 0.394 . . . . 0.0 111.467 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.86 138.62 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 56' ' ' TRP . 37.2 mm -111.26 128.35 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -104.55 112.11 65.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 30.6 Cg_endo -63.92 156.08 60.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.345 2.03 . . . . 0.0 112.043 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 4.1 pt-20 54.87 9.92 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.938 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -132.37 -5.33 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -126.12 143.56 51.08 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.798 0.332 . . . . 0.0 110.645 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -96.01 128.73 43.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.686 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -111.98 117.36 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.751 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 t -119.39 129.35 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.9 m0 -105.6 143.91 33.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.765 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 47' ' ' VAL . 42.9 t -137.23 101.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.207 0.527 . . . . 0.0 110.934 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . . . -152.65 -120.03 0.82 Allowed Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.359 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 44' ' ' ARG . 1.9 mm? -142.31 146.8 35.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 83' ' ' MET . 3.6 m -115.86 178.35 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -107.28 -165.72 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -22.42 66.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -80.88 -81.13 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 77' ' ' VAL . 1.0 OUTLIER 173.54 -34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -56.04 132.42 50.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.033 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.533 ' HA ' HG12 ' A' ' 77' ' ' VAL . 36.2 ttm -88.99 79.35 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -6.55 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.88 83.21 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.301 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 86' ' ' VAL . 2.0 p -89.69 126.96 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.074 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.2 m-85 -89.37 -32.49 17.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.227 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.34 148.98 15.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -113.44 141.72 46.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.4 m-85 -117.83 141.68 48.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.091 0.472 . . . . 0.0 111.596 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 64' ' ' ILE . 25.0 mt -125.2 156.17 38.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.605 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.932 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -163.8 117.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.998 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.69 104.63 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.622 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 11.9 m80 -51.9 109.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 0.0 111.244 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -166.25 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 18.7 pt-20 -138.02 -54.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.373 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -85.23 -0.23 53.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.418 0.628 . . . . 0.0 111.306 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -162.0 102.84 1.14 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -126.48 120.86 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -108.5 112.1 24.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.467 ' HB2' HG23 ' A' ' 92' ' ' ILE . 1.9 p90 -118.98 139.3 51.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.65 171.22 16.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.046 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' LYS . 8.1 p -152.05 143.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.62 142.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.378 177.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.878 ' CE3' HD12 ' A' ' 29' ' ' LEU . 65.6 m95 -113.31 149.09 34.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 159.71 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.828 0.347 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 3' ' ' THR . 1.1 m -64.19 -32.43 74.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.578 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 2' ' ' THR . 3.1 t 46.1 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -94.87 -27.67 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.33 141.45 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -89.91 -178.66 5.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -140.21 -177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.11 144.94 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.9 148.2 71.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.92 -53.26 7.29 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.531 2.154 . . . . 0.0 112.354 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.83 -29.96 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -65.93 -56.3 12.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -56.69 -46.62 81.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.4 mt -55.87 -42.98 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.01 -52.94 63.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 13' ' ' ALA . 3.4 mt -60.57 -59.74 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -49.03 -34.57 13.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.276 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -62.16 -54.08 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.68 -31.56 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' A' ' 24' ' ' MET . 55.6 mt -68.57 -71.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.786 ' CD2' HG11 ' A' ' 74' ' ' VAL . 41.3 t80 -40.62 -30.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.792 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.67 -39.13 58.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.852 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.51 -34.62 14.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.746 ' HG2' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -84.61 -35.95 22.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -62.59 129.99 43.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.24 44.69 0.47 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.629 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -176.04 -24.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -120.8 -35.1 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.781 HD23 HG13 ' A' ' 34' ' ' ILE . 2.7 tt -64.47 139.6 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -44.32 139.21 3.39 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.994 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 4.1 Cg_endo -46.51 -52.51 7.3 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.961 2.441 . . . . 0.0 112.841 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.3 -57.44 10.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.693 ' CB ' HD21 ' A' ' 29' ' ' LEU . 4.2 m-20 -53.97 -28.32 36.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.781 HG13 HD23 ' A' ' 29' ' ' LEU . 74.2 mt -65.79 -46.28 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.001 0.429 . . . . 0.0 110.009 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.604 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.47 -54.54 44.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.038 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.06 -59.85 4.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -47.3 -30.63 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.995 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.07 -45.23 18.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.816 0.341 . . . . 0.0 111.42 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.604 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -76.05 -79.1 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.999 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -80.95 84.52 6.41 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -133.31 -30.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.685 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.31 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.01 -39.51 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.483 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.5 mpt_? -72.56 -40.43 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.132 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.15 113.46 3.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.188 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.97 151.17 21.6 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 74' ' ' VAL . 47.8 t -134.69 104.88 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 117.027 0.413 . . . . 0.0 110.961 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -94.38 147.42 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 72' ' ' VAL . 56.4 t80 -97.01 134.26 40.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -131.45 177.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.915 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.32 148.45 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 111.133 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 53' ' ' ALA . 88.4 m -45.55 165.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 52' ' ' THR . . . -117.06 -170.08 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.21 40.56 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -178.65 45.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.913 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 2.5 m95 -72.01 -19.75 61.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.444 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.32 63.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -148.97 -57.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.16 -61.03 1.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.473 HD11 HG13 ' A' ' 64' ' ' ILE . 33.8 pt -86.15 -23.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.406 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.03 -54.74 3.65 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.092 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.564 HG13 HD11 ' A' ' 64' ' ' ILE . 8.1 p -51.11 153.75 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.861 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -76.29 135.9 39.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.408 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 62' ' ' VAL . 20.1 mm -130.98 116.6 34.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 111.626 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.23 122.44 87.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 29.1 Cg_endo -64.11 153.44 76.22 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.283 1.989 . . . . 0.0 112.257 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.71 3.84 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.654 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -111.2 -16.12 13.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.712 0.292 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.73 154.83 40.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -106.27 122.83 47.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.226 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HG3' HG23 ' A' ' 50' ' ' VAL . 9.6 pt-20 -114.6 144.59 43.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.08 0.467 . . . . 0.0 111.631 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 49' ' ' PHE . 1.6 t -142.96 142.92 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 39.9 m0 -114.91 140.95 48.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.786 HG11 ' CD2' ' A' ' 21' ' ' PHE . 72.3 t -126.29 114.86 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 85' ' ' ASP . . . -150.65 -146.93 4.43 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.226 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.891 HD21 ' CE2' ' A' ' 87' ' ' PHE . 1.5 mm? -119.61 153.51 35.37 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -154.98 -168.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.857 0.36 . . . . 0.0 111.053 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -107.97 -156.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.486 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.86 -10.17 55.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.459 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -71.79 -8.75 56.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.577 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.58 78.09 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.813 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -148.37 -148.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.4 tpp -142.51 -82.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.021 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 44.12 41.01 3.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 169.31 78.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 p -90.04 134.94 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.804 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.891 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -92.73 -45.81 7.86 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -136.84 162.79 32.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.563 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' HG13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -138.14 140.14 39.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.5 m-85 -120.93 154.25 36.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.913 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 72.7 mt -139.97 121.16 14.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.646 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -135.6 125.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.029 0.442 . . . . 0.0 111.847 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 p -53.94 125.98 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.946 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -55.56 -41.46 73.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.146 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -56.66 143.85 34.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -32.61 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 154.14 42.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.678 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.31 -67.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.19 84.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.06 123.18 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.772 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -119.16 139.1 52.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.8 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.84 129.14 25.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.518 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 24' ' ' MET . 11.4 p -122.48 140.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.581 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.44 131.88 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.664 ' HE3' HD12 ' A' ' 29' ' ' LEU . 28.1 m95 -108.62 149.84 28.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 0.2 OUTLIER -61.47 159.49 12.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.858 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.918 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -146.05 24.44 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -77.35 119.08 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.721 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -111.23 104.76 13.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 mm -71.04 128.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.325 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.03 166.73 11.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.648 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -125.45 116.82 22.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.839 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.31 10.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.79 160.06 29.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -57.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.674 2.249 . . . . 0.0 112.171 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -31.19 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -64.81 -47.3 78.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.915 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -63.81 -50.66 68.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.4 mt -49.09 -36.58 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -38.18 72.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.722 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.9 mt -67.35 -63.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.1 -39.8 21.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.079 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.507 ' HD1' HG21 ' A' ' 47' ' ' VAL . 30.8 t80 -55.7 -51.38 67.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.191 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -30.06 70.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 17' ' ' ALA . 96.3 mt -64.27 -46.51 93.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -63.45 -52.16 62.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.447 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -59.19 -22.68 61.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.404 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 1.3 pp20? -103.94 -48.43 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 4.1 mtp -67.44 -57.41 6.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . . . -45.94 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.026 0.441 . . . . 0.0 111.79 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -48.11 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.98 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -146.19 23.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.778 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 7.1 m-80 -102.89 -48.09 4.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.0 tt -87.84 143.14 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.845 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.798 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.99 150.96 0.55 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.3 Cg_endo -53.45 -19.45 13.4 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.595 2.197 . . . . 0.0 112.592 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.23 72.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.459 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -74.5 -28.65 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.419 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.0 mt -59.17 -50.14 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.926 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -74.04 -42.91 59.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 87' ' ' PHE . 1.4 tp -57.7 -64.46 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.4 . . . . 0.0 110.491 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 5.2 m-85 -45.41 -29.87 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.163 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.548 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.77 -9.63 21.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 36' ' ' LEU . 10.3 pt20 -151.35 116.1 5.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 112.322 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' CA ' ' A' ' 45' ' ' GLY . 11.1 t80 -169.75 -38.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.938 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.48 -65.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -40.08 88.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.576 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -95.89 28.37 3.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.088 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 41' ' ' PHE . . . -94.9 120.84 6.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.606 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.34 98.22 0.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.303 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 74' ' ' VAL . 21.4 t -94.18 97.27 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.65 137.43 35.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.822 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 75.2 t80 -92.2 116.39 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -168.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -135.3 153.7 51.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 22.4 m -56.14 162.33 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.076 0.465 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB3' ' HD1' ' A' ' 56' ' ' TRP . . . -105.45 -151.24 0.45 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.042 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.96 31.24 0.98 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.766 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 79.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.697 ' HD1' ' HB3' ' A' ' 53' ' ' ALA . 7.7 p-90 -97.87 46.95 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.433 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER -69.04 61.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.47 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -130.41 -39.22 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.45 -38.3 12.65 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.685 HD11 ' CD1' ' A' ' 64' ' ' ILE . 4.7 pt -95.27 -26.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.049 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 90.73 -46.46 2.94 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.299 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -62.43 159.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.941 0.401 . . . . 0.0 111.764 -178.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -78.27 135.24 37.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.627 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.685 ' CD1' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.76 90.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.372 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 1.2 m-20 -75.79 113.52 27.88 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 5.7 Cg_exo -41.36 -72.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.194 2.596 . . . . 0.0 114.524 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -74.61 8.87 2.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 65' ' ' ASP . 8.3 mt-10 -121.34 -14.44 8.29 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.623 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.4 145.0 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.122 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -112.75 140.47 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.643 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -112.57 139.36 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.404 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.0 t -139.51 138.35 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.953 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -120.14 131.98 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.008 0.433 . . . . 0.0 111.162 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 47' ' ' VAL . 53.6 t -121.83 113.01 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.39 -124.15 2.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.216 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 76' ' ' LEU . 2.4 tp -146.94 71.64 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.052 0.453 . . . . 0.0 109.857 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 82' ' ' GLU . 33.7 m -55.45 173.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 0.0 112.096 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 80' ' ' GLN . 52.8 p-10 -89.69 -147.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.717 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 -5.44 16.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HG2' ' ND2' ' A' ' 78' ' ' ASN . 4.2 pt20 -118.8 34.65 5.12 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.664 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.31 87.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.742 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.3 mt-10 -156.43 155.98 33.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.881 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.2 tpp -142.63 104.1 4.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.285 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.77 -18.58 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.263 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.68 109.19 11.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.949 0.404 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.56 137.11 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 22.7 m-85 -89.56 -33.6 16.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.724 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 172.93 17.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.437 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.879 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.6 mttm -130.57 147.37 52.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.2 m-85 -125.45 134.57 52.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 112.026 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.495 HD13 HG23 ' A' ' 64' ' ' ILE . 15.0 mt -122.41 136.05 54.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.775 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -149.94 116.74 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.081 0.467 . . . . 0.0 111.835 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.7 m -46.99 149.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 19.5 m-70 -89.78 23.06 2.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -92.73 165.52 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.81 -59.27 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.09 121.24 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.395 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.19 110.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.05 140.1 47.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.944 0.402 . . . . 0.0 111.228 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.9 141.85 36.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.36 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 92' ' ' ILE . 30.6 p90 -138.15 142.03 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CD2' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -144.24 130.67 19.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.211 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -119.94 140.53 43.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.84 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.31 135.2 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.784 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 38.5 m95 -106.93 147.49 29.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.62 155.92 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.771 HG22 HG22 ' A' ' 3' ' ' THR . 1.1 m -165.61 -53.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.537 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.771 HG22 HG22 ' A' ' 2' ' ' THR . 9.9 t -167.53 109.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.33 -59.7 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.588 HD12 HH11 ' A' ' 95' ' ' ARG . 27.4 mm -97.57 133.6 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 129.78 44.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -93.45 -170.95 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.65 144.71 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 147.83 79.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.74 -49.52 16.96 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.565 2.177 . . . . 0.0 112.347 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -30.25 65.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -66.44 -49.76 65.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -65.01 -44.14 90.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.021 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.4 mt -59.79 -34.43 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -44.09 76.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 13' ' ' ALA . 5.0 mt -64.97 -54.78 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.88 -40.55 73.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.21 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.48 -52.04 66.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.56 -32.04 71.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 17' ' ' ALA . 19.4 mt -73.71 -28.75 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 32.5 t80 -77.26 -25.77 51.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.368 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.1 tp -78.11 -32.63 50.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.254 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.01 -38.18 9.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.174 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -75.95 -50.11 15.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.63 0.252 . . . . 0.0 111.577 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -49.12 111.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.406 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.41 -96.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.852 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.95 -4.48 52.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.1 m120 -90.54 -31.45 16.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.661 HD12 ' HE3' ' A' ' 105' ' ' TRP . 2.5 tt -92.66 139.27 30.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.65 132.9 13.94 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.976 -178.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.63 ' HA ' HD12 ' A' ' 34' ' ' ILE . 84.4 Cg_exo -42.07 -56.6 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.261 2.641 . . . . 0.0 113.627 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 -57.22 5.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 0.0 110.76 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.5 m-20 -49.95 -27.13 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.978 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 31' ' ' PRO . 51.3 mt -68.57 -53.48 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.129 0.49 . . . . 0.0 110.234 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -49.75 -60.38 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.181 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.53 HD12 ' NE2' ' A' ' 40' ' ' GLN . 4.5 mm? -51.05 -40.29 57.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.074 0.464 . . . . 0.0 110.664 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.5 t80 -64.97 -32.63 74.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.423 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.57 -39.12 28.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -79.18 -40.75 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.751 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.53 ' NE2' HD12 ' A' ' 36' ' ' LEU . 8.9 pt20 -128.98 106.38 8.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 111.811 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 34.6 t80 -165.02 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.232 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -31.75 72.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.281 0.563 . . . . 0.0 110.09 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.7 -22.65 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.113 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.761 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -130.36 31.99 4.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.997 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.09 114.14 2.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.773 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.94 165.94 22.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.115 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 73' ' ' TRP . 48.3 t -146.0 122.43 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.764 0.282 . . . . 0.0 110.57 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.38 164.07 13.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.346 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.814 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 16.0 t80 -106.8 108.16 19.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG23 ' CG ' ' A' ' 71' ' ' GLU . 3.2 m -103.8 -178.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.39 -175.62 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 53' ' ' ALA . 89.9 m -91.12 162.34 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' THR . . . -82.07 -160.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.26 -45.48 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.8 127.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.839 ' CH2' HD11 ' A' ' 91' ' ' LEU . 15.9 m0 -87.42 -75.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.533 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 1.5 mm-40 43.57 31.24 0.42 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -155.43 -37.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.865 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 24.1 mm-40 -82.12 -74.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 64' ' ' ILE . 19.1 pt -82.13 -46.86 19.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.259 . . . . 0.0 111.67 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 119.67 69.32 0.31 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.6 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 64' ' ' ILE . 13.0 p 175.57 151.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -64.91 -5.98 7.34 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.775 HD13 HG13 ' A' ' 62' ' ' VAL . 6.9 mm 59.19 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.209 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -112.92 82.35 5.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.902 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 35.8 Cg_exo -53.05 168.02 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.961 1.774 . . . . 0.0 111.837 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 56.25 12.47 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 27.7 mt-10 -135.15 -3.41 2.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.348 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 84.4 m-85 -132.11 142.26 49.45 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.814 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -91.02 124.06 34.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.888 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.713 ' CG ' HG23 ' A' ' 50' ' ' VAL . 6.1 tp10 -99.34 119.91 38.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.66 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -122.8 137.03 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.109 0.48 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.785 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m0 -115.17 141.01 48.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 47' ' ' VAL . 28.1 t -129.64 103.74 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.964 0.412 . . . . 0.0 111.356 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.44 20.56 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.703 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -102.32 153.16 20.27 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.824 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -150.11 -167.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.699 0.285 . . . . 0.0 110.778 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' H ' HG12 ' A' ' 77' ' ' VAL . 29.7 m-80 -103.62 -170.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -79.54 -13.35 59.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -74.26 -5.05 39.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.534 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.36 88.82 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.412 . . . . 0.0 111.017 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.824 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -151.46 -168.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.38 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.402 ' HE1' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -160.06 91.61 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.362 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -118.74 -9.93 10.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.137 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.74 84.75 2.26 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.958 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 73' ' ' TRP . 1.5 p -89.91 140.49 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -98.52 -29.7 12.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.9 167.95 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 103' ' ' VAL . 17.1 ttpt -142.44 139.77 31.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.5 m-85 -122.73 145.89 48.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.839 HD11 ' CH2' ' A' ' 56' ' ' TRP . 94.3 mt -124.52 119.35 28.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.188 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -130.08 122.35 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.819 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -55.95 118.46 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.498 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -56.39 -38.67 71.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.588 HH11 HD12 ' A' ' 5' ' ' ILE . 6.3 mtm-85 -59.66 176.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -32.33 10.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.037 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -79.67 150.39 30.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.717 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 40.53 31.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.206 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.06 103.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.072 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -117.83 137.26 52.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.067 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 12.3 p90 -134.81 137.94 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.547 ' ND1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -139.17 159.49 42.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.439 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' LYS . 7.3 p -151.02 142.71 16.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.594 HD11 ' HE3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.52 140.95 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.066 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.703 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 32.9 m95 -116.99 149.88 39.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 158.63 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.883 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HB ' ' A' ' 2' ' ' THR . 1.7 mpp? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.775 0.322 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.564 ' O ' ' CG2' ' A' ' 2' ' ' THR . 1.1 m 64.88 13.83 8.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.438 HG21 HD11 ' A' ' 5' ' ' ILE . 11.5 t -144.25 -166.2 2.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.796 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -144.97 69.83 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 3' ' ' THR . 1.7 mt -88.39 142.25 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 173.46 7.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.003 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -112.93 127.15 56.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.013 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.46 142.54 57.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.586 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -46.28 169.6 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.706 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.79 -59.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.95 2.433 . . . . 0.0 112.287 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.19 -28.53 68.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -57.18 -57.49 12.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.834 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.87 -52.1 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 49' ' ' PHE . 53.0 mt -45.04 -36.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.999 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.13 -39.89 75.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.557 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 20' ' ' ILE . 29.8 mm -61.87 -64.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.808 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.813 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -47.96 -41.42 24.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -51.52 -54.82 23.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.206 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -25.76 67.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.357 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 17' ' ' ALA . 70.1 mt -75.95 -23.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.697 ' CG ' HG11 ' A' ' 74' ' ' VAL . 33.0 t80 -80.02 -32.49 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.426 . . . . 0.0 110.615 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD13 ' HZ ' ' A' ' 37' ' ' PHE . 3.0 mm? -80.33 -19.57 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.72 -41.12 6.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 20' ' ' ILE . 22.7 mtp -78.5 -45.05 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -61.14 159.72 11.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.341 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.05 40.04 4.69 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.566 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.3 -21.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.9 m-80 -110.35 -43.79 3.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.776 0.322 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.0 tt -75.94 151.74 37.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.03 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.863 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -48.37 155.13 0.98 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 44.6 Cg_exo -56.93 -30.64 86.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.793 2.329 . . . . 0.0 112.711 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.04 -58.61 5.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 111.373 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.672 ' OD2' HD13 ' A' ' 29' ' ' LEU . 46.2 t0 -64.5 -27.87 69.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.382 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 87.2 mt -60.04 -43.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.435 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.579 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -80.16 -44.11 20.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -62.8 -70.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.485 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.571 ' HZ ' HD13 ' A' ' 22' ' ' LEU . 1.3 t80 -48.48 -26.11 1.99 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.561 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.09 -52.15 11.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -69.98 -72.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.372 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.47 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 10.0 pt20 -77.19 -135.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 14.8 t80 87.51 -27.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.896 0.379 . . . . 0.0 110.622 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.35 -65.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.16 -30.56 11.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -24.23 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.58 128.24 8.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.686 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.08 153.18 24.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.114 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 73' ' ' TRP . 62.5 t -139.09 125.68 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.643 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 pt-20 -108.8 157.51 18.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.82 114.59 27.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 71' ' ' GLU . 12.8 m -113.7 -177.3 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -111.42 168.06 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.58 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.3 m -54.06 154.75 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.825 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -86.42 -163.53 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -95.43 37.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.887 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 3.0 t0 80.12 109.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.825 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -134.97 30.07 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.481 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 77.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' TRP . 4.0 mt-10 -154.87 -34.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.349 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.21 -49.66 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.97 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 64' ' ' ILE . 4.1 pt -70.69 -36.67 66.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 0.0 110.978 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.64 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 94.26 60.24 1.12 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.092 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.64 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.42 141.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.03 135.87 52.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 60' ' ' ILE . 6.9 mm -105.54 128.01 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 111.538 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.68 109.94 39.3 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.385 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.95 156.08 51.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.244 1.962 . . . . 0.0 112.111 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 62.04 8.28 2.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.87 -4.35 8.6 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.58 0.229 . . . . 0.0 111.427 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -148.01 135.35 20.54 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.945 0.402 . . . . 0.0 111.443 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.04 123.45 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.994 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.462 ' CG ' HG23 ' A' ' 50' ' ' VAL . 23.1 tt0 -101.7 119.66 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.946 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 48' ' ' GLU . 7.0 p -127.91 124.34 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.72 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.83 ' O ' HG13 ' A' ' 47' ' ' VAL . 24.9 m0 -89.84 141.74 28.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.697 HG11 ' CG ' ' A' ' 21' ' ' PHE . 88.7 t -129.32 96.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.5 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.88 -141.31 3.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.363 -0.923 . . . . 0.0 113.853 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.34 172.09 13.16 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 78' ' ' ASN . 6.2 t -153.67 163.93 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.503 ' N ' HG12 ' A' ' 77' ' ' VAL . 5.6 m120 -89.45 -152.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -91.64 26.1 2.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -108.94 -0.4 19.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.443 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.18 38.15 28.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.749 0.309 . . . . 0.0 111.574 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' N ' HG11 ' A' ' 77' ' ' VAL . 5.3 mm-40 -98.26 -158.37 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.387 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -163.44 32.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.71 0.69 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.31 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.65 73.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.979 0.419 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.88 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 8.4 m-85 -89.72 -41.66 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.99 162.46 39.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.573 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.791 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.9 mttt -118.26 143.71 46.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 3.2 m-85 -124.04 136.77 54.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.076 0.465 . . . . 0.0 112.199 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.566 HD12 ' CD2' ' A' ' 102' ' ' HIS . 24.4 mt -121.27 124.32 44.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.858 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.698 HG22 ' NH2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -119.27 122.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.29 127.74 33.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.022 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.989 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.7 m-70 -75.78 -4.47 40.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.729 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.34 116.89 24.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -40.36 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.268 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 149.24 46.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.66 -65.57 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.698 ' NH2' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 61.91 92.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' N ' ' NH1' ' A' ' 99' ' ' ARG . 7.7 mm-40 -113.91 145.83 40.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.517 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 39.7 p90 -137.82 143.82 41.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.901 0.381 . . . . 0.0 111.817 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.566 ' CD2' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -138.67 150.47 46.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 89' ' ' LYS . 10.9 p -150.17 142.31 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.849 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.69 138.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 178.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 46.4 m95 -113.86 147.03 39.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.15 152.01 41.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mmm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.828 0.346 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -65.43 -46.23 80.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.557 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.3 t -151.05 -43.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.967 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -110.35 166.98 10.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mt -125.84 152.61 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -89.97 127.72 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.634 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -177.38 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.49 159.33 26.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.29 146.82 38.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.795 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.94 -54.51 5.33 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.696 ' HA ' HD12 ' A' ' 14' ' ' ILE . 6.3 p-10 -67.13 -33.63 75.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.032 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 16' ' ' ILE . 86.8 m -68.15 -46.55 70.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.77 76.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.797 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 11' ' ' ASP . 48.2 mt -61.76 -58.07 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.03 -31.17 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.117 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 12' ' ' THR . 3.4 mm -70.25 -59.07 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB3' HG11 ' A' ' 72' ' ' VAL . . . -61.67 -47.2 86.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.2 -45.0 65.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -62.6 -40.19 96.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.825 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.4 mt -77.44 -15.92 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 72.2 t80 -73.07 -61.98 1.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.24 -4.89 38.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.03 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.1 tt0 -96.75 -52.33 3.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.812 0.339 . . . . 0.0 110.991 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.437 ' O ' ' C ' ' A' ' 25' ' ' ALA . 2.1 ttp -75.07 -37.12 61.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 21' ' ' PHE . . . -27.62 141.53 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.145 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.72 -86.01 0.4 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -71.75 69.08 0.65 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 169.17 -43.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.773 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.906 HD12 ' CE3' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -86.61 161.47 18.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.094 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.832 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -86.89 149.99 49.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.973 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.1 Cg_endo -50.95 -55.01 4.49 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.033 2.489 . . . . 0.0 113.336 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.29 -59.4 4.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.79 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.788 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -56.36 -24.22 42.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 40.5 mt -71.97 -39.46 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.056 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.4 tt -59.83 -52.68 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -57.18 -46.6 82.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.243 0.544 . . . . 0.0 110.473 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 1.9 t80 -55.03 -23.06 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.773 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB2' HD22 ' A' ' 39' ' ' LEU . 22.1 m120 -80.59 -41.01 24.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -104.11 14.13 31.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB2' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -147.68 23.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.085 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.5 t80 -112.1 -12.81 13.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.177 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.92 -35.26 17.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.19 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.82 -24.78 9.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.876 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.443 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 27.66 8.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.671 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.71 110.12 3.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.025 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.47 140.67 11.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.682 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.76 140.38 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.925 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -125.53 131.01 52.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.981 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 70.7 t80 -73.32 114.88 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.46 -173.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -114.08 -175.75 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.667 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 53' ' ' ALA . 32.9 m -93.47 161.78 14.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -85.23 -153.35 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.96 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.43 -45.1 10.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 3.4 p-10 172.11 93.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.77 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -107.84 47.65 0.88 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 64.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.368 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -151.44 -41.44 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.07 -55.2 5.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.75 HD11 ' CD1' ' A' ' 64' ' ' ILE . 9.3 pt -84.34 -13.72 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.323 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 63.49 77.5 0.22 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 169.76 149.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.32 . . . . 0.0 110.76 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 125.4 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.75 ' CD1' HD11 ' A' ' 60' ' ' ILE . 7.4 mm -100.72 145.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -143.2 95.78 5.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.245 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 7.3 Cg_endo -49.54 160.41 1.06 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.465 2.11 . . . . 0.0 112.197 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.57 -59.25 0.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.548 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.59 -28.99 15.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.074 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.36 146.84 47.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -99.52 140.17 34.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.258 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 50' ' ' VAL . 5.8 tp10 -105.74 129.75 53.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.01 0.433 . . . . 0.0 111.461 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.761 HG11 ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -131.6 123.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.16 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.561 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 17.0 m0 -106.43 145.74 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.587 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 4.8 t -127.28 101.96 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.13 -143.49 9.05 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.591 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 40' ' ' GLN . 2.1 tp -138.96 61.48 1.57 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.401 0.62 . . . . 0.0 110.18 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 6.9 m -47.33 174.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.612 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -130.95 -131.51 0.2 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.983 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -77.81 -22.12 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -94.15 -90.23 0.21 Allowed 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.131 -0.356 . . . . 0.0 111.653 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 77' ' ' VAL . 2.6 p30 -173.51 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.93 104.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 110.328 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.657 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 6.5 ptp -50.14 -26.03 4.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.478 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.73 -20.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -157.32 131.09 8.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.48 135.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.624 ' CE2' HD22 ' A' ' 76' ' ' LEU . 9.1 m-85 -89.44 -35.84 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -157.79 163.38 38.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.301 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.903 ' O ' HG23 ' A' ' 103' ' ' VAL . 1.4 mttt -132.38 147.1 52.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -134.61 135.46 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.799 ' C ' HD13 ' A' ' 92' ' ' ILE . 3.0 mt -120.54 131.13 54.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.082 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.799 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -132.97 136.59 55.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -63.92 128.85 37.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.669 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.458 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 22.3 m-70 -72.85 -25.14 61.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.321 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.69 156.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.67 -61.33 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ASP . 11.4 pt-20 -85.44 151.41 24.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER 49.8 103.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.814 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.16 126.88 43.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.33 141.27 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.056 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -135.33 142.04 45.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.207 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.571 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.91 128.08 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.383 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 89' ' ' LYS . 5.1 p -115.18 136.45 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.287 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -105.37 119.42 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.934 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.906 ' CE3' HD12 ' A' ' 29' ' ' LEU . 83.9 m95 -101.91 149.37 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.66 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -64.26 150.76 45.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.85 0.357 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.796 HG22 HG22 ' A' ' 3' ' ' THR . 1.1 m -102.78 -50.15 3.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.556 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.796 HG22 HG22 ' A' ' 2' ' ' THR . 10.1 t -167.52 99.67 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.853 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -118.3 75.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.6 mm -117.92 129.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.464 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -150.16 16.68 0.84 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.239 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' ' HB3' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -150.99 160.84 43.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.13 153.19 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.485 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.04 149.89 94.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.92 -55.42 3.24 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.571 2.181 . . . . 0.0 112.49 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.23 -31.15 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.207 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -64.5 -61.32 2.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.64 -44.64 81.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.41 -38.78 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -49.22 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 HG21 ' NH2' ' A' ' 99' ' ' ARG . 5.2 mm -57.06 -49.66 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.956 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.43 -37.48 67.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.132 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.55 -57.38 12.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.801 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.44 -41.91 61.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 17' ' ' ALA . 13.5 mt -60.56 -70.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 20.3 t80 -39.55 -33.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.751 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tp -69.69 -41.99 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.005 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.24 -36.31 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -66.94 -57.11 7.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.169 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . . . -48.65 112.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.46 -90.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.07 4.53 52.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.569 0.223 . . . . 0.0 111.387 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 105' ' ' TRP . 1.1 p30 -101.8 -21.95 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' A' ' 105' ' ' TRP . 3.2 tt -103.84 143.68 32.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.573 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -49.89 130.72 21.83 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.2 Cg_exo -46.89 -44.36 22.64 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.92 2.414 . . . . 0.0 113.136 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.0 36.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.451 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -55.72 -25.87 42.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 31' ' ' PRO . 52.0 mt -65.38 -54.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.983 0.421 . . . . 0.0 110.204 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.38 -48.93 55.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.644 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.721 HD22 ' OE1' ' A' ' 40' ' ' GLN . 16.1 mt -60.01 -68.23 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.401 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -45.04 -32.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.006 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.84 -37.95 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.326 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.18 -19.27 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.721 ' OE1' HD22 ' A' ' 36' ' ' LEU . 3.7 pt20 -144.53 115.82 8.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.064 0.459 . . . . 0.0 111.19 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -171.56 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.52 -33.1 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.306 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.87 -24.1 16.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.352 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.05 43.4 3.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.724 0.297 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.18 125.6 8.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.57 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.18 113.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 74' ' ' VAL . 35.7 t -108.48 117.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.715 0.293 . . . . 0.0 110.576 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -111.69 163.43 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.765 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 41.4 t80 -104.33 118.97 37.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.69 HG23 ' CB ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -109.91 177.8 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.095 0.474 . . . . 0.0 111.668 -179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' C ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.91 152.63 21.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 21.9 m -67.84 154.77 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.588 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.977 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -79.51 -152.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.41 -46.49 9.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' TRP . 8.0 p-10 -161.13 -41.35 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.977 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 3.0 p-90 22.92 114.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -139.72 19.03 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.975 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -96.49 -26.81 15.15 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.96 -68.31 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.962 ' CD1' HD11 ' A' ' 64' ' ' ILE . 23.1 pt -63.48 -42.58 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.085 0.469 . . . . 0.0 110.431 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 130.89 -63.75 0.62 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.676 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -81.7 -179.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -77.23 168.77 19.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.962 HD11 ' CD1' ' A' ' 60' ' ' ILE . 21.5 mm -135.07 145.23 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.081 0.467 . . . . 0.0 111.63 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-20 -121.52 107.36 36.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 32.8 Cg_endo -64.03 152.41 81.07 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.101 1.867 . . . . 0.0 112.101 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 72.33 -3.95 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.399 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -107.69 -16.62 14.29 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.952 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -137.91 146.93 43.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -93.06 137.78 32.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.578 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.69 ' CB ' HG23 ' A' ' 50' ' ' VAL . 8.2 mm-40 -107.58 130.39 54.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.826 HG11 ' CB ' ' A' ' 17' ' ' ALA . 14.1 p -135.06 106.75 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.71 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' HG11 ' A' ' 86' ' ' VAL . 8.2 m0 -89.17 138.92 30.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.345 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 47' ' ' VAL . 42.0 t -120.81 112.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.475 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 -125.71 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.922 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.6 tp -146.15 61.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.078 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 78' ' ' ASN . 26.7 t -57.13 159.26 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.617 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -108.02 -170.49 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -31.42 72.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.808 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -69.29 -11.99 61.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.366 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.41 33.05 0.7 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.801 0.334 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.36 130.55 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.423 ' HB2' HG22 ' A' ' 77' ' ' VAL . 24.5 ttm -102.93 122.68 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.991 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.64 -19.79 11.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 132.13 43.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG11 ' CZ3' ' A' ' 73' ' ' TRP . 0.7 OUTLIER -103.51 144.42 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 76' ' ' LEU . 1.7 m-85 -107.02 -23.84 12.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -175.77 175.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.435 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.4 mttp -141.46 139.12 33.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.539 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 1.1 m-85 -126.66 131.39 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.203 0.525 . . . . 0.0 112.24 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -115.21 130.06 56.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.988 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -131.09 132.54 63.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -64.14 130.06 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.845 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 93.8 m-70 -77.31 -18.61 57.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.468 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -67.56 168.12 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.084 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.71 -69.26 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 98' ' ' ASP . 7.9 mt-10 -61.12 144.34 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.125 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER 57.7 115.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.233 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH2' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.81 90.49 3.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.787 0.327 . . . . 0.0 110.274 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -89.65 126.62 35.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 28.4 p90 -146.28 138.39 25.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.715 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -133.94 134.47 42.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.429 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.3 p -114.39 146.8 18.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 89' ' ' LYS . 4.8 mp -111.63 138.58 39.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.233 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.667 ' HE3' HD12 ' A' ' 29' ' ' LEU . 57.2 m95 -122.61 147.4 46.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.111 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.79 144.74 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.883 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 2' ' ' THR . 3.1 t -82.34 59.06 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.184 0.516 . . . . 0.0 110.661 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p 60.73 -171.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.772 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 97.64 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.469 HG22 ' H ' ' A' ' 6' ' ' LYS . 1.1 mt -127.36 165.04 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.743 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -89.61 -179.46 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.791 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -135.58 171.24 14.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.42 159.34 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.12 157.71 34.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.12 -50.32 7.65 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.551 2.167 . . . . 0.0 112.202 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.9 -30.07 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -48.44 63.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.59 87.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.57 -41.27 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -52.22 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.53 ' CD1' HD12 ' A' ' 92' ' ' ILE . 1.4 pp -70.76 -39.02 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -61.64 -41.34 97.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.582 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -60.81 -46.27 91.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.229 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.17 -34.44 75.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.233 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 17' ' ' ALA . 58.2 mt -67.13 -46.71 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.637 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 21.8 t80 -51.83 -56.75 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.74 -12.33 60.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.752 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.0 tp10 -93.62 -60.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -76.14 -38.28 56.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -47.34 110.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 111.407 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.64 -92.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.872 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.33 -2.97 47.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 8.6 m120 -95.77 -28.79 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.8 tt -92.92 157.41 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.425 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.935 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -80.44 149.91 69.47 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 111.69 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.62 -47.85 21.3 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.827 2.352 . . . . 0.0 113.38 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.95 0.97 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 111.899 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.733 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -60.29 -23.15 63.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 29' ' ' LEU . 13.9 mt -70.99 -35.02 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.907 0.384 . . . . 0.0 110.213 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -69.06 -48.35 63.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.806 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.607 HD23 ' NE2' ' A' ' 40' ' ' GLN . 2.0 mt -60.19 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.7 t80 -39.68 -31.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.308 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -74.08 -49.2 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.615 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 2.4 mm? -82.86 -20.12 36.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.607 ' NE2' HD23 ' A' ' 36' ' ' LEU . 3.9 pt20 -136.39 111.23 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -174.66 -49.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.321 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -51.4 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 52.71 0.88 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 0.0 111.198 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 122.71 7.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.64 119.92 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.289 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 74' ' ' VAL . 39.1 t -104.76 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.35 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.86 136.73 36.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -87.06 133.28 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -129.96 -169.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.689 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -127.92 171.19 12.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.682 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -63.57 154.56 32.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -88.42 -160.91 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.951 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -94.15 33.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.208 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 2.1 m-20 83.73 112.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.728 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.8 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -138.74 33.33 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -59.62 79.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -155.95 -37.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.85 -47.51 7.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.663 0.268 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 64' ' ' ILE . 1.7 pt -74.52 -28.98 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.015 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.648 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 79.21 69.05 1.43 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.459 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 172.99 140.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 110.682 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -53.56 136.36 38.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.802 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 60' ' ' ILE . 14.1 mm -110.09 131.69 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.446 . . . . 0.0 111.649 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 73.8 m-20 -134.82 104.67 10.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.051 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 34.3 Cg_endo -64.67 160.59 39.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.164 1.91 . . . . 0.0 112.441 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER 74.39 -8.3 1.5 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.207 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.2 pt-20 -118.59 -5.42 10.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.177 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.486 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 60.2 m-85 -131.99 147.99 52.49 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.955 0.407 . . . . 0.0 110.825 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.35 128.66 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.051 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' HG23 ' A' ' 50' ' ' VAL . 4.8 tp10 -96.65 132.89 41.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.0 111.492 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 17' ' ' ALA . 1.5 t -131.39 135.23 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.728 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.545 ' CE2' ' HD2' ' A' ' 89' ' ' LYS . 6.0 m0 -118.57 135.72 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.048 0.451 . . . . 0.0 111.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 47' ' ' VAL . 36.0 t -126.73 109.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.77 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.76 -136.76 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.074 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.661 HD22 ' HE1' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -142.06 59.26 1.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 109.863 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.725 HG12 ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -46.84 141.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.93 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -89.46 -129.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.229 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.543 ' C ' ' HG3' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -101.58 -176.75 3.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.299 0.571 . . . . 0.0 109.999 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HG3' ' C ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER 40.62 19.08 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.422 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' GLU . 1.7 t70 73.45 76.65 0.13 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.828 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.725 ' C ' HG12 ' A' ' 77' ' ' VAL . 1.4 mt-10 -152.13 123.99 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.261 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.652 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 21.2 ttm -101.29 -71.98 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.047 0.451 . . . . 0.0 110.688 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -19.24 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 83' ' ' MET . 2.0 m-20 -139.2 115.26 10.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.46 149.27 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.514 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.661 ' HE1' HD22 ' A' ' 76' ' ' LEU . 3.6 m-85 -97.1 -36.14 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . -160.59 167.97 25.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.923 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HB2' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -129.87 147.12 51.6 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.2 m-85 -130.83 135.95 48.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' ND1' ' A' ' 102' ' ' HIS . 2.6 mt -128.5 131.91 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.446 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -142.19 129.98 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.164 0.507 . . . . 0.0 112.147 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.68 135.61 46.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.936 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -75.19 -21.02 59.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 174.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.266 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 -57.35 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 123.5 30.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.78 110.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.67 139.5 45.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.24 142.26 42.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.445 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB3' HG23 ' A' ' 92' ' ' ILE . 27.4 p90 -136.09 142.46 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.007 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.565 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.92 132.73 34.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.176 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.2 p -122.1 144.4 31.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 89' ' ' LYS . 1.9 mp -101.25 135.33 38.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.393 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.791 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.7 m95 -117.65 -90.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.73 131.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.8 mttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.866 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.794 0.33 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.04 158.8 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.296 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -104.91 -15.33 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.243 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.17 138.4 52.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.44 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 144.03 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -89.81 -172.93 3.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.629 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -141.94 172.9 12.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.362 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -99.6 169.61 9.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.515 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.2 m-20 -104.45 144.59 29.01 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.571 0.224 . . . . 0.0 110.49 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.35 -53.64 6.77 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.494 2.129 . . . . 0.0 112.593 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -53.76 -37.42 63.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.367 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 16' ' ' ILE . 65.2 m -82.28 -35.27 28.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.416 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.613 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -64.96 -32.95 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.93 -59.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.002 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.6 -29.47 1.84 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.204 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 12' ' ' THR . 1.1 pp -78.62 -45.08 25.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.615 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -70.24 -31.82 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.039 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.26 -45.01 96.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.106 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -24.91 63.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.8 mt -75.37 -28.47 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.492 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.729 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.6 t80 -80.36 -41.85 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.85 -3.76 49.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 7.6 pt-20 -116.97 -45.07 2.78 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 ttp -85.9 -45.55 11.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -51.99 122.93 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.745 0.307 . . . . 0.0 111.49 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.56 -67.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -7.83 59.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.0 -72.56 0.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 30' ' ' ASP . 5.3 tt -63.96 127.62 32.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.263 0.554 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.832 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -40.24 153.42 0.21 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.642 -178.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HA ' HD12 ' A' ' 34' ' ' ILE . 22.9 Cg_exo -64.73 -33.09 55.61 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.717 2.278 . . . . 0.0 112.667 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.38 -55.76 27.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 111.296 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.661 ' CB ' HD21 ' A' ' 29' ' ' LEU . 6.5 m-20 -62.54 -22.82 66.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.436 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 31' ' ' PRO . 97.0 mt -72.75 -47.46 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.51 -45.47 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.335 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.25 -57.44 10.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -55.77 -34.81 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.776 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.66 -44.28 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -77.22 -14.49 59.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.139 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 1.6 mm100 -120.36 -144.97 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.224 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 1.2 t80 83.1 -19.38 0.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.488 0.315 . . . . 0.0 111.632 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.77 -39.82 17.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.74 -29.92 8.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' CB ' ' HG ' ' A' ' 76' ' ' LEU . 1.5 mmp_? -115.76 27.54 9.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.002 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.71 114.54 4.46 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.402 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.33 146.49 16.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.763 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 73' ' ' TRP . 88.0 t -146.77 118.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.183 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.94 155.37 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.444 . . . . 0.0 111.522 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CE1' ' HB1' ' A' ' 13' ' ' ALA . 70.4 t80 -101.55 133.94 45.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -142.6 140.68 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.54 -173.17 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.446 . . . . 0.0 110.737 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 16.0 m -83.81 169.82 14.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.467 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.81 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -97.14 -160.31 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 3.7 p30 -93.77 30.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.518 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 t0 85.57 108.86 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -129.21 69.59 1.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.798 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 17.7 mt-10 -80.76 53.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.316 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 -49.65 2.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -83.21 -53.28 5.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 ' CD1' ' A' ' 64' ' ' ILE . 6.3 pt -81.59 -34.99 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.935 0.398 . . . . 0.0 109.954 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 57' ' ' GLU . . . 88.37 -39.72 3.11 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.55 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG11 ' CE1' ' A' ' 102' ' ' HIS . 4.1 p -58.16 154.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 111.647 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.53 120.34 16.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.475 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 2.3 mm -98.64 160.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.376 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.17 117.92 4.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 27.2 Cg_endo -62.2 152.46 75.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.308 2.005 . . . . 0.0 112.3 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -65.22 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -24.86 7.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.471 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 2.7 m-85 -110.93 149.28 30.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -118.38 123.89 46.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.353 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' HG2' HG23 ' A' ' 50' ' ' VAL . 17.4 tt0 -102.25 144.25 31.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.27 0.557 . . . . 0.0 111.367 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 17' ' ' ALA . 1.8 t -132.74 140.41 47.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.584 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.809 ' O ' HG13 ' A' ' 47' ' ' VAL . 17.6 m0 -114.9 132.48 56.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.0 111.177 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 47' ' ' VAL . 62.1 t -124.98 97.59 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.628 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -126.17 -133.4 3.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.588 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.633 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.4 tp -140.69 83.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 83' ' ' MET . 35.0 m -64.34 178.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.0 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -115.64 -171.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.96 -16.85 64.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.262 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -97.27 26.55 4.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.293 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 39.82 55.4 2.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.904 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.42 104.63 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.597 ' HB2' HG12 ' A' ' 77' ' ' VAL . 35.8 ttm -69.79 117.56 11.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 19.82 17.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.655 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 104.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.814 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 p -89.57 142.43 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.11 0.481 . . . . 0.0 111.524 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HE2' HD13 ' A' ' 76' ' ' LEU . 13.9 m-85 -89.81 -33.74 16.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.691 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -166.53 165.76 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.736 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.795 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.9 mttt -132.16 146.23 51.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.3 m-85 -126.3 130.21 50.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.458 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.522 HD12 ' ND1' ' A' ' 102' ' ' HIS . 5.2 mt -110.78 135.6 51.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.83 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.404 HG13 HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -139.03 123.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.577 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 156.75 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.758 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.825 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 20.4 m-70 -101.92 23.02 12.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.086 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -87.4 148.15 25.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.0 111.106 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -61.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.73 158.48 15.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 44.72 94.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.2 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.98 151.66 27.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.144 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -130.53 140.76 50.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 24.3 p90 -138.19 142.75 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -137.68 161.98 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.875 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.6 143.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.512 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.12 137.26 43.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.538 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 27.2 m95 -117.02 149.83 39.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.26 28.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.877 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 129.75 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 p -93.51 -14.68 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.776 ' O ' HD13 ' A' ' 5' ' ' ILE . 2.3 mm-40 78.18 21.5 0.86 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.787 0.327 . . . . 0.0 110.996 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 4' ' ' GLU . 10.6 mm -129.77 128.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -130.07 161.5 30.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -98.32 -172.82 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -105.11 143.06 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.777 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 150.83 14.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.785 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.92 -50.18 10.94 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.164 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -21.98 60.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.205 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.415 HG22 HD22 ' A' ' 8' ' ' LEU . 27.9 m -82.43 -49.15 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.409 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -63.22 -36.19 82.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.258 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -72.24 -57.55 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -44.74 -48.42 10.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.736 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -66.72 -45.33 88.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.088 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.67 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.045 0.45 . . . . 0.0 110.265 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.5 -36.43 71.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.922 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.32 -27.24 62.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.822 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.546 HG22 ' HE2' ' A' ' 90' ' ' PHE . 49.3 mt -74.1 -33.16 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.691 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 47.8 t80 -78.25 -23.63 47.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.07 0.462 . . . . 0.0 110.411 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.28 -33.29 37.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.238 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.18 -34.26 11.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.285 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 27.9 mtp -83.08 -50.9 8.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.523 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -55.14 138.76 43.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 111.321 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.79 21.07 5.51 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -160.11 -42.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HB3' ' CG ' ' A' ' 105' ' ' TRP . 2.5 m120 -76.59 -57.47 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -65.25 175.05 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.793 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.846 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -75.76 153.66 85.19 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.74 0.305 . . . . 0.0 111.017 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.73 ' HA ' HD12 ' A' ' 34' ' ' ILE . 52.2 Cg_exo -55.85 -58.02 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.907 2.404 . . . . 0.0 113.141 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.04 -46.33 11.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 111.64 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.64 ' CB ' HD22 ' A' ' 29' ' ' LEU . 12.7 m-20 -62.41 -27.69 69.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.5 mt -68.94 -48.45 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.877 0.37 . . . . 0.0 110.548 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.9 tp -57.57 -62.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -44.68 -45.23 9.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.195 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -35.79 75.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -68.43 -53.34 24.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.4 mm? -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -83.28 -136.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 72.98 -58.66 0.59 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.687 0.279 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.47 -42.71 98.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.36 -48.98 7.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -116.85 66.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.734 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.53 134.02 12.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.298 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.02 115.32 1.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.388 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -151.62 68.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -84.98 136.51 33.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 82.1 t80 -91.02 89.68 7.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.71 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.97 3.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 51.5 m -90.27 165.17 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.143 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 52' ' ' THR . . . -122.34 164.16 18.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.9 -31.87 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.82 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.826 ' CH2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -66.83 -27.94 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -60.72 67.35 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.506 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' TRP . 5.7 mt-10 -156.23 -54.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.19 -67.88 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' CG1' ' A' ' 62' ' ' VAL . 45.6 pt -71.46 -34.18 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 94.13 48.95 2.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.676 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.591 HG13 HD11 ' A' ' 64' ' ' ILE . 9.6 p 179.6 132.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' HG3' ' A' ' 57' ' ' GLU . 1.3 mt -65.71 135.3 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.591 HD11 HG13 ' A' ' 62' ' ' VAL . 17.9 mm -121.07 146.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.62 109.39 5.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 24.4 Cg_endo -62.89 153.26 74.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.186 1.924 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 62.73 7.07 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.563 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -128.25 17.27 6.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.405 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 31.1 m-85 -150.65 142.07 23.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.9 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.991 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -89.45 116.5 27.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -110.39 104.99 13.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.58 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.89 135.78 31.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.282 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 10.0 m0 -115.77 89.76 3.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.188 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 47' ' ' VAL . 72.6 t -89.7 99.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.041 0.448 . . . . 0.0 110.972 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.01 -132.55 3.46 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.462 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.2 tp -140.24 108.97 5.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 82' ' ' GLU . 57.2 t -96.28 148.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -92.24 -164.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.54 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.299 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.28 -6.87 48.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HA ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 67.07 30.14 7.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.721 0.296 . . . . 0.0 111.332 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.4 mm-40 -105.54 147.47 28.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.56 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.83 86.08 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 111.103 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.31 12.76 23.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.59 91.91 1.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.879 0.371 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.721 HG21 ' HG2' ' A' ' 89' ' ' LYS . 2.5 p -89.72 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' A' ' 76' ' ' LEU . 3.2 m-85 -97.4 -49.65 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.36 121.1 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.395 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.721 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -103.37 131.5 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.152 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.546 ' HE2' HG22 ' A' ' 20' ' ' ILE . 2.6 m-85 -111.7 153.26 26.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 0.0 111.775 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.826 HD11 ' CH2' ' A' ' 56' ' ' TRP . 15.3 mt -137.07 109.07 7.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.553 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.504 HG21 ' NH2' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -115.84 136.87 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.749 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -71.98 93.08 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.904 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.991 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 96.6 m-70 -31.92 -49.16 0.17 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.223 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -41.32 143.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.964 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -48.56 46.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 98' ' ' ASP . 8.3 mt-10 -72.11 145.33 48.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.099 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER 57.57 115.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.287 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 92' ' ' ILE . 13.4 tpt180 -109.66 113.79 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.838 0.351 . . . . 0.0 110.504 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CG ' ' HB2' ' A' ' 93' ' ' SER . 7.8 pt-20 -128.62 103.76 7.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 92' ' ' ILE . 26.2 p90 -112.07 146.26 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.93 161.38 39.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.443 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.8 p -152.74 141.66 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.82 132.69 58.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 29' ' ' LEU . 88.0 m95 -111.59 -81.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.412 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.64 139.97 11.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.871 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.14 121.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.79 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -98.86 131.03 45.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.69 -60.96 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.67 142.65 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 175.56 5.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.96 134.07 52.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.952 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.1 148.3 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.988 -179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.597 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -47.28 140.22 7.2 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.687 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -58.42 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.448 2.098 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -31.3 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -59.6 -55.23 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.906 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -58.36 -52.79 64.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.024 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -46.42 -38.85 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.182 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.04 -46.95 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 13' ' ' ALA . 4.7 mt -60.86 -63.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.902 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -47.05 -38.27 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -55.14 -52.67 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.103 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.98 -21.7 66.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.667 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 17' ' ' ALA . 77.9 mt -77.2 -30.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.042 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' CD2' HG11 ' A' ' 74' ' ' VAL . 15.0 t80 -76.68 -28.18 55.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.481 . . . . 0.0 110.136 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.1 tp -78.2 -32.78 50.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.391 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.36 -38.38 10.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.128 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 19.0 mtp -74.09 -51.21 16.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -50.0 145.66 5.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.401 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.13 29.92 9.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.279 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -152.36 -35.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.623 0.249 . . . . 0.0 111.357 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.469 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -121.04 -30.47 4.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.326 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD12 ' HE3' ' A' ' 105' ' ' TRP . 5.2 tt -68.94 141.17 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -58.5 140.27 84.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.53 -54.83 4.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.085 2.523 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.82 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.21 -28.89 68.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.301 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.591 HG12 HD22 ' A' ' 29' ' ' LEU . 54.3 mt -66.1 -52.29 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -55.69 30.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -49.78 -39.57 38.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 111.417 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -80.88 -36.82 30.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.4 -23.8 46.57 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -86.18 -27.77 24.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.622 ' HG3' HD21 ' A' ' 76' ' ' LEU . 12.4 pt20 -150.08 95.6 2.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.814 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.8 t80 -130.74 -40.24 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.201 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -68.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.919 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.42 -39.9 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.7 mpt_? -112.59 62.03 0.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.04 133.65 11.77 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.178 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.13 142.58 9.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.928 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 74' ' ' VAL . 39.5 t -146.04 80.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -76.87 140.46 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.812 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.02 88.43 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' CG ' ' A' ' 71' ' ' GLU . 1.8 m -89.52 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.153 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.73 175.5 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.761 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -60.4 154.18 21.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -75.03 -149.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -38.19 14.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 110.195 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 56' ' ' TRP . 4.0 p30 -151.3 -35.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.234 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.622 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 6.3 m95 70.84 2.28 4.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.634 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.8 59.59 0.89 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.876 0.369 . . . . 0.0 111.107 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.5 -49.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.799 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 5.1 mm-40 -75.99 -73.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.622 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 48.0 pt -75.13 -34.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.297 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 82.21 79.88 0.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.722 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 168.7 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -70.34 121.24 17.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.69 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 60' ' ' ILE . 27.0 mm -124.17 112.43 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.264 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.64 115.2 20.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.76 151.21 82.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.24 1.96 . . . . 0.0 111.921 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 77.71 -29.84 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.05 6.36 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.391 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -141.85 151.39 42.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 111.434 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -99.28 131.62 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.651 ' CG ' HG23 ' A' ' 50' ' ' VAL . 2.2 tp10 -115.72 110.23 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.582 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.902 HG11 ' HB1' ' A' ' 17' ' ' ALA . 8.8 p -113.73 135.24 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.176 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 18.7 m0 -117.9 136.35 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.321 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 47' ' ' VAL . 58.0 t -135.59 108.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 0.0 111.39 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.57 -115.23 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.622 HD21 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -150.04 155.25 39.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -140.58 -178.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.472 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.54 -173.86 2.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -26.12 65.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.965 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -79.16 -9.63 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.414 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.58 88.78 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.828 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.9 mt-10 -144.11 147.05 33.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 tpt -120.82 80.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 -5.51 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 84.95 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.7 p -89.84 131.73 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.665 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 76' ' ' LEU . 14.7 m-85 -89.47 -37.06 15.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.589 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.883 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -144.74 162.1 37.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.15 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.653 ' HE2' HD12 ' A' ' 104' ' ' ILE . 3.8 mttm -146.26 130.64 17.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.614 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -120.33 148.69 43.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 56' ' ' TRP . 58.9 mt -129.29 118.16 21.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.385 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -129.29 147.93 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.317 0.58 . . . . 0.0 112.553 -178.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.86 122.16 26.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.534 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.943 ' CE1' HD12 ' A' ' 8' ' ' LEU . 92.1 m-70 -58.82 -15.37 12.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.827 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.72 -55.81 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.62 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.84 0.06 28.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 112.063 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.89 105.01 2.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.92 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.46 118.64 22.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.056 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -104.51 127.45 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 21.6 p90 -118.26 138.9 52.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.848 0.356 . . . . 0.0 111.232 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -147.62 101.6 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.4 p -99.86 144.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.026 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.653 HD12 ' HE2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.9 131.1 73.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.974 179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.883 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 26.8 m95 -105.46 153.55 21.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.42 160.45 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.896 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.592 0.234 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -88.68 26.05 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.487 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 m -92.15 143.63 26.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.644 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -138.6 156.06 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mt -94.51 157.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 115.63 28.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -177.89 5.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.087 HD21 ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -130.16 148.54 52.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HD22 ' A' ' 8' ' ' LEU . 1.2 m-20 -80.59 134.82 53.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.056 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.43 -42.17 22.87 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 112.32 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -27.32 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.649 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -77.33 -37.07 53.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.087 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -65.71 -44.96 84.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.62 -42.63 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.959 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.34 -55.41 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.75 -42.09 94.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.031 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -60.12 -39.42 86.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.953 0.406 . . . . 0.0 110.309 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.65 -47.83 81.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.096 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.92 65.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.667 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.5 mt -62.61 -73.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 70.0 t80 -42.49 -29.45 0.28 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.381 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.51 HD12 ' HZ ' ' A' ' 37' ' ' PHE . 1.9 tp -64.69 -45.17 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.48 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.1 pt-20 -103.4 -28.57 11.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.405 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -72.14 -53.42 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 111.204 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 137.69 41.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.428 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.771 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 162.79 -85.7 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.894 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.6 3.59 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' CD2' ' A' ' 105' ' ' TRP . 0.9 OUTLIER -92.26 -42.64 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.263 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.851 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.4 tt -97.27 154.56 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.851 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.95 149.91 4.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.8 Cg_endo -53.64 -25.86 35.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.523 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.03 -60.42 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.64 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.659 ' HB3' HD22 ' A' ' 29' ' ' LEU . 45.1 t0 -58.21 -29.01 65.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.51 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 96.5 mt -61.2 -47.97 91.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 110.172 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -68.76 -47.21 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.438 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.454 HD23 ' OE1' ' A' ' 40' ' ' GLN . 5.6 mp -60.37 -59.09 5.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.426 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HZ ' HD12 ' A' ' 22' ' ' LEU . 4.1 t80 -42.12 -30.61 0.3 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.296 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -76.96 -50.71 12.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 35' ' ' LEU . 1.9 mm? -83.35 -63.17 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.618 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.859 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.48 92.83 9.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 111.659 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.2 t80 -163.95 -37.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.64 -62.54 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -102.62 -15.45 16.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.529 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' O ' HD12 ' A' ' 76' ' ' LEU . 20.6 mmt180 -102.75 -5.38 23.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.651 0.262 . . . . 0.0 111.396 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -91.15 132.71 11.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.17 145.46 13.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.368 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 74' ' ' VAL . 28.9 t -130.99 96.65 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.906 0.384 . . . . 0.0 111.006 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' A' ' 83' ' ' MET . 2.2 pt-20 -84.31 164.48 18.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.962 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.615 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 36.8 t80 -114.28 135.85 53.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.496 HG23 ' CG ' ' A' ' 71' ' ' GLU . 6.4 m -132.21 -174.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.17 166.09 13.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 66' ' ' PRO . 8.0 m -54.69 155.96 3.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.88 -177.29 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.03 26.25 10.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.77 39.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.853 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -65.22 -29.8 70.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.276 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 14.2 mt-10 -59.44 -16.63 24.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -92.68 -34.03 14.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 36.5 mt-10 -78.93 -57.66 3.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.853 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 42.0 pt -93.93 -36.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.415 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 123.61 -72.53 0.41 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m -56.88 173.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.814 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' O ' HD13 ' A' ' 64' ' ' ILE . 4.7 mp -89.82 136.4 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.485 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CG1' HD11 ' A' ' 60' ' ' ILE . 25.9 mm -124.9 116.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.755 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -65.36 112.07 7.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG21 ' A' ' 52' ' ' THR . 19.5 Cg_endo -61.42 163.75 16.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.792 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.7 pt-20 48.81 20.31 0.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.974 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -129.05 -14.44 4.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.584 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HE2' ' HG ' ' A' ' 93' ' ' SER . 64.2 m-85 -123.92 162.7 22.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.836 0.35 . . . . 0.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -109.1 122.15 46.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.496 ' CG ' HG23 ' A' ' 50' ' ' VAL . 35.0 tt0 -106.03 123.52 48.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.499 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.5 t -115.99 147.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.64 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -124.44 135.92 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 47' ' ' VAL . 49.1 t -128.42 111.01 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.091 0.472 . . . . 0.0 111.14 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.66 -127.22 3.07 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.166 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.859 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.8 tp -149.18 57.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' ASN . 6.3 p -63.71 158.55 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.702 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.5 m-80 -95.13 -144.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.929 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -93.23 22.88 4.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.662 0.267 . . . . 0.0 111.223 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -114.23 -11.76 12.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.543 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 71.37 28.81 2.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.385 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 77' ' ' VAL . 65.3 mt-10 -114.46 119.35 36.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.71 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.401 ' HE2' ' HG2' ' A' ' 48' ' ' GLU . 10.0 tpp -84.89 98.55 10.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.458 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.83 -23.88 26.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.24 125.61 16.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.41 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -107.08 135.59 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.709 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.3 m-85 -90.11 -38.32 13.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.74 175.96 12.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.788 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.637 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.17 140.61 22.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -123.32 147.56 46.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.778 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 34.2 mt -131.47 124.8 30.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.141 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.45 149.39 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.467 ' HG ' ' HE2' ' A' ' 69' ' ' TYR . 17.8 m -69.34 123.29 20.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.953 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.754 ' NE2' HD12 ' A' ' 8' ' ' LEU . 11.5 m80 -49.91 -48.62 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.634 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -42.87 160.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.098 0.475 . . . . 0.0 111.828 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -99.17 -34.63 10.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.112 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 3.3 pt-20 -91.3 126.69 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.93 106.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.8 148.54 45.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.507 . . . . 0.0 111.616 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.58 133.32 56.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.489 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 39.7 p90 -120.67 139.13 53.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.79 103.03 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.0 111.058 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.5 p -98.79 141.76 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.918 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.514 HD12 ' CE ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -108.2 135.55 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.151 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.801 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 46.9 m95 -115.52 140.72 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.23 159.19 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -110.33 -33.49 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.533 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -131.16 110.33 11.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 179.56 77.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 mt -128.72 127.78 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -106.71 123.73 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.785 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 177.76 6.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 16' ' ' ILE . 3.2 mt -139.38 135.29 33.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.37 164.93 53.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.578 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.65 -59.21 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.219 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 14' ' ' ILE . 9.7 t70 -63.87 -30.27 71.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 8' ' ' LEU . 13.7 m -73.27 -42.82 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -60.81 -35.33 76.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 11' ' ' ASP . 23.8 mt -71.35 -57.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.12 -39.84 2.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.263 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.1 mt -65.86 -57.34 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -56.59 -29.07 61.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.12 -55.45 25.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.8 -31.21 62.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.752 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 17' ' ' ALA . 78.7 mt -64.02 -74.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.144 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 44.8 t80 -39.51 -32.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.415 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 22' ' ' LEU . 2.0 tp -63.77 -43.02 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -29.26 10.41 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -57.86 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.682 0.277 . . . . 0.0 111.434 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -50.25 116.52 1.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.395 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.21 -89.94 0.08 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.92 2.78 32.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.4 m-80 -103.04 -59.12 1.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 33' ' ' ASP . 5.1 tt -64.1 135.26 56.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.78 137.49 3.34 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.964 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 34' ' ' ILE . 6.1 Cg_endo -48.21 -43.06 32.44 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.852 2.368 . . . . 0.0 112.754 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.0 -58.86 5.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.599 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.719 ' CB ' HD21 ' A' ' 29' ' ' LEU . 41.2 m-20 -58.06 -24.68 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 31' ' ' PRO . 92.5 mt -67.99 -50.93 54.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 109.991 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -53.7 -51.13 64.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.756 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -55.16 37.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.141 0.496 . . . . 0.0 110.417 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 2.1 t80 -46.19 -30.08 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.901 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -59.07 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.466 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.2 mm? -64.18 -21.26 66.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.837 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.619 ' HG3' HD21 ' A' ' 76' ' ' LEU . 3.9 pt20 -148.8 118.61 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.652 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' GLY . 63.4 t80 179.98 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.756 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -48.39 -63.5 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.25 -33.17 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.41 33.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -104.58 62.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.552 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.21 116.72 5.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.497 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 72' ' ' VAL . 38.7 t -102.34 107.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.77 0.319 . . . . 0.0 110.865 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.37 150.62 24.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.415 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 35.0 t80 -103.72 141.73 35.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.091 0.472 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.709 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.12 152.41 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.921 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -92.9 158.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.702 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 98.2 m -46.88 167.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.064 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 52' ' ' THR . . . -103.07 -169.04 1.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.72 32.59 4.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.23 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.959 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.5 m95 68.14 6.57 5.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.991 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.45 -1.8 19.88 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.71 -44.02 5.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 60.1 mm-40 -73.3 -56.28 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.439 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.815 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 18.0 pt -103.15 -35.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.675 0.274 . . . . 0.0 111.02 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 -53.02 0.6 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.301 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.78 152.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.238 0.542 . . . . 0.0 111.878 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -62.92 156.49 24.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.721 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 63' ' ' LEU . 34.5 mm -150.35 128.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.85 108.08 4.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.616 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 9.6 Cg_endo -52.9 157.69 7.56 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.288 1.992 . . . . 0.0 112.287 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 20.1 mt-10 69.64 -59.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.16 -29.03 1.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.814 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -116.65 152.16 34.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 111.355 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -112.37 133.11 54.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.816 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG3' HG23 ' A' ' 50' ' ' VAL . 8.0 pt-20 -112.53 133.48 54.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG13 ' CG1' ' A' ' 47' ' ' VAL . 2.2 t -121.22 147.45 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.84 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.452 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 12.2 m0 -120.49 133.57 55.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 111.226 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 21' ' ' PHE . 45.1 t -126.93 110.59 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.907 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.45 -132.27 3.75 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.264 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.619 HD21 ' HG3' ' A' ' 40' ' ' GLN . 2.3 tp -142.16 64.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 0.0 110.093 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 83' ' ' MET . 22.3 t -49.4 159.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.831 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.5 m-80 -89.65 -160.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.61 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -70.91 -9.7 58.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -91.95 -87.76 0.21 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.52 0.2 . . . . 0.0 111.17 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HA ' HG11 ' A' ' 77' ' ' VAL . 1.4 p30 179.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -57.38 129.65 42.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 77' ' ' VAL . 25.3 ttm -107.52 122.71 47.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.037 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.52 -3.18 13.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -137.56 108.23 6.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.863 0.363 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -97.38 138.74 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.858 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.568 ' HE2' HD22 ' A' ' 76' ' ' LEU . 2.5 m-85 -90.0 -46.35 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.681 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.723 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -143.99 173.19 11.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -150.4 136.0 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' HG21 ' A' ' 103' ' ' VAL . 1.4 m-85 -121.17 142.2 50.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.959 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 13.8 mt -119.96 133.43 55.56 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.02 143.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.92 132.32 46.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.65 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.0 -32.95 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 178.24 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.031 0.443 . . . . 0.0 111.277 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.64 -12.84 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.356 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -133.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 51.52 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 110.665 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -62.09 141.65 58.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.116 0.484 . . . . 0.0 111.905 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -117.46 149.63 40.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.595 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 35.5 p90 -139.16 143.36 38.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.708 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.705 ' CD2' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -150.04 118.79 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.143 0.497 . . . . 0.0 111.525 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -107.24 144.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.906 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -111.81 135.9 49.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 37.3 m95 -117.07 149.36 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 5.1 ttmt -67.63 153.46 43.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.851 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.825 0.345 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -106.95 25.36 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m 60.83 95.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.42 -34.98 5.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.924 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 95' ' ' ARG . 33.5 mm -82.35 134.62 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.245 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -115.04 162.06 17.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.708 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -89.92 178.91 6.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' HG22 ' A' ' 12' ' ' THR . 0.9 OUTLIER -105.71 143.89 33.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.064 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.83 157.82 57.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.83 -64.49 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.638 2.225 . . . . 0.0 112.248 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.68 -32.83 67.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' CD2' ' A' ' 8' ' ' LEU . 69.4 m -72.58 -36.46 68.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -65.06 -26.77 68.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.26 -62.12 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.97 -32.49 3.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.793 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 12' ' ' THR . 1.3 pp -76.86 -48.04 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.74 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.59 -35.84 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 110.198 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.59 -43.88 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.939 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -66.1 -27.86 68.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.136 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 17' ' ' ALA . 50.3 mt -74.25 -28.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.1 t80 -69.01 -45.97 69.19 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -80.02 -2.98 46.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 1.1 mm-40 -95.78 -56.83 2.54 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.3 mtp -92.18 -30.62 15.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.63 122.94 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.01 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.84 35.97 1.09 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.124 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -163.04 -32.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.44 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 5.2 t30 -116.27 -34.91 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 33' ' ' ASP . 3.0 tt -80.07 124.31 28.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 111.062 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.771 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -34.2 150.12 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.561 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 34' ' ' ILE . 26.9 Cg_endo -62.77 -34.49 72.83 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.536 2.157 . . . . 0.0 112.667 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.91 -58.15 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.868 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.792 ' HB2' HD21 ' A' ' 29' ' ' LEU . 61.8 m-20 -61.24 -19.43 61.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 31' ' ' PRO . 83.5 mt -75.23 -51.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.932 0.396 . . . . 0.0 110.388 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.3 tt -54.27 -51.8 63.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.738 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -52.02 66.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.247 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 4.0 t80 -46.46 -28.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.914 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -77.01 -49.99 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.6 44.02 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.01 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -150.57 -44.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.2 t80 -61.02 -12.01 10.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.717 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.59 -46.55 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -119.45 -13.31 9.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.607 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.461 ' O ' HD12 ' A' ' 76' ' ' LEU . 6.0 mtt-85 -118.18 41.66 2.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.142 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.92 108.82 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.52 154.06 24.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.297 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 73' ' ' TRP . 75.9 t -144.07 119.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -101.92 142.99 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.71 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 59.2 t80 -91.67 138.26 31.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.295 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.04 142.13 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.599 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.32 -174.78 1.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 53' ' ' ALA . 61.7 m -72.33 165.0 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -91.15 -160.78 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.6 OUTLIER -95.02 32.19 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.347 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 84.34 121.74 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -146.71 55.36 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.47 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -72.0 79.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.692 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.7 -43.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.772 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.59 -48.07 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.435 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 64' ' ' ILE . 5.1 pt -80.13 -14.46 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 54.86 77.4 0.15 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.25 140.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.86 122.92 12.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 60' ' ' ILE . 9.2 mm -97.68 144.85 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 43.5 m-20 -146.78 105.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.284 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 31.4 Cg_endo -64.0 155.69 62.98 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 80.29 -14.62 0.82 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.904 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.9 pt-20 -115.09 2.17 14.09 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.523 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 54.5 m-85 -138.96 144.73 39.12 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.099 0.476 . . . . 0.0 111.231 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.71 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -110.98 120.21 41.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.918 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 50' ' ' VAL . 14.3 tt0 -92.84 130.79 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.759 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -117.16 141.25 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.516 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.5 m0 -117.62 136.26 53.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 21' ' ' PHE . 59.8 t -125.07 102.03 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.472 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.18 -144.39 8.66 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.079 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 87' ' ' PHE . 2.1 tp -138.64 81.79 1.87 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.276 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 2.2 m -67.17 170.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.191 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -115.34 -165.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.428 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.87 -16.29 58.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.531 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.45 -85.83 0.17 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.154 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.7 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.332 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.618 ' C ' HG12 ' A' ' 77' ' ' VAL . 32.3 mt-10 -147.99 120.3 8.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -71.69 -25.68 62.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.38 6.51 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' MET . 1.5 m-20 178.42 121.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.66 141.61 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.884 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD22 ' A' ' 76' ' ' LEU . 2.3 m-85 -89.51 -34.89 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.413 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.2 161.99 19.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.62 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.826 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.6 mttt -129.36 148.24 51.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' A' ' 103' ' ' VAL . 2.9 m-85 -128.82 138.61 52.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 111.877 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.444 HD12 ' ND1' ' A' ' 102' ' ' HIS . 3.7 mt -119.66 134.03 55.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.151 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.123 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -74.3 147.87 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -91.72 22.26 4.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HA ' HG23 ' A' ' 5' ' ' ILE . 1.3 mtp180 -96.99 152.97 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.35 -40.57 14.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.47 114.28 28.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.47 100.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.723 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.86 127.25 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.46 156.5 18.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -149.53 144.62 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.03 159.95 40.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.015 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.34 141.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.63 133.36 51.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.752 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.634 ' HE3' HD12 ' A' ' 29' ' ' LEU . 33.9 m95 -115.88 150.17 37.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.93 153.57 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.6 pttm . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.888 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 2' ' ' THR . 3.2 ptm . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.658 0.266 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.624 HG23 ' N ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 58.54 -176.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.624 ' N ' HG23 ' A' ' 2' ' ' THR . 4.8 t -135.13 97.81 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.36 -174.3 2.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 6' ' ' LYS . 0.4 OUTLIER -79.49 169.65 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.9 -170.2 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -127.41 139.81 52.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.114 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD22 ' CG2' ' A' ' 12' ' ' THR . 3.7 mt -63.98 150.47 45.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.2 141.89 93.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' HD12 ' A' ' 14' ' ' ILE . 88.8 Cg_exo -47.12 -48.2 15.26 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.55 2.166 . . . . 0.0 112.725 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.9 -21.86 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.471 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.659 ' CG2' HD22 ' A' ' 8' ' ' LEU . 26.6 m -81.01 -61.17 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.558 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.46 -30.27 64.9 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 10' ' ' PRO . 96.1 mt -76.28 -59.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -42.1 -48.77 4.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.568 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CD1' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -63.62 -40.22 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.04 -42.67 94.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.442 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -52.16 -44.85 64.82 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.243 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 -30.56 71.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.485 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.4 mt -73.0 -29.75 29.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t80 -67.91 -47.8 67.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -71.81 -23.41 61.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.17 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.718 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.49 ' CE ' HG11 ' A' ' 103' ' ' VAL . 5.8 mtp -75.1 -46.01 37.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -42.75 110.83 0.2 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.804 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.52 -114.28 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.392 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.98 -37.66 78.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.309 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.01 -37.13 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.6 tt -88.07 151.08 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.913 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -71.13 134.55 85.21 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.097 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.947 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.3 Cg_exo -46.11 -59.36 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.722 2.281 . . . . 0.0 112.951 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.14 -50.35 20.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.556 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 29' ' ' LEU . 47.0 m-20 -60.22 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.7 mt -66.66 -52.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.111 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.731 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -57.34 -51.76 68.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 110.356 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 1.8 tp -52.39 -51.06 61.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 110.556 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -49.04 -42.58 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.9 -57.06 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.731 HD22 ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -89.99 49.11 1.66 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.498 ' HB3' HD21 ' A' ' 76' ' ' LEU . 19.3 mm-40 -155.62 -48.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -42.91 -37.47 1.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.545 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.06 -45.03 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.22 -61.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.061 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.19 63.06 3.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.36 133.88 11.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.72 128.34 4.59 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.413 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -150.17 59.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.49 . . . . 0.0 110.245 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.22 125.61 31.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.381 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 79.3 t80 -83.63 97.65 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.45 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.476 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -90.34 166.18 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.356 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -98.17 162.08 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.853 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 48.4 m -52.09 163.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' THR . . . -137.18 162.34 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.08 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.91 -29.25 18.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.794 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.21 -2.7 22.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.674 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.764 ' CZ2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -46.39 -29.59 1.76 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.553 0.216 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.81 63.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -166.93 -44.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.369 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.97 -70.54 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.104 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.71 -32.12 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.273 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 62' ' ' VAL . . . 77.72 47.75 8.46 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.93 113.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.498 0.19 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.93 127.16 15.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.57 137.73 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -66.1 109.69 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.795 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.3 Cg_endo -59.33 157.89 28.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.326 2.017 . . . . 0.0 112.411 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.4 pt-20 48.62 20.53 0.33 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.777 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 19.2 mt-10 -137.74 18.82 2.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.713 0.292 . . . . 0.0 110.973 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 68' ' ' GLU . 20.8 m-85 -148.09 145.51 28.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.72 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.001 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -90.11 114.19 26.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' HG2' HG23 ' A' ' 50' ' ' VAL . 27.8 tt0 -110.62 103.4 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.485 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 17' ' ' ALA . 13.3 p -94.5 136.39 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.464 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.601 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 3.8 m0 -121.25 94.16 4.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 47' ' ' VAL . 96.1 t -97.97 106.33 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.135 0.493 . . . . 0.0 111.056 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -132.2 -137.53 3.99 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.955 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.506 HD22 ' HE2' ' A' ' 87' ' ' PHE . 1.1 mp -139.18 112.67 8.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.298 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 81' ' ' ASP . 16.0 m -100.13 179.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.255 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -93.7 -166.2 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.552 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.02 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.404 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -75.13 -72.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.483 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 166.19 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.621 0.248 . . . . 0.0 111.413 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.69 135.88 3.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.9 tpp -119.56 123.91 45.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.652 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.58 21.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -160.4 89.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.854 HG21 ' HG3' ' A' ' 89' ' ' LYS . 7.3 p -89.67 149.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.418 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HE2' HD22 ' A' ' 76' ' ' LEU . 24.6 m-85 -98.69 -43.73 6.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.728 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.765 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.53 122.27 7.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.854 ' HG3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.59 132.89 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 2.6 m-85 -113.99 155.58 25.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.764 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 39.8 mt -134.66 110.32 9.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.558 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.64 134.37 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.589 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.13 97.11 2.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.49 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 1.001 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m-70 -37.28 -46.6 0.76 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.948 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.31 138.0 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 111.412 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.93 80.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' ARG . 10.9 pt-20 -67.38 -173.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.25 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 69.62 62.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.458 . . . . 0.0 110.509 -179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.31 150.71 23.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 8.8 p90 -146.83 140.74 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -138.28 157.42 46.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -151.41 138.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -114.91 110.22 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.096 178.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.908 ' CE3' HD12 ' A' ' 29' ' ' LEU . 91.2 m95 -92.42 149.25 21.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -176.95 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 ttp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -105.08 -10.8 16.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.683 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -87.4 -36.75 17.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.35 -53.23 60.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 HG23 ' HG2' ' A' ' 95' ' ' ARG . 2.0 mt -103.41 144.74 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.003 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 147.15 23.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.592 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -176.59 3.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.052 0.453 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 155.43 35.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.37 147.77 53.98 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.49 -54.89 4.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.543 2.162 . . . . 0.0 112.392 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.52 -28.93 68.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 16' ' ' ILE . 58.3 m -72.85 -44.95 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.39 89.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.62 -57.88 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.2 -45.98 5.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.232 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 12' ' ' THR . 5.6 mt -72.89 -39.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -61.15 -49.79 75.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.711 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.88 -43.62 77.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -35.37 77.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 17' ' ' ALA . 49.7 mt -66.24 -45.68 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.691 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 74' ' ' VAL . 7.2 t80 -54.33 -59.67 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.554 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.8 mm? -64.01 -14.5 54.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.159 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.7 -57.75 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.539 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -83.4 -38.49 21.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.6 151.11 8.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 0.0 111.516 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.762 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 148.52 -111.9 0.55 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.417 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -74.02 -3.64 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 1.3 m120 -98.46 -5.85 31.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.499 0.19 . . . . 0.0 111.213 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.735 HD23 HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -103.59 -25.44 13.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.732 0.301 . . . . 0.0 111.481 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 29' ' ' LEU . 12.6 t70 106.01 137.23 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.754 0.822 . . . . 0.0 111.441 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -43.41 -58.89 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.22 2.613 . . . . 0.0 113.044 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.34 -58.62 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.034 0.445 . . . . 0.0 111.137 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.71 ' C ' HD21 ' A' ' 29' ' ' LEU . 3.6 m-20 -57.32 -28.95 63.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' O ' ' A' ' 26' ' ' GLY . 52.9 mt -71.61 -49.82 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-O 121.301 0.572 . . . . 0.0 109.697 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.629 ' HG ' HD23 ' A' ' 39' ' ' LEU . 5.5 tp -45.85 -66.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.299 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.544 HD23 ' CZ ' ' A' ' 87' ' ' PHE . 28.6 tp -53.9 -35.02 61.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.337 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 2.7 t80 -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.16 -62.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.1 mm? -52.88 -23.54 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.622 ' O ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.3 115.64 8.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.273 0.558 . . . . 0.0 111.817 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' O ' ' HA3' ' A' ' 45' ' ' GLY . 15.5 t80 -169.79 -53.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.919 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -34.91 72.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.14 -46.85 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.262 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -119.55 53.85 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 111.116 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -119.22 120.4 4.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.727 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.77 137.37 6.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.716 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.31 126.04 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.889 0.376 . . . . 0.0 110.964 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.48 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.997 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 51.2 t80 -87.35 139.53 30.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -133.01 175.91 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.29 148.3 33.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 49.7 m -41.74 160.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.14 0.495 . . . . 0.0 111.574 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -99.67 -161.4 0.87 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.235 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.65 39.84 1.04 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.177 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 2.7 m-20 76.6 117.76 0.06 Allowed 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.703 ' HZ2' HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -125.88 44.98 2.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.718 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -58.72 70.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -155.41 -45.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.731 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.72 -68.01 0.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.419 0.628 . . . . 0.0 110.268 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -69.74 -50.88 45.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.389 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 96.14 72.85 1.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.303 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 60' ' ' ILE . 10.6 p 172.49 142.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.667 0.27 . . . . 0.0 110.577 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.99 123.22 7.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 111.347 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.901 HD11 ' CD1' ' A' ' 60' ' ' ILE . 27.6 mm -103.51 132.07 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.68 111.78 41.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.51 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 28.0 Cg_endo -63.1 152.97 76.82 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.406 2.071 . . . . 0.0 112.902 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 60.77 8.98 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.033 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -119.97 -13.71 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.561 0.22 . . . . 0.0 111.517 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.7 136.38 49.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 111.02 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -89.32 117.96 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.782 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.779 ' HG3' HG23 ' A' ' 50' ' ' VAL . 11.0 pt-20 -107.17 138.15 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.089 0.471 . . . . 0.0 111.336 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 17' ' ' ALA . 10.8 p -134.65 142.46 40.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -106.17 144.84 32.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 21' ' ' PHE . 48.9 t -128.7 101.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.5 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.37 -138.66 5.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.392 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.643 HD22 ' CE2' ' A' ' 87' ' ' PHE . 1.6 tp -143.59 51.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.329 0.585 . . . . 0.0 109.66 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 83' ' ' MET . 24.8 m -46.9 174.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.267 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -92.2 -161.31 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.667 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.22 -14.53 63.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.747 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.01 -85.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.497 0.189 . . . . 0.0 111.176 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' HG11 ' A' ' 77' ' ' VAL . 3.5 p-10 179.4 -35.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.592 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -45.71 137.11 5.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.754 0.311 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.592 ' HA ' HG12 ' A' ' 77' ' ' VAL . 49.7 ttm -119.8 121.15 38.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.17 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.26 -3.75 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.093 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -142.12 93.97 2.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -89.91 144.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.169 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.643 ' CE2' HD22 ' A' ' 76' ' ' LEU . 29.0 m-85 -89.66 -34.86 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.357 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -161.66 164.6 29.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.108 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 103' ' ' VAL . 4.9 mttt -126.4 144.82 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -125.05 165.94 17.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.703 HD21 ' HZ2' ' A' ' 56' ' ' TRP . 13.2 mt -147.82 123.77 10.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.378 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.58 HG22 ' HD2' ' A' ' 99' ' ' ARG . 2.2 mp -125.68 137.72 56.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 111.749 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 117.47 7.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -59.44 -37.78 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.226 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HG2' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -54.44 -179.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -111.37 -43.11 3.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.203 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 122.48 26.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.318 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 65.89 112.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 92' ' ' ILE . 2.9 tpp85 -114.47 132.13 56.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.905 0.383 . . . . 0.0 111.246 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.16 134.83 50.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 26.6 p90 -140.96 144.24 34.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.547 ' CD2' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -138.19 156.21 47.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.858 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.5 p -151.52 145.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.28 136.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.214 177.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.671 ' HE3' HD12 ' A' ' 29' ' ' LEU . 45.6 m95 -108.87 -104.13 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.739 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 153.33 6.69 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.235 0.471 . . . . 0.0 110.932 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptp . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.862 0.363 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.537 ' C ' HG23 ' A' ' 3' ' ' THR . 1.1 m -172.9 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.537 HG23 ' C ' ' A' ' 2' ' ' THR . 1.3 p 76.76 -147.28 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.367 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' N ' ' OG1' ' A' ' 3' ' ' THR . 15.1 mm-40 44.37 -168.86 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.934 0.397 . . . . 0.0 111.698 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mt -130.39 156.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.515 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.21 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 110.46 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 132.93 40.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.601 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.46 159.2 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.1 152.73 74.26 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.658 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.69 -60.21 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -65.96 -28.25 68.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -67.15 -54.21 23.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.69 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.88 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.6 mt -47.22 -36.5 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -67.03 -39.92 87.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.32 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.11 -62.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.779 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.46 -37.26 16.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.86 -54.74 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.409 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -31.77 56.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 17' ' ' ALA . 53.4 mt -62.08 -73.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CE2' ' CZ ' ' A' ' 41' ' ' PHE . 85.6 t80 -41.13 -30.35 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.817 0.342 . . . . 0.0 111.448 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.9 tp -64.98 -45.1 87.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.52 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.68 -29.02 11.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -51.48 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.92 105.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.275 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.46 -82.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.703 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.47 1.1 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 6.9 m120 -93.11 -28.53 16.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.845 HD12 ' CE3' ' A' ' 105' ' ' TRP . 3.7 tt -96.26 138.93 33.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.542 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -50.41 150.21 4.85 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.796 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 13.5 Cg_exo -70.21 25.02 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.342 2.694 . . . . 0.0 113.735 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.04 -67.04 1.01 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.239 0.542 . . . . 0.0 109.876 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.825 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.69 -21.69 41.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.763 178.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.564 HG13 HD22 ' A' ' 29' ' ' LEU . 39.9 mt -63.33 -41.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -61.77 -47.25 86.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.578 178.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -55.21 -40.61 70.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.254 179.144 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.8 t80 -58.32 -32.92 68.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.216 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -50.54 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.204 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.1 mm? -66.78 -39.13 87.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.27 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.17 -157.75 0.65 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 6.5 t80 83.85 -26.57 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -88.14 -33.2 18.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.482 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -105.86 -28.1 10.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.654 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 39.55 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.753 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 129.0 9.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.39 127.9 2.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.265 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 73' ' ' TRP . 40.0 t -127.02 112.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.4 173.82 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.697 ' CZ ' ' HB1' ' A' ' 70' ' ' ALA . 17.2 t80 -126.79 122.27 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 71' ' ' GLU . 30.3 m -120.8 -165.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -124.03 171.49 9.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 53' ' ' ALA . 57.1 m -60.11 161.63 6.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 52' ' ' THR . . . -113.56 -170.6 1.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 25.82 11.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.055 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -165.68 65.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.661 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.747 ' CH2' HD11 ' A' ' 91' ' ' LEU . 4.6 m95 -95.97 -29.0 14.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.289 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' CD ' HD22 ' A' ' 63' ' ' LEU . 43.0 mt-10 -69.27 64.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.182 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.74 -51.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HG3' ' CZ3' ' A' ' 56' ' ' TRP . 1.4 pm0 -78.27 -66.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.519 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 104' ' ' ILE . 29.2 pt -75.49 -38.97 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 0.0 111.429 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 83.28 81.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.601 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.47 148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 122.481 0.312 . . . . 0.0 110.344 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -58.86 126.54 28.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 63' ' ' LEU . 23.7 mm -125.68 94.9 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -70.47 117.5 55.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.6 152.35 74.18 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.113 1.875 . . . . 0.0 111.962 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 69.32 -1.02 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.34 -9.28 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.693 0.283 . . . . 0.0 111.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -132.75 130.9 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 49' ' ' PHE . . . -89.59 125.88 35.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.542 ' HA ' HD23 ' A' ' 91' ' ' LEU . 30.9 tt0 -103.78 113.95 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.27 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.42 144.11 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.131 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.594 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m0 -118.43 137.59 53.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.37 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 47' ' ' VAL . 51.4 t -122.95 106.29 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.426 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.32 -142.7 7.08 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.62 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.702 HD22 ' CZ ' ' A' ' 87' ' ' PHE . 2.6 tp -145.06 49.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.286 0.565 . . . . 0.0 110.057 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 78' ' ' ASN . 13.2 p -71.15 161.85 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.288 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.3 p30 -89.75 -140.43 0.14 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -75.01 -49.56 19.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.446 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 2.4 pt20 -52.17 -18.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' HG21 ' A' ' 77' ' ' VAL . 4.2 p-10 50.33 49.29 20.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.088 0.47 . . . . 0.0 111.216 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 77' ' ' VAL . 2.0 mt-10 -95.09 23.81 5.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.469 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' GLU . 1.7 tpt 29.68 95.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' CB ' ' A' ' 85' ' ' ASP . 4.4 t70 -144.15 49.9 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 164.03 82.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.441 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 5.3 p -88.94 135.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.702 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 5.7 m-85 -89.09 -47.88 7.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.601 0.715 . . . . 0.0 109.239 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -146.51 169.91 17.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -134.5 147.45 50.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.0 m-85 -126.28 144.24 50.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.747 HD11 ' CH2' ' A' ' 56' ' ' TRP . 21.1 mt -133.0 127.39 34.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.718 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 148.21 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 112.535 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -67.89 129.7 40.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.725 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.511 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 37.9 m-70 -75.15 -36.18 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -54.45 -178.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.6 pt-20 -104.17 -49.74 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.245 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -73.53 133.07 43.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER 58.45 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -123.13 111.37 16.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.85 132.24 53.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 9.8 p90 -123.33 140.15 53.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.0 p -150.3 141.26 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -111.11 135.71 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.845 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.2 m95 -109.56 148.61 30.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 153.93 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.898 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.828 0.347 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.59 -178.42 5.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.27 143.94 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.08 149.77 93.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.01 -53.34 7.14 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.558 2.172 . . . . 0.0 112.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -33.44 70.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.526 ' O ' HD12 ' A' ' 16' ' ' ILE . 4.4 m -65.47 -52.47 52.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -59.67 -48.02 83.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.87 -40.7 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.87 -55.37 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 12' ' ' THR . 3.3 mt -58.73 -53.44 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.233 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.885 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -57.32 -40.44 77.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.22 -49.2 70.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.776 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.86 -30.84 71.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.658 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.885 HD12 ' HA ' ' A' ' 17' ' ' ALA . 23.3 mt -72.63 -27.78 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.714 ' CD2' HG11 ' A' ' 74' ' ' VAL . 22.2 t80 -77.23 -27.91 53.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.32 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -34.1 38.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.534 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 13.1 pt-20 -92.08 -37.47 12.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.151 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.1 mtp -76.32 -50.57 13.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -45.59 96.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.484 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.05 -115.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 111.188 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.18 -25.74 67.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.91 HD12 ' CZ3' ' A' ' 105' ' ' TRP . 4.2 tt -94.89 150.44 20.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.007 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.87 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.09 137.22 97.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 34' ' ' ILE . 71.5 Cg_exo -49.16 -64.8 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.622 2.215 . . . . 0.0 112.985 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.17 -43.37 21.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.66 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.3 m-20 -66.15 -28.68 68.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.988 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 31' ' ' PRO . 18.4 mt -67.05 -47.16 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.278 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.3 tp -57.95 -60.75 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.616 HD11 ' NE2' ' A' ' 40' ' ' GLN . 12.5 tp -46.13 -44.37 15.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.516 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.456 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.7 t80 -64.22 -26.3 68.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.802 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.92 -38.02 33.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.399 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.512 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.3 mm? -83.68 -40.18 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.401 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.837 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.6 pt20 -121.75 106.24 11.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.22 0.533 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 76' ' ' LEU . 55.3 t80 -163.9 -38.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.025 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -63.34 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.645 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -27.93 64.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.784 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -120.88 59.1 0.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 110.502 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.62 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -91.73 134.6 12.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.564 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.03 123.82 2.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.21 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.893 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -150.35 68.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.414 . . . . 0.0 110.46 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.42 129.56 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.532 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' ' HB1' ' A' ' 13' ' ' ALA . 57.8 t80 -90.4 94.02 9.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 71' ' ' GLU . 10.8 m -90.04 178.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.916 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -104.51 -178.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 35.7 m -73.22 165.72 24.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 52' ' ' THR . . . -139.2 171.93 13.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.032 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.96 -28.7 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.89 46.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.34 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.879 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.1 m95 -92.14 -42.39 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.65 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.84 64.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -161.88 -48.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.451 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.87 -73.16 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.554 HG23 ' HZ3' ' A' ' 56' ' ' TRP . 15.2 pt -61.57 -30.12 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.612 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 93.17 45.92 3.43 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.975 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.612 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 179.5 132.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.02 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.3 pp -66.32 141.0 58.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 63' ' ' LEU . 37.2 mm -125.13 145.86 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -73.35 121.27 84.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.393 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 7.1 Cg_exo -69.9 162.37 42.4 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.114 1.876 . . . . 0.0 112.142 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.02 22.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -137.15 12.98 3.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.414 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -146.18 147.17 31.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.846 ' HB3' HG12 ' A' ' 92' ' ' ILE . . . -89.7 112.6 23.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.62 120.0 35.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.498 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.0 t -119.7 134.42 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.096 0.474 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 9.2 m0 -122.49 117.07 25.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.679 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.893 HG22 ' CG1' ' A' ' 47' ' ' VAL . 54.1 t -114.72 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -131.55 -135.16 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.967 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -139.79 125.88 19.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 45' ' ' GLY . 32.8 m -114.75 175.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 111.675 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -103.78 -164.18 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -3.06 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.464 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.0 -5.15 30.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.476 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.91 96.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.667 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -148.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 tpt -178.51 58.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.387 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.59 85.74 2.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.754 0.312 . . . . 0.0 110.964 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 p -89.88 135.59 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.797 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 9.1 m-85 -91.47 -49.72 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.025 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -148.32 139.1 22.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -112.44 132.45 55.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.631 0.253 . . . . 0.0 110.565 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.495 ' CD2' ' HB ' ' A' ' 103' ' ' VAL . 1.2 m-85 -110.19 145.78 36.67 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.879 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 92.8 mt -127.14 105.57 8.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.177 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -109.37 127.5 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.875 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.2 100.36 0.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.2 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 41.5 m-70 -37.09 -57.16 0.87 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.286 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -44.2 162.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.151 0.5 . . . . 0.0 111.847 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.1 pt-20 -86.0 -48.67 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -65.88 133.53 51.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.86 116.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -113.74 93.42 4.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.94 103.37 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -120.33 110.92 17.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.7 p80 -128.69 117.19 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.4 . . . . 0.0 111.148 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.495 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 7.2 p -98.1 150.27 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.32 130.08 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.91 ' CZ3' HD12 ' A' ' 29' ' ' LEU . 63.8 m95 -112.11 130.01 56.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.245 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.09 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.983 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 94' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.039 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -89.57 174.61 7.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.043 0.449 . . . . 0.0 111.358 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 147.13 62.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.94 -54.28 5.55 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.595 2.197 . . . . 0.0 112.338 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -30.06 69.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.6 m -68.36 -51.76 40.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.06 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.0 48.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.803 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -47.38 -33.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.797 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.02 -37.05 72.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 20' ' ' ILE . 13.8 mm -61.79 -62.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' CB ' HG11 ' A' ' 72' ' ' VAL . . . -52.13 -40.81 61.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.51 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -53.5 -57.3 11.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -61.43 -28.77 69.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 16' ' ' ILE . 77.8 mt -74.34 -25.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.857 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 37' ' ' PHE . 4.4 t80 -75.13 -51.89 12.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 110.47 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -65.71 -20.74 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.28 -46.89 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -80.15 -41.12 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.37 150.43 4.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.386 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.95 41.26 3.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.659 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -171.64 -29.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 33.1 t30 -115.94 -35.36 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.711 0.291 . . . . 0.0 111.003 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.767 HD23 HG13 ' A' ' 34' ' ' ILE . 2.8 tt -68.06 133.97 49.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -54.06 146.28 30.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.04 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.7 Cg_exo -47.64 -52.73 7.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.902 2.401 . . . . 0.0 113.017 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.4 48.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.58 ' CB ' HD21 ' A' ' 29' ' ' LEU . 74.1 m-20 -54.47 -32.0 56.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.767 HG13 HD23 ' A' ' 29' ' ' LEU . 91.2 mt -63.73 -47.79 89.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.054 0.455 . . . . 0.0 110.046 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -50.03 -57.48 7.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.617 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' GLN . 5.5 mp -63.28 -62.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -42.61 -30.03 0.33 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -82.19 -74.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.517 . . . . 0.0 111.771 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -69.32 -29.8 67.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.252 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' LEU . 1.6 tp-100 -90.98 25.3 2.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.829 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.1 t80 -102.83 -47.6 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -55.74 -42.47 75.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -39.02 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.936 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.1 mmt85 -130.39 80.89 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.32 107.38 0.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 146.66 17.48 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.127 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 74' ' ' VAL . 44.1 t -132.75 110.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.669 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.38 150.51 20.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 64.5 t80 -103.17 106.34 16.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.652 HG23 ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -105.79 -178.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.09 172.55 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 53' ' ' ALA . 7.6 m -65.38 164.71 13.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 52' ' ' THR . . . -128.11 162.46 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -98.45 36.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.12 33.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.687 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.9 m95 -80.36 -20.57 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.348 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.86 61.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 -47.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HG2' ' CE3' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -84.72 -64.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.687 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 14.0 pt -74.99 -27.59 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 70.76 79.22 0.38 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.792 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.64 ' CG1' HD12 ' A' ' 60' ' ' ILE . 6.9 p 164.53 139.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.671 0.272 . . . . 0.0 110.52 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -58.93 138.08 57.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.907 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 63' ' ' LEU . 26.9 mm -133.66 100.43 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.745 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.77 108.1 1.2 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.141 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.03 158.81 23.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.144 1.896 . . . . 0.0 112.366 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 76.03 -10.53 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.373 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -118.54 16.27 13.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.709 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 84.8 m-85 -138.79 132.25 30.33 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -90.75 112.55 24.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.797 ' OE1' HD21 ' A' ' 91' ' ' LEU . 7.8 tp10 -90.1 128.35 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.7 t -127.77 136.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.304 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 13.6 m0 -119.18 139.87 51.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.728 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 47' ' ' VAL . 13.4 t -129.37 110.58 20.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.643 ' C ' HD13 ' A' ' 76' ' ' LEU . . . -146.37 -155.34 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.757 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.992 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.17 50.47 1.09 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.724 0.297 . . . . 0.0 111.367 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 83' ' ' MET . 23.7 m -43.23 171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.204 0.526 . . . . 0.0 111.892 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -120.86 -165.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.96 -28.25 69.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -75.76 -31.0 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.29 27.73 1.06 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.367 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.51 22.85 6.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.8 ' HA ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 30.11 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.217 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -27.97 36.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.976 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.88 11.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -108.38 124.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.435 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.992 ' CE2' HD21 ' A' ' 76' ' ' LEU . 3.5 m-85 -89.2 -26.75 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.343 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.31 151.75 17.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -132.65 141.04 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.5 m-85 -120.93 148.4 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 71' ' ' GLU . 44.7 mt -132.76 117.89 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -125.0 140.26 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.09 0.471 . . . . 0.0 111.857 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 99' ' ' ARG . 3.1 p -69.49 122.08 18.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.777 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 36.8 m-70 -66.0 -32.22 73.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.287 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -55.74 177.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.71 -50.53 3.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.446 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -74.3 122.46 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.502 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.16 112.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.413 HH21 HG21 ' A' ' 16' ' ' ILE . 4.9 ttt-85 -120.71 114.88 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.702 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.58 134.95 42.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 23.5 p90 -127.08 140.26 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.612 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.09 153.29 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.118 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 11.4 p -150.17 137.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.802 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -115.56 130.25 70.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.601 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.2 m95 -108.75 150.64 27.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.997 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -64.05 161.06 16.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -117.57 125.37 50.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 12' ' ' THR . 1.9 mt -52.0 157.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.37 142.94 51.04 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.612 ' O ' HD12 ' A' ' 14' ' ' ILE . 77.7 Cg_exo -48.01 -57.28 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.529 2.153 . . . . 0.0 112.498 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -57.98 -41.54 83.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.67 HG22 HD11 ' A' ' 16' ' ' ILE . 11.9 m -52.94 -64.54 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -47.92 -46.4 31.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.786 0.327 . . . . 0.0 111.353 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -51.78 -43.87 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -39.26 71.03 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.046 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' THR . 5.1 mt -66.98 -66.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.848 0.356 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -48.7 -42.31 34.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -54.99 -50.84 68.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.21 -34.84 47.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.501 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.37 -69.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 30.1 t80 -41.43 -28.07 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.787 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -71.8 -45.35 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.702 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.72 -27.04 14.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 mtp -77.0 -46.44 23.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.734 0.302 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -57.4 -174.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.389 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 34' ' ' ILE . . . 56.81 32.02 61.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -157.84 -28.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.8 m120 -117.11 -19.85 9.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -98.37 161.68 13.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.745 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.4 p30 -62.23 133.14 94.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.689 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.84 ' HA ' HD12 ' A' ' 34' ' ' ILE . 79.2 Cg_exo -41.7 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.734 2.289 . . . . 0.0 113.075 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.16 37.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.723 ' CB ' HD22 ' A' ' 29' ' ' LEU . 42.7 t0 -56.41 -32.14 64.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.303 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.8 mt -61.56 -50.21 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.237 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.588 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -66.2 -48.79 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.208 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.627 HD13 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -57.47 -56.0 27.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.0 t80 -51.58 -26.16 8.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.989 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.57 -63.99 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 39' ' ' LEU . 1.4 mm? -67.4 -25.65 66.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.279 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HG3' HD13 ' A' ' 36' ' ' LEU . 31.1 mm-40 -101.91 -146.16 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 t80 70.61 -58.2 0.56 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.778 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.71 -37.12 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.8 -42.76 7.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 mmt-85 -119.08 52.14 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.83 133.06 11.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.42 113.16 0.72 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 74' ' ' VAL . 7.0 p -150.71 99.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -107.79 146.57 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.279 0.562 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 66.2 t80 -85.19 97.92 10.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.658 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 71' ' ' GLU . 3.0 m -89.96 176.89 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.374 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.747 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.95 163.22 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.32 13.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.11 -14.34 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.98 44.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.088 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.67 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 9.0 m95 -98.8 -29.8 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.915 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -68.27 61.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -162.63 -46.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.525 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -75.74 -78.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 64' ' ' ILE . 27.0 pt -71.65 -28.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.449 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.646 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 74.28 81.53 0.44 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.485 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.646 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.67 146.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 63' ' ' LEU . 3.0 pp -71.31 113.29 8.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.467 HG22 ' CD2' ' A' ' 69' ' ' TYR . 31.4 mm -109.31 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.192 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 8.6 m-20 -55.56 106.29 0.65 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 52' ' ' THR . 18.3 Cg_endo -60.25 157.12 36.73 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.108 1.872 . . . . 0.0 112.304 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 75.25 -9.24 1.42 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.348 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 1.8 pt-20 -120.13 19.83 12.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.574 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.467 ' CD2' HG22 ' A' ' 64' ' ' ILE . 75.5 m-85 -141.55 139.82 33.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.965 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.35 114.49 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.869 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -96.67 129.39 44.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.715 HG11 ' HB1' ' A' ' 17' ' ' ALA . 6.0 p -135.21 130.42 51.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.547 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 14.4 m0 -114.54 135.62 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 47' ' ' VAL . 16.6 t -127.63 111.14 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.986 0.422 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.12 -131.91 2.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.403 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.512 HD13 ' HE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -138.04 158.36 44.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -147.83 -177.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 111.306 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -118.53 -168.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.787 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -28.45 62.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.036 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.24 -14.56 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.439 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.51 72.6 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.43 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG12 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -140.82 148.82 41.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.28 105.78 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.26 -4.53 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.01 88.88 2.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.729 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.5 p -89.69 138.22 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.827 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.512 ' HE2' HD13 ' A' ' 76' ' ' LEU . 16.9 m-85 -89.39 -48.94 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.9 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.692 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -138.65 166.11 25.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.729 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -146.34 135.75 22.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.8 m-85 -126.98 144.02 51.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.905 HD12 ' CE1' ' A' ' 102' ' ' HIS . 3.1 mt -131.67 124.02 29.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -130.24 142.85 42.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 112.273 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.8 p -65.09 120.29 12.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.936 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.965 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 89.2 m-70 -62.74 -24.7 67.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -54.06 174.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.67 -65.49 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -71.64 131.52 43.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.2 112.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.33 115.98 21.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.354 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.12 120.93 38.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.103 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.42 ' HB3' HG22 ' A' ' 92' ' ' ILE . 19.5 p90 -124.5 143.85 50.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.327 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.905 ' CE1' HD12 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -143.76 168.95 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.351 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 13.4 p -151.05 143.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.471 HG21 ' HE3' ' A' ' 89' ' ' LYS . 3.9 mp -112.6 110.55 32.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.338 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.692 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 55.7 m95 -96.26 149.33 21.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 110.967 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.01 155.53 32.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.938 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.802 0.334 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -139.79 -178.42 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.007 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 12' ' ' THR . 1.9 mt -111.91 139.4 47.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.82 149.31 95.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.538 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.41 -59.79 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.437 2.091 . . . . 0.0 112.415 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -24.87 65.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 16' ' ' ILE . 92.7 m -76.16 -43.34 43.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.24 -29.37 70.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -79.83 -58.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -41.4 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.641 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -70.27 -43.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.079 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -64.11 -45.32 89.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.015 0.436 . . . . 0.0 110.356 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -51.35 -46.82 62.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -61.72 -27.91 69.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.479 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 17' ' ' ALA . 51.8 mt -75.12 -30.91 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.6 t80 -68.41 -51.28 45.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.14 -16.52 63.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.662 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 2.7 tp10 -94.13 -51.14 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.656 0.265 . . . . 0.0 111.511 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.411 ' CE ' HG12 ' A' ' 103' ' ' VAL . 15.4 mtp -74.61 -44.37 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -48.68 162.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.521 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.01 54.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.553 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -151.29 -33.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.62 0.248 . . . . 0.0 111.632 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.2 t30 -126.69 -39.18 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.723 0.297 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.891 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.5 tt -55.56 139.23 44.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.891 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -57.26 136.71 81.12 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.755 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 76.8 Cg_exo -48.51 -51.92 9.41 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.0 113.297 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.59 -58.74 5.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.085 0.469 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.625 ' CB ' HD21 ' A' ' 29' ' ' LEU . 68.3 m-20 -51.69 -29.95 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.841 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 38' ' ' ASN . 57.5 mt -69.09 -47.79 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 39' ' ' LEU . 1.2 tp -45.18 -59.64 2.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.666 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 8.8 mt -56.91 -47.31 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.254 0.55 . . . . 0.0 110.241 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HZ ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -48.25 -51.66 24.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.434 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.724 HD21 HG22 ' A' ' 34' ' ' ILE . 1.8 p30 -80.3 -40.79 26.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.847 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.6 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -72.73 -9.41 58.61 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 8.9 mm-40 -126.91 -137.52 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.939 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' HA2' ' A' ' 46' ' ' GLY . 2.6 t80 72.15 -56.09 0.65 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.796 0.332 . . . . 0.0 111.617 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -51.82 -39.64 59.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.14 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 27.44 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.673 ' HB3' HD12 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -131.89 -4.06 3.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA3' HG22 ' A' ' 77' ' ' VAL . . . 135.83 163.2 9.88 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.56 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA2' ' CE1' ' A' ' 41' ' ' PHE . . . -125.19 -115.02 2.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.792 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 73' ' ' TRP . 59.6 t -132.43 136.98 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.969 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -122.99 131.78 53.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 17.3 t80 -88.74 113.0 23.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.094 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 71' ' ' GLU . 34.5 m -107.69 -176.88 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -98.38 170.61 8.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 111.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.3 m -70.06 157.28 37.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.95 -156.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.136 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.1 -42.14 11.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.45 129.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.767 ' O ' HG12 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -162.42 150.54 14.4 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.415 0.626 . . . . 0.0 110.304 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.04 32.48 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.219 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -113.64 -25.34 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.226 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.87 -54.57 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.622 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.2 pt -75.91 -44.82 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.789 0.328 . . . . 0.0 110.952 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 104.41 54.37 0.79 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.107 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.455 HG12 HD12 ' A' ' 60' ' ' ILE . 14.8 p 175.95 140.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 120.927 0.394 . . . . 0.0 111.467 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.86 138.62 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 56' ' ' TRP . 37.2 mm -111.26 128.35 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -104.55 112.11 65.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 30.6 Cg_endo -63.92 156.08 60.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.345 2.03 . . . . 0.0 112.043 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 4.1 pt-20 54.87 9.92 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.938 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -132.37 -5.33 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -126.12 143.56 51.08 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.798 0.332 . . . . 0.0 110.645 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -96.01 128.73 43.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.686 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -111.98 117.36 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.751 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 t -119.39 129.35 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.9 m0 -105.6 143.91 33.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.765 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 47' ' ' VAL . 42.9 t -137.23 101.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.207 0.527 . . . . 0.0 110.934 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . . . -152.65 -120.03 0.82 Allowed Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.359 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 44' ' ' ARG . 1.9 mm? -142.31 146.8 35.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 83' ' ' MET . 3.6 m -115.86 178.35 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.28 -165.72 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -22.42 66.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -80.88 -81.13 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 77' ' ' VAL . 1.0 OUTLIER 173.54 -34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -56.04 132.42 50.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.033 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.533 ' HA ' HG12 ' A' ' 77' ' ' VAL . 36.2 ttm -88.99 79.35 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -6.55 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.88 83.21 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.301 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 86' ' ' VAL . 2.0 p -89.69 126.96 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.074 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.2 m-85 -89.37 -32.49 17.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.227 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.34 148.98 15.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -113.44 141.72 46.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.4 m-85 -117.83 141.68 48.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.091 0.472 . . . . 0.0 111.596 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 64' ' ' ILE . 25.0 mt -125.2 156.17 38.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.605 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.932 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -163.8 117.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.998 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.69 104.63 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.822 ' HE1' ' HB2' ' A' ' 70' ' ' ALA . 23.9 m-70 -51.9 109.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 0.0 111.244 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -166.25 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 18.7 pt-20 -138.02 -54.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.373 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -85.23 -0.23 53.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.418 0.628 . . . . 0.0 111.306 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -162.0 102.84 1.14 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -126.48 120.86 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -108.5 112.1 24.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.467 ' HB2' HG23 ' A' ' 92' ' ' ILE . 1.9 p90 -118.98 139.3 51.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.504 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -148.65 171.22 16.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.046 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' LYS . 8.1 p -152.05 143.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.62 142.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.378 177.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.878 ' CE3' HD12 ' A' ' 29' ' ' LEU . 65.6 m95 -113.31 149.09 34.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 159.71 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.784 0.326 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -140.21 -177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.11 144.94 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.9 148.2 71.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.92 -53.26 7.29 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.531 2.154 . . . . 0.0 112.354 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.83 -29.96 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -65.93 -56.3 12.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -56.69 -46.62 81.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.4 mt -55.87 -42.98 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.01 -52.94 63.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 13' ' ' ALA . 3.4 mt -60.57 -59.74 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -49.03 -34.57 13.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.276 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -62.16 -54.08 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.68 -31.56 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' A' ' 24' ' ' MET . 55.6 mt -68.57 -71.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.786 ' CD2' HG11 ' A' ' 74' ' ' VAL . 41.3 t80 -40.62 -30.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.792 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.67 -39.13 58.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.852 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.51 -34.62 14.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.746 ' HG2' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -84.61 -35.95 22.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -62.59 129.99 43.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.24 44.69 0.47 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.629 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -176.04 -24.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -120.8 -35.1 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.781 HD23 HG13 ' A' ' 34' ' ' ILE . 2.7 tt -64.47 139.6 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -44.32 139.21 3.39 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.994 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 4.1 Cg_endo -46.51 -52.51 7.3 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.961 2.441 . . . . 0.0 112.841 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.3 -57.44 10.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.693 ' CB ' HD21 ' A' ' 29' ' ' LEU . 4.2 m-20 -53.97 -28.32 36.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.781 HG13 HD23 ' A' ' 29' ' ' LEU . 74.2 mt -65.79 -46.28 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.001 0.429 . . . . 0.0 110.009 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.604 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.47 -54.54 44.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.038 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.06 -59.85 4.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -47.3 -30.63 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.995 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.07 -45.23 18.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.816 0.341 . . . . 0.0 111.42 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.604 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -76.05 -79.1 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.999 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -80.95 84.52 6.41 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -133.31 -30.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.685 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.31 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.01 -39.51 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.483 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.5 mpt_? -72.56 -40.43 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.132 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.15 113.46 3.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.188 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.97 151.17 21.6 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 74' ' ' VAL . 47.8 t -134.69 104.88 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 117.027 0.413 . . . . 0.0 110.961 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -94.38 147.42 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 72' ' ' VAL . 56.4 t80 -97.01 134.26 40.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -131.45 177.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.915 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.32 148.45 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 111.133 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 53' ' ' ALA . 88.4 m -45.55 165.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 52' ' ' THR . . . -117.06 -170.08 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.21 40.56 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -178.65 45.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.913 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 2.5 m95 -72.01 -19.75 61.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.444 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.32 63.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -148.97 -57.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.16 -61.03 1.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.473 HD11 HG13 ' A' ' 64' ' ' ILE . 33.8 pt -86.15 -23.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.406 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.03 -54.74 3.65 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.092 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.564 HG13 HD11 ' A' ' 64' ' ' ILE . 8.1 p -51.11 153.75 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.861 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -76.29 135.9 39.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.408 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 62' ' ' VAL . 20.1 mm -130.98 116.6 34.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 111.626 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.23 122.44 87.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 29.1 Cg_endo -64.11 153.44 76.22 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.283 1.989 . . . . 0.0 112.257 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.71 3.84 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.654 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -111.2 -16.12 13.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.712 0.292 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.73 154.83 40.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -106.27 122.83 47.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.226 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HG3' HG23 ' A' ' 50' ' ' VAL . 9.6 pt-20 -114.6 144.59 43.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.08 0.467 . . . . 0.0 111.631 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 49' ' ' PHE . 1.6 t -142.96 142.92 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 39.9 m0 -114.91 140.95 48.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.786 HG11 ' CD2' ' A' ' 21' ' ' PHE . 72.3 t -126.29 114.86 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 85' ' ' ASP . . . -150.65 -146.93 4.43 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.226 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.891 HD21 ' CE2' ' A' ' 87' ' ' PHE . 1.5 mm? -119.61 153.51 35.37 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -154.98 -168.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.857 0.36 . . . . 0.0 111.053 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -107.97 -156.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.486 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.86 -10.17 55.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.459 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -71.79 -8.75 56.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.577 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.58 78.09 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.813 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -148.37 -148.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.4 tpp -142.51 -82.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.021 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 44.12 41.01 3.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 169.31 78.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 p -90.04 134.94 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.804 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.891 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -92.73 -45.81 7.86 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -136.84 162.79 32.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.563 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' HG13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -138.14 140.14 39.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.5 m-85 -120.93 154.25 36.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.913 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 72.7 mt -139.97 121.16 14.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.646 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -135.6 125.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.029 0.442 . . . . 0.0 111.847 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 p -53.94 125.98 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.946 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -55.56 -41.46 73.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.146 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -56.66 143.85 34.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -32.61 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 154.14 42.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.678 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.31 -67.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.19 84.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.06 123.18 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.772 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -119.16 139.1 52.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.8 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.84 129.14 25.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.518 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 24' ' ' MET . 11.4 p -122.48 140.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.581 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.44 131.88 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.664 ' HE3' HD12 ' A' ' 29' ' ' LEU . 28.1 m95 -108.62 149.84 28.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 0.2 OUTLIER -61.47 159.49 12.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.858 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.918 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.984 0.421 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -125.45 116.82 22.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.839 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.31 10.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.79 160.06 29.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -57.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.674 2.249 . . . . 0.0 112.171 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -31.19 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -64.81 -47.3 78.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.915 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -63.81 -50.66 68.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.4 mt -49.09 -36.58 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -38.18 72.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.722 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.9 mt -67.35 -63.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.1 -39.8 21.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.079 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.507 ' HD1' HG21 ' A' ' 47' ' ' VAL . 30.8 t80 -55.7 -51.38 67.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.191 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -30.06 70.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 17' ' ' ALA . 96.3 mt -64.27 -46.51 93.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -63.45 -52.16 62.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.447 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -59.19 -22.68 61.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.404 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 1.3 pp20? -103.94 -48.43 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 4.1 mtp -67.44 -57.41 6.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . . . -45.94 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.026 0.441 . . . . 0.0 111.79 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -48.11 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.98 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -146.19 23.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.778 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 7.1 m-80 -102.89 -48.09 4.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.0 tt -87.84 143.14 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.845 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.798 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.99 150.96 0.55 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.3 Cg_endo -53.45 -19.45 13.4 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.595 2.197 . . . . 0.0 112.592 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.23 72.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.459 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -74.5 -28.65 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.419 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.0 mt -59.17 -50.14 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.926 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -74.04 -42.91 59.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 87' ' ' PHE . 1.4 tp -57.7 -64.46 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.4 . . . . 0.0 110.491 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 5.2 m-85 -45.41 -29.87 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.163 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.548 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.77 -9.63 21.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.486 HE21 HD21 ' A' ' 76' ' ' LEU . 20.7 pt20 -151.35 116.1 5.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 112.322 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' CA ' ' A' ' 45' ' ' GLY . 11.1 t80 -169.75 -38.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.938 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.48 -65.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -40.08 88.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.576 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -95.89 28.37 3.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.088 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 41' ' ' PHE . . . -94.9 120.84 6.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.606 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.34 98.22 0.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.303 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 74' ' ' VAL . 21.4 t -94.18 97.27 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.65 137.43 35.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.822 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 75.2 t80 -92.2 116.39 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -168.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -135.3 153.7 51.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 22.4 m -56.14 162.33 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.076 0.465 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB3' ' HD1' ' A' ' 56' ' ' TRP . . . -105.45 -151.24 0.45 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.042 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.96 31.24 0.98 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.766 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 79.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.697 ' HD1' ' HB3' ' A' ' 53' ' ' ALA . 7.7 p-90 -97.87 46.95 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.433 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER -69.04 61.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.47 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -130.41 -39.22 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.45 -38.3 12.65 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.685 HD11 ' CD1' ' A' ' 64' ' ' ILE . 4.7 pt -95.27 -26.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.049 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 90.73 -46.46 2.94 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.299 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -62.43 159.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.941 0.401 . . . . 0.0 111.764 -178.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -78.27 135.24 37.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.627 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.685 ' CD1' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.76 90.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.372 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 1.2 m-20 -75.79 113.52 27.88 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 5.7 Cg_exo -41.36 -72.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.194 2.596 . . . . 0.0 114.524 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -74.61 8.87 2.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 65' ' ' ASP . 8.3 mt-10 -121.34 -14.44 8.29 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.623 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.4 145.0 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.122 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -112.75 140.47 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.643 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -112.57 139.36 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.404 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.0 t -139.51 138.35 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.953 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -120.14 131.98 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.008 0.433 . . . . 0.0 111.162 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 47' ' ' VAL . 53.6 t -121.83 113.01 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.39 -124.15 2.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.216 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.486 HD21 HE21 ' A' ' 40' ' ' GLN . 2.4 tp -146.94 71.64 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.052 0.453 . . . . 0.0 109.857 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 82' ' ' GLU . 33.7 m -55.45 173.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 0.0 112.096 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -147.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.717 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 -5.44 16.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.8 34.65 5.12 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.664 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.31 87.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.742 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.3 mt-10 -156.43 155.98 33.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.881 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.2 tpp -142.63 104.1 4.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.285 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.77 -18.58 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.263 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.68 109.19 11.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.949 0.404 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.56 137.11 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 22.7 m-85 -89.56 -33.6 16.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.724 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 172.93 17.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.437 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.879 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.6 mttm -130.57 147.37 52.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.2 m-85 -125.45 134.57 52.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 112.026 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.594 HD12 ' CE1' ' A' ' 102' ' ' HIS . 15.0 mt -122.41 136.05 54.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.775 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -149.94 116.74 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.081 0.467 . . . . 0.0 111.835 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.7 m -46.99 149.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 19.5 m-70 -89.78 23.06 2.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -92.73 165.52 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.81 -59.27 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.09 121.24 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.395 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.19 110.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.05 140.1 47.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.944 0.402 . . . . 0.0 111.228 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.9 141.85 36.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.36 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 92' ' ' ILE . 30.6 p90 -138.15 142.03 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.594 ' CE1' HD12 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -144.24 130.67 19.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.211 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -119.94 140.53 43.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.84 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.31 135.2 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.784 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 38.5 m95 -106.93 147.49 29.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.62 155.92 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -93.45 -170.95 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.65 144.71 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 147.83 79.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.74 -49.52 16.96 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.565 2.177 . . . . 0.0 112.347 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -30.25 65.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -66.44 -49.76 65.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -65.01 -44.14 90.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.021 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.4 mt -59.79 -34.43 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -44.09 76.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 13' ' ' ALA . 5.0 mt -64.97 -54.78 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.88 -40.55 73.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.21 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.48 -52.04 66.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.56 -32.04 71.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 17' ' ' ALA . 19.4 mt -73.71 -28.75 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 32.5 t80 -77.26 -25.77 51.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.368 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.1 tp -78.11 -32.63 50.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.254 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.01 -38.18 9.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.174 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -75.95 -50.11 15.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.63 0.252 . . . . 0.0 111.577 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -49.12 111.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.406 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.41 -96.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.852 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.95 -4.48 52.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.1 m120 -90.54 -31.45 16.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.661 HD12 ' HE3' ' A' ' 105' ' ' TRP . 2.5 tt -92.66 139.27 30.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.65 132.9 13.94 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.976 -178.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.63 ' HA ' HD12 ' A' ' 34' ' ' ILE . 84.4 Cg_exo -42.07 -56.6 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.261 2.641 . . . . 0.0 113.627 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 -57.22 5.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 0.0 110.76 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.5 m-20 -49.95 -27.13 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.978 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 31' ' ' PRO . 51.3 mt -68.57 -53.48 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.129 0.49 . . . . 0.0 110.234 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -49.75 -60.38 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.181 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.53 HD12 ' NE2' ' A' ' 40' ' ' GLN . 4.5 mm? -51.05 -40.29 57.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.074 0.464 . . . . 0.0 110.664 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.5 t80 -64.97 -32.63 74.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.423 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.57 -39.12 28.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -79.18 -40.75 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.751 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.53 ' NE2' HD12 ' A' ' 36' ' ' LEU . 8.9 pt20 -128.98 106.38 8.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 111.811 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 34.6 t80 -165.02 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.232 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -31.75 72.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.281 0.563 . . . . 0.0 110.09 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.7 -22.65 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.113 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.761 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -130.36 31.99 4.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.997 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.09 114.14 2.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.773 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.94 165.94 22.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.115 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 73' ' ' TRP . 48.3 t -146.0 122.43 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.764 0.282 . . . . 0.0 110.57 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.38 164.07 13.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.346 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.814 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 16.0 t80 -106.8 108.16 19.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG23 ' CG ' ' A' ' 71' ' ' GLU . 3.2 m -103.8 -178.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.39 -175.62 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 53' ' ' ALA . 89.9 m -91.12 162.34 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' THR . . . -82.07 -160.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.26 -45.48 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.8 127.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.839 ' CH2' HD11 ' A' ' 91' ' ' LEU . 15.9 m0 -87.42 -75.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.533 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 1.5 mm-40 43.57 31.24 0.42 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -155.43 -37.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.865 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.551 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 24.1 mm-40 -82.12 -74.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 64' ' ' ILE . 19.1 pt -82.13 -46.86 19.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.259 . . . . 0.0 111.67 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 119.67 69.32 0.31 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.6 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 64' ' ' ILE . 13.0 p 175.57 151.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -64.91 -5.98 7.34 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.775 HD13 HG13 ' A' ' 62' ' ' VAL . 6.9 mm 59.19 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.209 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -112.92 82.35 5.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.902 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 35.8 Cg_exo -53.05 168.02 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.961 1.774 . . . . 0.0 111.837 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 56.25 12.47 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 27.7 mt-10 -135.15 -3.41 2.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.348 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 84.4 m-85 -132.11 142.26 49.45 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.814 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -91.02 124.06 34.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.888 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.713 ' CG ' HG23 ' A' ' 50' ' ' VAL . 6.1 tp10 -99.34 119.91 38.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.66 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.65 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -122.8 137.03 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.109 0.48 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.785 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m0 -115.17 141.01 48.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 47' ' ' VAL . 28.1 t -129.64 103.74 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.964 0.412 . . . . 0.0 111.356 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.44 20.56 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.703 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -102.32 153.16 20.27 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.824 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -150.11 -167.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.699 0.285 . . . . 0.0 110.778 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.426 ' H ' HG12 ' A' ' 77' ' ' VAL . 29.7 m-80 -103.62 -170.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -79.54 -13.35 59.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -74.26 -5.05 39.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.534 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.36 88.82 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.412 . . . . 0.0 111.017 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.824 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -151.46 -168.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.38 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.402 ' HE1' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -160.06 91.61 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.362 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -118.74 -9.93 10.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.137 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.74 84.75 2.26 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.958 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 73' ' ' TRP . 1.5 p -89.91 140.49 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -98.52 -29.7 12.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.9 167.95 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 103' ' ' VAL . 17.1 ttpt -142.44 139.77 31.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.5 m-85 -122.73 145.89 48.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.839 HD11 ' CH2' ' A' ' 56' ' ' TRP . 94.3 mt -124.52 119.35 28.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.188 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -130.08 122.35 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.819 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -55.95 118.46 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.498 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -56.39 -38.67 71.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -59.66 176.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.965 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -32.33 10.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.037 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -79.67 150.39 30.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.717 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 40.53 31.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.206 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.06 103.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.072 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -117.83 137.26 52.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.067 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 12.3 p90 -134.81 137.94 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.547 ' ND1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -139.17 159.49 42.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.439 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' LYS . 7.3 p -151.02 142.71 16.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.594 HD11 ' HE3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.52 140.95 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.066 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.703 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 32.9 m95 -116.99 149.88 39.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 158.63 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.883 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -112.93 127.15 56.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.013 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.46 142.54 57.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.586 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -46.28 169.6 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.706 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.79 -59.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.95 2.433 . . . . 0.0 112.287 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.19 -28.53 68.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -57.18 -57.49 12.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.834 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.87 -52.1 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 49' ' ' PHE . 53.0 mt -45.04 -36.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.999 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.13 -39.89 75.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.557 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 20' ' ' ILE . 29.8 mm -61.87 -64.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.808 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.813 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -47.96 -41.42 24.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -51.52 -54.82 23.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.206 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -25.76 67.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.357 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 17' ' ' ALA . 70.1 mt -75.95 -23.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.697 ' CG ' HG11 ' A' ' 74' ' ' VAL . 33.0 t80 -80.02 -32.49 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.426 . . . . 0.0 110.615 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD13 ' HZ ' ' A' ' 37' ' ' PHE . 3.0 mm? -80.33 -19.57 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.72 -41.12 6.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 20' ' ' ILE . 22.7 mtp -78.5 -45.05 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -61.14 159.72 11.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.341 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.05 40.04 4.69 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.566 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.3 -21.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.9 m-80 -110.35 -43.79 3.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.776 0.322 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.0 tt -75.94 151.74 37.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.03 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.863 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -48.37 155.13 0.98 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 44.6 Cg_exo -56.93 -30.64 86.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.793 2.329 . . . . 0.0 112.711 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.04 -58.61 5.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 111.373 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.672 ' OD2' HD13 ' A' ' 29' ' ' LEU . 46.2 t0 -64.5 -27.87 69.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.382 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 87.2 mt -60.04 -43.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.435 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.579 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -80.16 -44.11 20.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -62.8 -70.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.485 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.571 ' HZ ' HD13 ' A' ' 22' ' ' LEU . 1.3 t80 -48.48 -26.11 1.99 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.561 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.09 -52.15 11.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -69.98 -72.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.372 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.573 ' NE2' HD21 ' A' ' 76' ' ' LEU . 20.2 pt20 -77.19 -135.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 14.8 t80 87.51 -27.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.896 0.379 . . . . 0.0 110.622 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.35 -65.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.16 -30.56 11.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -24.23 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.58 128.24 8.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.686 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.08 153.18 24.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.114 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 73' ' ' TRP . 62.5 t -139.09 125.68 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.643 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 pt-20 -108.8 157.51 18.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.82 114.59 27.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 71' ' ' GLU . 12.8 m -113.7 -177.3 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -111.42 168.06 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.58 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.3 m -54.06 154.75 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.825 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -86.42 -163.53 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -95.43 37.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.887 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 3.0 t0 80.12 109.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.825 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -134.97 30.07 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.481 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 77.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' TRP . 4.0 mt-10 -154.87 -34.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.349 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.21 -49.66 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.97 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 64' ' ' ILE . 4.1 pt -70.69 -36.67 66.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 0.0 110.978 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.64 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 94.26 60.24 1.12 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.092 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.64 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.42 141.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.03 135.87 52.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 60' ' ' ILE . 6.9 mm -105.54 128.01 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 111.538 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.68 109.94 39.3 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.385 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.95 156.08 51.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.244 1.962 . . . . 0.0 112.111 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 62.04 8.28 2.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.87 -4.35 8.6 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.58 0.229 . . . . 0.0 111.427 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -148.01 135.35 20.54 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.945 0.402 . . . . 0.0 111.443 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.04 123.45 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.994 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.462 ' CG ' HG23 ' A' ' 50' ' ' VAL . 23.1 tt0 -101.7 119.66 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.946 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 48' ' ' GLU . 7.0 p -127.91 124.34 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.72 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.83 ' O ' HG13 ' A' ' 47' ' ' VAL . 24.9 m0 -89.84 141.74 28.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.697 HG11 ' CG ' ' A' ' 21' ' ' PHE . 88.7 t -129.32 96.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.5 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.88 -141.31 3.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.363 -0.923 . . . . 0.0 113.853 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.573 HD21 ' NE2' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -142.34 172.09 13.16 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 78' ' ' ASN . 6.2 t -153.67 163.93 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.503 ' N ' HG12 ' A' ' 77' ' ' VAL . 5.3 m-80 -89.45 -152.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -91.64 26.1 2.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 82' ' ' GLU . 5.8 pt20 -108.94 -0.4 19.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.443 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.18 38.15 28.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.749 0.309 . . . . 0.0 111.574 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 5.3 mm-40 -98.26 -158.37 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.387 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -163.44 32.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.71 0.69 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.31 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.65 73.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.979 0.419 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.88 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 8.4 m-85 -89.72 -41.66 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.99 162.46 39.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.573 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.791 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.9 mttt -118.26 143.71 46.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 3.2 m-85 -124.04 136.77 54.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.076 0.465 . . . . 0.0 112.199 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.519 ' C ' HD13 ' A' ' 92' ' ' ILE . 24.4 mt -121.27 124.32 44.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.858 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.698 HG22 ' NH2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -119.27 122.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.29 127.74 33.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.022 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.989 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.7 m-70 -75.78 -4.47 40.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.729 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.34 116.89 24.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -40.36 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.268 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 149.24 46.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.66 -65.57 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.698 ' NH2' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 61.91 92.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' N ' ' NH1' ' A' ' 99' ' ' ARG . 7.7 mm-40 -113.91 145.83 40.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.517 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 39.7 p90 -137.82 143.82 41.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.901 0.381 . . . . 0.0 111.817 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.67 150.47 46.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 89' ' ' LYS . 10.9 p -150.17 142.31 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.849 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.69 138.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 178.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 46.4 m95 -113.86 147.03 39.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.15 152.01 41.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.728 0.299 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -177.38 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.49 159.33 26.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.29 146.82 38.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.795 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.94 -54.51 5.33 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.696 ' HA ' HD12 ' A' ' 14' ' ' ILE . 6.3 p-10 -67.13 -33.63 75.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.032 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 16' ' ' ILE . 86.8 m -68.15 -46.55 70.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.77 76.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.797 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 11' ' ' ASP . 48.2 mt -61.76 -58.07 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.03 -31.17 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.117 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 12' ' ' THR . 3.4 mm -70.25 -59.07 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB3' HG11 ' A' ' 72' ' ' VAL . . . -61.67 -47.2 86.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.2 -45.0 65.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -62.6 -40.19 96.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.825 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.4 mt -77.44 -15.92 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 72.2 t80 -73.07 -61.98 1.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.24 -4.89 38.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.03 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.1 tt0 -96.75 -52.33 3.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.812 0.339 . . . . 0.0 110.991 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.437 ' O ' ' C ' ' A' ' 25' ' ' ALA . 2.1 ttp -75.07 -37.12 61.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 21' ' ' PHE . . . -27.62 141.53 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.145 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.72 -86.01 0.4 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -71.75 69.08 0.65 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 169.17 -43.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.773 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.906 HD12 ' CE3' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -86.61 161.47 18.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.094 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.832 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -86.89 149.99 49.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.973 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.1 Cg_endo -50.95 -55.01 4.49 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.033 2.489 . . . . 0.0 113.336 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.29 -59.4 4.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.79 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.788 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -56.36 -24.22 42.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 40.5 mt -71.97 -39.46 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.056 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.4 tt -59.83 -52.68 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -57.18 -46.6 82.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.243 0.544 . . . . 0.0 110.473 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 1.9 t80 -55.03 -23.06 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.773 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB2' HD22 ' A' ' 39' ' ' LEU . 22.1 m120 -80.59 -41.01 24.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -104.11 14.13 31.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB2' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -147.68 23.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.085 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.5 t80 -112.1 -12.81 13.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.177 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.92 -35.26 17.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.19 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.82 -24.78 9.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.876 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.443 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 27.66 8.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.671 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.71 110.12 3.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.025 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.47 140.67 11.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.682 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.76 140.38 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.925 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -125.53 131.01 52.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.981 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 70.7 t80 -73.32 114.88 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.46 -173.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -114.08 -175.75 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.667 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 53' ' ' ALA . 32.9 m -93.47 161.78 14.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -85.23 -153.35 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.96 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.43 -45.1 10.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 3.4 p-10 172.11 93.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.77 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -107.84 47.65 0.88 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 64.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.368 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -151.44 -41.44 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.07 -55.2 5.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.75 HD11 ' CD1' ' A' ' 64' ' ' ILE . 9.3 pt -84.34 -13.72 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.323 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 63.49 77.5 0.22 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 169.76 149.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.32 . . . . 0.0 110.76 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 125.4 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.75 ' CD1' HD11 ' A' ' 60' ' ' ILE . 7.4 mm -100.72 145.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -143.2 95.78 5.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.245 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 7.3 Cg_endo -49.54 160.41 1.06 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.465 2.11 . . . . 0.0 112.197 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.57 -59.25 0.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.548 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.59 -28.99 15.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.074 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.36 146.84 47.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -99.52 140.17 34.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.258 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 50' ' ' VAL . 5.8 tp10 -105.74 129.75 53.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.01 0.433 . . . . 0.0 111.461 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.761 HG11 ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -131.6 123.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.16 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.561 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 17.0 m0 -106.43 145.74 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.587 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 4.8 t -127.28 101.96 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.13 -143.49 9.05 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.591 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 40' ' ' GLN . 2.1 tp -138.96 61.48 1.57 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.401 0.62 . . . . 0.0 110.18 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 6.9 m -47.33 174.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.612 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -130.95 -131.51 0.2 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.983 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -77.81 -22.12 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -90.23 0.21 Allowed 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.131 -0.356 . . . . 0.0 111.653 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 77' ' ' VAL . 2.6 p30 -173.51 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.93 104.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 110.328 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.657 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 6.5 ptp -50.14 -26.03 4.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.478 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.73 -20.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -157.32 131.09 8.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.48 135.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.624 ' CE2' HD22 ' A' ' 76' ' ' LEU . 9.1 m-85 -89.44 -35.84 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -157.79 163.38 38.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.301 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.903 ' O ' HG23 ' A' ' 103' ' ' VAL . 1.4 mttt -132.38 147.1 52.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -134.61 135.46 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.799 ' C ' HD13 ' A' ' 92' ' ' ILE . 3.0 mt -120.54 131.13 54.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.082 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.799 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -132.97 136.59 55.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -63.92 128.85 37.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.669 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.458 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 22.3 m-70 -72.85 -25.14 61.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.321 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.69 156.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.67 -61.33 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ASP . 11.4 pt-20 -85.44 151.41 24.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER 49.8 103.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.814 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.16 126.88 43.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.33 141.27 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.056 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -135.33 142.04 45.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.207 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.571 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.91 128.08 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.383 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 89' ' ' LYS . 5.1 p -115.18 136.45 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.287 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -105.37 119.42 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.934 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.906 ' CE3' HD12 ' A' ' 29' ' ' LEU . 83.9 m95 -101.91 149.37 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.66 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -64.26 150.76 45.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' ' HB3' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -150.99 160.84 43.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.13 153.19 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.485 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.04 149.89 94.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.92 -55.42 3.24 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.571 2.181 . . . . 0.0 112.49 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.23 -31.15 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.207 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -64.5 -61.32 2.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.64 -44.64 81.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.41 -38.78 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -49.22 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 HG21 ' NH2' ' A' ' 99' ' ' ARG . 5.2 mm -57.06 -49.66 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.956 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.43 -37.48 67.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.132 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.55 -57.38 12.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.801 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.44 -41.91 61.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 17' ' ' ALA . 13.5 mt -60.56 -70.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 20.3 t80 -39.55 -33.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.751 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tp -69.69 -41.99 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.005 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.24 -36.31 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -66.94 -57.11 7.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.169 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.662 ' HA ' HD21 ' A' ' 28' ' ' ASN . . . -48.65 112.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.46 -90.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.07 4.53 52.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.569 0.223 . . . . 0.0 111.387 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.662 HD21 ' HA ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -101.8 -21.95 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' A' ' 105' ' ' TRP . 3.2 tt -103.84 143.68 32.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.573 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -49.89 130.72 21.83 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.2 Cg_exo -46.89 -44.36 22.64 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.92 2.414 . . . . 0.0 113.136 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.0 36.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.451 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -55.72 -25.87 42.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 31' ' ' PRO . 52.0 mt -65.38 -54.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.983 0.421 . . . . 0.0 110.204 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.38 -48.93 55.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.644 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.871 HD22 ' NE2' ' A' ' 40' ' ' GLN . 16.1 mt -60.01 -68.23 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.401 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -45.04 -32.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.006 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.84 -37.95 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.326 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.18 -19.27 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.871 ' NE2' HD22 ' A' ' 36' ' ' LEU . 14.2 pt20 -144.53 115.82 8.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.064 0.459 . . . . 0.0 111.19 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -171.56 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.52 -33.1 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.306 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.87 -24.1 16.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.352 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.05 43.4 3.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.724 0.297 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.18 125.6 8.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.57 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.18 113.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 74' ' ' VAL . 35.7 t -108.48 117.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.715 0.293 . . . . 0.0 110.576 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -111.69 163.43 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.765 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 41.4 t80 -104.33 118.97 37.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.69 HG23 ' CB ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -109.91 177.8 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.095 0.474 . . . . 0.0 111.668 -179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' C ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.91 152.63 21.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 21.9 m -67.84 154.77 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.588 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.977 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -79.51 -152.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.41 -46.49 9.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' TRP . 8.0 p-10 -161.13 -41.35 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.977 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 3.0 p-90 22.92 114.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -139.72 19.03 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.975 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -96.49 -26.81 15.15 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.96 -68.31 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.962 ' CD1' HD11 ' A' ' 64' ' ' ILE . 23.1 pt -63.48 -42.58 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.085 0.469 . . . . 0.0 110.431 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 130.89 -63.75 0.62 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.676 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -81.7 -179.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -77.23 168.77 19.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.962 HD11 ' CD1' ' A' ' 60' ' ' ILE . 21.5 mm -135.07 145.23 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.081 0.467 . . . . 0.0 111.63 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-20 -121.52 107.36 36.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 32.8 Cg_endo -64.03 152.41 81.07 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.101 1.867 . . . . 0.0 112.101 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 72.33 -3.95 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.399 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -107.69 -16.62 14.29 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.952 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -137.91 146.93 43.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -93.06 137.78 32.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.578 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.69 ' CB ' HG23 ' A' ' 50' ' ' VAL . 8.2 mm-40 -107.58 130.39 54.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.826 HG11 ' CB ' ' A' ' 17' ' ' ALA . 14.1 p -135.06 106.75 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.71 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' HG11 ' A' ' 86' ' ' VAL . 8.2 m0 -89.17 138.92 30.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.345 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 47' ' ' VAL . 42.0 t -120.81 112.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.475 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 -125.71 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.922 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.6 tp -146.15 61.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.078 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 78' ' ' ASN . 26.7 t -57.13 159.26 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.617 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -108.02 -170.49 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -31.42 72.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.808 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -69.29 -11.99 61.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.366 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.41 33.05 0.7 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.801 0.334 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.36 130.55 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.423 ' HB2' HG22 ' A' ' 77' ' ' VAL . 24.5 ttm -102.93 122.68 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.991 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.64 -19.79 11.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 132.13 43.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG11 ' CZ3' ' A' ' 73' ' ' TRP . 0.7 OUTLIER -103.51 144.42 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 76' ' ' LEU . 1.7 m-85 -107.02 -23.84 12.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -175.77 175.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.435 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.4 mttp -141.46 139.12 33.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.539 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 1.1 m-85 -126.66 131.39 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.203 0.525 . . . . 0.0 112.24 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -115.21 130.06 56.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.988 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -131.09 132.54 63.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -64.14 130.06 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.845 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 93.8 m-70 -77.31 -18.61 57.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.468 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -67.56 168.12 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.084 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.71 -69.26 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 98' ' ' ASP . 7.9 mt-10 -61.12 144.34 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.125 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER 57.7 115.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.233 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH2' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.81 90.49 3.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.787 0.327 . . . . 0.0 110.274 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -89.65 126.62 35.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 28.4 p90 -146.28 138.39 25.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.715 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -133.94 134.47 42.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.429 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.3 p -114.39 146.8 18.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 89' ' ' LYS . 4.8 mp -111.63 138.58 39.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.233 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.667 ' HE3' HD12 ' A' ' 29' ' ' LEU . 57.2 m95 -122.61 147.4 46.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.111 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.79 144.74 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.883 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.744 0.307 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -135.58 171.24 14.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.42 159.34 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.12 157.71 34.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.12 -50.32 7.65 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.551 2.167 . . . . 0.0 112.202 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.9 -30.07 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -48.44 63.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.59 87.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.57 -41.27 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -52.22 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.53 ' CD1' HD12 ' A' ' 92' ' ' ILE . 1.4 pp -70.76 -39.02 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -61.64 -41.34 97.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.582 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -60.81 -46.27 91.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.229 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.17 -34.44 75.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.233 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 17' ' ' ALA . 58.2 mt -67.13 -46.71 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.637 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 21.8 t80 -51.83 -56.75 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.74 -12.33 60.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.752 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.0 tp10 -93.62 -60.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -76.14 -38.28 56.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -47.34 110.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 111.407 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.64 -92.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.872 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.33 -2.97 47.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.6 m-80 -95.77 -28.79 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.8 tt -92.92 157.41 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.425 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.935 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -80.44 149.91 69.47 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 111.69 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.62 -47.85 21.3 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.827 2.352 . . . . 0.0 113.38 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.95 0.97 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 111.899 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.733 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -60.29 -23.15 63.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 29' ' ' LEU . 13.9 mt -70.99 -35.02 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.907 0.384 . . . . 0.0 110.213 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -69.06 -48.35 63.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.806 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.607 HD23 ' NE2' ' A' ' 40' ' ' GLN . 2.0 mt -60.19 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.7 t80 -39.68 -31.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.308 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -74.08 -49.2 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.615 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 2.4 mm? -82.86 -20.12 36.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.607 ' NE2' HD23 ' A' ' 36' ' ' LEU . 3.9 pt20 -136.39 111.23 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -174.66 -49.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.321 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -51.4 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 52.71 0.88 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 0.0 111.198 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 122.71 7.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.64 119.92 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.289 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 74' ' ' VAL . 39.1 t -104.76 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.35 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.86 136.73 36.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -87.06 133.28 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -129.96 -169.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.689 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -127.92 171.19 12.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.682 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -63.57 154.56 32.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -88.42 -160.91 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.951 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -94.15 33.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.208 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 2.1 m-20 83.73 112.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.728 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.8 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -138.74 33.33 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -59.62 79.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -155.95 -37.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.85 -47.51 7.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.663 0.268 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 64' ' ' ILE . 1.7 pt -74.52 -28.98 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.015 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.648 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 79.21 69.05 1.43 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.459 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 172.99 140.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 110.682 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -53.56 136.36 38.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.802 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 60' ' ' ILE . 14.1 mm -110.09 131.69 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.446 . . . . 0.0 111.649 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 73.8 m-20 -134.82 104.67 10.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.051 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 34.3 Cg_endo -64.67 160.59 39.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.164 1.91 . . . . 0.0 112.441 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER 74.39 -8.3 1.5 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.207 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.486 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.2 pt-20 -118.59 -5.42 10.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.177 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.486 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 60.2 m-85 -131.99 147.99 52.49 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.955 0.407 . . . . 0.0 110.825 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.35 128.66 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.051 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' HG23 ' A' ' 50' ' ' VAL . 4.8 tp10 -96.65 132.89 41.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.0 111.492 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 17' ' ' ALA . 1.5 t -131.39 135.23 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.728 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.545 ' CE2' ' HD2' ' A' ' 89' ' ' LYS . 6.0 m0 -118.57 135.72 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.048 0.451 . . . . 0.0 111.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 47' ' ' VAL . 36.0 t -126.73 109.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.77 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.76 -136.76 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.074 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.661 HD22 ' HE1' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -142.06 59.26 1.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 109.863 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.725 HG12 ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -46.84 141.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.93 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -89.46 -129.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.229 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.543 ' C ' ' HG3' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -101.58 -176.75 3.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.299 0.571 . . . . 0.0 109.999 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HG3' ' C ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER 40.62 19.08 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.422 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' GLU . 1.7 t70 73.45 76.65 0.13 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.828 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.725 ' C ' HG12 ' A' ' 77' ' ' VAL . 1.4 mt-10 -152.13 123.99 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.261 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.652 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 21.2 ttm -101.29 -71.98 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.047 0.451 . . . . 0.0 110.688 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -19.24 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 83' ' ' MET . 2.0 m-20 -139.2 115.26 10.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.46 149.27 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.514 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.661 ' HE1' HD22 ' A' ' 76' ' ' LEU . 3.6 m-85 -97.1 -36.14 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . -160.59 167.97 25.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.923 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HB2' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -129.87 147.12 51.6 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.2 m-85 -130.83 135.95 48.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' ND1' ' A' ' 102' ' ' HIS . 2.6 mt -128.5 131.91 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.446 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -142.19 129.98 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.164 0.507 . . . . 0.0 112.147 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.68 135.61 46.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.936 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -75.19 -21.02 59.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 174.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.266 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 -57.35 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 123.5 30.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.78 110.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.67 139.5 45.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.24 142.26 42.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.445 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB3' HG23 ' A' ' 92' ' ' ILE . 27.4 p90 -136.09 142.46 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.007 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.565 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.92 132.73 34.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.176 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.2 p -122.1 144.4 31.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 89' ' ' LYS . 1.9 mp -101.25 135.33 38.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.393 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.791 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.7 m95 -117.65 -90.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.73 131.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.8 mttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.866 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.608 0.242 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -141.94 172.9 12.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.362 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -99.6 169.61 9.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.515 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.2 m-20 -104.45 144.59 29.01 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.571 0.224 . . . . 0.0 110.49 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.35 -53.64 6.77 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.494 2.129 . . . . 0.0 112.593 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -53.76 -37.42 63.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.367 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 16' ' ' ILE . 65.2 m -82.28 -35.27 28.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.416 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.613 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -64.96 -32.95 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.93 -59.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.002 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.6 -29.47 1.84 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.204 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 12' ' ' THR . 1.1 pp -78.62 -45.08 25.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.615 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -70.24 -31.82 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.039 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.26 -45.01 96.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.106 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -24.91 63.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.8 mt -75.37 -28.47 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.492 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.729 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.6 t80 -80.36 -41.85 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.85 -3.76 49.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 7.6 pt-20 -116.97 -45.07 2.78 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 ttp -85.9 -45.55 11.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -51.99 122.93 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.745 0.307 . . . . 0.0 111.49 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.56 -67.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -7.83 59.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -100.0 -72.56 0.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 30' ' ' ASP . 5.3 tt -63.96 127.62 32.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.263 0.554 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.832 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -40.24 153.42 0.21 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.642 -178.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HA ' HD12 ' A' ' 34' ' ' ILE . 22.9 Cg_exo -64.73 -33.09 55.61 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.717 2.278 . . . . 0.0 112.667 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.38 -55.76 27.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 111.296 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.661 ' CB ' HD21 ' A' ' 29' ' ' LEU . 6.5 m-20 -62.54 -22.82 66.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.436 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 31' ' ' PRO . 97.0 mt -72.75 -47.46 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.51 -45.47 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.335 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.25 -57.44 10.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -55.77 -34.81 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.776 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.66 -44.28 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -77.22 -14.49 59.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.139 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 1.6 mm100 -120.36 -144.97 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.224 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 1.2 t80 83.1 -19.38 0.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.488 0.315 . . . . 0.0 111.632 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.77 -39.82 17.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.74 -29.92 8.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' CB ' ' HG ' ' A' ' 76' ' ' LEU . 1.5 mmp_? -115.76 27.54 9.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.002 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.71 114.54 4.46 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.402 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.33 146.49 16.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.763 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 73' ' ' TRP . 88.0 t -146.77 118.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.183 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.94 155.37 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.444 . . . . 0.0 111.522 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CE1' ' HB1' ' A' ' 13' ' ' ALA . 70.4 t80 -101.55 133.94 45.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -142.6 140.68 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.54 -173.17 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.446 . . . . 0.0 110.737 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 16.0 m -83.81 169.82 14.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.467 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.81 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -97.14 -160.31 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 3.7 p30 -93.77 30.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.518 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 t0 85.57 108.86 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -129.21 69.59 1.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.798 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 17.7 mt-10 -80.76 53.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.316 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 -49.65 2.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -83.21 -53.28 5.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 ' CD1' ' A' ' 64' ' ' ILE . 6.3 pt -81.59 -34.99 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.935 0.398 . . . . 0.0 109.954 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 57' ' ' GLU . . . 88.37 -39.72 3.11 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.55 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.504 HG11 ' CE1' ' A' ' 102' ' ' HIS . 4.1 p -58.16 154.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 111.647 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.53 120.34 16.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.475 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 2.3 mm -98.64 160.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.376 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.17 117.92 4.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 27.2 Cg_endo -62.2 152.46 75.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.308 2.005 . . . . 0.0 112.3 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -65.22 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -24.86 7.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.471 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 2.7 m-85 -110.93 149.28 30.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -118.38 123.89 46.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.353 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' HG2' HG23 ' A' ' 50' ' ' VAL . 17.4 tt0 -102.25 144.25 31.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.27 0.557 . . . . 0.0 111.367 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 17' ' ' ALA . 1.8 t -132.74 140.41 47.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.584 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.809 ' O ' HG13 ' A' ' 47' ' ' VAL . 17.6 m0 -114.9 132.48 56.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.0 111.177 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 47' ' ' VAL . 62.1 t -124.98 97.59 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.628 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -126.17 -133.4 3.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.588 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.633 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.4 tp -140.69 83.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 83' ' ' MET . 35.0 m -64.34 178.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.0 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -115.64 -171.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.96 -16.85 64.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.262 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -97.27 26.55 4.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.293 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 39.82 55.4 2.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.904 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.42 104.63 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.597 ' HB2' HG12 ' A' ' 77' ' ' VAL . 35.8 ttm -69.79 117.56 11.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 19.82 17.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.655 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 104.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.814 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 p -89.57 142.43 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.11 0.481 . . . . 0.0 111.524 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HE2' HD13 ' A' ' 76' ' ' LEU . 13.9 m-85 -89.81 -33.74 16.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.691 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -166.53 165.76 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.736 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.795 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.9 mttt -132.16 146.23 51.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.3 m-85 -126.3 130.21 50.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.458 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.522 HD12 ' ND1' ' A' ' 102' ' ' HIS . 5.2 mt -110.78 135.6 51.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.83 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.404 HG13 HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -139.03 123.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.577 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 156.75 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.758 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.825 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 20.4 m-70 -101.92 23.02 12.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.086 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -87.4 148.15 25.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.0 111.106 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -61.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.73 158.48 15.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 44.72 94.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.2 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.98 151.66 27.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.144 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -130.53 140.76 50.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 24.3 p90 -138.19 142.75 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -137.68 161.98 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.875 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.6 143.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.512 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.12 137.26 43.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.538 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 27.2 m95 -117.02 149.83 39.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.26 28.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.877 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.925 0.393 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -98.32 -172.82 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -105.11 143.06 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.777 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 150.83 14.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.785 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.92 -50.18 10.94 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.164 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -21.98 60.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.205 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.415 HG22 HD22 ' A' ' 8' ' ' LEU . 27.9 m -82.43 -49.15 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.409 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -63.22 -36.19 82.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.258 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -72.24 -57.55 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -44.74 -48.42 10.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.736 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -66.72 -45.33 88.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.088 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.67 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.045 0.45 . . . . 0.0 110.265 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.5 -36.43 71.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.922 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.32 -27.24 62.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.822 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.546 HG22 ' HE2' ' A' ' 90' ' ' PHE . 49.3 mt -74.1 -33.16 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.691 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 47.8 t80 -78.25 -23.63 47.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.07 0.462 . . . . 0.0 110.411 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.28 -33.29 37.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.238 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.18 -34.26 11.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.285 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 27.9 mtp -83.08 -50.9 8.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.523 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -55.14 138.76 43.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 111.321 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.79 21.07 5.51 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -160.11 -42.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HB3' ' CG ' ' A' ' 105' ' ' TRP . 2.5 m120 -76.59 -57.47 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -65.25 175.05 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.793 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.846 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -75.76 153.66 85.19 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.74 0.305 . . . . 0.0 111.017 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.73 ' HA ' HD12 ' A' ' 34' ' ' ILE . 52.2 Cg_exo -55.85 -58.02 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.907 2.404 . . . . 0.0 113.141 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.04 -46.33 11.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 111.64 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.64 ' CB ' HD22 ' A' ' 29' ' ' LEU . 12.7 m-20 -62.41 -27.69 69.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.5 mt -68.94 -48.45 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.877 0.37 . . . . 0.0 110.548 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.9 tp -57.57 -62.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -44.68 -45.23 9.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.195 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -35.79 75.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -68.43 -53.34 24.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.4 mm? -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -83.28 -136.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 72.98 -58.66 0.59 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.687 0.279 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.47 -42.71 98.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.36 -48.98 7.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -116.85 66.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.734 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.53 134.02 12.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.298 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.02 115.32 1.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.388 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -151.62 68.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -84.98 136.51 33.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 82.1 t80 -91.02 89.68 7.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.71 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.97 3.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 51.5 m -90.27 165.17 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.143 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 52' ' ' THR . . . -122.34 164.16 18.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.9 -31.87 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.82 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.826 ' CH2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -66.83 -27.94 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -60.72 67.35 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.506 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' TRP . 5.7 mt-10 -156.23 -54.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.19 -67.88 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' CG1' ' A' ' 62' ' ' VAL . 45.6 pt -71.46 -34.18 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 94.13 48.95 2.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.676 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.591 HG13 HD11 ' A' ' 64' ' ' ILE . 9.6 p 179.6 132.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' HG3' ' A' ' 57' ' ' GLU . 1.3 mt -65.71 135.3 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.591 HD11 HG13 ' A' ' 62' ' ' VAL . 17.9 mm -121.07 146.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.62 109.39 5.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 24.4 Cg_endo -62.89 153.26 74.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.186 1.924 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 62.73 7.07 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.563 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -128.25 17.27 6.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.405 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 31.1 m-85 -150.65 142.07 23.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.9 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.991 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -89.45 116.5 27.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -110.39 104.99 13.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.58 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.89 135.78 31.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.282 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 10.0 m0 -115.77 89.76 3.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.188 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 47' ' ' VAL . 72.6 t -89.7 99.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.041 0.448 . . . . 0.0 110.972 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.01 -132.55 3.46 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.462 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.2 tp -140.24 108.97 5.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 82' ' ' GLU . 57.2 t -96.28 148.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -92.24 -164.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.54 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.299 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.28 -6.87 48.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HA ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 67.07 30.14 7.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.721 0.296 . . . . 0.0 111.332 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.4 mm-40 -105.54 147.47 28.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.56 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.83 86.08 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 111.103 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.31 12.76 23.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.59 91.91 1.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.879 0.371 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.721 HG21 ' HG2' ' A' ' 89' ' ' LYS . 2.5 p -89.72 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' A' ' 76' ' ' LEU . 3.2 m-85 -97.4 -49.65 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.36 121.1 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.395 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.721 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -103.37 131.5 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.152 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.546 ' HE2' HG22 ' A' ' 20' ' ' ILE . 2.6 m-85 -111.7 153.26 26.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 0.0 111.775 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.826 HD11 ' CH2' ' A' ' 56' ' ' TRP . 15.3 mt -137.07 109.07 7.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.553 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.504 HG21 ' NH2' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -115.84 136.87 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.749 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -71.98 93.08 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.904 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.991 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 96.6 m-70 -31.92 -49.16 0.17 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.223 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -41.32 143.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.964 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -48.56 46.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 98' ' ' ASP . 8.3 mt-10 -72.11 145.33 48.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.099 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER 57.57 115.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.287 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 92' ' ' ILE . 13.4 tpt180 -109.66 113.79 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.838 0.351 . . . . 0.0 110.504 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CG ' ' HB2' ' A' ' 93' ' ' SER . 7.8 pt-20 -128.62 103.76 7.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 92' ' ' ILE . 26.2 p90 -112.07 146.26 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.531 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -144.93 161.38 39.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.443 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.8 p -152.74 141.66 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.82 132.69 58.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 29' ' ' LEU . 88.0 m95 -111.59 -81.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.412 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.64 139.97 11.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.871 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.96 134.07 52.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.952 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.1 148.3 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.988 -179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.597 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -47.28 140.22 7.2 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.687 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -58.42 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.448 2.098 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -31.3 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -59.6 -55.23 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.906 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -58.36 -52.79 64.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.024 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -46.42 -38.85 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.182 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.04 -46.95 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 13' ' ' ALA . 4.7 mt -60.86 -63.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.902 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -47.05 -38.27 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -55.14 -52.67 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.103 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.98 -21.7 66.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.667 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 17' ' ' ALA . 77.9 mt -77.2 -30.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.042 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' CD2' HG11 ' A' ' 74' ' ' VAL . 15.0 t80 -76.68 -28.18 55.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.481 . . . . 0.0 110.136 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.1 tp -78.2 -32.78 50.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.391 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.36 -38.38 10.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.128 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 19.0 mtp -74.09 -51.21 16.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -50.0 145.66 5.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.401 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.13 29.92 9.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.279 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -152.36 -35.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.623 0.249 . . . . 0.0 111.357 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.469 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -121.04 -30.47 4.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.326 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD12 ' HE3' ' A' ' 105' ' ' TRP . 5.2 tt -68.94 141.17 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -58.5 140.27 84.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.53 -54.83 4.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.085 2.523 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.82 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.21 -28.89 68.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.301 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.591 HG12 HD22 ' A' ' 29' ' ' LEU . 54.3 mt -66.1 -52.29 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -55.69 30.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -49.78 -39.57 38.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 111.417 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -80.88 -36.82 30.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.4 -23.8 46.57 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -86.18 -27.77 24.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.622 ' HG3' HD21 ' A' ' 76' ' ' LEU . 12.4 pt20 -150.08 95.6 2.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.814 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.8 t80 -130.74 -40.24 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.201 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -68.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.919 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.42 -39.9 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.7 mpt_? -112.59 62.03 0.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.04 133.65 11.77 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.178 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.13 142.58 9.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.928 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 74' ' ' VAL . 39.5 t -146.04 80.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -76.87 140.46 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.812 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.02 88.43 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' CG ' ' A' ' 71' ' ' GLU . 1.8 m -89.52 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.153 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.73 175.5 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.761 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -60.4 154.18 21.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -75.03 -149.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -38.19 14.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 110.195 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 56' ' ' TRP . 4.0 p30 -151.3 -35.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.234 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.622 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 6.3 m95 70.84 2.28 4.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.634 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.8 59.59 0.89 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.876 0.369 . . . . 0.0 111.107 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.5 -49.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.799 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 5.1 mm-40 -75.99 -73.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.622 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 48.0 pt -75.13 -34.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.297 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 82.21 79.88 0.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.722 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 168.7 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -70.34 121.24 17.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.69 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 60' ' ' ILE . 27.0 mm -124.17 112.43 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.264 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.64 115.2 20.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.76 151.21 82.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.24 1.96 . . . . 0.0 111.921 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 77.71 -29.84 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.05 6.36 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.391 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -141.85 151.39 42.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 111.434 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -99.28 131.62 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.651 ' CG ' HG23 ' A' ' 50' ' ' VAL . 2.2 tp10 -115.72 110.23 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.582 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.902 HG11 ' HB1' ' A' ' 17' ' ' ALA . 8.8 p -113.73 135.24 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.176 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 18.7 m0 -117.9 136.35 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.321 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 47' ' ' VAL . 58.0 t -135.59 108.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 0.0 111.39 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.57 -115.23 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.622 HD21 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -150.04 155.25 39.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -140.58 -178.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.472 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.54 -173.86 2.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -26.12 65.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.965 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -79.16 -9.63 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.414 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.58 88.78 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.828 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.9 mt-10 -144.11 147.05 33.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 tpt -120.82 80.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 -5.51 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 84.95 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.7 p -89.84 131.73 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.665 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 76' ' ' LEU . 14.7 m-85 -89.47 -37.06 15.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.589 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.883 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -144.74 162.1 37.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.15 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.653 ' HE2' HD12 ' A' ' 104' ' ' ILE . 3.8 mttm -146.26 130.64 17.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.614 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -120.33 148.69 43.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 56' ' ' TRP . 58.9 mt -129.29 118.16 21.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.385 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -129.29 147.93 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.317 0.58 . . . . 0.0 112.553 -178.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.86 122.16 26.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.534 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.943 ' CE1' HD12 ' A' ' 8' ' ' LEU . 92.1 m-70 -58.82 -15.37 12.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.827 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.72 -55.81 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.62 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.84 0.06 28.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 112.063 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.89 105.01 2.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.92 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.46 118.64 22.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.056 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -104.51 127.45 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 21.6 p90 -118.26 138.9 52.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.848 0.356 . . . . 0.0 111.232 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -147.62 101.6 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.4 p -99.86 144.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.026 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.653 HD12 ' HE2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.9 131.1 73.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.974 179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.883 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 26.8 m95 -105.46 153.55 21.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.42 160.45 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.896 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -177.89 5.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.087 HD21 ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -130.16 148.54 52.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HD22 ' A' ' 8' ' ' LEU . 1.2 m-20 -80.59 134.82 53.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.056 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.43 -42.17 22.87 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 112.32 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -27.32 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.649 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -77.33 -37.07 53.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.087 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -65.71 -44.96 84.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.62 -42.63 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.959 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.34 -55.41 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.75 -42.09 94.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.031 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -60.12 -39.42 86.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.953 0.406 . . . . 0.0 110.309 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.65 -47.83 81.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.096 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.92 65.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.667 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.5 mt -62.61 -73.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 70.0 t80 -42.49 -29.45 0.28 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.381 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.51 HD12 ' HZ ' ' A' ' 37' ' ' PHE . 1.9 tp -64.69 -45.17 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.48 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.1 pt-20 -103.4 -28.57 11.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.405 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -72.14 -53.42 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 111.204 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 137.69 41.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.428 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.771 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 162.79 -85.7 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.894 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.6 3.59 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' CD2' ' A' ' 105' ' ' TRP . 0.9 OUTLIER -92.26 -42.64 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.263 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.851 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.4 tt -97.27 154.56 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.851 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.95 149.91 4.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.8 Cg_endo -53.64 -25.86 35.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.523 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.03 -60.42 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.64 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.659 ' HB3' HD22 ' A' ' 29' ' ' LEU . 45.1 t0 -58.21 -29.01 65.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.51 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 96.5 mt -61.2 -47.97 91.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 110.172 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -68.76 -47.21 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.438 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.454 HD23 ' OE1' ' A' ' 40' ' ' GLN . 5.6 mp -60.37 -59.09 5.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.426 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HZ ' HD12 ' A' ' 22' ' ' LEU . 4.1 t80 -42.12 -30.61 0.3 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.296 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -76.96 -50.71 12.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 35' ' ' LEU . 1.9 mm? -83.35 -63.17 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.618 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.859 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.48 92.83 9.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 111.659 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.2 t80 -163.95 -37.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.64 -62.54 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -102.62 -15.45 16.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.529 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' O ' HD12 ' A' ' 76' ' ' LEU . 20.6 mmt180 -102.75 -5.38 23.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.651 0.262 . . . . 0.0 111.396 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -91.15 132.71 11.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.17 145.46 13.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.368 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 74' ' ' VAL . 28.9 t -130.99 96.65 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.906 0.384 . . . . 0.0 111.006 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' A' ' 83' ' ' MET . 2.2 pt-20 -84.31 164.48 18.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.962 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.615 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 36.8 t80 -114.28 135.85 53.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.496 HG23 ' CG ' ' A' ' 71' ' ' GLU . 6.4 m -132.21 -174.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.17 166.09 13.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 66' ' ' PRO . 8.0 m -54.69 155.96 3.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.88 -177.29 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.03 26.25 10.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.77 39.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.853 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -65.22 -29.8 70.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.276 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 14.2 mt-10 -59.44 -16.63 24.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -92.68 -34.03 14.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 36.5 mt-10 -78.93 -57.66 3.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.853 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 42.0 pt -93.93 -36.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.415 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 123.61 -72.53 0.41 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m -56.88 173.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.814 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' O ' HD13 ' A' ' 64' ' ' ILE . 4.7 mp -89.82 136.4 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.485 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CG1' HD11 ' A' ' 60' ' ' ILE . 25.9 mm -124.9 116.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.755 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -65.36 112.07 7.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG21 ' A' ' 52' ' ' THR . 19.5 Cg_endo -61.42 163.75 16.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.792 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.7 pt-20 48.81 20.31 0.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.974 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -129.05 -14.44 4.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.584 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HE2' ' HG ' ' A' ' 93' ' ' SER . 64.2 m-85 -123.92 162.7 22.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.836 0.35 . . . . 0.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -109.1 122.15 46.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.496 ' CG ' HG23 ' A' ' 50' ' ' VAL . 35.0 tt0 -106.03 123.52 48.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.499 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.5 t -115.99 147.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.64 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -124.44 135.92 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 47' ' ' VAL . 49.1 t -128.42 111.01 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.091 0.472 . . . . 0.0 111.14 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.66 -127.22 3.07 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.166 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.859 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.8 tp -149.18 57.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' ASN . 6.3 p -63.71 158.55 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.702 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.5 m-80 -95.13 -144.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.929 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -93.23 22.88 4.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.662 0.267 . . . . 0.0 111.223 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -114.23 -11.76 12.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.543 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 71.37 28.81 2.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.385 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 77' ' ' VAL . 65.3 mt-10 -114.46 119.35 36.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.71 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.401 ' HE2' ' HG2' ' A' ' 48' ' ' GLU . 10.0 tpp -84.89 98.55 10.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.458 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.83 -23.88 26.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.24 125.61 16.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.41 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -107.08 135.59 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.709 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.3 m-85 -90.11 -38.32 13.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.74 175.96 12.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.788 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.637 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.17 140.61 22.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -123.32 147.56 46.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.778 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 34.2 mt -131.47 124.8 30.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.141 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.45 149.39 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.467 ' HG ' ' HE2' ' A' ' 69' ' ' TYR . 17.8 m -69.34 123.29 20.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.953 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.954 ' CE1' HD12 ' A' ' 8' ' ' LEU . 8.3 m-70 -49.91 -48.62 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.634 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -42.87 160.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.098 0.475 . . . . 0.0 111.828 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -99.17 -34.63 10.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.112 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 3.3 pt-20 -91.3 126.69 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.93 106.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.8 148.54 45.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.507 . . . . 0.0 111.616 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.58 133.32 56.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.489 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 39.7 p90 -120.67 139.13 53.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.79 103.03 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.0 111.058 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.5 p -98.79 141.76 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.918 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.514 HD12 ' CE ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -108.2 135.55 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.151 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.801 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 46.9 m95 -115.52 140.72 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.23 159.19 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mttm . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.822 0.344 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 177.76 6.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 16' ' ' ILE . 3.2 mt -139.38 135.29 33.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.37 164.93 53.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.578 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.65 -59.21 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.219 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 14' ' ' ILE . 9.7 t70 -63.87 -30.27 71.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 8' ' ' LEU . 13.7 m -73.27 -42.82 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -60.81 -35.33 76.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 11' ' ' ASP . 23.8 mt -71.35 -57.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.12 -39.84 2.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.263 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.1 mt -65.86 -57.34 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -56.59 -29.07 61.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.12 -55.45 25.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.8 -31.21 62.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.752 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 17' ' ' ALA . 78.7 mt -64.02 -74.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.144 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 44.8 t80 -39.51 -32.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.415 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 22' ' ' LEU . 2.0 tp -63.77 -43.02 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -29.26 10.41 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -57.86 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.682 0.277 . . . . 0.0 111.434 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -50.25 116.52 1.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.395 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.21 -89.94 0.08 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.92 2.78 32.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.4 m-80 -103.04 -59.12 1.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 33' ' ' ASP . 5.1 tt -64.1 135.26 56.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.78 137.49 3.34 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.964 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 34' ' ' ILE . 6.1 Cg_endo -48.21 -43.06 32.44 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.852 2.368 . . . . 0.0 112.754 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.0 -58.86 5.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.599 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.719 ' CB ' HD21 ' A' ' 29' ' ' LEU . 41.2 m-20 -58.06 -24.68 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 31' ' ' PRO . 92.5 mt -67.99 -50.93 54.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 109.991 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -53.7 -51.13 64.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.756 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -55.16 37.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.141 0.496 . . . . 0.0 110.417 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 2.1 t80 -46.19 -30.08 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.901 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -59.07 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.466 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.2 mm? -64.18 -21.26 66.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.837 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.619 ' HG3' HD21 ' A' ' 76' ' ' LEU . 4.8 pt20 -148.8 118.61 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.652 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' GLY . 63.4 t80 179.98 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.756 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -48.39 -63.5 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.25 -33.17 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.41 33.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -104.58 62.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.552 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.21 116.72 5.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.497 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 72' ' ' VAL . 38.7 t -102.34 107.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.77 0.319 . . . . 0.0 110.865 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.37 150.62 24.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.415 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 35.0 t80 -103.72 141.73 35.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.091 0.472 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.709 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.12 152.41 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.921 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -92.9 158.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.702 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 98.2 m -46.88 167.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.064 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 52' ' ' THR . . . -103.07 -169.04 1.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.72 32.59 4.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.23 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.959 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.5 m95 68.14 6.57 5.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.991 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.45 -1.8 19.88 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.71 -44.02 5.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 60.1 mm-40 -73.3 -56.28 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.439 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.815 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 18.0 pt -103.15 -35.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.675 0.274 . . . . 0.0 111.02 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 -53.02 0.6 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.301 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.78 152.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.238 0.542 . . . . 0.0 111.878 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -62.92 156.49 24.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.721 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 63' ' ' LEU . 34.5 mm -150.35 128.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.85 108.08 4.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.616 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 9.6 Cg_endo -52.9 157.69 7.56 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.288 1.992 . . . . 0.0 112.287 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 20.1 mt-10 69.64 -59.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.16 -29.03 1.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.814 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -116.65 152.16 34.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 111.355 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -112.37 133.11 54.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.816 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG3' HG23 ' A' ' 50' ' ' VAL . 8.0 pt-20 -112.53 133.48 54.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG13 ' CG1' ' A' ' 47' ' ' VAL . 2.2 t -121.22 147.45 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.84 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.452 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 12.2 m0 -120.49 133.57 55.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 111.226 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 21' ' ' PHE . 45.1 t -126.93 110.59 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.907 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.45 -132.27 3.75 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.264 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.619 HD21 ' HG3' ' A' ' 40' ' ' GLN . 2.3 tp -142.16 64.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 0.0 110.093 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 83' ' ' MET . 22.3 t -49.4 159.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.831 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.5 m-80 -89.65 -160.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.61 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -70.91 -9.7 58.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.95 -87.76 0.21 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.52 0.2 . . . . 0.0 111.17 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HA ' HG11 ' A' ' 77' ' ' VAL . 1.4 p30 179.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -57.38 129.65 42.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 77' ' ' VAL . 25.3 ttm -107.52 122.71 47.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.037 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.52 -3.18 13.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -137.56 108.23 6.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.863 0.363 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -97.38 138.74 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.858 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.568 ' HE2' HD22 ' A' ' 76' ' ' LEU . 2.5 m-85 -90.0 -46.35 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.681 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.723 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -143.99 173.19 11.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -150.4 136.0 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' HG21 ' A' ' 103' ' ' VAL . 1.4 m-85 -121.17 142.2 50.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.959 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 13.8 mt -119.96 133.43 55.56 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.02 143.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.92 132.32 46.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.65 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.0 -32.95 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 178.24 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.031 0.443 . . . . 0.0 111.277 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.64 -12.84 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.356 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -133.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 51.52 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 110.665 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -62.09 141.65 58.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.116 0.484 . . . . 0.0 111.905 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -117.46 149.63 40.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.595 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 35.5 p90 -139.16 143.36 38.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.708 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.505 ' ND1' HD12 ' A' ' 91' ' ' LEU . 0.3 OUTLIER -150.04 118.79 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.143 0.497 . . . . 0.0 111.525 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -107.24 144.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.906 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -111.81 135.9 49.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 37.3 m95 -117.07 149.36 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 5.1 ttmt -67.63 153.46 43.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.851 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tptt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.721 0.296 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -89.92 178.91 6.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' HG22 ' A' ' 12' ' ' THR . 0.9 OUTLIER -105.71 143.89 33.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.064 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.83 157.82 57.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.83 -64.49 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.638 2.225 . . . . 0.0 112.248 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.68 -32.83 67.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' CD2' ' A' ' 8' ' ' LEU . 69.4 m -72.58 -36.46 68.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.437 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -65.06 -26.77 68.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.26 -62.12 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.97 -32.49 3.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.793 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 12' ' ' THR . 1.3 pp -76.86 -48.04 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.74 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.59 -35.84 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 110.198 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.59 -43.88 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.939 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -66.1 -27.86 68.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.136 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 17' ' ' ALA . 50.3 mt -74.25 -28.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.1 t80 -69.01 -45.97 69.19 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -80.02 -2.98 46.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 1.1 mm-40 -95.78 -56.83 2.54 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.3 mtp -92.18 -30.62 15.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.63 122.94 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.01 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.84 35.97 1.09 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.124 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -163.04 -32.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.44 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 5.2 t30 -116.27 -34.91 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 33' ' ' ASP . 3.0 tt -80.07 124.31 28.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 111.062 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.771 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -34.2 150.12 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.561 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 34' ' ' ILE . 26.9 Cg_endo -62.77 -34.49 72.83 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.536 2.157 . . . . 0.0 112.667 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.91 -58.15 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.868 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.792 ' HB2' HD21 ' A' ' 29' ' ' LEU . 61.8 m-20 -61.24 -19.43 61.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 31' ' ' PRO . 83.5 mt -75.23 -51.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.932 0.396 . . . . 0.0 110.388 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.3 tt -54.27 -51.8 63.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.738 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -52.02 66.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.247 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 4.0 t80 -46.46 -28.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.914 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -77.01 -49.99 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.6 44.02 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.01 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -150.57 -44.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.2 t80 -61.02 -12.01 10.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.717 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.59 -46.55 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -119.45 -13.31 9.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.607 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.461 ' O ' HD12 ' A' ' 76' ' ' LEU . 6.0 mtt-85 -118.18 41.66 2.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.142 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.92 108.82 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.52 154.06 24.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.297 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 73' ' ' TRP . 75.9 t -144.07 119.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -101.92 142.99 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.71 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 59.2 t80 -91.67 138.26 31.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.295 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.04 142.13 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.599 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.32 -174.78 1.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 53' ' ' ALA . 61.7 m -72.33 165.0 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -91.15 -160.78 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.6 OUTLIER -95.02 32.19 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.347 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 84.34 121.74 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -146.71 55.36 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.47 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -72.0 79.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.692 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.7 -43.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.772 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.59 -48.07 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.435 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 64' ' ' ILE . 5.1 pt -80.13 -14.46 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 54.86 77.4 0.15 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.25 140.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.86 122.92 12.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 60' ' ' ILE . 9.2 mm -97.68 144.85 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 43.5 m-20 -146.78 105.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.284 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 31.4 Cg_endo -64.0 155.69 62.98 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 80.29 -14.62 0.82 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.904 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.9 pt-20 -115.09 2.17 14.09 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.523 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 54.5 m-85 -138.96 144.73 39.12 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.099 0.476 . . . . 0.0 111.231 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.71 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -110.98 120.21 41.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.918 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 50' ' ' VAL . 14.3 tt0 -92.84 130.79 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.759 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -117.16 141.25 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.516 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.5 m0 -117.62 136.26 53.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 21' ' ' PHE . 59.8 t -125.07 102.03 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.472 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.18 -144.39 8.66 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.079 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 87' ' ' PHE . 2.1 tp -138.64 81.79 1.87 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.276 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 2.2 m -67.17 170.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.191 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -115.34 -165.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.428 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.87 -16.29 58.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.531 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.45 -85.83 0.17 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.154 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.7 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.332 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.618 ' C ' HG12 ' A' ' 77' ' ' VAL . 32.3 mt-10 -147.99 120.3 8.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -71.69 -25.68 62.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.38 6.51 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' MET . 1.5 m-20 178.42 121.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.66 141.61 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.884 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD22 ' A' ' 76' ' ' LEU . 2.3 m-85 -89.51 -34.89 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.413 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.2 161.99 19.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.62 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.826 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.6 mttt -129.36 148.24 51.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' A' ' 103' ' ' VAL . 2.9 m-85 -128.82 138.61 52.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 111.877 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.444 HD12 ' ND1' ' A' ' 102' ' ' HIS . 3.7 mt -119.66 134.03 55.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.151 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.123 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -74.3 147.87 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -91.72 22.26 4.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -96.99 152.97 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.35 -40.57 14.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.47 114.28 28.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.47 100.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.723 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.86 127.25 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.46 156.5 18.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -149.53 144.62 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.03 159.95 40.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.015 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.34 141.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.63 133.36 51.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.752 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.634 ' HE3' HD12 ' A' ' 29' ' ' LEU . 33.9 m95 -115.88 150.17 37.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.93 153.57 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.6 pttm . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.888 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.784 0.326 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -127.41 139.81 52.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.114 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD22 ' CG2' ' A' ' 12' ' ' THR . 3.7 mt -63.98 150.47 45.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.2 141.89 93.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' HD12 ' A' ' 14' ' ' ILE . 88.8 Cg_exo -47.12 -48.2 15.26 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.55 2.166 . . . . 0.0 112.725 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.9 -21.86 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.471 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.659 ' CG2' HD22 ' A' ' 8' ' ' LEU . 26.6 m -81.01 -61.17 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.558 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.46 -30.27 64.9 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 10' ' ' PRO . 96.1 mt -76.28 -59.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -42.1 -48.77 4.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.568 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CD1' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -63.62 -40.22 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.04 -42.67 94.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.442 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -52.16 -44.85 64.82 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.243 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 -30.56 71.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.485 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.4 mt -73.0 -29.75 29.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t80 -67.91 -47.8 67.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -71.81 -23.41 61.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.17 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.718 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.49 ' CE ' HG11 ' A' ' 103' ' ' VAL . 5.8 mtp -75.1 -46.01 37.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -42.75 110.83 0.2 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.804 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.52 -114.28 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.392 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.98 -37.66 78.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.309 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.01 -37.13 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.6 tt -88.07 151.08 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.913 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -71.13 134.55 85.21 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.097 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.947 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.3 Cg_exo -46.11 -59.36 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.722 2.281 . . . . 0.0 112.951 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.14 -50.35 20.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.556 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 29' ' ' LEU . 47.0 m-20 -60.22 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.7 mt -66.66 -52.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.111 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.731 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -57.34 -51.76 68.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 110.356 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 1.8 tp -52.39 -51.06 61.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 110.556 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -49.04 -42.58 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.9 -57.06 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.731 HD22 ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -89.99 49.11 1.66 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.498 ' HB3' HD21 ' A' ' 76' ' ' LEU . 14.5 mm100 -155.62 -48.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -42.91 -37.47 1.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.545 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.06 -45.03 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.22 -61.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.061 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.19 63.06 3.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.36 133.88 11.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.72 128.34 4.59 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.413 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -150.17 59.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.49 . . . . 0.0 110.245 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.22 125.61 31.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.381 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 79.3 t80 -83.63 97.65 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.45 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.476 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -90.34 166.18 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.356 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -98.17 162.08 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.853 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 48.4 m -52.09 163.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' THR . . . -137.18 162.34 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.08 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.91 -29.25 18.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.794 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.21 -2.7 22.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.674 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.764 ' CZ2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -46.39 -29.59 1.76 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.553 0.216 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.81 63.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -166.93 -44.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.369 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.97 -70.54 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.104 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.71 -32.12 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.273 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 62' ' ' VAL . . . 77.72 47.75 8.46 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.93 113.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.498 0.19 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.93 127.16 15.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.57 137.73 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -66.1 109.69 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.795 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.3 Cg_endo -59.33 157.89 28.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.326 2.017 . . . . 0.0 112.411 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.4 pt-20 48.62 20.53 0.33 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.777 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 19.2 mt-10 -137.74 18.82 2.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.713 0.292 . . . . 0.0 110.973 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 68' ' ' GLU . 20.8 m-85 -148.09 145.51 28.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.72 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.001 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -90.11 114.19 26.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' HG2' HG23 ' A' ' 50' ' ' VAL . 27.8 tt0 -110.62 103.4 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.485 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 17' ' ' ALA . 13.3 p -94.5 136.39 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.464 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.601 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 3.8 m0 -121.25 94.16 4.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 47' ' ' VAL . 96.1 t -97.97 106.33 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.135 0.493 . . . . 0.0 111.056 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -132.2 -137.53 3.99 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.955 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.506 HD22 ' HE2' ' A' ' 87' ' ' PHE . 1.1 mp -139.18 112.67 8.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.298 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 81' ' ' ASP . 16.0 m -100.13 179.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.255 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -93.7 -166.2 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.552 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.02 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.404 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -75.13 -72.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.483 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 166.19 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.621 0.248 . . . . 0.0 111.413 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.69 135.88 3.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.9 tpp -119.56 123.91 45.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.652 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.58 21.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -160.4 89.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.854 HG21 ' HG3' ' A' ' 89' ' ' LYS . 7.3 p -89.67 149.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.418 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HE2' HD22 ' A' ' 76' ' ' LEU . 24.6 m-85 -98.69 -43.73 6.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.728 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.765 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.53 122.27 7.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.854 ' HG3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.59 132.89 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 2.6 m-85 -113.99 155.58 25.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.764 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 39.8 mt -134.66 110.32 9.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.558 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.64 134.37 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.589 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.13 97.11 2.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.49 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 1.001 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m-70 -37.28 -46.6 0.76 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.948 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.31 138.0 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 111.412 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.93 80.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' ARG . 10.9 pt-20 -67.38 -173.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.25 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 69.62 62.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.458 . . . . 0.0 110.509 -179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.31 150.71 23.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 8.8 p90 -146.83 140.74 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.602 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.28 157.42 46.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -151.41 138.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -114.91 110.22 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.096 178.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.908 ' CE3' HD12 ' A' ' 29' ' ' LEU . 91.2 m95 -92.42 149.25 21.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -176.95 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.753 0.311 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -176.59 3.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.052 0.453 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 155.43 35.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.37 147.77 53.98 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.49 -54.89 4.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.543 2.162 . . . . 0.0 112.392 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.52 -28.93 68.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 16' ' ' ILE . 58.3 m -72.85 -44.95 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.39 89.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.62 -57.88 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.2 -45.98 5.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.232 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 12' ' ' THR . 5.6 mt -72.89 -39.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -61.15 -49.79 75.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.711 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.88 -43.62 77.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -35.37 77.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 17' ' ' ALA . 49.7 mt -66.24 -45.68 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.691 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 74' ' ' VAL . 7.2 t80 -54.33 -59.67 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.554 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.8 mm? -64.01 -14.5 54.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.159 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.7 -57.75 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.539 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -83.4 -38.49 21.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.6 151.11 8.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 0.0 111.516 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.762 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 148.52 -111.9 0.55 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.417 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -74.02 -3.64 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 1.3 m120 -98.46 -5.85 31.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.499 0.19 . . . . 0.0 111.213 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.735 HD23 HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -103.59 -25.44 13.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.732 0.301 . . . . 0.0 111.481 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 29' ' ' LEU . 12.6 t70 106.01 137.23 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.754 0.822 . . . . 0.0 111.441 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -43.41 -58.89 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.22 2.613 . . . . 0.0 113.044 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.34 -58.62 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.034 0.445 . . . . 0.0 111.137 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.71 ' C ' HD21 ' A' ' 29' ' ' LEU . 3.6 m-20 -57.32 -28.95 63.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' O ' ' A' ' 26' ' ' GLY . 52.9 mt -71.61 -49.82 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-O 121.301 0.572 . . . . 0.0 109.697 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.629 ' HG ' HD23 ' A' ' 39' ' ' LEU . 5.5 tp -45.85 -66.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.299 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.544 HD23 ' CZ ' ' A' ' 87' ' ' PHE . 28.6 tp -53.9 -35.02 61.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.337 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 2.7 t80 -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.16 -62.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.1 mm? -52.88 -23.54 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.622 ' O ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.3 115.64 8.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.273 0.558 . . . . 0.0 111.817 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' O ' ' HA3' ' A' ' 45' ' ' GLY . 15.5 t80 -169.79 -53.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.919 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -34.91 72.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.14 -46.85 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.262 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -119.55 53.85 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 111.116 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -119.22 120.4 4.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.727 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.77 137.37 6.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.716 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.31 126.04 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.889 0.376 . . . . 0.0 110.964 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.48 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.997 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 51.2 t80 -87.35 139.53 30.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -133.01 175.91 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.29 148.3 33.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 49.7 m -41.74 160.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.14 0.495 . . . . 0.0 111.574 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -99.67 -161.4 0.87 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.235 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.65 39.84 1.04 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.177 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 2.7 m-20 76.6 117.76 0.06 Allowed 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.703 ' HZ2' HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -125.88 44.98 2.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.718 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -58.72 70.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -155.41 -45.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.731 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.72 -68.01 0.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.419 0.628 . . . . 0.0 110.268 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -69.74 -50.88 45.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.389 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 96.14 72.85 1.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.303 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 60' ' ' ILE . 10.6 p 172.49 142.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.667 0.27 . . . . 0.0 110.577 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.99 123.22 7.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 111.347 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.901 HD11 ' CD1' ' A' ' 60' ' ' ILE . 27.6 mm -103.51 132.07 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.68 111.78 41.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.51 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 28.0 Cg_endo -63.1 152.97 76.82 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.406 2.071 . . . . 0.0 112.902 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 60.77 8.98 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.033 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -119.97 -13.71 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.561 0.22 . . . . 0.0 111.517 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.7 136.38 49.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 111.02 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -89.32 117.96 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.782 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.779 ' HG3' HG23 ' A' ' 50' ' ' VAL . 11.0 pt-20 -107.17 138.15 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.089 0.471 . . . . 0.0 111.336 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 17' ' ' ALA . 10.8 p -134.65 142.46 40.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -106.17 144.84 32.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 21' ' ' PHE . 48.9 t -128.7 101.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.5 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.37 -138.66 5.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.392 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.643 HD22 ' CE2' ' A' ' 87' ' ' PHE . 1.6 tp -143.59 51.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.329 0.585 . . . . 0.0 109.66 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 83' ' ' MET . 24.8 m -46.9 174.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.267 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -92.2 -161.31 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.667 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.22 -14.53 63.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.747 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.01 -85.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.497 0.189 . . . . 0.0 111.176 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' HG11 ' A' ' 77' ' ' VAL . 3.5 p-10 179.4 -35.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.592 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -45.71 137.11 5.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.754 0.311 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.592 ' HA ' HG12 ' A' ' 77' ' ' VAL . 49.7 ttm -119.8 121.15 38.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.17 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.26 -3.75 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.093 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -142.12 93.97 2.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -89.91 144.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.169 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.643 ' CE2' HD22 ' A' ' 76' ' ' LEU . 29.0 m-85 -89.66 -34.86 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.357 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -161.66 164.6 29.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.108 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 103' ' ' VAL . 4.9 mttt -126.4 144.82 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -125.05 165.94 17.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.703 HD21 ' HZ2' ' A' ' 56' ' ' TRP . 13.2 mt -147.82 123.77 10.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.378 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.58 HG22 ' HD2' ' A' ' 99' ' ' ARG . 2.2 mp -125.68 137.72 56.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 111.749 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 117.47 7.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -59.44 -37.78 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.226 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.44 -179.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -111.37 -43.11 3.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.203 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 122.48 26.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.318 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 65.89 112.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 92' ' ' ILE . 2.9 tpp85 -114.47 132.13 56.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.905 0.383 . . . . 0.0 111.246 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.16 134.83 50.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 26.6 p90 -140.96 144.24 34.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.563 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.19 156.21 47.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.858 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.5 p -151.52 145.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.28 136.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.214 177.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.671 ' HE3' HD12 ' A' ' 29' ' ' LEU . 45.6 m95 -108.87 -104.13 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.739 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 153.33 6.69 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.235 0.471 . . . . 0.0 110.932 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.154 0.502 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 132.93 40.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.601 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.46 159.2 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.1 152.73 74.26 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.658 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.69 -60.21 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -65.96 -28.25 68.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -67.15 -54.21 23.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.69 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.88 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.6 mt -47.22 -36.5 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -67.03 -39.92 87.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.32 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.11 -62.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.779 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.46 -37.26 16.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.86 -54.74 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.409 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -31.77 56.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 17' ' ' ALA . 53.4 mt -62.08 -73.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CE2' ' CZ ' ' A' ' 41' ' ' PHE . 85.6 t80 -41.13 -30.35 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.817 0.342 . . . . 0.0 111.448 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.9 tp -64.98 -45.1 87.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.52 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.68 -29.02 11.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -51.48 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.92 105.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.275 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.46 -82.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.703 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.47 1.1 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 6.9 m120 -93.11 -28.53 16.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.845 HD12 ' CE3' ' A' ' 105' ' ' TRP . 3.7 tt -96.26 138.93 33.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.542 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -50.41 150.21 4.85 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.796 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 13.5 Cg_exo -70.21 25.02 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.342 2.694 . . . . 0.0 113.735 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.04 -67.04 1.01 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.239 0.542 . . . . 0.0 109.876 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.825 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.69 -21.69 41.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.763 178.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.564 HG13 HD22 ' A' ' 29' ' ' LEU . 39.9 mt -63.33 -41.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -61.77 -47.25 86.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.578 178.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -55.21 -40.61 70.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.254 179.144 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.8 t80 -58.32 -32.92 68.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.216 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -50.54 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.204 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.1 mm? -66.78 -39.13 87.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.27 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.17 -157.75 0.65 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 6.5 t80 83.85 -26.57 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -88.14 -33.2 18.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.482 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -105.86 -28.1 10.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.654 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 39.55 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.753 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 129.0 9.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.39 127.9 2.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.265 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 73' ' ' TRP . 40.0 t -127.02 112.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.4 173.82 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.697 ' CZ ' ' HB1' ' A' ' 70' ' ' ALA . 17.2 t80 -126.79 122.27 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 71' ' ' GLU . 30.3 m -120.8 -165.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -124.03 171.49 9.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 53' ' ' ALA . 57.1 m -60.11 161.63 6.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 52' ' ' THR . . . -113.56 -170.6 1.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 25.82 11.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.055 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -165.68 65.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.661 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.747 ' CH2' HD11 ' A' ' 91' ' ' LEU . 4.6 m95 -95.97 -29.0 14.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.289 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' CD ' HD22 ' A' ' 63' ' ' LEU . 43.0 mt-10 -69.27 64.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.182 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.74 -51.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HG3' ' CZ3' ' A' ' 56' ' ' TRP . 1.4 pm0 -78.27 -66.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.519 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 104' ' ' ILE . 29.2 pt -75.49 -38.97 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 0.0 111.429 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 83.28 81.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.601 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.47 148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 122.481 0.312 . . . . 0.0 110.344 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -58.86 126.54 28.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 63' ' ' LEU . 23.7 mm -125.68 94.9 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -70.47 117.5 55.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.6 152.35 74.18 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.113 1.875 . . . . 0.0 111.962 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 69.32 -1.02 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.34 -9.28 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.693 0.283 . . . . 0.0 111.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -132.75 130.9 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 49' ' ' PHE . . . -89.59 125.88 35.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.542 ' HA ' HD23 ' A' ' 91' ' ' LEU . 30.9 tt0 -103.78 113.95 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.27 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.42 144.11 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.131 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.594 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m0 -118.43 137.59 53.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.37 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 47' ' ' VAL . 51.4 t -122.95 106.29 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.426 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.32 -142.7 7.08 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.62 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.702 HD22 ' CZ ' ' A' ' 87' ' ' PHE . 2.6 tp -145.06 49.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.286 0.565 . . . . 0.0 110.057 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 78' ' ' ASN . 13.2 p -71.15 161.85 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.288 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.3 p30 -89.75 -140.43 0.14 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -75.01 -49.56 19.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.446 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -52.17 -18.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' HG21 ' A' ' 77' ' ' VAL . 4.2 p-10 50.33 49.29 20.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.088 0.47 . . . . 0.0 111.216 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 77' ' ' VAL . 2.0 mt-10 -95.09 23.81 5.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.469 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' GLU . 1.7 tpt 29.68 95.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' CB ' ' A' ' 85' ' ' ASP . 4.4 t70 -144.15 49.9 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 164.03 82.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.441 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 5.3 p -88.94 135.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.702 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 5.7 m-85 -89.09 -47.88 7.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.601 0.715 . . . . 0.0 109.239 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -146.51 169.91 17.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -134.5 147.45 50.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.0 m-85 -126.28 144.24 50.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.747 HD11 ' CH2' ' A' ' 56' ' ' TRP . 21.1 mt -133.0 127.39 34.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.718 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 148.21 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 112.535 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -67.89 129.7 40.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.725 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.511 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 37.9 m-70 -75.15 -36.18 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -54.45 -178.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.6 pt-20 -104.17 -49.74 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.245 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -73.53 133.07 43.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER 58.45 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -123.13 111.37 16.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.85 132.24 53.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 9.8 p90 -123.33 140.15 53.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.0 p -150.3 141.26 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -111.11 135.71 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.845 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.2 m95 -109.56 148.61 30.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 153.93 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.898 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.905 0.383 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.69 -7.08 10.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.835 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -132.27 -155.78 0.71 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.851 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.15 -48.81 2.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 110.642 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mt -107.61 125.18 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.647 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.19 139.55 50.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.59 -178.42 5.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.27 143.94 42.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.08 149.77 93.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.01 -53.34 7.14 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.558 2.172 . . . . 0.0 112.425 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -33.44 70.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.526 ' O ' HD12 ' A' ' 16' ' ' ILE . 4.4 m -65.47 -52.47 52.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -59.67 -48.02 83.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.037 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.87 -40.7 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.87 -55.37 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.911 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 12' ' ' THR . 3.3 mt -58.73 -53.44 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.233 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.885 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -57.32 -40.44 77.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.22 -49.2 70.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.776 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.86 -30.84 71.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.658 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.885 HD12 ' HA ' ' A' ' 17' ' ' ALA . 23.3 mt -72.63 -27.78 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.714 ' CD2' HG11 ' A' ' 74' ' ' VAL . 22.2 t80 -77.23 -27.91 53.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.32 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -34.1 38.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.534 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 13.1 pt-20 -92.08 -37.47 12.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.151 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 16.1 mtp -76.32 -50.57 13.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -45.59 96.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.484 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.05 -115.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 111.188 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.18 -25.74 67.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.91 HD12 ' CZ3' ' A' ' 105' ' ' TRP . 4.2 tt -94.89 150.44 20.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.007 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.87 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -63.09 137.22 97.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.212 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 34' ' ' ILE . 71.5 Cg_exo -49.16 -64.8 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.622 2.215 . . . . 0.0 112.985 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.17 -43.37 21.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.66 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.3 m-20 -66.15 -28.68 68.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.988 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 31' ' ' PRO . 18.4 mt -67.05 -47.16 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.278 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.3 tp -57.95 -60.75 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.616 HD11 ' NE2' ' A' ' 40' ' ' GLN . 12.5 tp -46.13 -44.37 15.71 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.516 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.456 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.7 t80 -64.22 -26.3 68.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.802 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.92 -38.02 33.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.399 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.512 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.3 mm? -83.68 -40.18 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.401 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.837 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.6 pt20 -121.75 106.24 11.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.22 0.533 . . . . 0.0 111.199 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 76' ' ' LEU . 55.3 t80 -163.9 -38.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.025 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -63.34 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.645 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -27.93 64.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.784 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -120.88 59.1 0.93 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 110.502 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.62 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -91.73 134.6 12.34 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.564 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.03 123.82 2.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.21 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.893 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -150.35 68.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.414 . . . . 0.0 110.46 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.42 129.56 34.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.532 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' ' HB1' ' A' ' 13' ' ' ALA . 57.8 t80 -90.4 94.02 9.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 71' ' ' GLU . 10.8 m -90.04 178.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.916 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -104.51 -178.23 3.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 35.7 m -73.22 165.72 24.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 52' ' ' THR . . . -139.2 171.93 13.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.032 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.96 -28.7 18.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.89 46.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.34 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.879 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.1 m95 -92.14 -42.39 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.65 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.84 64.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -161.88 -48.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.451 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.87 -73.16 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.554 HG23 ' HZ3' ' A' ' 56' ' ' TRP . 15.2 pt -61.57 -30.12 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.612 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 93.17 45.92 3.43 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.975 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.612 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 179.5 132.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 111.02 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.3 pp -66.32 141.0 58.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 63' ' ' LEU . 37.2 mm -125.13 145.86 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -73.35 121.27 84.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.393 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 7.1 Cg_exo -69.9 162.37 42.4 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.114 1.876 . . . . 0.0 112.142 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.02 22.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.74 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -137.15 12.98 3.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.414 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -146.18 147.17 31.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.846 ' HB3' HG12 ' A' ' 92' ' ' ILE . . . -89.7 112.6 23.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.62 120.0 35.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.665 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.498 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.0 t -119.7 134.42 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.096 0.474 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 9.2 m0 -122.49 117.07 25.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.679 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.893 HG22 ' CG1' ' A' ' 47' ' ' VAL . 54.1 t -114.72 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -131.55 -135.16 3.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.967 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -139.79 125.88 19.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 45' ' ' GLY . 32.8 m -114.75 175.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 111.675 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -103.78 -164.18 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.22 -3.06 44.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.464 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.0 -5.15 30.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.476 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.91 96.03 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.667 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.12 -148.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 tpt -178.51 58.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.387 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.59 85.74 2.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.754 0.312 . . . . 0.0 110.964 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 p -89.88 135.59 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.797 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 9.1 m-85 -91.47 -49.72 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.025 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -148.32 139.1 22.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 73' ' ' TRP . 0.2 OUTLIER -112.44 132.45 55.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.631 0.253 . . . . 0.0 110.565 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.495 ' CD2' ' HB ' ' A' ' 103' ' ' VAL . 1.2 m-85 -110.19 145.78 36.67 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.879 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 92.8 mt -127.14 105.57 8.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.177 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -109.37 127.5 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.875 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.2 100.36 0.33 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.2 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 41.5 m-70 -37.09 -57.16 0.87 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.286 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -44.2 162.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.151 0.5 . . . . 0.0 111.847 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.1 pt-20 -86.0 -48.67 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.996 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -65.88 133.53 51.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.86 116.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -113.74 93.42 4.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.94 103.37 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 10.3 p90 -120.33 110.92 17.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.7 p80 -128.69 117.19 20.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.939 0.4 . . . . 0.0 111.148 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.495 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 7.2 p -98.1 150.27 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.32 130.08 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.91 ' CZ3' HD12 ' A' ' 29' ' ' LEU . 63.8 m95 -112.11 130.01 56.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.245 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.09 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.983 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttm . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.825 0.345 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.784 HG22 ' O ' ' A' ' 2' ' ' THR . 1.3 m -139.16 50.93 1.8 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.564 0.697 . . . . 0.0 110.088 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 t -90.18 63.74 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.96 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -81.14 121.04 25.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.87 129.79 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.379 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -126.84 139.91 52.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.381 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -89.57 174.61 7.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.043 0.449 . . . . 0.0 111.358 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 147.13 62.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -51.94 -54.28 5.55 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.595 2.197 . . . . 0.0 112.338 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -30.06 69.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.6 m -68.36 -51.76 40.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.06 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.51 -53.0 48.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.803 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -47.38 -33.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.797 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.02 -37.05 72.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 20' ' ' ILE . 13.8 mm -61.79 -62.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.053 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' CB ' HG11 ' A' ' 72' ' ' VAL . . . -52.13 -40.81 61.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.51 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -53.5 -57.3 11.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.01 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -61.43 -28.77 69.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 16' ' ' ILE . 77.8 mt -74.34 -25.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.857 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.519 ' CE1' ' CE2' ' A' ' 37' ' ' PHE . 4.4 t80 -75.13 -51.89 12.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 110.47 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -65.71 -20.74 66.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.814 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -96.28 -46.89 6.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -80.15 -41.12 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.37 150.43 4.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.386 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.95 41.26 3.11 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.659 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -171.64 -29.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 33.1 t30 -115.94 -35.36 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.711 0.291 . . . . 0.0 111.003 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.767 HD23 HG13 ' A' ' 34' ' ' ILE . 2.8 tt -68.06 133.97 49.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -54.06 146.28 30.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.04 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.7 Cg_exo -47.64 -52.73 7.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.902 2.401 . . . . 0.0 113.017 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.4 48.36 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.58 ' CB ' HD21 ' A' ' 29' ' ' LEU . 74.1 m-20 -54.47 -32.0 56.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.702 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.767 HG13 HD23 ' A' ' 29' ' ' LEU . 91.2 mt -63.73 -47.79 89.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.054 0.455 . . . . 0.0 110.046 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -50.03 -57.48 7.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.617 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' GLN . 5.5 mp -63.28 -62.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.99 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -42.61 -30.03 0.33 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -82.19 -74.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.517 . . . . 0.0 111.771 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -69.32 -29.8 67.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.252 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' LEU . 1.6 tp-100 -90.98 25.3 2.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.829 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.1 t80 -102.83 -47.6 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -55.74 -42.47 75.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -39.02 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.936 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.1 mmt85 -130.39 80.89 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.793 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.32 107.38 0.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.707 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 146.66 17.48 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.127 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 74' ' ' VAL . 44.1 t -132.75 110.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.669 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.38 150.51 20.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.187 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 64.5 t80 -103.17 106.34 16.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.652 HG23 ' CG ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -105.79 -178.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.09 172.55 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 53' ' ' ALA . 7.6 m -65.38 164.71 13.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 52' ' ' THR . . . -128.11 162.46 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -98.45 36.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.12 33.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.687 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 1.9 m95 -80.36 -20.57 43.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.348 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.86 61.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 -47.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.924 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HG2' ' CE3' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -84.72 -64.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.687 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 14.0 pt -74.99 -27.59 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 70.76 79.22 0.38 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.792 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.64 ' CG1' HD12 ' A' ' 60' ' ' ILE . 6.9 p 164.53 139.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.671 0.272 . . . . 0.0 110.52 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -58.93 138.08 57.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.907 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 63' ' ' LEU . 26.9 mm -133.66 100.43 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.745 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.77 108.1 1.2 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.141 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.03 158.81 23.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.144 1.896 . . . . 0.0 112.366 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 76.03 -10.53 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.373 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -118.54 16.27 13.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.709 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 84.8 m-85 -138.79 132.25 30.33 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -90.75 112.55 24.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.722 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.797 ' OE1' HD21 ' A' ' 91' ' ' LEU . 7.8 tp10 -90.1 128.35 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.7 t -127.77 136.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.304 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 13.6 m0 -119.18 139.87 51.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.728 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 47' ' ' VAL . 13.4 t -129.37 110.58 20.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.643 ' C ' HD13 ' A' ' 76' ' ' LEU . . . -146.37 -155.34 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.757 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.992 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.17 50.47 1.09 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.724 0.297 . . . . 0.0 111.367 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' ' 83' ' ' MET . 23.7 m -43.23 171.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.204 0.526 . . . . 0.0 111.892 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -120.86 -165.95 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.96 -28.25 69.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -75.76 -31.0 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.29 27.73 1.06 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.367 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.51 22.85 6.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.8 ' HA ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 30.11 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.217 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -27.97 36.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.976 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.88 11.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -108.38 124.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.435 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.992 ' CE2' HD21 ' A' ' 76' ' ' LEU . 3.5 m-85 -89.2 -26.75 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.343 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.31 151.75 17.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -132.65 141.04 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.5 m-85 -120.93 148.4 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 71' ' ' GLU . 44.7 mt -132.76 117.89 18.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -125.0 140.26 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.09 0.471 . . . . 0.0 111.857 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 99' ' ' ARG . 3.1 p -69.49 122.08 18.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.777 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 36.8 m-70 -66.0 -32.22 73.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.287 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -55.74 177.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -103.71 -50.53 3.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.446 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -74.3 122.46 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.502 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.16 112.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.413 HH21 HG21 ' A' ' 16' ' ' ILE . 4.9 ttt-85 -120.71 114.88 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.702 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.58 134.95 42.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 23.5 p90 -127.08 140.26 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.612 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.09 153.29 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.118 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 11.4 p -150.17 137.53 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.802 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -115.56 130.25 70.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.601 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.2 m95 -108.75 150.64 27.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.997 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -64.05 161.06 16.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -65.99 111.93 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.506 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t -73.82 132.04 42.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -107.79 140.01 41.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG21 ' HG2' ' A' ' 95' ' ' ARG . 2.7 mt -91.56 124.71 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.73 -172.19 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.756 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -117.57 125.37 50.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 12' ' ' THR . 1.9 mt -52.0 157.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.37 142.94 51.04 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' O ' HD12 ' A' ' 14' ' ' ILE . 77.7 Cg_exo -48.01 -57.28 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.529 2.153 . . . . 0.0 112.498 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -57.98 -41.54 83.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.67 HG22 HD11 ' A' ' 16' ' ' ILE . 11.9 m -52.94 -64.54 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -47.92 -46.4 31.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.786 0.327 . . . . 0.0 111.353 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -51.78 -43.87 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -39.26 71.03 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.046 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' THR . 5.1 mt -66.98 -66.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.848 0.356 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -48.7 -42.31 34.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -54.99 -50.84 68.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.21 -34.84 47.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.501 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.9 mt -61.37 -69.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 30.1 t80 -41.43 -28.07 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.787 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -71.8 -45.35 61.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.702 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.72 -27.04 14.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 mtp -77.0 -46.44 23.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.734 0.302 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -57.4 -174.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.389 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 34' ' ' ILE . . . 56.81 32.02 61.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -157.84 -28.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.8 m120 -117.11 -19.85 9.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -98.37 161.68 13.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.745 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.4 p30 -62.23 133.14 94.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.689 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.84 ' HA ' HD12 ' A' ' 34' ' ' ILE . 79.2 Cg_exo -41.7 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.734 2.289 . . . . 0.0 113.075 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.16 37.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.723 ' CB ' HD22 ' A' ' 29' ' ' LEU . 42.7 t0 -56.41 -32.14 64.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.303 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.8 mt -61.56 -50.21 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.237 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.588 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -66.2 -48.79 69.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.208 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.627 HD13 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -57.47 -56.0 27.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.542 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.0 t80 -51.58 -26.16 8.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.989 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.57 -63.99 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.248 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 39' ' ' LEU . 1.4 mm? -67.4 -25.65 66.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.279 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HG3' HD13 ' A' ' 36' ' ' LEU . 31.1 mm-40 -101.91 -146.16 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 t80 70.61 -58.2 0.56 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.778 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.71 -37.12 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.8 -42.76 7.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 mmt-85 -119.08 52.14 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.83 133.06 11.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.42 113.16 0.72 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.432 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 74' ' ' VAL . 7.0 p -150.71 99.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -107.79 146.57 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.279 0.562 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 66.2 t80 -85.19 97.92 10.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.658 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 71' ' ' GLU . 3.0 m -89.96 176.89 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.374 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.747 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.95 163.22 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.32 13.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.11 -14.34 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.98 44.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.088 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.67 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 9.0 m95 -98.8 -29.8 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.915 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -68.27 61.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -162.63 -46.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.525 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -75.74 -78.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 64' ' ' ILE . 27.0 pt -71.65 -28.64 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.449 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.646 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 74.28 81.53 0.44 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.485 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.646 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.67 146.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 63' ' ' LEU . 3.0 pp -71.31 113.29 8.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.764 0.316 . . . . 0.0 110.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.467 HG22 ' CD2' ' A' ' 69' ' ' TYR . 31.4 mm -109.31 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.192 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 8.6 m-20 -55.56 106.29 0.65 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 52' ' ' THR . 18.3 Cg_endo -60.25 157.12 36.73 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.108 1.872 . . . . 0.0 112.304 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 75.25 -9.24 1.42 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.348 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 1.8 pt-20 -120.13 19.83 12.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.574 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' CD2' HG22 ' A' ' 64' ' ' ILE . 75.5 m-85 -141.55 139.82 33.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.959 0.409 . . . . 0.0 111.218 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.965 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.35 114.49 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.518 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.869 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -96.67 129.39 44.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.715 HG11 ' HB1' ' A' ' 17' ' ' ALA . 6.0 p -135.21 130.42 51.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.547 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 14.4 m0 -114.54 135.62 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.903 HG22 HG23 ' A' ' 47' ' ' VAL . 16.6 t -127.63 111.14 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.986 0.422 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.12 -131.91 2.42 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.403 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.512 HD13 ' HE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -138.04 158.36 44.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -147.83 -177.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 111.306 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -118.53 -168.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.787 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -28.45 62.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.036 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.24 -14.56 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.439 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.51 72.6 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.43 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG12 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -140.82 148.82 41.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.532 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.28 105.78 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.26 -4.53 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -131.01 88.88 2.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.987 0.422 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.729 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.5 p -89.69 138.22 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.827 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.512 ' HE2' HD13 ' A' ' 76' ' ' LEU . 16.9 m-85 -89.39 -48.94 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.9 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.692 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -138.65 166.11 25.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.614 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.729 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -146.34 135.75 22.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.8 m-85 -126.98 144.02 51.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.905 HD12 ' CE1' ' A' ' 102' ' ' HIS . 3.1 mt -131.67 124.02 29.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -130.24 142.85 42.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 112.273 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.8 p -65.09 120.29 12.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.936 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.965 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 89.2 m-70 -62.74 -24.7 67.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.445 ' HG2' HG21 ' A' ' 5' ' ' ILE . 57.6 mtp180 -54.06 174.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.361 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.67 -65.49 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -71.64 131.52 43.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.317 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.2 112.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.33 115.98 21.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.354 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.12 120.93 38.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.103 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.42 ' HB3' HG22 ' A' ' 92' ' ' ILE . 19.5 p90 -124.5 143.85 50.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 111.327 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.905 ' CE1' HD12 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -143.76 168.95 18.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.351 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 13.4 p -151.05 143.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.471 HG21 ' HE3' ' A' ' 89' ' ' LYS . 3.9 mp -112.6 110.55 32.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.338 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.692 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 55.7 m95 -96.26 149.33 21.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 110.967 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.01 155.53 32.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.938 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.938 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 2' ' ' THR . 0.5 OUTLIER -129.01 9.04 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -177.13 136.42 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -85.97 -54.86 4.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 mt -112.36 127.22 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -173.58 3.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.844 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -139.79 -178.42 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.007 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 12' ' ' THR . 1.9 mt -111.91 139.4 47.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.82 149.31 95.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.538 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.41 -59.79 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.437 2.091 . . . . 0.0 112.415 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -24.87 65.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 16' ' ' ILE . 92.7 m -76.16 -43.34 43.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.082 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.24 -29.37 70.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -79.83 -58.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.611 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -41.4 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.641 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -70.27 -43.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.079 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.856 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -64.11 -45.32 89.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.015 0.436 . . . . 0.0 110.356 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -51.35 -46.82 62.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -61.72 -27.91 69.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.479 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 17' ' ' ALA . 51.8 mt -75.12 -30.91 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.6 t80 -68.41 -51.28 45.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.14 -16.52 63.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.662 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 2.7 tp10 -94.13 -51.14 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.656 0.265 . . . . 0.0 111.511 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.411 ' CE ' HG12 ' A' ' 103' ' ' VAL . 15.4 mtp -74.61 -44.37 50.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -48.68 162.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 111.521 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.72 32.01 54.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.553 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -151.29 -33.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.62 0.248 . . . . 0.0 111.632 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.2 t30 -126.69 -39.18 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.723 0.297 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.891 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.5 tt -55.56 139.23 44.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.891 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -57.26 136.71 81.12 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.755 -179.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 76.8 Cg_exo -48.51 -51.92 9.41 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.0 113.297 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.59 -58.74 5.83 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.085 0.469 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.625 ' CB ' HD21 ' A' ' 29' ' ' LEU . 68.3 m-20 -51.69 -29.95 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.841 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 38' ' ' ASN . 57.5 mt -69.09 -47.79 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 39' ' ' LEU . 1.2 tp -45.18 -59.64 2.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.666 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 8.8 mt -56.91 -47.31 80.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.254 0.55 . . . . 0.0 110.241 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' HZ ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -48.25 -51.66 24.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.434 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.724 HD21 HG22 ' A' ' 34' ' ' ILE . 1.8 p30 -80.3 -40.79 26.14 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.847 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.6 ' HG ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -72.73 -9.41 58.61 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 8.9 mm-40 -126.91 -137.52 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.939 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.584 ' CE1' ' HA2' ' A' ' 46' ' ' GLY . 2.6 t80 72.15 -56.09 0.65 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.796 0.332 . . . . 0.0 111.617 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -51.82 -39.64 59.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.14 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.19 27.44 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.673 ' HB3' HD12 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -131.89 -4.06 3.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' HA3' HG22 ' A' ' 77' ' ' VAL . . . 135.83 163.2 9.88 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.56 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA2' ' CE1' ' A' ' 41' ' ' PHE . . . -125.19 -115.02 2.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.792 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 73' ' ' TRP . 59.6 t -132.43 136.98 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.969 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -122.99 131.78 53.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.668 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 17.3 t80 -88.74 113.0 23.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.094 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.686 HG23 ' HB3' ' A' ' 71' ' ' GLU . 34.5 m -107.69 -176.88 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -98.38 170.61 8.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 111.093 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.3 m -70.06 157.28 37.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.95 -156.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.136 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.1 -42.14 11.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.45 129.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.767 ' O ' HG12 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -162.42 150.54 14.4 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.415 0.626 . . . . 0.0 110.304 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.04 32.48 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.219 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -113.64 -25.34 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.226 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.87 -54.57 3.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.622 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.2 pt -75.91 -44.82 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.789 0.328 . . . . 0.0 110.952 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 104.41 54.37 0.79 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.107 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.455 HG12 HD12 ' A' ' 60' ' ' ILE . 14.8 p 175.95 140.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-O 120.927 0.394 . . . . 0.0 111.467 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.86 138.62 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 56' ' ' TRP . 37.2 mm -111.26 128.35 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -104.55 112.11 65.31 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 30.6 Cg_endo -63.92 156.08 60.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.345 2.03 . . . . 0.0 112.043 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 4.1 pt-20 54.87 9.92 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.938 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -132.37 -5.33 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -126.12 143.56 51.08 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.798 0.332 . . . . 0.0 110.645 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -96.01 128.73 43.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.686 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -111.98 117.36 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.751 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 t -119.39 129.35 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.615 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.9 m0 -105.6 143.91 33.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.765 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 47' ' ' VAL . 42.9 t -137.23 101.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.207 0.527 . . . . 0.0 110.934 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . . . -152.65 -120.03 0.82 Allowed Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.359 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 44' ' ' ARG . 1.9 mm? -142.31 146.8 35.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 83' ' ' MET . 3.6 m -115.86 178.35 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.357 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.28 -165.72 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 -22.42 66.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -80.88 -81.13 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 77' ' ' VAL . 1.0 OUTLIER 173.54 -34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -56.04 132.42 50.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.033 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.533 ' HA ' HG12 ' A' ' 77' ' ' VAL . 36.2 ttm -88.99 79.35 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.78 -6.55 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.88 83.21 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.301 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 86' ' ' VAL . 2.0 p -89.69 126.96 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.074 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.2 m-85 -89.37 -32.49 17.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.227 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' ILE . . . -161.34 148.98 15.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -113.44 141.72 46.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 2.4 m-85 -117.83 141.68 48.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.091 0.472 . . . . 0.0 111.596 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 64' ' ' ILE . 25.0 mt -125.2 156.17 38.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.605 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.932 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -163.8 117.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.998 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.69 104.63 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.742 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.822 ' HE1' ' HB2' ' A' ' 70' ' ' ALA . 23.9 m-70 -51.9 109.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 0.0 111.244 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -166.25 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 18.7 pt-20 -138.02 -54.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.373 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -85.23 -0.23 53.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.418 0.628 . . . . 0.0 111.306 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -162.0 102.84 1.14 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -126.48 120.86 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -108.5 112.1 24.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.467 ' HB2' HG23 ' A' ' 92' ' ' ILE . 1.9 p90 -118.98 139.3 51.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.504 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -148.65 171.22 16.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.046 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' LYS . 8.1 p -152.05 143.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.62 142.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.378 177.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.878 ' CE3' HD12 ' A' ' 29' ' ' LEU . 65.6 m95 -113.31 149.09 34.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 159.71 6.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.828 0.347 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 3' ' ' THR . 1.1 m -64.19 -32.43 74.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.578 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 2' ' ' THR . 3.1 t 46.1 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -94.87 -27.67 15.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.33 141.45 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -89.91 -178.66 5.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -140.21 -177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.11 144.94 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.9 148.2 71.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.92 -53.26 7.29 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.531 2.154 . . . . 0.0 112.354 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.83 -29.96 69.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -65.93 -56.3 12.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.986 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -56.69 -46.62 81.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.4 mt -55.87 -42.98 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.01 -52.94 63.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 13' ' ' ALA . 3.4 mt -60.57 -59.74 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -49.03 -34.57 13.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.276 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -62.16 -54.08 46.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.68 -31.56 48.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' A' ' 24' ' ' MET . 55.6 mt -68.57 -71.83 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.786 ' CD2' HG11 ' A' ' 74' ' ' VAL . 41.3 t80 -40.62 -30.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.792 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.67 -39.13 58.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.852 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -92.51 -34.62 14.0 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.746 ' HG2' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -84.61 -35.95 22.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -62.59 129.99 43.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.24 44.69 0.47 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.629 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -176.04 -24.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -120.8 -35.1 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.781 HD23 HG13 ' A' ' 34' ' ' ILE . 2.7 tt -64.47 139.6 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -44.32 139.21 3.39 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.994 -179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 4.1 Cg_endo -46.51 -52.51 7.3 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.961 2.441 . . . . 0.0 112.841 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.3 -57.44 10.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.693 ' CB ' HD21 ' A' ' 29' ' ' LEU . 4.2 m-20 -53.97 -28.32 36.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.272 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.781 HG13 HD23 ' A' ' 29' ' ' LEU . 74.2 mt -65.79 -46.28 89.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.001 0.429 . . . . 0.0 110.009 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.604 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.47 -54.54 44.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.038 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 mt -59.06 -59.85 4.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -47.3 -30.63 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.995 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.07 -45.23 18.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.816 0.341 . . . . 0.0 111.42 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.604 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -76.05 -79.1 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.999 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -80.95 84.52 6.41 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -133.31 -30.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.685 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.31 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.01 -39.51 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.483 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 76' ' ' LEU . 5.5 mpt_? -72.56 -40.43 66.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.132 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.15 113.46 3.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.188 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.97 151.17 21.6 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 74' ' ' VAL . 47.8 t -134.69 104.88 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 117.027 0.413 . . . . 0.0 110.961 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -94.38 147.42 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 72' ' ' VAL . 56.4 t80 -97.01 134.26 40.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -131.45 177.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.915 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.32 148.45 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 111.133 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 53' ' ' ALA . 88.4 m -45.55 165.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.289 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 52' ' ' THR . . . -117.06 -170.08 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.21 40.56 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -178.65 45.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.705 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.913 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 2.5 m95 -72.01 -19.75 61.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.444 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.32 63.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -148.97 -57.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.16 -61.03 1.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.473 HD11 HG13 ' A' ' 64' ' ' ILE . 33.8 pt -86.15 -23.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.406 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.03 -54.74 3.65 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.092 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.564 HG13 HD11 ' A' ' 64' ' ' ILE . 8.1 p -51.11 153.75 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.861 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -76.29 135.9 39.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.408 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 62' ' ' VAL . 20.1 mm -130.98 116.6 34.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 111.626 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -73.23 122.44 87.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.854 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 29.1 Cg_endo -64.11 153.44 76.22 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.283 1.989 . . . . 0.0 112.257 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.71 3.84 2.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.654 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -111.2 -16.12 13.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.712 0.292 . . . . 0.0 111.211 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -124.73 154.83 40.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -106.27 122.83 47.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.226 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HG3' HG23 ' A' ' 50' ' ' VAL . 9.6 pt-20 -114.6 144.59 43.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.08 0.467 . . . . 0.0 111.631 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 49' ' ' PHE . 1.6 t -142.96 142.92 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 39.9 m0 -114.91 140.95 48.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.786 HG11 ' CD2' ' A' ' 21' ' ' PHE . 72.3 t -126.29 114.86 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.593 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 85' ' ' ASP . . . -150.65 -146.93 4.43 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.226 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.891 HD21 ' CE2' ' A' ' 87' ' ' PHE . 1.5 mm? -119.61 153.51 35.37 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -154.98 -168.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.857 0.36 . . . . 0.0 111.053 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -107.97 -156.93 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.486 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -85.86 -10.17 55.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.459 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -71.79 -8.75 56.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.577 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.58 78.09 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.813 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -148.37 -148.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.4 tpp -142.51 -82.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.021 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 44.12 41.01 3.85 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 169.31 78.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.338 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 p -90.04 134.94 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.804 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.891 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -92.73 -45.81 7.86 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.601 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -136.84 162.79 32.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.563 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' HG13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -138.14 140.14 39.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.5 m-85 -120.93 154.25 36.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.913 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 72.7 mt -139.97 121.16 14.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.646 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -135.6 125.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.029 0.442 . . . . 0.0 111.847 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.7 p -53.94 125.98 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.946 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -55.56 -41.46 73.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.146 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -56.66 143.85 34.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -32.61 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 154.14 42.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.678 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.31 -67.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.19 84.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.704 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.06 123.18 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.772 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -119.16 139.1 52.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.8 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.84 129.14 25.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.518 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 24' ' ' MET . 11.4 p -122.48 140.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.581 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' N ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.44 131.88 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.664 ' HE3' HD12 ' A' ' 29' ' ' LEU . 28.1 m95 -108.62 149.84 28.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 0.2 OUTLIER -61.47 159.49 12.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.858 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.918 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.884 0.373 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -146.05 24.44 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -77.35 119.08 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.721 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -111.23 104.76 13.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.673 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 mm -71.04 128.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.325 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.03 166.73 11.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.648 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -125.45 116.82 22.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.839 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.31 10.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.79 160.06 29.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -57.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.674 2.249 . . . . 0.0 112.171 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -31.19 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -64.81 -47.3 78.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.915 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -63.81 -50.66 68.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.4 mt -49.09 -36.58 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -38.18 72.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.722 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.9 mt -67.35 -63.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.1 -39.8 21.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.079 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.507 ' HD1' HG21 ' A' ' 47' ' ' VAL . 30.8 t80 -55.7 -51.38 67.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.191 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.66 -30.06 70.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 17' ' ' ALA . 96.3 mt -64.27 -46.51 93.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -63.45 -52.16 62.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.447 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -59.19 -22.68 61.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.404 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 1.3 pp20? -103.94 -48.43 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 4.1 mtp -67.44 -57.41 6.6 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' CH2' ' A' ' 105' ' ' TRP . . . -45.94 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.026 0.441 . . . . 0.0 111.79 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -48.11 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.98 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -146.19 23.71 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.778 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 7.1 m-80 -102.89 -48.09 4.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.0 tt -87.84 143.14 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.845 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.798 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.99 150.96 0.55 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.092 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.3 Cg_endo -53.45 -19.45 13.4 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.595 2.197 . . . . 0.0 112.592 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.23 72.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.459 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -74.5 -28.65 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.419 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.0 mt -59.17 -50.14 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.926 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -74.04 -42.91 59.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 87' ' ' PHE . 1.4 tp -57.7 -64.46 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.941 0.4 . . . . 0.0 110.491 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 5.2 m-85 -45.41 -29.87 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.163 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.548 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.77 -9.63 21.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.486 HE21 HD21 ' A' ' 76' ' ' LEU . 20.7 pt20 -151.35 116.1 5.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.337 0.589 . . . . 0.0 112.322 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' CA ' ' A' ' 45' ' ' GLY . 11.1 t80 -169.75 -38.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.938 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -56.48 -65.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -40.08 88.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.576 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -95.89 28.37 3.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.088 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 41' ' ' PHE . . . -94.9 120.84 6.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.606 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.34 98.22 0.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.303 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 74' ' ' VAL . 21.4 t -94.18 97.27 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.65 137.43 35.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.822 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 75.2 t80 -92.2 116.39 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.468 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -168.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -135.3 153.7 51.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 22.4 m -56.14 162.33 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.076 0.465 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB3' ' HD1' ' A' ' 56' ' ' TRP . . . -105.45 -151.24 0.45 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.042 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.96 31.24 0.98 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.766 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 79.53 88.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.697 ' HD1' ' HB3' ' A' ' 53' ' ' ALA . 7.7 p-90 -97.87 46.95 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.433 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER -69.04 61.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.47 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -130.41 -39.22 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.968 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -91.45 -38.3 12.65 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.685 HD11 ' CD1' ' A' ' 64' ' ' ILE . 4.7 pt -95.27 -26.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.049 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 90.73 -46.46 2.94 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.299 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -62.43 159.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.941 0.401 . . . . 0.0 111.764 -178.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -78.27 135.24 37.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.627 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.685 ' CD1' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.76 90.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.372 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 1.2 m-20 -75.79 113.52 27.88 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 5.7 Cg_exo -41.36 -72.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.194 2.596 . . . . 0.0 114.524 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -74.61 8.87 2.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 65' ' ' ASP . 8.3 mt-10 -121.34 -14.44 8.29 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.623 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.4 145.0 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.122 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -112.75 140.47 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.643 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -112.57 139.36 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.404 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.0 t -139.51 138.35 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.953 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -120.14 131.98 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.008 0.433 . . . . 0.0 111.162 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 47' ' ' VAL . 53.6 t -121.83 113.01 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.39 -124.15 2.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.216 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.486 HD21 HE21 ' A' ' 40' ' ' GLN . 2.4 tp -146.94 71.64 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.052 0.453 . . . . 0.0 109.857 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 82' ' ' GLU . 33.7 m -55.45 173.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.31 0.576 . . . . 0.0 112.096 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -147.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.717 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 -5.44 16.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.8 34.65 5.12 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.664 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.31 87.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.742 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.3 mt-10 -156.43 155.98 33.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.881 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.2 tpp -142.63 104.1 4.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.285 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.77 -18.58 8.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.263 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.68 109.19 11.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.949 0.404 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.56 137.11 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.531 ' HZ ' HD23 ' A' ' 36' ' ' LEU . 22.7 m-85 -89.56 -33.6 16.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.724 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 172.93 17.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.437 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.879 ' HB2' HD11 ' A' ' 104' ' ' ILE . 6.6 mttm -130.57 147.37 52.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.2 m-85 -125.45 134.57 52.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 112.026 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.594 HD12 ' CE1' ' A' ' 102' ' ' HIS . 15.0 mt -122.41 136.05 54.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.775 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -149.94 116.74 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.081 0.467 . . . . 0.0 111.835 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.7 m -46.99 149.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 19.5 m-70 -89.78 23.06 2.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -92.73 165.52 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.81 -59.27 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -84.09 121.24 27.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.395 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.19 110.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.05 140.1 47.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.944 0.402 . . . . 0.0 111.228 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.9 141.85 36.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.36 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 92' ' ' ILE . 30.6 p90 -138.15 142.03 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.594 ' CE1' HD12 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -144.24 130.67 19.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.211 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -119.94 140.53 43.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.84 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.31 135.2 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.784 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 38.5 m95 -106.93 147.49 29.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.62 155.92 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.771 HG22 HG22 ' A' ' 3' ' ' THR . 1.1 m -165.61 -53.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.537 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.771 HG22 HG22 ' A' ' 2' ' ' THR . 9.9 t -167.53 109.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.33 -59.7 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.588 HD12 HH11 ' A' ' 95' ' ' ARG . 27.4 mm -97.57 133.6 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.5 129.78 44.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -93.45 -170.95 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.65 144.71 48.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 147.83 79.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.74 -49.52 16.96 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.565 2.177 . . . . 0.0 112.347 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -30.25 65.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -66.44 -49.76 65.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -65.01 -44.14 90.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.021 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.4 mt -59.79 -34.43 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -44.09 76.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 13' ' ' ALA . 5.0 mt -64.97 -54.78 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.88 -40.55 73.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.21 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.48 -52.04 66.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.56 -32.04 71.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 17' ' ' ALA . 19.4 mt -73.71 -28.75 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 32.5 t80 -77.26 -25.77 51.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.368 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 22' ' ' LEU . 1.1 tp -78.11 -32.63 50.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.254 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.01 -38.18 9.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.174 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 22.7 mtp -75.95 -50.11 15.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.63 0.252 . . . . 0.0 111.577 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -49.12 111.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.406 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.41 -96.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.852 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.95 -4.48 52.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.1 m120 -90.54 -31.45 16.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.661 HD12 ' HE3' ' A' ' 105' ' ' TRP . 2.5 tt -92.66 139.27 30.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.65 132.9 13.94 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.976 -178.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.63 ' HA ' HD12 ' A' ' 34' ' ' ILE . 84.4 Cg_exo -42.07 -56.6 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.261 2.641 . . . . 0.0 113.627 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 -57.22 5.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 0.0 110.76 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 29' ' ' LEU . 1.5 m-20 -49.95 -27.13 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.978 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 31' ' ' PRO . 51.3 mt -68.57 -53.48 27.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.129 0.49 . . . . 0.0 110.234 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -49.75 -60.38 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.181 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.53 HD12 ' NE2' ' A' ' 40' ' ' GLN . 4.5 mm? -51.05 -40.29 57.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.074 0.464 . . . . 0.0 110.664 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.454 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.5 t80 -64.97 -32.63 74.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.423 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.57 -39.12 28.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.928 0.394 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -79.18 -40.75 30.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.751 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.53 ' NE2' HD12 ' A' ' 36' ' ' LEU . 8.9 pt20 -128.98 106.38 8.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 111.811 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 34.6 t80 -165.02 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.232 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.51 -31.75 72.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.281 0.563 . . . . 0.0 110.09 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.7 -22.65 10.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.113 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.761 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -130.36 31.99 4.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.997 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.09 114.14 2.62 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.773 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.94 165.94 22.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.115 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 73' ' ' TRP . 48.3 t -146.0 122.43 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.764 0.282 . . . . 0.0 110.57 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.38 164.07 13.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.346 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.814 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 16.0 t80 -106.8 108.16 19.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG23 ' CG ' ' A' ' 71' ' ' GLU . 3.2 m -103.8 -178.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.39 -175.62 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 53' ' ' ALA . 89.9 m -91.12 162.34 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 52' ' ' THR . . . -82.07 -160.09 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.26 -45.48 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.8 127.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.839 ' CH2' HD11 ' A' ' 91' ' ' LEU . 15.9 m0 -87.42 -75.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.533 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 63' ' ' LEU . 1.5 mm-40 43.57 31.24 0.42 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -155.43 -37.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.865 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 24.1 mm-40 -82.12 -74.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.691 HD11 ' CD1' ' A' ' 64' ' ' ILE . 19.1 pt -82.13 -46.86 19.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.259 . . . . 0.0 111.67 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 119.67 69.32 0.31 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.6 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 64' ' ' ILE . 13.0 p 175.57 151.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 63' ' ' LEU . 4.4 tt -64.91 -5.98 7.34 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.775 HD13 HG13 ' A' ' 62' ' ' VAL . 6.9 mm 59.19 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.209 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -112.92 82.35 5.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.902 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 35.8 Cg_exo -53.05 168.02 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.961 1.774 . . . . 0.0 111.837 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 56.25 12.47 1.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 27.7 mt-10 -135.15 -3.41 2.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.348 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 84.4 m-85 -132.11 142.26 49.45 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.814 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -91.02 124.06 34.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.888 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.713 ' CG ' HG23 ' A' ' 50' ' ' VAL . 6.1 tp10 -99.34 119.91 38.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.66 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -122.8 137.03 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.109 0.48 . . . . 0.0 111.052 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.785 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m0 -115.17 141.01 48.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 47' ' ' VAL . 28.1 t -129.64 103.74 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.964 0.412 . . . . 0.0 111.356 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.44 20.56 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.703 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -102.32 153.16 20.27 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.824 HG11 ' C ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -150.11 -167.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-O 120.699 0.285 . . . . 0.0 110.778 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' H ' HG12 ' A' ' 77' ' ' VAL . 29.7 m-80 -103.62 -170.14 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -79.54 -13.35 59.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -74.26 -5.05 39.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.534 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.36 88.82 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.964 0.412 . . . . 0.0 111.017 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.824 ' C ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -151.46 -168.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.38 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.402 ' HE1' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -160.06 91.61 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.362 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -118.74 -9.93 10.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.137 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -128.74 84.75 2.26 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.958 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 73' ' ' TRP . 1.5 p -89.91 140.49 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.761 ' CE2' HD21 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -98.52 -29.7 12.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.9 167.95 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 103' ' ' VAL . 17.1 ttpt -142.44 139.77 31.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.5 m-85 -122.73 145.89 48.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.839 HD11 ' CH2' ' A' ' 56' ' ' TRP . 94.3 mt -124.52 119.35 28.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.188 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.614 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -130.08 122.35 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 111.819 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -55.95 118.46 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.498 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -56.39 -38.67 71.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.588 HH11 HD12 ' A' ' 5' ' ' ILE . 6.3 mtm-85 -59.66 176.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -32.33 10.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.037 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -79.67 150.39 30.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.717 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 40.53 31.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.206 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.06 103.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.072 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -117.83 137.26 52.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.067 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 12.3 p90 -134.81 137.94 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.547 ' ND1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -139.17 159.49 42.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.439 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' LYS . 7.3 p -151.02 142.71 16.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.594 HD11 ' HE3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -112.52 140.95 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.066 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.703 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 32.9 m95 -116.99 149.88 39.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.168 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.24 158.63 22.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.883 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.989 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HB ' ' A' ' 2' ' ' THR . 1.7 mpp? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.775 0.322 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.564 ' O ' ' CG2' ' A' ' 2' ' ' THR . 1.1 m 64.88 13.83 8.82 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.438 HG21 HD11 ' A' ' 5' ' ' ILE . 11.5 t -144.25 -166.2 2.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.796 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -144.97 69.83 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 3' ' ' THR . 1.7 mt -88.39 142.25 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 173.46 7.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.003 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -112.93 127.15 56.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.013 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -62.46 142.54 57.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.586 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -46.28 169.6 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.706 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.79 -59.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.95 2.433 . . . . 0.0 112.287 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.19 -28.53 68.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -57.18 -57.49 12.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.834 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.87 -52.1 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 49' ' ' PHE . 53.0 mt -45.04 -36.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.999 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.13 -39.89 75.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.557 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 20' ' ' ILE . 29.8 mm -61.87 -64.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.808 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.813 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -47.96 -41.42 24.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -51.52 -54.82 23.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.206 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -25.76 67.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.357 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' A' ' 17' ' ' ALA . 70.1 mt -75.95 -23.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.697 ' CG ' HG11 ' A' ' 74' ' ' VAL . 33.0 t80 -80.02 -32.49 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.426 . . . . 0.0 110.615 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD13 ' HZ ' ' A' ' 37' ' ' PHE . 3.0 mm? -80.33 -19.57 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.72 -41.12 6.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 20' ' ' ILE . 22.7 mtp -78.5 -45.05 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -61.14 159.72 11.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 111.341 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.05 40.04 4.69 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.566 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.3 -21.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 2.9 m-80 -110.35 -43.79 3.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.776 0.322 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.0 tt -75.94 151.74 37.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.03 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.863 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -48.37 155.13 0.98 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 44.6 Cg_exo -56.93 -30.64 86.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.793 2.329 . . . . 0.0 112.711 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.04 -58.61 5.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.811 0.338 . . . . 0.0 111.373 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.672 ' OD2' HD13 ' A' ' 29' ' ' LEU . 46.2 t0 -64.5 -27.87 69.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.382 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 87.2 mt -60.04 -43.19 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.435 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.579 ' HG ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -80.16 -44.11 20.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -62.8 -70.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.485 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.571 ' HZ ' HD13 ' A' ' 22' ' ' LEU . 1.3 t80 -48.48 -26.11 1.99 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.561 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.09 -52.15 11.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD22 ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -69.98 -72.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.372 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.573 ' NE2' HD21 ' A' ' 76' ' ' LEU . 20.2 pt20 -77.19 -135.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 14.8 t80 87.51 -27.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.896 0.379 . . . . 0.0 110.622 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -54.35 -65.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.16 -30.56 11.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 -24.23 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.58 128.24 8.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.686 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.08 153.18 24.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.114 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 73' ' ' TRP . 62.5 t -139.09 125.68 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.643 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 72' ' ' VAL . 1.3 pt-20 -108.8 157.51 18.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.729 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.82 114.59 27.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.921 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 71' ' ' GLU . 12.8 m -113.7 -177.3 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -111.42 168.06 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.58 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.3 m -54.06 154.75 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.825 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -86.42 -163.53 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -95.43 37.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.887 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 3.0 t0 80.12 109.1 0.07 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.825 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -134.97 30.07 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.481 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 77.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' TRP . 4.0 mt-10 -154.87 -34.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.349 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.21 -49.66 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.97 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 64' ' ' ILE . 4.1 pt -70.69 -36.67 66.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 0.0 110.978 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.64 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 94.26 60.24 1.12 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.092 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.64 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.42 141.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.03 135.87 52.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.872 HD11 HD11 ' A' ' 60' ' ' ILE . 6.9 mm -105.54 128.01 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 111.538 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.68 109.94 39.3 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.385 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.95 156.08 51.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.244 1.962 . . . . 0.0 112.111 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 62.04 8.28 2.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.87 -4.35 8.6 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.58 0.229 . . . . 0.0 111.427 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -148.01 135.35 20.54 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.945 0.402 . . . . 0.0 111.443 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -91.04 123.45 34.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.994 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.462 ' CG ' HG23 ' A' ' 50' ' ' VAL . 23.1 tt0 -101.7 119.66 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 0.0 110.946 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 48' ' ' GLU . 7.0 p -127.91 124.34 62.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.72 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.83 ' O ' HG13 ' A' ' 47' ' ' VAL . 24.9 m0 -89.84 141.74 28.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.697 HG11 ' CG ' ' A' ' 21' ' ' PHE . 88.7 t -129.32 96.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.5 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.88 -141.31 3.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.363 -0.923 . . . . 0.0 113.853 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.573 HD21 ' NE2' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -142.34 172.09 13.16 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 78' ' ' ASN . 6.2 t -153.67 163.93 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.503 ' N ' HG12 ' A' ' 77' ' ' VAL . 5.3 m-80 -89.45 -152.05 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.403 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -91.64 26.1 2.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.183 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 82' ' ' GLU . 5.8 pt20 -108.94 -0.4 19.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.443 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.18 38.15 28.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.749 0.309 . . . . 0.0 111.574 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 5.3 mm-40 -98.26 -158.37 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.387 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -163.44 32.34 0.09 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -90.71 0.69 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.31 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.65 73.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.979 0.419 . . . . 0.0 110.663 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.88 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.029 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 8.4 m-85 -89.72 -41.66 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.99 162.46 39.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.573 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.791 ' O ' HG23 ' A' ' 103' ' ' VAL . 22.9 mttt -118.26 143.71 46.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 3.2 m-85 -124.04 136.77 54.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.076 0.465 . . . . 0.0 112.199 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.519 ' C ' HD13 ' A' ' 92' ' ' ILE . 24.4 mt -121.27 124.32 44.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.858 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.698 HG22 ' NH2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -119.27 122.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.29 127.74 33.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.022 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.989 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.7 m-70 -75.78 -4.47 40.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.729 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.34 116.89 24.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -40.36 63.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.268 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 149.24 46.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.66 -65.57 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.698 ' NH2' HG22 ' A' ' 92' ' ' ILE . 0.4 OUTLIER 61.91 92.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' N ' ' NH1' ' A' ' 99' ' ' ARG . 7.7 mm-40 -113.91 145.83 40.94 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.517 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 39.7 p90 -137.82 143.82 41.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.901 0.381 . . . . 0.0 111.817 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.67 150.47 46.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 89' ' ' LYS . 10.9 p -150.17 142.31 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.849 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.69 138.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.778 178.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 28' ' ' ASN . 46.4 m95 -113.86 147.03 39.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.15 152.01 41.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mmm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.828 0.346 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -65.43 -46.23 80.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.557 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.3 t -151.05 -43.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.967 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -110.35 166.98 10.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mt -125.84 152.61 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -89.97 127.72 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.634 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -177.38 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.49 159.33 26.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.29 146.82 38.77 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.795 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.94 -54.51 5.33 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.696 ' HA ' HD12 ' A' ' 14' ' ' ILE . 6.3 p-10 -67.13 -33.63 75.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.032 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 16' ' ' ILE . 86.8 m -68.15 -46.55 70.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.77 76.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.024 0.44 . . . . 0.0 110.797 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 11' ' ' ASP . 48.2 mt -61.76 -58.07 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.03 -31.17 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.117 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 12' ' ' THR . 3.4 mm -70.25 -59.07 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.0 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB3' HG11 ' A' ' 72' ' ' VAL . . . -61.67 -47.2 86.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.186 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.2 -45.0 65.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -62.6 -40.19 96.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.825 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 20' ' ' ILE . 14.4 mt -77.44 -15.92 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 72.2 t80 -73.07 -61.98 1.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.43 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.24 -4.89 38.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.03 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.1 tt0 -96.75 -52.33 3.95 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.812 0.339 . . . . 0.0 110.991 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.437 ' O ' ' C ' ' A' ' 25' ' ' ALA . 2.1 ttp -75.07 -37.12 61.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 21' ' ' PHE . . . -27.62 141.53 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.145 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.72 -86.01 0.4 Allowed Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -71.75 69.08 0.65 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.1 OUTLIER 169.17 -43.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.773 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.906 HD12 ' CE3' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -86.61 161.47 18.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.094 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.832 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -86.89 149.99 49.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.973 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.1 Cg_endo -50.95 -55.01 4.49 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.033 2.489 . . . . 0.0 113.336 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.29 -59.4 4.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.79 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.788 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -56.36 -24.22 42.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.183 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 40.5 mt -71.97 -39.46 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.056 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.4 tt -59.83 -52.68 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -57.18 -46.6 82.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.243 0.544 . . . . 0.0 110.473 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 1.9 t80 -55.03 -23.06 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.773 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB2' HD22 ' A' ' 39' ' ' LEU . 22.1 m120 -80.59 -41.01 24.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.8 OUTLIER -104.11 14.13 31.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB2' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -147.68 23.42 1.12 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.085 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.5 t80 -112.1 -12.81 13.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.177 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.92 -35.26 17.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 0.0 110.19 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -112.82 -24.78 9.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.876 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.443 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 27.66 8.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.671 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.71 110.12 3.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.025 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.47 140.67 11.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.682 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.76 140.38 45.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 0.0 110.925 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -125.53 131.01 52.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.981 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 70.7 t80 -73.32 114.88 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -107.46 -173.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -114.08 -175.75 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.667 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 53' ' ' ALA . 32.9 m -93.47 161.78 14.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -85.23 -153.35 0.17 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.96 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.43 -45.1 10.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 3.4 p-10 172.11 93.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.77 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -107.84 47.65 0.88 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 64.02 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.368 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -151.44 -41.44 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.07 -55.2 5.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.13 0.49 . . . . 0.0 110.28 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.75 HD11 ' CD1' ' A' ' 64' ' ' ILE . 9.3 pt -84.34 -13.72 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.323 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 63.49 77.5 0.22 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 169.76 149.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.32 . . . . 0.0 110.76 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 125.4 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.283 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.75 ' CD1' HD11 ' A' ' 60' ' ' ILE . 7.4 mm -100.72 145.28 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.439 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -143.2 95.78 5.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.245 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 7.3 Cg_endo -49.54 160.41 1.06 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.465 2.11 . . . . 0.0 112.197 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.57 -59.25 0.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.548 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.59 -28.99 15.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.074 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.36 146.84 47.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.104 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -99.52 140.17 34.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.258 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 50' ' ' VAL . 5.8 tp10 -105.74 129.75 53.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.01 0.433 . . . . 0.0 111.461 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.761 HG11 ' HB3' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -131.6 123.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.16 179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.561 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 17.0 m0 -106.43 145.74 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.587 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 4.8 t -127.28 101.96 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.13 -143.49 9.05 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.591 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 40' ' ' GLN . 2.1 tp -138.96 61.48 1.57 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.401 0.62 . . . . 0.0 110.18 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 6.9 m -47.33 174.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.612 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -130.95 -131.51 0.2 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.983 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -77.81 -22.12 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -90.23 0.21 Allowed 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.131 -0.356 . . . . 0.0 111.653 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 77' ' ' VAL . 2.6 p30 -173.51 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.93 104.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 110.328 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.657 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 6.5 ptp -50.14 -26.03 4.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.478 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.73 -20.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -157.32 131.09 8.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.48 135.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.624 ' CE2' HD22 ' A' ' 76' ' ' LEU . 9.1 m-85 -89.44 -35.84 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -157.79 163.38 38.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.301 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.903 ' O ' HG23 ' A' ' 103' ' ' VAL . 1.4 mttt -132.38 147.1 52.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -134.61 135.46 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.799 ' C ' HD13 ' A' ' 92' ' ' ILE . 3.0 mt -120.54 131.13 54.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.082 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.799 HD13 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -132.97 136.59 55.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 t -63.92 128.85 37.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.669 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.458 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 22.3 m-70 -72.85 -25.14 61.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.321 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.69 156.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.67 -61.33 2.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 98' ' ' ASP . 11.4 pt-20 -85.44 151.41 24.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.323 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER 49.8 103.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.814 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.16 126.88 43.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -110.33 141.27 43.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.056 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -135.33 142.04 45.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.207 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.571 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.91 128.08 24.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.383 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 89' ' ' LYS . 5.1 p -115.18 136.45 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.287 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -105.37 119.42 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.934 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.906 ' CE3' HD12 ' A' ' 29' ' ' LEU . 83.9 m95 -101.91 149.37 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.66 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -64.26 150.76 45.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.85 0.357 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.796 HG22 HG22 ' A' ' 3' ' ' THR . 1.1 m -102.78 -50.15 3.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.556 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.796 HG22 HG22 ' A' ' 2' ' ' THR . 10.1 t -167.52 99.67 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.853 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -118.3 75.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.6 mm -117.92 129.01 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.464 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -150.16 16.68 0.84 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.239 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' ' HB3' ' A' ' 94' ' ' HIS . 0.1 OUTLIER -150.99 160.84 43.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.13 153.19 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.485 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.04 149.89 94.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.92 -55.42 3.24 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.571 2.181 . . . . 0.0 112.49 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.23 -31.15 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.207 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -64.5 -61.32 2.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.64 -44.64 81.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.41 -38.78 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.768 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -49.22 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.595 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 HG21 ' NH2' ' A' ' 99' ' ' ARG . 5.2 mm -57.06 -49.66 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.956 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -55.43 -37.48 67.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.132 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.55 -57.38 12.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.801 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.44 -41.91 61.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 17' ' ' ALA . 13.5 mt -60.56 -70.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.737 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 20.3 t80 -39.55 -33.12 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.751 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tp -69.69 -41.99 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.005 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.24 -36.31 10.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -66.94 -57.11 7.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.169 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.662 ' HA ' HD21 ' A' ' 28' ' ' ASN . . . -48.65 112.28 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.45 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.46 -90.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.07 4.53 52.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.569 0.223 . . . . 0.0 111.387 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.662 HD21 ' HA ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -101.8 -21.95 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' A' ' 105' ' ' TRP . 3.2 tt -103.84 143.68 32.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.573 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -49.89 130.72 21.83 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.2 Cg_exo -46.89 -44.36 22.64 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.92 2.414 . . . . 0.0 113.136 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.19 -55.0 36.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.046 0.451 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -55.72 -25.87 42.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 31' ' ' PRO . 52.0 mt -65.38 -54.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.983 0.421 . . . . 0.0 110.204 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.38 -48.93 55.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.644 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.871 HD22 ' NE2' ' A' ' 40' ' ' GLN . 16.1 mt -60.01 -68.23 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.401 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 1.1 t80 -45.04 -32.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.006 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.84 -37.95 33.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.326 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -84.18 -19.27 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.627 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.871 ' NE2' HD22 ' A' ' 36' ' ' LEU . 14.2 pt20 -144.53 115.82 8.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.064 0.459 . . . . 0.0 111.19 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -171.56 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.52 -33.1 74.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.306 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.87 -24.1 16.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.352 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.05 43.4 3.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.724 0.297 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.18 125.6 8.63 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.57 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.18 113.37 0.59 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 74' ' ' VAL . 35.7 t -108.48 117.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.715 0.293 . . . . 0.0 110.576 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -111.69 163.43 14.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.765 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 41.4 t80 -104.33 118.97 37.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.69 HG23 ' CB ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -109.91 177.8 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.095 0.474 . . . . 0.0 111.668 -179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' C ' ' HG3' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -103.91 152.63 21.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 71' ' ' GLU . 21.9 m -67.84 154.77 40.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.588 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.977 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -79.51 -152.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.41 -46.49 9.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' TRP . 8.0 p-10 -161.13 -41.35 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.977 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 3.0 p-90 22.92 114.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -139.72 19.03 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.975 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -96.49 -26.81 15.15 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.96 -68.31 0.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.962 ' CD1' HD11 ' A' ' 64' ' ' ILE . 23.1 pt -63.48 -42.58 96.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.085 0.469 . . . . 0.0 110.431 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 130.89 -63.75 0.62 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.676 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -81.7 -179.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -77.23 168.77 19.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.962 HD11 ' CD1' ' A' ' 60' ' ' ILE . 21.5 mm -135.07 145.23 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.081 0.467 . . . . 0.0 111.63 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-20 -121.52 107.36 36.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 32.8 Cg_endo -64.03 152.41 81.07 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.101 1.867 . . . . 0.0 112.101 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 72.33 -3.95 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.399 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -107.69 -16.62 14.29 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.952 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -137.91 146.93 43.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -93.06 137.78 32.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.578 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.69 ' CB ' HG23 ' A' ' 50' ' ' VAL . 8.2 mm-40 -107.58 130.39 54.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.826 HG11 ' CB ' ' A' ' 17' ' ' ALA . 14.1 p -135.06 106.75 7.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.71 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' HG11 ' A' ' 86' ' ' VAL . 8.2 m0 -89.17 138.92 30.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.099 0.476 . . . . 0.0 111.345 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 47' ' ' VAL . 42.0 t -120.81 112.39 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.475 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 -125.71 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.922 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.6 tp -146.15 61.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.078 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 78' ' ' ASN . 26.7 t -57.13 159.26 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.617 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -108.02 -170.49 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -31.42 72.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.91 0.386 . . . . 0.0 110.808 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -69.29 -11.99 61.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.366 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.41 33.05 0.7 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.801 0.334 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.36 130.55 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.423 ' HB2' HG22 ' A' ' 77' ' ' VAL . 24.5 ttm -102.93 122.68 45.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.846 0.355 . . . . 0.0 110.991 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.64 -19.79 11.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 132.13 43.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG11 ' CZ3' ' A' ' 73' ' ' TRP . 0.7 OUTLIER -103.51 144.42 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 76' ' ' LEU . 1.7 m-85 -107.02 -23.84 12.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -175.77 175.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.435 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.814 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.4 mttp -141.46 139.12 33.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.539 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 1.1 m-85 -126.66 131.39 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.203 0.525 . . . . 0.0 112.24 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -115.21 130.06 56.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.988 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.59 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -131.09 132.54 63.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 p -64.14 130.06 42.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.845 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 93.8 m-70 -77.31 -18.61 57.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.468 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -67.56 168.12 11.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.084 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.71 -69.26 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 98' ' ' ASP . 7.9 mt-10 -61.12 144.34 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.125 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.3 OUTLIER 57.7 115.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.233 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH2' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.81 90.49 3.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.787 0.327 . . . . 0.0 110.274 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -89.65 126.62 35.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 28.4 p90 -146.28 138.39 25.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.715 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -133.94 134.47 42.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.429 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 8.3 p -114.39 146.8 18.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.814 HD13 ' HB2' ' A' ' 89' ' ' LYS . 4.8 mp -111.63 138.58 39.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.233 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.667 ' HE3' HD12 ' A' ' 29' ' ' LEU . 57.2 m95 -122.61 147.4 46.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.111 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.79 144.74 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.883 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 2' ' ' THR . 3.1 t -82.34 59.06 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.184 0.516 . . . . 0.0 110.661 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p 60.73 -171.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.772 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 97.64 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.469 HG22 ' H ' ' A' ' 6' ' ' LYS . 1.1 mt -127.36 165.04 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.743 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -89.61 -179.46 5.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.791 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -135.58 171.24 14.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.42 159.34 27.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.12 157.71 34.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.12 -50.32 7.65 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.551 2.167 . . . . 0.0 112.202 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.9 -30.07 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -68.81 -48.44 63.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.59 87.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.57 -41.27 91.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -52.22 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.53 ' CD1' HD12 ' A' ' 92' ' ' ILE . 1.4 pp -70.76 -39.02 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -61.64 -41.34 97.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.582 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -60.81 -46.27 91.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.229 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.17 -34.44 75.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.233 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 17' ' ' ALA . 58.2 mt -67.13 -46.71 83.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.637 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 21.8 t80 -51.83 -56.75 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 0.0 110.958 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.74 -12.33 60.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.752 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.0 tp10 -93.62 -60.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -76.14 -38.28 56.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -47.34 110.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 111.407 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.64 -92.46 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.872 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -80.33 -2.97 47.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.6 m-80 -95.77 -28.79 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 30' ' ' ASP . 5.8 tt -92.92 157.41 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.425 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.935 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -80.44 149.91 69.47 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 111.69 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.62 -47.85 21.3 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.827 2.352 . . . . 0.0 113.38 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.95 0.97 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 111.899 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.733 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -60.29 -23.15 63.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 29' ' ' LEU . 13.9 mt -70.99 -35.02 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.907 0.384 . . . . 0.0 110.213 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -69.06 -48.35 63.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.806 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.607 HD23 ' NE2' ' A' ' 40' ' ' GLN . 2.0 mt -60.19 -62.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.7 t80 -39.68 -31.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.308 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -74.08 -49.2 25.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.615 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 35' ' ' LEU . 2.4 mm? -82.86 -20.12 36.19 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.607 ' NE2' HD23 ' A' ' 36' ' ' LEU . 3.9 pt20 -136.39 111.23 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 111.754 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -174.66 -49.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.321 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -51.4 7.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 52.71 0.88 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 0.0 111.198 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 122.71 7.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.64 119.92 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.289 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 74' ' ' VAL . 39.1 t -104.76 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.836 0.35 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.86 136.73 36.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.128 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -87.06 133.28 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -129.96 -169.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.689 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -127.92 171.19 12.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.682 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -63.57 154.56 32.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -88.42 -160.91 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.951 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -94.15 33.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.208 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 2.1 m-20 83.73 112.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.728 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.8 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -138.74 33.33 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -59.62 79.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -155.95 -37.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.449 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.85 -47.51 7.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.663 0.268 . . . . 0.0 111.086 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 64' ' ' ILE . 1.7 pt -74.52 -28.98 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.756 0.312 . . . . 0.0 111.015 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.648 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 79.21 69.05 1.43 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.459 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 172.99 140.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.705 0.288 . . . . 0.0 110.682 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -53.56 136.36 38.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.802 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 60' ' ' ILE . 14.1 mm -110.09 131.69 60.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.446 . . . . 0.0 111.649 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 73.8 m-20 -134.82 104.67 10.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.051 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 34.3 Cg_endo -64.67 160.59 39.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.164 1.91 . . . . 0.0 112.441 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER 74.39 -8.3 1.5 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.207 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.2 pt-20 -118.59 -5.42 10.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.177 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.486 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 60.2 m-85 -131.99 147.99 52.49 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.955 0.407 . . . . 0.0 110.825 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.35 128.66 53.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.051 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' HG23 ' A' ' 50' ' ' VAL . 4.8 tp10 -96.65 132.89 41.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.0 111.492 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.638 HG11 ' HB1' ' A' ' 17' ' ' ALA . 1.5 t -131.39 135.23 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.728 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.545 ' CE2' ' HD2' ' A' ' 89' ' ' LYS . 6.0 m0 -118.57 135.72 54.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.048 0.451 . . . . 0.0 111.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 47' ' ' VAL . 36.0 t -126.73 109.54 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.77 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.76 -136.76 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.074 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.661 HD22 ' HE1' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -142.06 59.26 1.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.331 0.586 . . . . 0.0 109.863 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.725 HG12 ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -46.84 141.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.93 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -89.46 -129.38 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.229 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.543 ' C ' ' HG3' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -101.58 -176.75 3.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.299 0.571 . . . . 0.0 109.999 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HG3' ' C ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER 40.62 19.08 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.422 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 79' ' ' GLU . 1.7 t70 73.45 76.65 0.13 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.828 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.725 ' C ' HG12 ' A' ' 77' ' ' VAL . 1.4 mt-10 -152.13 123.99 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.261 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.652 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 21.2 ttm -101.29 -71.98 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.047 0.451 . . . . 0.0 110.688 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -19.24 0.22 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 83' ' ' MET . 2.0 m-20 -139.2 115.26 10.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.645 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.46 149.27 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.514 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.661 ' HE1' HD22 ' A' ' 76' ' ' LEU . 3.6 m-85 -97.1 -36.14 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 104' ' ' ILE . . . -160.59 167.97 25.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.923 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HB2' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -129.87 147.12 51.6 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.2 m-85 -130.83 135.95 48.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' ND1' ' A' ' 102' ' ' HIS . 2.6 mt -128.5 131.91 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.446 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -142.19 129.98 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.164 0.507 . . . . 0.0 112.147 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.68 135.61 46.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.936 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -75.19 -21.02 59.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 174.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.266 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 -57.35 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 123.5 30.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.78 110.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.67 139.5 45.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.24 142.26 42.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.445 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB3' HG23 ' A' ' 92' ' ' ILE . 27.4 p90 -136.09 142.46 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.007 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.565 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -136.92 132.73 34.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.176 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.2 p -122.1 144.4 31.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.728 HD13 ' HB2' ' A' ' 89' ' ' LYS . 1.9 mp -101.25 135.33 38.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.393 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.791 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.7 m95 -117.65 -90.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.73 131.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.84 0.352 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.8 mttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.866 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.794 0.33 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.04 158.8 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.296 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -104.91 -15.33 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.243 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.17 138.4 52.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.44 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mm -64.35 144.03 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -89.81 -172.93 3.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.629 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -141.94 172.9 12.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 0.0 111.362 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -99.6 169.61 9.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.515 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.2 m-20 -104.45 144.59 29.01 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.571 0.224 . . . . 0.0 110.49 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.35 -53.64 6.77 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.494 2.129 . . . . 0.0 112.593 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -53.76 -37.42 63.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.367 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 16' ' ' ILE . 65.2 m -82.28 -35.27 28.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.416 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.613 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -64.96 -32.95 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.93 -59.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.002 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.6 -29.47 1.84 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.204 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 12' ' ' THR . 1.1 pp -78.62 -45.08 25.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.615 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -70.24 -31.82 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.039 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.26 -45.01 96.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.106 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -24.91 63.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.8 mt -75.37 -28.47 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.492 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.729 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.6 t80 -80.36 -41.85 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.85 -3.76 49.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 7.6 pt-20 -116.97 -45.07 2.78 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 ttp -85.9 -45.55 11.42 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -51.99 122.93 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.745 0.307 . . . . 0.0 111.49 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.56 -67.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -7.83 59.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -100.0 -72.56 0.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 30' ' ' ASP . 5.3 tt -63.96 127.62 32.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.263 0.554 . . . . 0.0 110.899 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.832 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -40.24 153.42 0.21 Allowed Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.642 -178.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HA ' HD12 ' A' ' 34' ' ' ILE . 22.9 Cg_exo -64.73 -33.09 55.61 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.717 2.278 . . . . 0.0 112.667 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.38 -55.76 27.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 111.296 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.661 ' CB ' HD21 ' A' ' 29' ' ' LEU . 6.5 m-20 -62.54 -22.82 66.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.436 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 31' ' ' PRO . 97.0 mt -72.75 -47.46 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.51 -45.47 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.335 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.25 -57.44 10.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.288 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -55.77 -34.81 65.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.776 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.66 -44.28 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -77.22 -14.49 59.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.139 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HG2' ' HG ' ' A' ' 39' ' ' LEU . 1.6 mm100 -120.36 -144.97 0.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.224 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 1.2 t80 83.1 -19.38 0.4 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.488 0.315 . . . . 0.0 111.632 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.77 -39.82 17.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.74 -29.92 8.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' CB ' ' HG ' ' A' ' 76' ' ' LEU . 1.5 mmp_? -115.76 27.54 9.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.002 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.71 114.54 4.46 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.402 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.33 146.49 16.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.763 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.809 HG13 ' O ' ' A' ' 73' ' ' TRP . 88.0 t -146.77 118.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.183 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.94 155.37 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.033 0.444 . . . . 0.0 111.522 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CE1' ' HB1' ' A' ' 13' ' ' ALA . 70.4 t80 -101.55 133.94 45.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -142.6 140.68 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.54 -173.17 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.036 0.446 . . . . 0.0 110.737 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 16.0 m -83.81 169.82 14.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.467 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.81 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -97.14 -160.31 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.941 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 3.7 p30 -93.77 30.95 1.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.518 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 1.7 t0 85.57 108.86 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -129.21 69.59 1.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.798 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 17.7 mt-10 -80.76 53.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.316 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 -49.65 2.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -83.21 -53.28 5.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD11 ' CD1' ' A' ' 64' ' ' ILE . 6.3 pt -81.59 -34.99 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.935 0.398 . . . . 0.0 109.954 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 57' ' ' GLU . . . 88.37 -39.72 3.11 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.55 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG11 ' CE1' ' A' ' 102' ' ' HIS . 4.1 p -58.16 154.94 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 111.647 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.53 120.34 16.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.475 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 55' ' ' ASP . 2.3 mm -98.64 160.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.376 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.17 117.92 4.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.399 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 27.2 Cg_endo -62.2 152.46 75.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.308 2.005 . . . . 0.0 112.3 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -65.22 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -24.86 7.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.471 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 2.7 m-85 -110.93 149.28 30.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HB2' ' NE2' ' A' ' 94' ' ' HIS . . . -118.38 123.89 46.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.353 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' HG2' HG23 ' A' ' 50' ' ' VAL . 17.4 tt0 -102.25 144.25 31.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.27 0.557 . . . . 0.0 111.367 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 17' ' ' ALA . 1.8 t -132.74 140.41 47.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.584 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.809 ' O ' HG13 ' A' ' 47' ' ' VAL . 17.6 m0 -114.9 132.48 56.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.0 111.177 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 47' ' ' VAL . 62.1 t -124.98 97.59 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.628 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -126.17 -133.4 3.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.588 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.633 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.4 tp -140.69 83.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 83' ' ' MET . 35.0 m -64.34 178.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.0 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -115.64 -171.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.96 -16.85 64.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.262 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -97.27 26.55 4.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.293 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 39.82 55.4 2.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.904 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.42 104.63 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.844 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.597 ' HB2' HG12 ' A' ' 77' ' ' VAL . 35.8 ttm -69.79 117.56 11.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.407 . . . . 0.0 111.369 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 19.82 17.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.655 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 104.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.814 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 p -89.57 142.43 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.11 0.481 . . . . 0.0 111.524 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HE2' HD13 ' A' ' 76' ' ' LEU . 13.9 m-85 -89.81 -33.74 16.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.691 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -166.53 165.76 16.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.736 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.795 ' O ' HG23 ' A' ' 103' ' ' VAL . 8.9 mttt -132.16 146.23 51.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 3.3 m-85 -126.3 130.21 50.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.458 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.522 HD12 ' ND1' ' A' ' 102' ' ' HIS . 5.2 mt -110.78 135.6 51.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.83 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.404 HG13 HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -139.03 123.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.577 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 156.75 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.758 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.825 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 20.4 m-70 -101.92 23.02 12.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.086 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -87.4 148.15 25.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.0 111.106 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -61.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.73 158.48 15.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 44.72 94.0 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.2 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.98 151.66 27.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.144 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -130.53 140.76 50.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.463 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 24.3 p90 -138.19 142.75 40.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.334 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -137.68 161.98 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.875 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.6 143.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.512 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.12 137.26 43.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.538 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 29' ' ' LEU . 27.2 m95 -117.02 149.83 39.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.26 28.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.877 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -74.9 129.75 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 p -93.51 -14.68 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.776 ' O ' HD13 ' A' ' 5' ' ' ILE . 2.3 mm-40 78.18 21.5 0.86 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.787 0.327 . . . . 0.0 110.996 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 4' ' ' GLU . 10.6 mm -129.77 128.19 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -130.07 161.5 30.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.091 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -98.32 -172.82 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -105.11 143.06 33.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.777 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.18 150.83 14.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.785 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.92 -50.18 10.94 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.164 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -21.98 60.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.205 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.415 HG22 HD22 ' A' ' 8' ' ' LEU . 27.9 m -82.43 -49.15 10.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.409 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -63.22 -36.19 82.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.258 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -72.24 -57.55 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -44.74 -48.42 10.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.736 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -66.72 -45.33 88.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.088 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.67 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.045 0.45 . . . . 0.0 110.265 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.5 -36.43 71.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.922 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.32 -27.24 62.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.822 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.546 HG22 ' HE2' ' A' ' 90' ' ' PHE . 49.3 mt -74.1 -33.16 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.691 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 47.8 t80 -78.25 -23.63 47.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.07 0.462 . . . . 0.0 110.411 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.28 -33.29 37.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.238 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.18 -34.26 11.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.285 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 27.9 mtp -83.08 -50.9 8.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.523 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -55.14 138.76 43.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 111.321 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.79 21.07 5.51 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.639 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -160.11 -42.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HB3' ' CG ' ' A' ' 105' ' ' TRP . 2.5 m120 -76.59 -57.47 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -65.25 175.05 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.793 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.846 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -75.76 153.66 85.19 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-O 120.74 0.305 . . . . 0.0 111.017 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.73 ' HA ' HD12 ' A' ' 34' ' ' ILE . 52.2 Cg_exo -55.85 -58.02 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.907 2.404 . . . . 0.0 113.141 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.04 -46.33 11.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 111.64 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.64 ' CB ' HD22 ' A' ' 29' ' ' LEU . 12.7 m-20 -62.41 -27.69 69.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 31' ' ' PRO . 84.5 mt -68.94 -48.45 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.877 0.37 . . . . 0.0 110.548 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.56 ' HG ' HD23 ' A' ' 39' ' ' LEU . 1.9 tp -57.57 -62.34 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.643 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -44.68 -45.23 9.61 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.195 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -35.79 75.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -68.43 -53.34 24.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.4 mm? -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -83.28 -136.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 72.98 -58.66 0.59 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.687 0.279 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.47 -42.71 98.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.525 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.36 -48.98 7.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -116.85 66.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.734 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.53 134.02 12.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.298 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.02 115.32 1.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.388 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -151.62 68.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -84.98 136.51 33.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' CB ' ' A' ' 13' ' ' ALA . 82.1 t80 -91.02 89.68 7.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 m -89.71 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.97 3.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 51.5 m -90.27 165.17 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.143 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 52' ' ' THR . . . -122.34 164.16 18.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.033 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.9 -31.87 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.82 42.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.826 ' CH2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -66.83 -27.94 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.841 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -60.72 67.35 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.506 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' TRP . 5.7 mt-10 -156.23 -54.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.19 -67.88 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' CG1' ' A' ' 62' ' ' VAL . 45.6 pt -71.46 -34.18 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 94.13 48.95 2.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.676 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.591 HG13 HD11 ' A' ' 64' ' ' ILE . 9.6 p 179.6 132.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' HG3' ' A' ' 57' ' ' GLU . 1.3 mt -65.71 135.3 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.591 HD11 HG13 ' A' ' 62' ' ' VAL . 17.9 mm -121.07 146.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.168 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.62 109.39 5.43 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 24.4 Cg_endo -62.89 153.26 74.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.186 1.924 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 62.73 7.07 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.563 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -128.25 17.27 6.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.405 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 31.1 m-85 -150.65 142.07 23.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.9 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.991 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -89.45 116.5 27.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -110.39 104.99 13.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.58 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.89 135.78 31.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.282 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 10.0 m0 -115.77 89.76 3.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.188 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 47' ' ' VAL . 72.6 t -89.7 99.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.041 0.448 . . . . 0.0 110.972 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.01 -132.55 3.46 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.462 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' A' ' 87' ' ' PHE . 1.2 tp -140.24 108.97 5.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 0.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 82' ' ' GLU . 57.2 t -96.28 148.88 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -92.24 -164.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -26.54 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.299 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.28 -6.87 48.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HA ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 67.07 30.14 7.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.721 0.296 . . . . 0.0 111.332 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.4 mm-40 -105.54 147.47 28.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.56 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -111.83 86.08 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 111.103 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.31 12.76 23.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.59 91.91 1.44 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.879 0.371 . . . . 0.0 110.786 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.721 HG21 ' HG2' ' A' ' 89' ' ' LYS . 2.5 p -89.72 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' A' ' 76' ' ' LEU . 3.2 m-85 -97.4 -49.65 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.36 121.1 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.395 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.721 ' HG2' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -103.37 131.5 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.152 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.546 ' HE2' HG22 ' A' ' 20' ' ' ILE . 2.6 m-85 -111.7 153.26 26.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 0.0 111.775 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.826 HD11 ' CH2' ' A' ' 56' ' ' TRP . 15.3 mt -137.07 109.07 7.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.553 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.504 HG21 ' NH2' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -115.84 136.87 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.749 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -71.98 93.08 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.904 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.991 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 96.6 m-70 -31.92 -49.16 0.17 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.223 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -41.32 143.8 0.4 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.964 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -48.56 46.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.851 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 98' ' ' ASP . 8.3 mt-10 -72.11 145.33 48.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.099 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 97' ' ' GLU . 0.7 OUTLIER 57.57 115.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.287 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 92' ' ' ILE . 13.4 tpt180 -109.66 113.79 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.838 0.351 . . . . 0.0 110.504 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CG ' ' HB2' ' A' ' 93' ' ' SER . 7.8 pt-20 -128.62 103.76 7.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.433 ' HB3' HG22 ' A' ' 92' ' ' ILE . 26.2 p90 -112.07 146.26 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.531 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -144.93 161.38 39.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.443 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 12.8 p -152.74 141.66 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.82 132.69 58.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 29' ' ' LEU . 88.0 m95 -111.59 -81.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.412 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.64 139.97 11.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.871 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mtt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.14 121.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.79 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -98.86 131.03 45.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -59.69 -60.96 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.67 142.65 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 175.56 5.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.96 134.07 52.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.952 HD13 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.1 148.3 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.988 -179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.597 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -47.28 140.22 7.2 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.687 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -58.42 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.448 2.098 . . . . 0.0 112.324 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -31.3 72.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -59.6 -55.23 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.906 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -58.36 -52.79 64.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.024 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -46.42 -38.85 3.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.182 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.04 -46.95 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 13' ' ' ALA . 4.7 mt -60.86 -63.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.902 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -47.05 -38.27 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -55.14 -52.67 62.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.103 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.98 -21.7 66.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.667 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 17' ' ' ALA . 77.9 mt -77.2 -30.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.042 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' CD2' HG11 ' A' ' 74' ' ' VAL . 15.0 t80 -76.68 -28.18 55.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.481 . . . . 0.0 110.136 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.1 tp -78.2 -32.78 50.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.391 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.36 -38.38 10.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.128 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 19.0 mtp -74.09 -51.21 16.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -50.0 145.66 5.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.401 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.13 29.92 9.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.279 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -152.36 -35.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.623 0.249 . . . . 0.0 111.357 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.469 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.8 OUTLIER -121.04 -30.47 4.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.326 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD12 ' HE3' ' A' ' 105' ' ' TRP . 5.2 tt -68.94 141.17 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -58.5 140.27 84.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.584 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -48.53 -54.83 4.75 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.085 2.523 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.82 42.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.21 -28.89 68.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.301 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.591 HG12 HD22 ' A' ' 29' ' ' LEU . 54.3 mt -66.1 -52.29 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -55.69 30.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -49.78 -39.57 38.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 111.417 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -80.88 -36.82 30.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -78.4 -23.8 46.57 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -86.18 -27.77 24.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.622 ' HG3' HD21 ' A' ' 76' ' ' LEU . 12.4 pt20 -150.08 95.6 2.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.814 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 31.8 t80 -130.74 -40.24 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.201 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -68.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.919 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.42 -39.9 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.7 mpt_? -112.59 62.03 0.63 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.855 0.359 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.04 133.65 11.77 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.178 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.13 142.58 9.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.928 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 74' ' ' VAL . 39.5 t -146.04 80.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -76.87 140.46 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.812 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -103.02 88.43 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.326 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.651 HG23 ' CG ' ' A' ' 71' ' ' GLU . 1.8 m -89.52 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.153 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.73 175.5 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.761 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -60.4 154.18 21.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -75.03 -149.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -38.19 14.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 110.195 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 56' ' ' TRP . 4.0 p30 -151.3 -35.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.234 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.622 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 6.3 m95 70.84 2.28 4.11 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.634 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.8 59.59 0.89 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.876 0.369 . . . . 0.0 111.107 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.5 -49.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.799 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . 5.1 mm-40 -75.99 -73.42 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.622 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 48.0 pt -75.13 -34.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.297 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 82.21 79.88 0.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.722 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 168.7 148.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.603 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -70.34 121.24 17.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.69 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.427 HG13 HD11 ' A' ' 60' ' ' ILE . 27.0 mm -124.17 112.43 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.264 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.64 115.2 20.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.76 151.21 82.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.24 1.96 . . . . 0.0 111.921 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 77.71 -29.84 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.138 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.05 6.36 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.391 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -141.85 151.39 42.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 111.434 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' HG13 ' A' ' 92' ' ' ILE . . . -99.28 131.62 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.651 ' CG ' HG23 ' A' ' 50' ' ' VAL . 2.2 tp10 -115.72 110.23 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.582 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.902 HG11 ' HB1' ' A' ' 17' ' ' ALA . 8.8 p -113.73 135.24 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.176 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 18.7 m0 -117.9 136.35 53.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.321 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 47' ' ' VAL . 58.0 t -135.59 108.94 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.295 0.569 . . . . 0.0 111.39 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.57 -115.23 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.622 HD21 ' HG3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -150.04 155.25 39.56 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 82' ' ' GLU . 34.8 m -140.58 -178.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.472 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.54 -173.86 2.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -26.12 65.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.965 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -79.16 -9.63 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.414 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.58 88.78 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.921 0.391 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.828 ' O ' HG12 ' A' ' 77' ' ' VAL . 3.9 mt-10 -144.11 147.05 33.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 tpt -120.82 80.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 -5.51 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 84.95 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 89' ' ' LYS . 1.7 p -89.84 131.73 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.665 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HD22 ' A' ' 76' ' ' LEU . 14.7 m-85 -89.47 -37.06 15.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.589 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.883 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -144.74 162.1 37.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.15 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.653 ' HE2' HD12 ' A' ' 104' ' ' ILE . 3.8 mttm -146.26 130.64 17.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.614 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -120.33 148.69 43.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 56' ' ' TRP . 58.9 mt -129.29 118.16 21.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.385 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.561 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -129.29 147.93 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.317 0.58 . . . . 0.0 112.553 -178.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.86 122.16 26.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.534 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.943 ' CE1' HD12 ' A' ' 8' ' ' LEU . 92.1 m-70 -58.82 -15.37 12.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.827 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.72 -55.81 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.62 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.84 0.06 28.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 112.063 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.89 105.01 2.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.92 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.46 118.64 22.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.971 0.415 . . . . 0.0 111.056 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -104.51 127.45 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 21.6 p90 -118.26 138.9 52.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.848 0.356 . . . . 0.0 111.232 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -147.62 101.6 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.059 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.4 p -99.86 144.68 11.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.026 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.653 HD12 ' HE2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.9 131.1 73.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.974 179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.883 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 26.8 m95 -105.46 153.55 21.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.998 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.42 160.45 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.896 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.592 0.234 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -88.68 26.05 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.487 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 m -92.15 143.63 26.25 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.644 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -138.6 156.06 47.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mt -94.51 157.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.15 115.63 28.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -177.89 5.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.274 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.087 HD21 ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -130.16 148.54 52.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HD22 ' A' ' 8' ' ' LEU . 1.2 m-20 -80.59 134.82 53.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.056 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -46.43 -42.17 22.87 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 112.32 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -27.32 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.649 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -77.33 -37.07 53.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.087 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -65.71 -44.96 84.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.62 -42.63 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.959 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.34 -55.41 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.75 -42.09 94.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.031 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -60.12 -39.42 86.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.953 0.406 . . . . 0.0 110.309 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.65 -47.83 81.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.096 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.92 65.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.667 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.5 mt -62.61 -73.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.441 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 70.0 t80 -42.49 -29.45 0.28 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.381 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.51 HD12 ' HZ ' ' A' ' 37' ' ' PHE . 1.9 tp -64.69 -45.17 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.48 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 24' ' ' MET . 2.1 pt-20 -103.4 -28.57 11.73 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.405 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -72.14 -53.42 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 111.204 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 137.69 41.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.428 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.771 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 162.79 -85.7 0.11 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.894 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -92.6 3.59 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' CD2' ' A' ' 105' ' ' TRP . 0.9 OUTLIER -92.26 -42.64 9.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.263 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.851 HD23 ' N ' ' A' ' 30' ' ' ASP . 3.4 tt -97.27 154.56 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.851 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -49.95 149.91 4.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.838 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.8 Cg_endo -53.64 -25.86 35.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.523 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.03 -60.42 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.64 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.659 ' HB3' HD22 ' A' ' 29' ' ' LEU . 45.1 t0 -58.21 -29.01 65.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.51 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 31' ' ' PRO . 96.5 mt -61.2 -47.97 91.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 110.172 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -68.76 -47.21 66.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.438 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.454 HD23 ' OE1' ' A' ' 40' ' ' GLN . 5.6 mp -60.37 -59.09 5.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.426 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' HZ ' HD12 ' A' ' 22' ' ' LEU . 4.1 t80 -42.12 -30.61 0.3 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.296 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -76.96 -50.71 12.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 35' ' ' LEU . 1.9 mm? -83.35 -63.17 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.618 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.859 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.48 92.83 9.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.178 0.513 . . . . 0.0 111.659 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.2 t80 -163.95 -37.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.395 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.64 -62.54 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -102.62 -15.45 16.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.529 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' O ' HD12 ' A' ' 76' ' ' LEU . 20.6 mmt180 -102.75 -5.38 23.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.651 0.262 . . . . 0.0 111.396 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -91.15 132.71 11.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.17 145.46 13.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.368 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 74' ' ' VAL . 28.9 t -130.99 96.65 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.906 0.384 . . . . 0.0 111.006 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' A' ' 83' ' ' MET . 2.2 pt-20 -84.31 164.48 18.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.962 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.615 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 36.8 t80 -114.28 135.85 53.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.496 HG23 ' CG ' ' A' ' 71' ' ' GLU . 6.4 m -132.21 -174.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.17 166.09 13.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 66' ' ' PRO . 8.0 m -54.69 155.96 3.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.137 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.88 -177.29 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.172 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.03 26.25 10.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -165.77 39.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.853 ' CZ3' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -65.22 -29.8 70.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.276 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 14.2 mt-10 -59.44 -16.63 24.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -92.68 -34.03 14.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 36.5 mt-10 -78.93 -57.66 3.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.853 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 42.0 pt -93.93 -36.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.415 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 60' ' ' ILE . . . 123.61 -72.53 0.41 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m -56.88 173.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.814 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' O ' HD13 ' A' ' 64' ' ' ILE . 4.7 mp -89.82 136.4 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.485 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CG1' HD11 ' A' ' 60' ' ' ILE . 25.9 mm -124.9 116.42 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.755 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -65.36 112.07 7.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG21 ' A' ' 52' ' ' THR . 19.5 Cg_endo -61.42 163.75 16.97 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.407 2.072 . . . . 0.0 112.792 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.7 pt-20 48.81 20.31 0.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.974 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -129.05 -14.44 4.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.584 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HE2' ' HG ' ' A' ' 93' ' ' SER . 64.2 m-85 -123.92 162.7 22.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.836 0.35 . . . . 0.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -109.1 122.15 46.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.607 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.496 ' CG ' HG23 ' A' ' 50' ' ' VAL . 35.0 tt0 -106.03 123.52 48.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.499 HG11 ' HB1' ' A' ' 17' ' ' ALA . 2.5 t -115.99 147.78 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.64 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -124.44 135.92 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 47' ' ' VAL . 49.1 t -128.42 111.01 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.091 0.472 . . . . 0.0 111.14 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.66 -127.22 3.07 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.166 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.859 HD21 ' HG3' ' A' ' 40' ' ' GLN . 1.8 tp -149.18 57.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' ASN . 6.3 p -63.71 158.55 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.702 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.5 m-80 -95.13 -144.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.929 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -93.23 22.88 4.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.662 0.267 . . . . 0.0 111.223 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -114.23 -11.76 12.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.543 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 71.37 28.81 2.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.385 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 77' ' ' VAL . 65.3 mt-10 -114.46 119.35 36.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.71 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.401 ' HE2' ' HG2' ' A' ' 48' ' ' GLU . 10.0 tpp -84.89 98.55 10.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.458 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.83 -23.88 26.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.24 125.61 16.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.41 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -107.08 135.59 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.709 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.3 m-85 -90.11 -38.32 13.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -152.74 175.96 12.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.788 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.637 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.17 140.61 22.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 1.4 m-85 -123.32 147.56 46.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.778 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 34.2 mt -131.47 124.8 30.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.141 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.45 149.39 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.467 ' HG ' ' HE2' ' A' ' 69' ' ' TYR . 17.8 m -69.34 123.29 20.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.953 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.954 ' CE1' HD12 ' A' ' 8' ' ' LEU . 8.3 m-70 -49.91 -48.62 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.634 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -42.87 160.63 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.098 0.475 . . . . 0.0 111.828 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -99.17 -34.63 10.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.112 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 3.3 pt-20 -91.3 126.69 36.46 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.93 106.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -137.8 148.54 45.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.507 . . . . 0.0 111.616 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.58 133.32 56.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.489 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 39.7 p90 -120.67 139.13 53.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -143.79 103.03 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.0 111.058 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.5 p -98.79 141.76 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.918 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.514 HD12 ' CE ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -108.2 135.55 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.151 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.801 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 46.9 m95 -115.52 140.72 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.832 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.23 159.19 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.014 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -110.33 -33.49 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.533 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -131.16 110.33 11.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 179.56 77.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 mt -128.72 127.78 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -106.71 123.73 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.785 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 177.76 6.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 16' ' ' ILE . 3.2 mt -139.38 135.29 33.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.37 164.93 53.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.578 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.65 -59.21 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.219 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 14' ' ' ILE . 9.7 t70 -63.87 -30.27 71.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.426 HG22 ' CD2' ' A' ' 8' ' ' LEU . 13.7 m -73.27 -42.82 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 16' ' ' ILE . . . -60.81 -35.33 76.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 11' ' ' ASP . 23.8 mt -71.35 -57.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.12 -39.84 2.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.263 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 13' ' ' ALA . 7.1 mt -65.86 -57.34 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -56.59 -29.07 61.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.809 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -63.12 -55.45 25.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -55.8 -31.21 62.46 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.752 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 17' ' ' ALA . 78.7 mt -64.02 -74.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.144 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 25' ' ' ALA . 44.8 t80 -39.51 -32.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.415 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 22' ' ' LEU . 2.0 tp -63.77 -43.02 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.789 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -29.26 10.41 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -57.86 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.682 0.277 . . . . 0.0 111.434 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 21' ' ' PHE . . . -50.25 116.52 1.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.395 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.21 -89.94 0.08 OUTLIER Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.92 2.78 32.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 3.4 m-80 -103.04 -59.12 1.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 33' ' ' ASP . 5.1 tt -64.1 135.26 56.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.964 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -43.78 137.49 3.34 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.964 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.75 ' HA ' HD12 ' A' ' 34' ' ' ILE . 6.1 Cg_endo -48.21 -43.06 32.44 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.852 2.368 . . . . 0.0 112.754 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.0 -58.86 5.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.599 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.719 ' CB ' HD21 ' A' ' 29' ' ' LEU . 41.2 m-20 -58.06 -24.68 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 31' ' ' PRO . 92.5 mt -67.99 -50.93 54.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 109.991 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -53.7 -51.13 64.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.756 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -55.16 37.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.141 0.496 . . . . 0.0 110.417 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 2.1 t80 -46.19 -30.08 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.901 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -59.07 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.466 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.432 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.2 mm? -64.18 -21.26 66.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.837 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.619 ' HG3' HD21 ' A' ' 76' ' ' LEU . 4.8 pt20 -148.8 118.61 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.652 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' GLY . 63.4 t80 179.98 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.756 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -48.39 -63.5 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.25 -33.17 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -97.41 33.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -104.58 62.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.552 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.21 116.72 5.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.497 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 72' ' ' VAL . 38.7 t -102.34 107.06 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.77 0.319 . . . . 0.0 110.865 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -86.37 150.62 24.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.415 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 35.0 t80 -103.72 141.73 35.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.091 0.472 . . . . 0.0 111.335 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.709 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.12 152.41 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.921 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -92.9 158.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.702 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 98.2 m -46.88 167.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.064 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 52' ' ' THR . . . -103.07 -169.04 1.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.72 32.59 4.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.23 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.753 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.959 ' CZ2' HD21 ' A' ' 91' ' ' LEU . 4.5 m95 68.14 6.57 5.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.991 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.45 -1.8 19.88 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.71 -44.02 5.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . 60.1 mm-40 -73.3 -56.28 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.439 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.815 HG23 ' CZ3' ' A' ' 56' ' ' TRP . 18.0 pt -103.15 -35.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.675 0.274 . . . . 0.0 111.02 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 -53.02 0.6 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.301 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.78 152.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.238 0.542 . . . . 0.0 111.878 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -62.92 156.49 24.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.721 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 63' ' ' LEU . 34.5 mm -150.35 128.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.85 108.08 4.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.616 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 9.6 Cg_endo -52.9 157.69 7.56 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.288 1.992 . . . . 0.0 112.287 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 66' ' ' PRO . 20.1 mt-10 69.64 -59.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.16 -29.03 1.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.814 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -116.65 152.16 34.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 111.355 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -112.37 133.11 54.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.816 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.709 ' HG3' HG23 ' A' ' 50' ' ' VAL . 8.0 pt-20 -112.53 133.48 54.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG13 ' CG1' ' A' ' 47' ' ' VAL . 2.2 t -121.22 147.45 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.84 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.452 ' CE2' ' HD3' ' A' ' 89' ' ' LYS . 12.2 m0 -120.49 133.57 55.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 0.0 111.226 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 21' ' ' PHE . 45.1 t -126.93 110.59 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.907 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.45 -132.27 3.75 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.264 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.619 HD21 ' HG3' ' A' ' 40' ' ' GLN . 2.3 tp -142.16 64.79 1.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.209 0.528 . . . . 0.0 110.093 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 83' ' ' MET . 22.3 t -49.4 159.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.831 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 77' ' ' VAL . 29.5 m-80 -89.65 -160.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.61 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -70.91 -9.7 58.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.95 -87.76 0.21 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.52 0.2 . . . . 0.0 111.17 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HA ' HG11 ' A' ' 77' ' ' VAL . 1.4 p30 179.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 111.277 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -57.38 129.65 42.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 77' ' ' VAL . 25.3 ttm -107.52 122.71 47.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.037 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.52 -3.18 13.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -137.56 108.23 6.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.863 0.363 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -97.38 138.74 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.858 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.568 ' HE2' HD22 ' A' ' 76' ' ' LEU . 2.5 m-85 -90.0 -46.35 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.681 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.723 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -143.99 173.19 11.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -150.4 136.0 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' HG21 ' A' ' 103' ' ' VAL . 1.4 m-85 -121.17 142.2 50.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.959 HD21 ' CZ2' ' A' ' 56' ' ' TRP . 13.8 mt -119.96 133.43 55.56 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.02 143.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.92 132.32 46.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.65 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -64.0 -32.95 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.22 178.24 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.031 0.443 . . . . 0.0 111.277 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.64 -12.84 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.356 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -133.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 51.52 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 110.665 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -62.09 141.65 58.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.116 0.484 . . . . 0.0 111.905 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -117.46 149.63 40.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.595 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 35.5 p90 -139.16 143.36 38.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.708 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.505 ' ND1' HD12 ' A' ' 91' ' ' LEU . 0.3 OUTLIER -150.04 118.79 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.143 0.497 . . . . 0.0 111.525 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' LYS . 14.7 p -107.24 144.76 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.906 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -111.81 135.9 49.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 88' ' ' ALA . 37.3 m95 -117.07 149.36 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 5.1 ttmt -67.63 153.46 43.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.851 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.825 0.345 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -106.95 25.36 11.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m 60.83 95.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.42 -34.98 5.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.924 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 95' ' ' ARG . 33.5 mm -82.35 134.62 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.245 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -115.04 162.06 17.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.708 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -89.92 178.91 6.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' HG22 ' A' ' 12' ' ' THR . 0.9 OUTLIER -105.71 143.89 33.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.064 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.83 157.82 57.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.738 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.83 -64.49 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.638 2.225 . . . . 0.0 112.248 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.68 -32.83 67.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' CD2' ' A' ' 8' ' ' LEU . 69.4 m -72.58 -36.46 68.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.974 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . . . -65.06 -26.77 68.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.26 -62.12 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.97 -32.49 3.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.793 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 12' ' ' THR . 1.3 pp -76.86 -48.04 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.74 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.59 -35.84 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 110.198 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.59 -43.88 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.939 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -66.1 -27.86 68.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.136 178.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 17' ' ' ALA . 50.3 mt -74.25 -28.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 7.1 t80 -69.01 -45.97 69.19 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -80.02 -2.98 46.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 1.1 mm-40 -95.78 -56.83 2.54 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.3 mtp -92.18 -30.62 15.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.63 122.94 11.71 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.01 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.84 35.97 1.09 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.124 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -163.04 -32.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.44 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 5.2 t30 -116.27 -34.91 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 33' ' ' ASP . 3.0 tt -80.07 124.31 28.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 111.062 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.771 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -34.2 150.12 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.561 -179.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.884 ' HA ' HD12 ' A' ' 34' ' ' ILE . 26.9 Cg_endo -62.77 -34.49 72.83 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.536 2.157 . . . . 0.0 112.667 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.91 -58.15 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.868 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.792 ' HB2' HD21 ' A' ' 29' ' ' LEU . 61.8 m-20 -61.24 -19.43 61.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.274 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 31' ' ' PRO . 83.5 mt -75.23 -51.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.932 0.396 . . . . 0.0 110.388 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 39' ' ' LEU . 1.3 tt -54.27 -51.8 63.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.738 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -52.02 66.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.247 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 4.0 t80 -46.46 -28.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.914 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -77.01 -49.99 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.6 44.02 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.01 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -150.57 -44.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 1.2 t80 -61.02 -12.01 10.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.717 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.59 -46.55 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -119.45 -13.31 9.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.607 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.461 ' O ' HD12 ' A' ' 76' ' ' LEU . 6.0 mtt-85 -118.18 41.66 2.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.142 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.92 108.82 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.52 154.06 24.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.297 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 73' ' ' TRP . 75.9 t -144.07 119.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -101.92 142.99 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.71 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 59.2 t80 -91.67 138.26 31.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.295 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -150.04 142.13 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.599 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.32 -174.78 1.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.872 0.367 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 53' ' ' ALA . 61.7 m -72.33 165.0 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -91.15 -160.78 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 0.6 OUTLIER -95.02 32.19 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.347 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 84.34 121.74 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -146.71 55.36 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.47 -179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -72.0 79.44 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.692 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -153.7 -43.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.772 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.59 -48.07 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.435 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 64' ' ' ILE . 5.1 pt -80.13 -14.46 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.433 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 62' ' ' VAL . . . 54.86 77.4 0.15 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' C ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 174.25 140.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.86 122.92 12.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.534 HD11 HD11 ' A' ' 60' ' ' ILE . 9.2 mm -97.68 144.85 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 43.5 m-20 -146.78 105.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.284 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 31.4 Cg_endo -64.0 155.69 62.98 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 80.29 -14.62 0.82 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.904 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HG3' ' CD2' ' A' ' 69' ' ' TYR . 1.9 pt-20 -115.09 2.17 14.09 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.523 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 54.5 m-85 -138.96 144.73 39.12 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.099 0.476 . . . . 0.0 111.231 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.71 ' HB1' ' HE1' ' A' ' 49' ' ' PHE . . . -110.98 120.21 41.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.918 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HG2' HG23 ' A' ' 50' ' ' VAL . 14.3 tt0 -92.84 130.79 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.241 0.543 . . . . 0.0 111.759 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 17' ' ' ALA . 2.1 t -117.16 141.25 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.516 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.5 m0 -117.62 136.26 53.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 21' ' ' PHE . 59.8 t -125.07 102.03 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.472 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.18 -144.39 8.66 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.079 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 87' ' ' PHE . 2.1 tp -138.64 81.79 1.87 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.276 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 83' ' ' MET . 2.2 m -67.17 170.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.191 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -115.34 -165.11 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.428 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.87 -16.29 58.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.531 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.45 -85.83 0.17 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.154 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.7 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.332 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.618 ' C ' HG12 ' A' ' 77' ' ' VAL . 32.3 mt-10 -147.99 120.3 8.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -71.69 -25.68 62.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.38 6.51 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' MET . 1.5 m-20 178.42 121.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.66 141.61 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.884 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE2' HD22 ' A' ' 76' ' ' LEU . 2.3 m-85 -89.51 -34.89 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.413 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.2 161.99 19.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.62 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.826 ' O ' HG23 ' A' ' 103' ' ' VAL . 3.6 mttt -129.36 148.24 51.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' A' ' 103' ' ' VAL . 2.9 m-85 -128.82 138.61 52.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.036 0.446 . . . . 0.0 111.877 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.444 HD12 ' ND1' ' A' ' 102' ' ' HIS . 3.7 mt -119.66 134.03 55.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.151 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.123 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -74.3 147.87 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -91.72 22.26 4.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HA ' HG23 ' A' ' 5' ' ' ILE . 1.3 mtp180 -96.99 152.97 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.35 -40.57 14.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.47 114.28 28.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.47 100.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.723 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.86 127.25 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.46 156.5 18.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -149.53 144.62 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.03 159.95 40.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.015 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' LYS . 11.9 p -150.34 141.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -106.63 133.36 51.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.752 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.634 ' HE3' HD12 ' A' ' 29' ' ' LEU . 33.9 m95 -115.88 150.17 37.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.93 153.57 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.6 pttm . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.888 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 2' ' ' THR . 3.2 ptm . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.658 0.266 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.624 HG23 ' N ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 58.54 -176.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.624 ' N ' HG23 ' A' ' 2' ' ' THR . 4.8 t -135.13 97.81 3.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.817 0.342 . . . . 0.0 110.83 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.36 -174.3 2.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 6' ' ' LYS . 0.4 OUTLIER -79.49 169.65 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.9 -170.2 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -127.41 139.81 52.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.114 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD22 ' CG2' ' A' ' 12' ' ' THR . 3.7 mt -63.98 150.47 45.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.2 141.89 93.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.308 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' HD12 ' A' ' 14' ' ' ILE . 88.8 Cg_exo -47.12 -48.2 15.26 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.55 2.166 . . . . 0.0 112.725 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.9 -21.86 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.471 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.659 ' CG2' HD22 ' A' ' 8' ' ' LEU . 26.6 m -81.01 -61.17 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.558 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.46 -30.27 64.9 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 10' ' ' PRO . 96.1 mt -76.28 -59.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -42.1 -48.77 4.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.568 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CD1' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -63.62 -40.22 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -65.04 -42.67 94.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.442 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -52.16 -44.85 64.82 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.243 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.92 -30.56 71.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.485 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 17' ' ' ALA . 34.4 mt -73.0 -29.75 29.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.044 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t80 -67.91 -47.8 67.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -71.81 -23.41 61.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -87.17 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.718 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.49 ' CE ' HG11 ' A' ' 103' ' ' VAL . 5.8 mtp -75.1 -46.01 37.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 21' ' ' PHE . . . -42.75 110.83 0.2 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.804 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.52 -114.28 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.392 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.98 -37.66 78.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.309 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.01 -37.13 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' N ' ' A' ' 30' ' ' ASP . 4.6 tt -88.07 151.08 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.913 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -71.13 134.55 85.21 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.097 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.947 ' HA ' HD12 ' A' ' 34' ' ' ILE . 85.3 Cg_exo -46.11 -59.36 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.722 2.281 . . . . 0.0 112.951 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.14 -50.35 20.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.556 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HB3' HD21 ' A' ' 29' ' ' LEU . 47.0 m-20 -60.22 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 31' ' ' PRO . 50.7 mt -66.66 -52.71 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.111 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.731 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -57.34 -51.76 68.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 110.356 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 1.8 tp -52.39 -51.06 61.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 110.556 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' CZ ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -49.04 -42.58 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.9 -57.06 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.731 HD22 ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -89.99 49.11 1.66 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.498 ' HB3' HD21 ' A' ' 76' ' ' LEU . 14.5 mm100 -155.62 -48.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -42.91 -37.47 1.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.545 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -58.06 -45.03 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.22 -61.1 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.061 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.19 63.06 3.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.36 133.88 11.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.72 128.34 4.59 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.413 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -150.17 59.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.49 . . . . 0.0 110.245 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.22 125.61 31.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.381 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 79.3 t80 -83.63 97.65 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.45 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.476 HG23 ' HG2' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -90.34 166.18 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.356 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -98.17 162.08 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.853 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 48.4 m -52.09 163.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' N ' HG22 ' A' ' 52' ' ' THR . . . -137.18 162.34 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.08 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.91 -29.25 18.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.794 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.21 -2.7 22.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.674 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.764 ' CZ2' HD11 ' A' ' 91' ' ' LEU . 1.5 m95 -46.39 -29.59 1.76 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.553 0.216 . . . . 0.0 111.404 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.81 63.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -166.93 -44.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.369 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.97 -70.54 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.104 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.71 -32.12 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.273 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 62' ' ' VAL . . . 77.72 47.75 8.46 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.52 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.93 113.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.498 0.19 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.93 127.16 15.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.57 137.73 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -66.1 109.69 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.795 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.3 Cg_endo -59.33 157.89 28.95 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.326 2.017 . . . . 0.0 112.411 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 66' ' ' PRO . 7.4 pt-20 48.62 20.53 0.33 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.777 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 19.2 mt-10 -137.74 18.82 2.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.713 0.292 . . . . 0.0 110.973 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 68' ' ' GLU . 20.8 m-85 -148.09 145.51 28.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.72 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.001 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . . . -90.11 114.19 26.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' HG2' HG23 ' A' ' 50' ' ' VAL . 27.8 tt0 -110.62 103.4 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.485 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 17' ' ' ALA . 13.3 p -94.5 136.39 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.464 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.601 ' CD1' ' HB3' ' A' ' 89' ' ' LYS . 3.8 m0 -121.25 94.16 4.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 47' ' ' VAL . 96.1 t -97.97 106.33 18.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.135 0.493 . . . . 0.0 111.056 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 86' ' ' VAL . . . -132.2 -137.53 3.99 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.955 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.506 HD22 ' HE2' ' A' ' 87' ' ' PHE . 1.1 mp -139.18 112.67 8.29 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.298 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 81' ' ' ASP . 16.0 m -100.13 179.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.255 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -93.7 -166.2 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.552 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.02 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.404 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -75.13 -72.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.483 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.5 OUTLIER 166.19 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.621 0.248 . . . . 0.0 111.413 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.69 135.88 3.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.671 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.9 tpp -119.56 123.91 45.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.652 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.58 21.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.952 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -160.4 89.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.139 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.854 HG21 ' HG3' ' A' ' 89' ' ' LYS . 7.3 p -89.67 149.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.418 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HE2' HD22 ' A' ' 76' ' ' LEU . 24.6 m-85 -98.69 -43.73 6.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.728 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.765 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -151.53 122.27 7.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.804 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.854 ' HG3' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -113.59 132.89 55.57 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 2.6 m-85 -113.99 155.58 25.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.764 HD11 ' CZ2' ' A' ' 56' ' ' TRP . 39.8 mt -134.66 110.32 9.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.558 HG13 ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.64 134.37 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.589 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.13 97.11 2.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.49 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 1.001 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 98.1 m-70 -37.28 -46.6 0.76 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.948 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.31 138.0 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 111.412 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.93 80.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' ARG . 10.9 pt-20 -67.38 -173.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.25 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 69.62 62.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.458 . . . . 0.0 110.509 -179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.31 150.71 23.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 8.8 p90 -146.83 140.74 25.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.602 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.28 157.42 46.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 14.7 p -151.41 138.66 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -114.91 110.22 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.096 178.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.908 ' CE3' HD12 ' A' ' 29' ' ' LEU . 91.2 m95 -92.42 149.25 21.51 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -176.95 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.933 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 ttp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -105.08 -10.8 16.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.683 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -87.4 -36.75 17.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.35 -53.23 60.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 HG23 ' HG2' ' A' ' 95' ' ' ARG . 2.0 mt -103.41 144.74 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.003 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 147.15 23.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.592 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -176.59 3.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.052 0.453 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 155.43 35.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.37 147.77 53.98 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.49 -54.89 4.4 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.543 2.162 . . . . 0.0 112.392 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.52 -28.93 68.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 16' ' ' ILE . 58.3 m -72.85 -44.95 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.39 89.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.62 -57.88 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.2 -45.98 5.87 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.232 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 12' ' ' THR . 5.6 mt -72.89 -39.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.027 ' HB1' HG11 ' A' ' 72' ' ' VAL . . . -61.15 -49.79 75.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.711 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.88 -43.62 77.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -35.37 77.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 17' ' ' ALA . 49.7 mt -66.24 -45.68 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.691 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 74' ' ' VAL . 7.2 t80 -54.33 -59.67 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.554 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.8 mm? -64.01 -14.5 54.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.159 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.7 -57.75 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.539 ' SD ' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -83.4 -38.49 21.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -54.6 151.11 8.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 0.0 111.516 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.762 ' O ' HD11 ' A' ' 34' ' ' ILE . . . 148.52 -111.9 0.55 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.417 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -74.02 -3.64 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 105' ' ' TRP . 1.3 m120 -98.46 -5.85 31.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.499 0.19 . . . . 0.0 111.213 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.735 HD23 HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -103.59 -25.44 13.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.732 0.301 . . . . 0.0 111.481 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 29' ' ' LEU . 12.6 t70 106.01 137.23 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.754 0.822 . . . . 0.0 111.441 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -43.41 -58.89 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.22 2.613 . . . . 0.0 113.044 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.34 -58.62 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.034 0.445 . . . . 0.0 111.137 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.71 ' C ' HD21 ' A' ' 29' ' ' LEU . 3.6 m-20 -57.32 -28.95 63.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.495 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 ' O ' ' A' ' 26' ' ' GLY . 52.9 mt -71.61 -49.82 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 CA-C-O 121.301 0.572 . . . . 0.0 109.697 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.629 ' HG ' HD23 ' A' ' 39' ' ' LEU . 5.5 tp -45.85 -66.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.299 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.544 HD23 ' CZ ' ' A' ' 87' ' ' PHE . 28.6 tp -53.9 -35.02 61.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.337 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 2.7 t80 -68.42 -32.82 73.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.16 -62.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' HG ' ' A' ' 35' ' ' LEU . 2.1 mm? -52.88 -23.54 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.622 ' O ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.3 115.64 8.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.273 0.558 . . . . 0.0 111.817 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' O ' ' HA3' ' A' ' 45' ' ' GLY . 15.5 t80 -169.79 -53.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.919 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -34.91 72.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -91.14 -46.85 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.262 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -119.55 53.85 1.02 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 111.116 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -119.22 120.4 4.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.727 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.77 137.37 6.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.716 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.31 126.04 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.889 0.376 . . . . 0.0 110.964 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.48 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.997 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 51.2 t80 -87.35 139.53 30.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -133.01 175.91 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.29 148.3 33.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 49.7 m -41.74 160.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.14 0.495 . . . . 0.0 111.574 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -99.67 -161.4 0.87 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.235 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.65 39.84 1.04 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.177 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 2.7 m-20 76.6 117.76 0.06 Allowed 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.096 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.703 ' HZ2' HD21 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -125.88 44.98 2.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.718 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -58.72 70.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' TRP . 0.6 OUTLIER -155.41 -45.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.731 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.72 -68.01 0.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.419 0.628 . . . . 0.0 110.268 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -69.74 -50.88 45.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.389 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 96.14 72.85 1.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.303 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 60' ' ' ILE . 10.6 p 172.49 142.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.667 0.27 . . . . 0.0 110.577 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.99 123.22 7.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.904 0.383 . . . . 0.0 111.347 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.901 HD11 ' CD1' ' A' ' 60' ' ' ILE . 27.6 mm -103.51 132.07 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.837 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.68 111.78 41.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.51 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 28.0 Cg_endo -63.1 152.97 76.82 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.406 2.071 . . . . 0.0 112.902 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 60.77 8.98 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.033 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -119.97 -13.71 8.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.561 0.22 . . . . 0.0 111.517 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.7 136.38 49.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 111.02 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -89.32 117.96 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.782 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.779 ' HG3' HG23 ' A' ' 50' ' ' VAL . 11.0 pt-20 -107.17 138.15 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.089 0.471 . . . . 0.0 111.336 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.027 HG11 ' HB1' ' A' ' 17' ' ' ALA . 10.8 p -134.65 142.46 40.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.056 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -106.17 144.84 32.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 21' ' ' PHE . 48.9 t -128.7 101.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.5 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.37 -138.66 5.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.392 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.643 HD22 ' CE2' ' A' ' 87' ' ' PHE . 1.6 tp -143.59 51.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.329 0.585 . . . . 0.0 109.66 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 83' ' ' MET . 24.8 m -46.9 174.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.267 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -92.2 -161.31 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.667 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.22 -14.53 63.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.747 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.01 -85.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.497 0.189 . . . . 0.0 111.176 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' HG11 ' A' ' 77' ' ' VAL . 3.5 p-10 179.4 -35.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.579 0.228 . . . . 0.0 111.592 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -45.71 137.11 5.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.754 0.311 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.592 ' HA ' HG12 ' A' ' 77' ' ' VAL . 49.7 ttm -119.8 121.15 38.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.17 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -119.26 -3.75 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.093 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -142.12 93.97 2.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -89.91 144.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.169 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.643 ' CE2' HD22 ' A' ' 76' ' ' LEU . 29.0 m-85 -89.66 -34.86 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.357 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -161.66 164.6 29.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.108 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.768 ' O ' HG23 ' A' ' 103' ' ' VAL . 4.9 mttt -126.4 144.82 50.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -125.05 165.94 17.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.703 HD21 ' HZ2' ' A' ' 56' ' ' TRP . 13.2 mt -147.82 123.77 10.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.378 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.58 HG22 ' HD2' ' A' ' 99' ' ' ARG . 2.2 mp -125.68 137.72 56.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 111.749 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 117.47 7.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -59.44 -37.78 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.226 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HG2' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -54.44 -179.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -111.37 -43.11 3.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.203 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 122.48 26.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.318 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 65.89 112.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 92' ' ' ILE . 2.9 tpp85 -114.47 132.13 56.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.905 0.383 . . . . 0.0 111.246 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.16 134.83 50.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 26.6 p90 -140.96 144.24 34.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.097 0.475 . . . . 0.0 111.542 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.563 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.19 156.21 47.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.858 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.5 p -151.52 145.38 16.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -110.28 136.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.214 177.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.671 ' HE3' HD12 ' A' ' 29' ' ' LEU . 45.6 m95 -108.87 -104.13 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.739 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 153.33 6.69 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.235 0.471 . . . . 0.0 110.932 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptp . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.862 0.363 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.537 ' C ' HG23 ' A' ' 3' ' ' THR . 1.1 m -172.9 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.537 HG23 ' C ' ' A' ' 2' ' ' THR . 1.3 p 76.76 -147.28 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.367 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' N ' ' OG1' ' A' ' 3' ' ' THR . 15.1 mm-40 44.37 -168.86 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.934 0.397 . . . . 0.0 111.698 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mt -130.39 156.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.515 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.21 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.154 0.502 . . . . 0.0 110.46 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 132.93 40.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.601 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.46 159.2 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.1 152.73 74.26 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.658 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.69 -60.21 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.203 . . . . 0.0 112.153 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -65.96 -28.25 68.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.2 m -67.15 -54.21 23.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.32 -52.69 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 0.0 110.88 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.6 mt -47.22 -36.5 3.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -67.03 -39.92 87.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.32 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.11 -62.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.779 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 20' ' ' ILE . . . -48.46 -37.26 16.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -57.86 -54.74 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.409 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -31.77 56.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.858 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 17' ' ' ALA . 53.4 mt -62.08 -73.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.462 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CE2' ' CZ ' ' A' ' 41' ' ' PHE . 85.6 t80 -41.13 -30.35 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.817 0.342 . . . . 0.0 111.448 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 22' ' ' LEU . 1.9 tp -64.98 -45.1 87.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.52 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.68 -29.02 11.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -51.48 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.224 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -52.92 105.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.275 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.46 -82.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.703 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.47 1.1 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 6.9 m120 -93.11 -28.53 16.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.845 HD12 ' CE3' ' A' ' 105' ' ' TRP . 3.7 tt -96.26 138.93 33.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.542 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -50.41 150.21 4.85 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.796 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 13.5 Cg_exo -70.21 25.02 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.342 2.694 . . . . 0.0 113.735 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.04 -67.04 1.01 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.239 0.542 . . . . 0.0 109.876 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.825 ' HB2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.69 -21.69 41.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.763 178.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.564 HG13 HD22 ' A' ' 29' ' ' LEU . 39.9 mt -63.33 -41.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -61.77 -47.25 86.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.578 178.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -55.21 -40.61 70.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.254 179.144 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 1.8 t80 -58.32 -32.92 68.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.216 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -50.54 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.204 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 35' ' ' LEU . 3.1 mm? -66.78 -39.13 87.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.27 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.17 -157.75 0.65 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.499 ' CZ ' ' CE2' ' A' ' 21' ' ' PHE . 6.5 t80 83.85 -26.57 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -88.14 -33.2 18.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.482 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -105.86 -28.1 10.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.654 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 39.55 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.753 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 129.0 9.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.39 127.9 2.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.265 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 73' ' ' TRP . 40.0 t -127.02 112.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.4 173.82 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.697 ' CZ ' ' HB1' ' A' ' 70' ' ' ALA . 17.2 t80 -126.79 122.27 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 71' ' ' GLU . 30.3 m -120.8 -165.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -124.03 171.49 9.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 53' ' ' ALA . 57.1 m -60.11 161.63 6.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 52' ' ' THR . . . -113.56 -170.6 1.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 25.82 11.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.055 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -165.68 65.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.661 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.747 ' CH2' HD11 ' A' ' 91' ' ' LEU . 4.6 m95 -95.97 -29.0 14.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.289 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' CD ' HD22 ' A' ' 63' ' ' LEU . 43.0 mt-10 -69.27 64.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.182 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.74 -51.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HG3' ' CZ3' ' A' ' 56' ' ' TRP . 1.4 pm0 -78.27 -66.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.519 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 104' ' ' ILE . 29.2 pt -75.49 -38.97 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.727 0.299 . . . . 0.0 111.429 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 83.28 81.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.601 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER 170.47 148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 122.481 0.312 . . . . 0.0 110.344 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -58.86 126.54 28.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 63' ' ' LEU . 23.7 mm -125.68 94.9 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -70.47 117.5 55.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.6 152.35 74.18 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.113 1.875 . . . . 0.0 111.962 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 69.32 -1.02 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.34 -9.28 12.19 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.693 0.283 . . . . 0.0 111.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -132.75 130.9 40.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.697 ' HB1' ' CZ ' ' A' ' 49' ' ' PHE . . . -89.59 125.88 35.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.227 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.542 ' HA ' HD23 ' A' ' 91' ' ' LEU . 30.9 tt0 -103.78 113.95 27.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.27 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.42 144.11 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.131 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.594 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m0 -118.43 137.59 53.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.37 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 47' ' ' VAL . 51.4 t -122.95 106.29 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.426 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 86' ' ' VAL . . . -118.32 -142.7 7.08 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.62 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.702 HD22 ' CZ ' ' A' ' 87' ' ' PHE . 2.6 tp -145.06 49.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.286 0.565 . . . . 0.0 110.057 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 78' ' ' ASN . 13.2 p -71.15 161.85 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.288 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 77' ' ' VAL . 4.3 p30 -89.75 -140.43 0.14 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -75.01 -49.56 19.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.446 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -52.17 -18.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' HG21 ' A' ' 77' ' ' VAL . 4.2 p-10 50.33 49.29 20.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.088 0.47 . . . . 0.0 111.216 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 77' ' ' VAL . 2.0 mt-10 -95.09 23.81 5.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.469 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' GLU . 1.7 tpt 29.68 95.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' CB ' ' A' ' 85' ' ' ASP . 4.4 t70 -144.15 49.9 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.934 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 164.03 82.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.441 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 5.3 p -88.94 135.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.702 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 5.7 m-85 -89.09 -47.88 7.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.601 0.715 . . . . 0.0 109.239 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' ' CE3' ' A' ' 105' ' ' TRP . . . -146.51 169.91 17.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.965 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.747 ' O ' HG23 ' A' ' 103' ' ' VAL . 0.8 OUTLIER -134.5 147.45 50.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 90' ' ' PHE . 4.0 m-85 -126.28 144.24 50.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.747 HD11 ' CH2' ' A' ' 56' ' ' TRP . 21.1 mt -133.0 127.39 34.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.718 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.61 148.21 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 112.535 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -67.89 129.7 40.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.725 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.511 ' NE2' ' HB2' ' A' ' 70' ' ' ALA . 37.9 m-70 -75.15 -36.18 61.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -54.45 -178.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.566 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 9.6 pt-20 -104.17 -49.74 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.245 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.1 mt-10 -73.53 133.07 43.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER 58.45 113.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -123.13 111.37 16.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -106.85 132.24 53.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' HB3' ' NH2' ' A' ' 99' ' ' ARG . 9.8 p90 -123.33 140.15 53.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 89' ' ' LYS . 12.0 p -150.3 141.26 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.559 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -111.11 135.71 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.845 ' CE3' HD12 ' A' ' 29' ' ' LEU . 84.2 m95 -109.56 148.61 30.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.19 153.93 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.898 179.986 . . . . . . . . 0 0 . 1 stop_ save_